id	sid	tid	token	lemma	pos
bjp-80949	1	1	bangladesh	bangladesh	PROPN
bjp-80949	1	2	journal	journal	PROPN
bjp-80949	1	3	of	of	ADP
bjp-80949	1	4	pharmacology	pharmacology	NOUN
bjp-80949	1	5	research	research	NOUN
bjp-80949	1	6	article	article	NOUN
bjp-80949	1	7	bjp	bjp	NOUN
bjp-80949	1	8	introduction	introduction	NOUN
bjp-80949	1	9	lung	lung	NOUN
bjp-80949	1	10	cancer	cancer	NOUN
bjp-80949	1	11	accounts	account	VERB
bjp-80949	1	12	for	for	ADP
bjp-80949	1	13	12.8	12.8	NUM
bjp-80949	1	14	%	%	NOUN
bjp-80949	1	15	of	of	ADP
bjp-80949	1	16	cancer	cancer	NOUN
bjp-80949	1	17	diagnoses	diagnosis	NOUN
bjp-80949	1	18	and	and	CCONJ
bjp-80949	1	19	17.8	17.8	NUM
bjp-80949	1	20	%	%	NOUN
bjp-80949	1	21	of	of	ADP
bjp-80949	1	22	cancer	cancer	NOUN
bjp-80949	1	23	-	-	PUNCT
bjp-80949	1	24	related	relate	VERB
bjp-80949	1	25	deaths	death	NOUN
bjp-80949	1	26	globally	globally	ADV
bjp-80949	1	27	(	(	PUNCT
bjp-80949	1	28	subak	subak	NOUN
bjp-80949	1	29	et	et	PROPN
bjp-80949	1	30	al	al	PROPN
bjp-80949	1	31	.	.	PROPN
bjp-80949	1	32	,	,	PUNCT
bjp-80949	1	33	2020	2020	NUM
bjp-80949	1	34	)	)	PUNCT
bjp-80949	1	35	.	.	PUNCT
bjp-80949	2	1	lung	lung	NOUN
bjp-80949	2	2	cancer	cancer	NOUN
bjp-80949	2	3	is	be	AUX
bjp-80949	2	4	attributed	attribute	VERB
bjp-80949	2	5	to	to	ADP
bjp-80949	2	6	smoking	smoke	VERB
bjp-80949	2	7	in	in	ADP
bjp-80949	2	8	94	94	NUM
bjp-80949	2	9	%	%	NOUN
bjp-80949	2	10	of	of	ADP
bjp-80949	2	11	cases	case	NOUN
bjp-80949	2	12	,	,	PUNCT
bjp-80949	2	13	while	while	SCONJ
bjp-80949	2	14	the	the	DET
bjp-80949	2	15	remaining	remain	VERB
bjp-80949	2	16	6	6	NUM
bjp-80949	2	17	%	%	NOUN
bjp-80949	2	18	is	be	AUX
bjp-80949	2	19	linked	link	VERB
bjp-80949	2	20	to	to	ADP
bjp-80949	2	21	various	various	ADJ
bjp-80949	2	22	factors	factor	NOUN
bjp-80949	2	23	including	include	VERB
bjp-80949	2	24	age	age	NOUN
bjp-80949	2	25	,	,	PUNCT
bjp-80949	2	26	race	race	NOUN
bjp-80949	2	27	,	,	PUNCT
bjp-80949	2	28	gender	gender	NOUN
bjp-80949	2	29	,	,	PUNCT
bjp-80949	2	30	occupation	occupation	NOUN
bjp-80949	2	31	,	,	PUNCT
bjp-80949	2	32	air	air	NOUN
bjp-80949	2	33	pollution	pollution	NOUN
bjp-80949	2	34	,	,	PUNCT
bjp-80949	2	35	genetics	genetic	NOUN
bjp-80949	2	36	,	,	PUNCT
bjp-80949	2	37	and	and	CCONJ
bjp-80949	2	38	radiation	radiation	NOUN
bjp-80949	2	39	(	(	PUNCT
bjp-80949	2	40	alar	alar	PROPN
bjp-80949	2	41	and	and	CCONJ
bjp-80949	2	42	şahin	şahin	PROPN
bjp-80949	2	43	,	,	PUNCT
bjp-80949	2	44	2012	2012	NUM
bjp-80949	2	45	)	)	PUNCT
bjp-80949	2	46	.	.	PUNCT
bjp-80949	3	1	two	two	NUM
bjp-80949	3	2	major	major	ADJ
bjp-80949	3	3	types	type	NOUN
bjp-80949	3	4	of	of	ADP
bjp-80949	3	5	lung	lung	NOUN
bjp-80949	3	6	cancers	cancer	NOUN
bjp-80949	3	7	are	be	AUX
bjp-80949	3	8	recognized	recognize	VERB
bjp-80949	3	9	:	:	PUNCT
bjp-80949	3	10	small	small	ADJ
bjp-80949	3	11	cell	cell	NOUN
bjp-80949	3	12	(	(	PUNCT
bjp-80949	3	13	sclc	sclc	PROPN
bjp-80949	3	14	)	)	PUNCT
bjp-80949	3	15	and	and	CCONJ
bjp-80949	3	16	non	non	ADJ
bjp-80949	3	17	-	-	ADJ
bjp-80949	3	18	small	small	ADJ
bjp-80949	3	19	cell	cell	NOUN
bjp-80949	3	20	(	(	PUNCT
bjp-80949	3	21	nsclc	nsclc	NOUN
bjp-80949	3	22	)	)	PUNCT
bjp-80949	3	23	.	.	PUNCT
bjp-80949	4	1	while	while	SCONJ
bjp-80949	4	2	some	some	DET
bjp-80949	4	3	standards	standard	NOUN
bjp-80949	4	4	have	have	AUX
bjp-80949	4	5	been	be	AUX
bjp-80949	4	6	established	establish	VERB
bjp-80949	4	7	,	,	PUNCT
bjp-80949	4	8	various	various	ADJ
bjp-80949	4	9	approaches	approach	NOUN
bjp-80949	4	10	and	and	CCONJ
bjp-80949	4	11	treatments	treatment	NOUN
bjp-80949	4	12	are	be	AUX
bjp-80949	4	13	implemented	implement	VERB
bjp-80949	4	14	for	for	ADP
bjp-80949	4	15	each	each	DET
bjp-80949	4	16	type	type	NOUN
bjp-80949	4	17	of	of	ADP
bjp-80949	4	18	cancer	cancer	NOUN
bjp-80949	4	19	.	.	PUNCT
bjp-80949	5	1	as	as	SCONJ
bjp-80949	5	2	modern	modern	ADJ
bjp-80949	5	3	medicine	medicine	NOUN
bjp-80949	5	4	has	have	AUX
bjp-80949	5	5	advanced	advance	VERB
bjp-80949	5	6	,	,	PUNCT
bjp-80949	5	7	cancer	cancer	NOUN
bjp-80949	5	8	patients	patient	NOUN
bjp-80949	5	9	are	be	AUX
bjp-80949	5	10	increasingly	increasingly	ADV
bjp-80949	5	11	seeking	seek	VERB
bjp-80949	5	12	alternative	alternative	ADJ
bjp-80949	5	13	treatment	treatment	NOUN
bjp-80949	5	14	methods	method	NOUN
bjp-80949	5	15	rather	rather	ADV
bjp-80949	5	16	than	than	ADP
bjp-80949	5	17	relying	rely	VERB
bjp-80949	5	18	solely	solely	ADV
bjp-80949	5	19	on	on	ADP
bjp-80949	5	20	chemotherapy	chemotherapy	NOUN
bjp-80949	5	21	,	,	PUNCT
bjp-80949	5	22	radiotherapy	radiotherapy	NOUN
bjp-80949	5	23	,	,	PUNCT
bjp-80949	5	24	and	and	CCONJ
bjp-80949	5	25	surgery	surgery	NOUN
bjp-80949	5	26	(	(	PUNCT
bjp-80949	5	27	baykara	baykara	PROPN
bjp-80949	5	28	,	,	PUNCT
bjp-80949	5	29	2016	2016	NUM
bjp-80949	5	30	)	)	PUNCT
bjp-80949	5	31	.	.	PUNCT
bjp-80949	6	1	despite	despite	SCONJ
bjp-80949	6	2	being	be	AUX
bjp-80949	6	3	treated	treat	VERB
bjp-80949	6	4	with	with	ADP
bjp-80949	6	5	surgical	surgical	ADJ
bjp-80949	6	6	methods	method	NOUN
bjp-80949	6	7	,	,	PUNCT
bjp-80949	6	8	chemotherapy	chemotherapy	NOUN
bjp-80949	6	9	,	,	PUNCT
bjp-80949	6	10	and	and	CCONJ
bjp-80949	6	11	radiotherapy	radiotherapy	NOUN
bjp-80949	6	12	,	,	PUNCT
bjp-80949	6	13	the	the	DET
bjp-80949	6	14	survival	survival	NOUN
bjp-80949	6	15	rate	rate	NOUN
bjp-80949	6	16	for	for	ADP
bjp-80949	6	17	patients	patient	NOUN
bjp-80949	6	18	with	with	ADP
bjp-80949	6	19	this	this	DET
bjp-80949	6	20	type	type	NOUN
bjp-80949	6	21	of	of	ADP
bjp-80949	6	22	cancer	cancer	NOUN
bjp-80949	6	23	remains	remain	VERB
bjp-80949	6	24	quite	quite	ADV
bjp-80949	6	25	low	low	ADJ
bjp-80949	6	26	.	.	PUNCT
bjp-80949	7	1	consequently	consequently	ADV
bjp-80949	7	2	,	,	PUNCT
bjp-80949	7	3	it	it	PRON
bjp-80949	7	4	is	be	AUX
bjp-80949	7	5	essential	essential	ADJ
bjp-80949	7	6	to	to	PART
bjp-80949	7	7	investigate	investigate	VERB
bjp-80949	7	8	the	the	DET
bjp-80949	7	9	genetic	genetic	ADJ
bjp-80949	7	10	development	development	NOUN
bjp-80949	7	11	of	of	ADP
bjp-80949	7	12	lung	lung	NOUN
bjp-80949	7	13	cancer	cancer	NOUN
bjp-80949	7	14	and	and	CCONJ
bjp-80949	7	15	to	to	PART
bjp-80949	7	16	explore	explore	VERB
bjp-80949	7	17	new	new	ADJ
bjp-80949	7	18	treatment	treatment	NOUN
bjp-80949	7	19	methods	method	NOUN
bjp-80949	7	20	(	(	PUNCT
bjp-80949	7	21	zamani	zamani	PROPN
bjp-80949	7	22	and	and	CCONJ
bjp-80949	7	23	zamani	zamani	PROPN
bjp-80949	7	24	,	,	PUNCT
bjp-80949	7	25	2013	2013	NUM
bjp-80949	7	26	)	)	PUNCT
bjp-80949	7	27	.	.	PUNCT
bjp-80949	8	1	a	a	DET
bjp-80949	8	2	new	new	ADJ
bjp-80949	8	3	avenue	avenue	NOUN
bjp-80949	8	4	in	in	ADP
bjp-80949	8	5	lung	lung	NOUN
bjp-80949	8	6	cancer	cancer	NOUN
bjp-80949	8	7	therapy	therapy	NOUN
bjp-80949	8	8	being	be	AUX
bjp-80949	8	9	investigated	investigate	VERB
bjp-80949	8	10	is	be	AUX
bjp-80949	8	11	the	the	DET
bjp-80949	8	12	synergistic	synergistic	ADJ
bjp-80949	8	13	use	use	NOUN
bjp-80949	8	14	of	of	ADP
bjp-80949	8	15	natural	natural	ADJ
bjp-80949	8	16	compounds	compound	NOUN
bjp-80949	8	17	and	and	CCONJ
bjp-80949	8	18	conventional	conventional	ADJ
bjp-80949	8	19	anti	anti	ADJ
bjp-80949	8	20	-	-	ADJ
bjp-80949	8	21	cancer	cancer	ADJ
bjp-80949	8	22	drugs	drug	NOUN
bjp-80949	8	23	.	.	PUNCT
bjp-80949	9	1	one	one	NUM
bjp-80949	9	2	of	of	ADP
bjp-80949	9	3	the	the	DET
bjp-80949	9	4	natural	natural	ADJ
bjp-80949	9	5	compounds	compound	NOUN
bjp-80949	9	6	evaluated	evaluate	VERB
bjp-80949	9	7	for	for	ADP
bjp-80949	9	8	therapeutic	therapeutic	ADJ
bjp-80949	9	9	purposes	purpose	NOUN
bjp-80949	9	10	is	be	AUX
bjp-80949	9	11	carvacrol	carvacrol	NOUN
bjp-80949	9	12	.	.	PUNCT
bjp-80949	10	1	carvacrol	carvacrol	NOUN
bjp-80949	11	1	[	[	PUNCT
bjp-80949	11	2	2	2	NUM
bjp-80949	11	3	-	-	SYM
bjp-80949	11	4	methyl-5-(1methylethyl)-phenol	methyl-5-(1methylethyl)-phenol	NUM
bjp-80949	11	5	]	]	PUNCT
bjp-80949	11	6	is	be	AUX
bjp-80949	11	7	an	an	DET
bjp-80949	11	8	antioxidant	antioxidant	ADJ
bjp-80949	11	9	monoterpene	monoterpene	NOUN
bjp-80949	11	10	phenolic	phenolic	ADJ
bjp-80949	11	11	substance	substance	NOUN
bjp-80949	11	12	detected	detect	VERB
bjp-80949	11	13	in	in	ADP
bjp-80949	11	14	the	the	DET
bjp-80949	11	15	volatile	volatile	ADJ
bjp-80949	11	16	oils	oil	NOUN
bjp-80949	11	17	from	from	ADP
bjp-80949	11	18	aromatic	aromatic	ADJ
bjp-80949	11	19	plants	plant	NOUN
bjp-80949	11	20	such	such	ADJ
bjp-80949	11	21	as	as	ADP
bjp-80949	11	22	thymus	thymus	NOUN
bjp-80949	11	23	,	,	PUNCT
bjp-80949	11	24	peppercorn	peppercorn	ADJ
bjp-80949	11	25	and	and	CCONJ
bjp-80949	11	26	wild	wild	ADJ
bjp-80949	11	27	bergamot	bergamot	NOUN
bjp-80949	11	28	,	,	PUNCT
bjp-80949	11	29	which	which	PRON
bjp-80949	11	30	has	have	VERB
bjp-80949	11	31	a	a	DET
bjp-80949	11	32	curative	curative	ADJ
bjp-80949	11	33	effect	effect	NOUN
bjp-80949	11	34	on	on	ADP
bjp-80949	11	35	various	various	ADJ
bjp-80949	11	36	ailments	ailment	NOUN
bjp-80949	11	37	(	(	PUNCT
bjp-80949	11	38	arkali	arkali	PROPN
bjp-80949	11	39	et	et	PROPN
bjp-80949	11	40	al	al	PROPN
bjp-80949	11	41	.	.	PROPN
bjp-80949	11	42	,	,	PUNCT
bjp-80949	11	43	2021	2021	NUM
bjp-80949	11	44	)	)	PUNCT
bjp-80949	11	45	.	.	PUNCT
bjp-80949	12	1	the	the	DET
bjp-80949	12	2	consumption	consumption	NOUN
bjp-80949	12	3	of	of	ADP
bjp-80949	12	4	carvacrol	carvacrol	NOUN
bjp-80949	12	5	is	be	AUX
bjp-80949	12	6	typically	typically	ADV
bjp-80949	12	7	deemed	deem	VERB
bjp-80949	12	8	to	to	PART
bjp-80949	12	9	be	be	AUX
bjp-80949	12	10	safe	safe	ADJ
bjp-80949	12	11	.	.	PUNCT
bjp-80949	13	1	it	it	PRON
bjp-80949	13	2	is	be	AUX
bjp-80949	13	3	recognized	recognize	VERB
bjp-80949	13	4	by	by	ADP
bjp-80949	13	5	the	the	DET
bjp-80949	13	6	food	food	NOUN
bjp-80949	13	7	and	and	CCONJ
bjp-80949	13	8	drug	drug	PROPN
bjp-80949	13	9	administration	administration	PROPN
bjp-80949	13	10	(	(	PUNCT
bjp-80949	13	11	fda	fda	PROPN
bjp-80949	13	12	)	)	PUNCT
bjp-80949	13	13	as	as	ADV
bjp-80949	13	14	safe	safe	ADJ
bjp-80949	13	15	for	for	ADP
bjp-80949	13	16	use	use	NOUN
bjp-80949	13	17	in	in	ADP
bjp-80949	13	18	food	food	NOUN
bjp-80949	13	19	-	-	PUNCT
bjp-80949	13	20	grade	grade	NOUN
bjp-80949	13	21	substances	substance	NOUN
bjp-80949	13	22	(	(	PUNCT
bjp-80949	13	23	ultee	ultee	NOUN
bjp-80949	13	24	et	et	PROPN
bjp-80949	13	25	al	al	PROPN
bjp-80949	13	26	.	.	PROPN
bjp-80949	13	27	,	,	PUNCT
bjp-80949	13	28	1999	1999	NUM
bjp-80949	13	29	)	)	PUNCT
bjp-80949	13	30	.	.	PUNCT
bjp-80949	14	1	multiple	multiple	ADJ
bjp-80949	14	2	studies	study	NOUN
bjp-80949	14	3	have	have	AUX
bjp-80949	14	4	focused	focus	VERB
bjp-80949	14	5	on	on	ADP
bjp-80949	14	6	the	the	DET
bjp-80949	14	7	antibacterial	antibacterial	ADJ
bjp-80949	14	8	(	(	PUNCT
bjp-80949	14	9	rattanachaikunsopon	rattanachaikunsopon	NOUN
bjp-80949	14	10	and	and	CCONJ
bjp-80949	14	11	phumkhachorn	phumkhachorn	ADJ
bjp-80949	14	12	,	,	PUNCT
bjp-80949	14	13	2010	2010	NUM
bjp-80949	14	14	;	;	PUNCT
bjp-80949	14	15	ravishankar	ravishankar	NOUN
bjp-80949	14	16	et	et	PROPN
bjp-80949	14	17	al	al	PROPN
bjp-80949	14	18	.	.	PROPN
bjp-80949	14	19	,	,	PUNCT
bjp-80949	14	20	2010	2010	NUM
bjp-80949	14	21	;	;	PUNCT
bjp-80949	14	22	rivas	rivas	PROPN
bjp-80949	14	23	et	et	PROPN
bjp-80949	14	24	al	al	PROPN
bjp-80949	14	25	.	.	PROPN
bjp-80949	14	26	,	,	PUNCT
bjp-80949	14	27	2010	2010	NUM
bjp-80949	14	28	)	)	PUNCT
bjp-80949	14	29	,	,	PUNCT
bjp-80949	14	30	antifungal	antifungal	PROPN
bjp-80949	14	31	abstract	abstract	ADJ
bjp-80949	14	32	the	the	DET
bjp-80949	14	33	intention	intention	NOUN
bjp-80949	14	34	of	of	ADP
bjp-80949	14	35	this	this	DET
bjp-80949	14	36	work	work	NOUN
bjp-80949	14	37	was	be	AUX
bjp-80949	14	38	to	to	PART
bjp-80949	14	39	analyze	analyze	VERB
bjp-80949	14	40	that	that	DET
bjp-80949	14	41	carvacrol	carvacrol	NOUN
bjp-80949	14	42	could	could	AUX
bjp-80949	14	43	enhance	enhance	VERB
bjp-80949	14	44	cancer	cancer	NOUN
bjp-80949	14	45	-inhibiting	-inhibiting	NOUN
bjp-80949	14	46	potency	potency	NOUN
bjp-80949	14	47	of	of	ADP
bjp-80949	14	48	cetuximab	cetuximab	NOUN
bjp-80949	14	49	(	(	PUNCT
bjp-80949	14	50	monoclonal	monoclonal	NOUN
bjp-80949	14	51	antibody	antibody	NOUN
bjp-80949	14	52	)	)	PUNCT
bjp-80949	14	53	in	in	ADP
bjp-80949	14	54	lung	lung	NOUN
bjp-80949	14	55	cancer	cancer	NOUN
bjp-80949	14	56	cells	cell	NOUN
bjp-80949	14	57	.	.	PUNCT
bjp-80949	15	1	the	the	DET
bjp-80949	15	2	combination	combination	NOUN
bjp-80949	15	3	of	of	ADP
bjp-80949	15	4	cetuximab	cetuximab	NOUN
bjp-80949	15	5	and	and	CCONJ
bjp-80949	15	6	carvacrol	carvacrol	NOUN
bjp-80949	15	7	was	be	AUX
bjp-80949	15	8	found	find	VERB
bjp-80949	15	9	to	to	PART
bjp-80949	15	10	co	co	VERB
bjp-80949	15	11	-	-	ADJ
bjp-80949	15	12	operatively	operatively	ADV
bjp-80949	15	13	suppress	suppress	ADJ
bjp-80949	15	14	cell	cell	NOUN
bjp-80949	15	15	proliferation	proliferation	NOUN
bjp-80949	15	16	by	by	ADP
bjp-80949	15	17	enhancing	enhance	VERB
bjp-80949	15	18	apoptosis	apoptosis	NOUN
bjp-80949	15	19	and	and	CCONJ
bjp-80949	15	20	inducing	induce	VERB
bjp-80949	15	21	cell	cell	NOUN
bjp-80949	15	22	cycle	cycle	NOUN
bjp-80949	15	23	arrest	arrest	NOUN
bjp-80949	15	24	in	in	ADP
bjp-80949	15	25	a-549	a-549	PROPN
bjp-80949	15	26	and	and	CCONJ
bjp-80949	15	27	h1299	h1299	CCONJ
bjp-80949	15	28	cells	cell	NOUN
bjp-80949	15	29	.	.	PUNCT
bjp-80949	16	1	furthermore	furthermore	ADV
bjp-80949	16	2	,	,	PUNCT
bjp-80949	16	3	the	the	DET
bjp-80949	16	4	combination	combination	NOUN
bjp-80949	16	5	therapy	therapy	NOUN
bjp-80949	16	6	triggered	trigger	VERB
bjp-80949	16	7	cell	cell	NOUN
bjp-80949	16	8	death	death	NOUN
bjp-80949	16	9	by	by	ADP
bjp-80949	16	10	inducing	induce	VERB
bjp-80949	16	11	membrane	membrane	ADJ
bjp-80949	16	12	disruption	disruption	NOUN
bjp-80949	16	13	.	.	PUNCT
bjp-80949	17	1	the	the	DET
bjp-80949	17	2	most	most	ADV
bjp-80949	17	3	effective	effective	ADJ
bjp-80949	17	4	combinations	combination	NOUN
bjp-80949	17	5	were	be	AUX
bjp-80949	17	6	ic₁₀	ic₁₀	PROPN
bjp-80949	17	7	cetuximab	cetuximab	NOUN
bjp-80949	17	8	+	+	CCONJ
bjp-80949	17	9	ic₁₀	ic₁₀	PROPN
bjp-80949	17	10	carvacrol	carvacrol	NOUN
bjp-80949	17	11	for	for	ADP
bjp-80949	17	12	a-549	a-549	PROPN
bjp-80949	17	13	and	and	CCONJ
bjp-80949	17	14	ic₂₀	ic₂₀	PROPN
bjp-80949	17	15	cetuximab	cetuximab	NOUN
bjp-80949	17	16	+	+	CCONJ
bjp-80949	17	17	ic₁₀	ic₁₀	PROPN
bjp-80949	17	18	carvacrol	carvacrol	NOUN
bjp-80949	17	19	for	for	ADP
bjp-80949	17	20	h1299	h1299	PROPN
bjp-80949	17	21	(	(	PUNCT
bjp-80949	17	22	ci	ci	NOUN
bjp-80949	17	23	=	=	NOUN
bjp-80949	17	24	2.0	2.0	NUM
bjp-80949	17	25	)	)	PUNCT
bjp-80949	17	26	.	.	PUNCT
bjp-80949	18	1	ldh	ldh	PROPN
bjp-80949	18	2	activity	activity	NOUN
bjp-80949	18	3	increased	increase	VERB
bjp-80949	18	4	by	by	ADP
bjp-80949	18	5	101	101	NUM
bjp-80949	18	6	%	%	NOUN
bjp-80949	18	7	in	in	ADP
bjp-80949	18	8	a-549	a-549	PROPN
bjp-80949	18	9	and	and	CCONJ
bjp-80949	18	10	239	239	NUM
bjp-80949	18	11	%	%	NOUN
bjp-80949	18	12	in	in	ADP
bjp-80949	18	13	h1299	h1299	PROPN
bjp-80949	18	14	(	(	PUNCT
bjp-80949	18	15	p<0.05	p<0.05	NOUN
bjp-80949	18	16	)	)	PUNCT
bjp-80949	18	17	.	.	PUNCT
bjp-80949	19	1	caspase-3	caspase-3	NUM
bjp-80949	19	2	activity	activity	NOUN
bjp-80949	19	3	rose	rise	VERB
bjp-80949	19	4	by	by	ADP
bjp-80949	19	5	1.6	1.6	NUM
bjp-80949	19	6	-	-	NUM
bjp-80949	19	7	fold	fold	VERB
bjp-80949	19	8	in	in	ADP
bjp-80949	19	9	a549	a549	PROPN
bjp-80949	19	10	and	and	CCONJ
bjp-80949	19	11	1.4	1.4	NUM
bjp-80949	19	12	-	-	NOUN
bjp-80949	19	13	fold	fold	VERB
bjp-80949	19	14	in	in	ADP
bjp-80949	19	15	h1299	h1299	NOUN
bjp-80949	19	16	(	(	PUNCT
bjp-80949	19	17	p<0.05	p<0.05	NOUN
bjp-80949	19	18	)	)	PUNCT
bjp-80949	19	19	.	.	PUNCT
bjp-80949	20	1	the	the	DET
bjp-80949	20	2	combination	combination	NOUN
bjp-80949	20	3	decreased	decrease	VERB
bjp-80949	20	4	pcna	pcna	NOUN
bjp-80949	20	5	,	,	PUNCT
bjp-80949	20	6	topoisomerase	topoisomerase	PROPN
bjp-80949	20	7	ii	ii	NOUN
bjp-80949	20	8	-	-	NOUN
bjp-80949	20	9	alpha	alpha	NOUN
bjp-80949	20	10	,	,	PUNCT
bjp-80949	20	11	and	and	CCONJ
bjp-80949	20	12	cyclins	cyclin	VERB
bjp-80949	20	13	d1	d1	PROPN
bjp-80949	20	14	,	,	PUNCT
bjp-80949	20	15	d2	d2	PROPN
bjp-80949	20	16	,	,	PUNCT
bjp-80949	20	17	e	e	NOUN
bjp-80949	20	18	,	,	PUNCT
bjp-80949	20	19	a	a	PRON
bjp-80949	20	20	,	,	PUNCT
bjp-80949	20	21	and	and	CCONJ
bjp-80949	20	22	b	b	X
bjp-80949	20	23	(	(	PUNCT
bjp-80949	20	24	p<0.05	p<0.05	NOUN
bjp-80949	20	25	)	)	PUNCT
bjp-80949	20	26	.	.	PUNCT
bjp-80949	21	1	overall	overall	ADV
bjp-80949	21	2	,	,	PUNCT
bjp-80949	21	3	the	the	DET
bjp-80949	21	4	combination	combination	NOUN
bjp-80949	21	5	of	of	ADP
bjp-80949	21	6	carvacrol	carvacrol	NOUN
bjp-80949	21	7	and	and	CCONJ
bjp-80949	21	8	cetuximab	cetuximab	NOUN
bjp-80949	21	9	appears	appear	VERB
bjp-80949	21	10	to	to	PART
bjp-80949	21	11	enhance	enhance	VERB
bjp-80949	21	12	anti	anti	ADJ
bjp-80949	21	13	-	-	ADJ
bjp-80949	21	14	cancer	cancer	ADJ
bjp-80949	21	15	efficacy	efficacy	NOUN
bjp-80949	21	16	and	and	CCONJ
bjp-80949	21	17	may	may	AUX
bjp-80949	21	18	significantly	significantly	ADV
bjp-80949	21	19	improve	improve	VERB
bjp-80949	21	20	therapeutic	therapeutic	ADJ
bjp-80949	21	21	outcomes	outcome	NOUN
bjp-80949	21	22	in	in	ADP
bjp-80949	21	23	lung	lung	NOUN
bjp-80949	21	24	cancer	cancer	NOUN
bjp-80949	21	25	cells	cell	NOUN
bjp-80949	21	26	.	.	PUNCT
bjp-80949	22	1	article	article	NOUN
bjp-80949	22	2	info	info	NOUN
bjp-80949	22	3	received	receive	VERB
bjp-80949	22	4	:	:	PUNCT
bjp-80949	22	5	1	1	NUM
bjp-80949	22	6	april	april	PROPN
bjp-80949	22	7	2025	2025	NUM
bjp-80949	22	8	accepted	accept	VERB
bjp-80949	22	9	:	:	PUNCT
bjp-80949	22	10	22	22	NUM
bjp-80949	22	11	april	april	PROPN
bjp-80949	22	12	2025	2025	NUM
bjp-80949	22	13	available	available	ADJ
bjp-80949	22	14	online	online	NOUN
bjp-80949	22	15	:	:	PUNCT
bjp-80949	22	16	25	25	NUM
bjp-80949	22	17	april	april	PROPN
bjp-80949	22	18	2025	2025	NUM
bjp-80949	22	19	doi	doi	NOUN
bjp-80949	22	20	:	:	PUNCT
bjp-80949	22	21	10.3329	10.3329	NUM
bjp-80949	22	22	/	/	SYM
bjp-80949	22	23	bjp.v20i1.80949	bjp.v20i1.80949	PROPN
bjp-80949	22	24	cite	cite	VERB
bjp-80949	22	25	this	this	DET
bjp-80949	22	26	article	article	NOUN
bjp-80949	22	27	:	:	PUNCT
bjp-80949	22	28	erdogan	erdogan	VERB
bjp-80949	22	29	a	a	PRON
bjp-80949	22	30	,	,	PUNCT
bjp-80949	23	1	koras	koras	PROPN
bjp-80949	23	2	ra	ra	PROPN
bjp-80949	23	3	.	.	PROPN
bjp-80949	23	4	carvacrol	carvacrol	PROPN
bjp-80949	23	5	enhances	enhance	VERB
bjp-80949	23	6	the	the	DET
bjp-80949	23	7	sensitıvity	sensitıvity	NOUN
bjp-80949	23	8	of	of	ADP
bjp-80949	23	9	cetuximab	cetuximab	NOUN
bjp-80949	23	10	in	in	ADP
bjp-80949	23	11	lung	lung	NOUN
bjp-80949	23	12	cancer	cancer	NOUN
bjp-80949	23	13	cells	cell	NOUN
bjp-80949	23	14	through	through	ADP
bjp-80949	23	15	inducing	induce	VERB
bjp-80949	23	16	apoptosis	apoptosis	NOUN
bjp-80949	23	17	and	and	CCONJ
bjp-80949	23	18	cell	cell	NOUN
bjp-80949	23	19	cycle	cycle	NOUN
bjp-80949	23	20	arrest	arrest	NOUN
bjp-80949	23	21	.	.	PUNCT
bjp-80949	24	1	bangladesh	bangladesh	PROPN
bjp-80949	24	2	j	j	PROPN
bjp-80949	24	3	pharmacol	pharmacol	PROPN
bjp-80949	24	4	.	.	PUNCT
bjp-80949	25	1	2025	2025	NUM
bjp-80949	25	2	;	;	PUNCT
bjp-80949	25	3	20	20	NUM
bjp-80949	25	4	:	:	SYM
bjp-80949	25	5	2234	2234	NUM
bjp-80949	25	6	.	.	PUNCT
bjp-80949	26	1	carvacrol	carvacrol	NOUN
bjp-80949	26	2	enhances	enhance	VERB
bjp-80949	26	3	the	the	DET
bjp-80949	26	4	sensitıvity	sensitıvity	NOUN
bjp-80949	26	5	of	of	ADP
bjp-80949	26	6	cetuximab	cetuximab	NOUN
bjp-80949	26	7	in	in	ADP
bjp-80949	26	8	lung	lung	NOUN
bjp-80949	26	9	cancer	cancer	NOUN
bjp-80949	26	10	cells	cell	NOUN
bjp-80949	26	11	through	through	ADP
bjp-80949	26	12	inducing	induce	VERB
bjp-80949	26	13	apoptosis	apoptosis	NOUN
bjp-80949	26	14	and	and	CCONJ
bjp-80949	26	15	cell	cell	NOUN
bjp-80949	26	16	cycle	cycle	NOUN
bjp-80949	26	17	arrest	arrest	NOUN
bjp-80949	26	18	ayse	ayse	NOUN
bjp-80949	26	19	erdogan	erdogan	NOUN
bjp-80949	26	20	and	and	CCONJ
bjp-80949	26	21	rahime	rahime	ADJ
bjp-80949	26	22	aybike	aybike	PROPN
bjp-80949	26	23	koras	koras	PROPN
bjp-80949	26	24	department	department	PROPN
bjp-80949	26	25	of	of	ADP
bjp-80949	26	26	genetic	genetic	ADJ
bjp-80949	26	27	and	and	CCONJ
bjp-80949	26	28	bioengineering	bioengineering	NOUN
bjp-80949	26	29	,	,	PUNCT
bjp-80949	26	30	faculty	faculty	NOUN
bjp-80949	26	31	of	of	ADP
bjp-80949	26	32	engineering	engineering	NOUN
bjp-80949	26	33	,	,	PUNCT
bjp-80949	26	34	alanya	alanya	PROPN
bjp-80949	26	35	alaaddin	alaaddin	PROPN
bjp-80949	26	36	keykubat	keykubat	PROPN
bjp-80949	26	37	university	university	PROPN
bjp-80949	26	38	,	,	PUNCT
bjp-80949	26	39	alanya	alanya	PROPN
bjp-80949	26	40	,	,	PUNCT
bjp-80949	26	41	antalya	antalya	PROPN
bjp-80949	26	42	,	,	PUNCT
bjp-80949	26	43	turkey	turkey	PROPN
bjp-80949	26	44	.	.	PUNCT
bjp-80949	27	1	this	this	DET
bjp-80949	27	2	work	work	NOUN
bjp-80949	27	3	is	be	AUX
bjp-80949	27	4	licensed	license	VERB
bjp-80949	27	5	under	under	ADP
bjp-80949	27	6	a	a	DET
bjp-80949	27	7	creative	creative	ADJ
bjp-80949	27	8	commons	common	NOUN
bjp-80949	27	9	attribution	attribution	NOUN
bjp-80949	27	10	4.0	4.0	NUM
bjp-80949	27	11	license	license	NOUN
bjp-80949	27	12	.	.	PUNCT
bjp-80949	28	1	you	you	PRON
bjp-80949	28	2	are	be	AUX
bjp-80949	28	3	free	free	ADJ
bjp-80949	28	4	to	to	PART
bjp-80949	28	5	copy	copy	VERB
bjp-80949	28	6	,	,	PUNCT
bjp-80949	28	7	distribute	distribute	VERB
bjp-80949	28	8	and	and	CCONJ
bjp-80949	28	9	perform	perform	VERB
bjp-80949	28	10	the	the	DET
bjp-80949	28	11	work	work	NOUN
bjp-80949	28	12	.	.	PUNCT
bjp-80949	29	1	you	you	PRON
bjp-80949	29	2	must	must	AUX
bjp-80949	29	3	attribute	attribute	VERB
bjp-80949	29	4	the	the	DET
bjp-80949	29	5	work	work	NOUN
bjp-80949	29	6	in	in	ADP
bjp-80949	29	7	the	the	DET
bjp-80949	29	8	manner	manner	NOUN
bjp-80949	29	9	specified	specify	VERB
bjp-80949	29	10	by	by	ADP
bjp-80949	29	11	the	the	DET
bjp-80949	29	12	author	author	NOUN
bjp-80949	29	13	or	or	CCONJ
bjp-80949	29	14	licensor	licensor	NOUN
bjp-80949	29	15	.	.	PUNCT
bjp-80949	30	1	a	a	DET
bjp-80949	30	2	journal	journal	NOUN
bjp-80949	30	3	of	of	ADP
bjp-80949	30	4	the	the	DET
bjp-80949	30	5	bangladesh	bangladesh	NOUN
bjp-80949	30	6	pharmacological	pharmacological	ADJ
bjp-80949	30	7	society	society	NOUN
bjp-80949	30	8	(	(	PUNCT
bjp-80949	30	9	bdps	bdps	NOUN
bjp-80949	30	10	)	)	PUNCT
bjp-80949	30	11	bangladesh	bangladesh	PROPN
bjp-80949	30	12	j	j	PROPN
bjp-80949	30	13	pharmacol	pharmacol	PROPN
bjp-80949	30	14	2025	2025	NUM
bjp-80949	30	15	;	;	PUNCT
bjp-80949	30	16	20	20	NUM
bjp-80949	30	17	:	:	SYM
bjp-80949	30	18	22	22	NUM
bjp-80949	30	19	-	-	SYM
bjp-80949	30	20	34	34	NUM
bjp-80949	30	21	journal	journal	NOUN
bjp-80949	30	22	homepage	homepage	NOUN
bjp-80949	30	23	:	:	PUNCT
bjp-80949	30	24	www.bdpsjournal.org	www.bdpsjournal.org	NUM
bjp-80949	30	25	;	;	PUNCT
bjp-80949	30	26	www.banglajol.info	www.banglajol.info	PROPN
bjp-80949	30	27	abstracted	abstract	VERB
bjp-80949	30	28	/	/	SYM
bjp-80949	30	29	indexed	index	VERB
bjp-80949	30	30	in	in	ADP
bjp-80949	30	31	academic	academic	ADJ
bjp-80949	30	32	search	search	NOUN
bjp-80949	30	33	complete	complete	ADJ
bjp-80949	30	34	,	,	PUNCT
bjp-80949	30	35	agroforestry	agroforestry	NOUN
bjp-80949	30	36	abstracts	abstract	NOUN
bjp-80949	30	37	,	,	PUNCT
bjp-80949	30	38	asia	asia	PROPN
bjp-80949	30	39	journals	journal	NOUN
bjp-80949	30	40	online	online	ADV
bjp-80949	30	41	,	,	PUNCT
bjp-80949	30	42	bangladesh	bangladesh	NOUN
bjp-80949	30	43	journals	journal	NOUN
bjp-80949	30	44	online	online	ADV
bjp-80949	30	45	,	,	PUNCT
bjp-80949	30	46	biological	biological	ADJ
bjp-80949	30	47	abstracts	abstract	NOUN
bjp-80949	30	48	,	,	PUNCT
bjp-80949	30	49	biosis	biosis	NOUN
bjp-80949	30	50	previews	preview	NOUN
bjp-80949	30	51	,	,	PUNCT
bjp-80949	30	52	cab	cab	NOUN
bjp-80949	30	53	abstracts	abstract	NOUN
bjp-80949	30	54	,	,	PUNCT
bjp-80949	30	55	current	current	ADJ
bjp-80949	30	56	abstracts	abstract	NOUN
bjp-80949	30	57	,	,	PUNCT
bjp-80949	30	58	directory	directory	NOUN
bjp-80949	30	59	of	of	ADP
bjp-80949	30	60	open	open	ADJ
bjp-80949	30	61	access	access	NOUN
bjp-80949	30	62	journals	journal	NOUN
bjp-80949	30	63	,	,	PUNCT
bjp-80949	30	64	embase	embase	NOUN
bjp-80949	30	65	/	/	SYM
bjp-80949	30	66	excerpta	excerpta	NOUN
bjp-80949	30	67	medica	medica	NOUN
bjp-80949	30	68	,	,	PUNCT
bjp-80949	30	69	global	global	ADJ
bjp-80949	30	70	health	health	NOUN
bjp-80949	30	71	,	,	PUNCT
bjp-80949	30	72	google	google	PROPN
bjp-80949	30	73	scholar	scholar	NOUN
bjp-80949	30	74	,	,	PUNCT
bjp-80949	30	75	hinari	hinari	X
bjp-80949	30	76	(	(	PUNCT
bjp-80949	30	77	who	who	PRON
bjp-80949	30	78	)	)	PUNCT
bjp-80949	30	79	,	,	PUNCT
bjp-80949	30	80	international	international	ADJ
bjp-80949	30	81	pharmaceutical	pharmaceutical	ADJ
bjp-80949	30	82	abstracts	abstract	NOUN
bjp-80949	30	83	,	,	PUNCT
bjp-80949	30	84	open	open	ADJ
bjp-80949	30	85	j	j	PROPN
bjp-80949	30	86	-	-	PUNCT
bjp-80949	30	87	gate	gate	NOUN
bjp-80949	30	88	,	,	PUNCT
bjp-80949	30	89	science	science	NOUN
bjp-80949	30	90	citation	citation	NOUN
bjp-80949	30	91	index	index	NOUN
bjp-80949	30	92	expanded	expand	VERB
bjp-80949	30	93	,	,	PUNCT
bjp-80949	30	94	scopus	scopus	NOUN
bjp-80949	30	95	and	and	CCONJ
bjp-80949	30	96	social	social	ADJ
bjp-80949	30	97	sciences	sciences	PROPN
bjp-80949	30	98	citation	citation	NOUN
bjp-80949	30	99	index	index	NOUN
bjp-80949	30	100	issn	issn	PROPN
bjp-80949	30	101	:	:	PUNCT
bjp-80949	30	102	1991	1991	NUM
bjp-80949	30	103	-	-	SYM
bjp-80949	30	104	0088	0088	NUM
bjp-80949	30	105	(	(	PUNCT
bjp-80949	30	106	chami	chami	NOUN
bjp-80949	30	107	et	et	PROPN
bjp-80949	30	108	al	al	PROPN
bjp-80949	30	109	.	.	PROPN
bjp-80949	30	110	,	,	PUNCT
bjp-80949	30	111	2010	2010	NUM
bjp-80949	30	112	)	)	PUNCT
bjp-80949	30	113	,	,	PUNCT
bjp-80949	30	114	antiviral	antiviral	NOUN
bjp-80949	30	115	(	(	PUNCT
bjp-80949	30	116	pilau	pilau	PROPN
bjp-80949	30	117	et	et	PROPN
bjp-80949	30	118	al	al	PROPN
bjp-80949	30	119	.	.	PROPN
bjp-80949	30	120	,	,	PUNCT
bjp-80949	30	121	2011	2011	NUM
bjp-80949	30	122	)	)	PUNCT
bjp-80949	30	123	,	,	PUNCT
bjp-80949	30	124	immunomodulatory	immunomodulatory	PROPN
bjp-80949	30	125	(	(	PUNCT
bjp-80949	30	126	hashemipour	hashemipour	NOUN
bjp-80949	30	127	et	et	PROPN
bjp-80949	30	128	al	al	PROPN
bjp-80949	30	129	.	.	PROPN
bjp-80949	30	130	,	,	PUNCT
bjp-80949	30	131	2013	2013	NUM
bjp-80949	30	132	)	)	PUNCT
bjp-80949	30	133	,	,	PUNCT
bjp-80949	30	134	and	and	CCONJ
bjp-80949	30	135	antioxidant	antioxidant	ADJ
bjp-80949	30	136	properties	property	NOUN
bjp-80949	30	137	(	(	PUNCT
bjp-80949	30	138	alma	alma	NOUN
bjp-80949	30	139	et	et	PROPN
bjp-80949	30	140	al	al	PROPN
bjp-80949	30	141	.	.	PROPN
bjp-80949	30	142	,	,	PUNCT
bjp-80949	30	143	2003	2003	NUM
bjp-80949	30	144	;	;	PUNCT
bjp-80949	30	145	radonic	radonic	ADJ
bjp-80949	30	146	and	and	CCONJ
bjp-80949	30	147	milos	milo	NOUN
bjp-80949	30	148	,	,	PUNCT
bjp-80949	30	149	2003	2003	NUM
bjp-80949	30	150	)	)	PUNCT
bjp-80949	30	151	of	of	ADP
bjp-80949	30	152	carvacrol	carvacrol	PROPN
bjp-80949	30	153	,	,	PUNCT
bjp-80949	30	154	highlighting	highlight	VERB
bjp-80949	30	155	its	its	PRON
bjp-80949	30	156	therapeutic	therapeutic	ADJ
bjp-80949	30	157	benefits	benefit	NOUN
bjp-80949	30	158	for	for	ADP
bjp-80949	30	159	a	a	DET
bjp-80949	30	160	range	range	NOUN
bjp-80949	30	161	of	of	ADP
bjp-80949	30	162	conditions	condition	NOUN
bjp-80949	30	163	(	(	PUNCT
bjp-80949	30	164	arunasree	arunasree	NOUN
bjp-80949	30	165	,	,	PUNCT
bjp-80949	30	166	2010	2010	NUM
bjp-80949	30	167	;	;	PUNCT
bjp-80949	30	168	jayakumar	jayakumar	PROPN
bjp-80949	30	169	et	et	PROPN
bjp-80949	30	170	al	al	PROPN
bjp-80949	30	171	.	.	PROPN
bjp-80949	30	172	,	,	PUNCT
bjp-80949	30	173	2012	2012	NUM
bjp-80949	30	174	;	;	PUNCT
bjp-80949	30	175	melo	melo	PROPN
bjp-80949	30	176	et	et	PROPN
bjp-80949	30	177	al	al	PROPN
bjp-80949	30	178	.	.	PROPN
bjp-80949	30	179	,	,	PUNCT
bjp-80949	30	180	2014	2014	NUM
bjp-80949	30	181	)	)	PUNCT
bjp-80949	30	182	.	.	PUNCT
bjp-80949	31	1	recent	recent	ADJ
bjp-80949	31	2	findings	finding	NOUN
bjp-80949	31	3	show	show	VERB
bjp-80949	31	4	that	that	SCONJ
bjp-80949	31	5	people	people	NOUN
bjp-80949	31	6	who	who	PRON
bjp-80949	31	7	frequently	frequently	ADV
bjp-80949	31	8	consume	consume	VERB
bjp-80949	31	9	fruits	fruit	NOUN
bjp-80949	31	10	and	and	CCONJ
bjp-80949	31	11	vegetables	vegetable	NOUN
bjp-80949	31	12	abundant	abundant	ADJ
bjp-80949	31	13	in	in	ADP
bjp-80949	31	14	antioxidants	antioxidant	NOUN
bjp-80949	31	15	exhibit	exhibit	VERB
bjp-80949	31	16	a	a	DET
bjp-80949	31	17	reduced	reduce	VERB
bjp-80949	31	18	chance	chance	NOUN
bjp-80949	31	19	of	of	ADP
bjp-80949	31	20	developing	develop	VERB
bjp-80949	31	21	ailments	ailment	NOUN
bjp-80949	31	22	like	like	ADP
bjp-80949	31	23	cardiovascular	cardiovascular	ADJ
bjp-80949	31	24	disease	disease	NOUN
bjp-80949	31	25	and	and	CCONJ
bjp-80949	31	26	cancer	cancer	NOUN
bjp-80949	31	27	(	(	PUNCT
bjp-80949	31	28	yaman	yaman	PROPN
bjp-80949	31	29	et	et	PROPN
bjp-80949	31	30	al	al	PROPN
bjp-80949	31	31	.	.	PROPN
bjp-80949	31	32	,	,	PUNCT
bjp-80949	31	33	2018	2018	NUM
bjp-80949	31	34	)	)	PUNCT
bjp-80949	31	35	.	.	PUNCT
bjp-80949	32	1	it	it	PRON
bjp-80949	32	2	is	be	AUX
bjp-80949	32	3	recognized	recognize	VERB
bjp-80949	32	4	that	that	SCONJ
bjp-80949	32	5	polyphenol	polyphenol	NOUN
bjp-80949	32	6	compounds	compound	NOUN
bjp-80949	32	7	,	,	PUNCT
bjp-80949	32	8	particularly	particularly	ADV
bjp-80949	32	9	noted	note	VERB
bjp-80949	32	10	for	for	ADP
bjp-80949	32	11	their	their	PRON
bjp-80949	32	12	strong	strong	ADJ
bjp-80949	32	13	properties	property	NOUN
bjp-80949	32	14	that	that	PRON
bjp-80949	32	15	combat	combat	VERB
bjp-80949	32	16	oxidative	oxidative	ADJ
bjp-80949	32	17	damage	damage	NOUN
bjp-80949	32	18	,	,	PUNCT
bjp-80949	32	19	fulfill	fulfill	VERB
bjp-80949	32	20	a	a	DET
bjp-80949	32	21	pivotal	pivotal	ADJ
bjp-80949	32	22	role	role	NOUN
bjp-80949	32	23	in	in	ADP
bjp-80949	32	24	protecting	protect	VERB
bjp-80949	32	25	individuals	individual	NOUN
bjp-80949	32	26	from	from	ADP
bjp-80949	32	27	diseases	disease	NOUN
bjp-80949	32	28	,	,	PUNCT
bjp-80949	32	29	and	and	CCONJ
bjp-80949	32	30	research	research	NOUN
bjp-80949	32	31	in	in	ADP
bjp-80949	32	32	this	this	DET
bjp-80949	32	33	area	area	NOUN
bjp-80949	32	34	continues	continue	VERB
bjp-80949	32	35	to	to	PART
bjp-80949	32	36	grow	grow	VERB
bjp-80949	32	37	daily	daily	ADV
bjp-80949	32	38	(	(	PUNCT
bjp-80949	32	39	njume	njume	PROPN
bjp-80949	32	40	et	et	PROPN
bjp-80949	32	41	al	al	PROPN
bjp-80949	32	42	.	.	PROPN
bjp-80949	32	43	,	,	PUNCT
bjp-80949	32	44	2009	2009	NUM
bjp-80949	32	45	)	)	PUNCT
bjp-80949	32	46	.	.	PUNCT
bjp-80949	33	1	the	the	DET
bjp-80949	33	2	oxidative	oxidative	ADJ
bjp-80949	33	3	stress	stress	NOUN
bjp-80949	33	4	-	-	PUNCT
bjp-80949	33	5	reducing	reduce	VERB
bjp-80949	33	6	properties	property	NOUN
bjp-80949	33	7	of	of	ADP
bjp-80949	33	8	carvacrol	carvacrol	NOUN
bjp-80949	33	9	have	have	AUX
bjp-80949	33	10	been	be	AUX
bjp-80949	33	11	established	establish	VERB
bjp-80949	33	12	not	not	PART
bjp-80949	33	13	only	only	ADV
bjp-80949	33	14	in	in	ADP
bjp-80949	33	15	a	a	DET
bjp-80949	33	16	laboratory	laboratory	NOUN
bjp-80949	33	17	setting	setting	NOUN
bjp-80949	33	18	but	but	CCONJ
bjp-80949	33	19	also	also	ADV
bjp-80949	33	20	in	in	ADP
bjp-80949	33	21	preclinical	preclinical	ADJ
bjp-80949	33	22	models	model	NOUN
bjp-80949	33	23	of	of	ADP
bjp-80949	33	24	inflammation	inflammation	NOUN
bjp-80949	33	25	of	of	ADP
bjp-80949	33	26	the	the	DET
bjp-80949	33	27	pancreas	pancrea	NOUN
bjp-80949	33	28	,	,	PUNCT
bjp-80949	33	29	liver	liver	NOUN
bjp-80949	33	30	toxicity	toxicity	NOUN
bjp-80949	33	31	,	,	PUNCT
bjp-80949	33	32	and	and	CCONJ
bjp-80949	33	33	hepatocellular	hepatocellular	ADJ
bjp-80949	33	34	carcinoma	carcinoma	NOUN
bjp-80949	33	35	.	.	PUNCT
bjp-80949	34	1	several	several	ADJ
bjp-80949	34	2	laboratory	laboratory	NOUN
bjp-80949	34	3	setting	set	VERB
bjp-80949	34	4	studies	study	NOUN
bjp-80949	34	5	have	have	AUX
bjp-80949	34	6	indicated	indicate	VERB
bjp-80949	34	7	that	that	SCONJ
bjp-80949	34	8	carvacrol	carvacrol	NOUN
bjp-80949	34	9	may	may	AUX
bjp-80949	34	10	possess	possess	VERB
bjp-80949	34	11	strong	strong	ADJ
bjp-80949	34	12	cancer	cancer	NOUN
bjp-80949	34	13	-	-	PUNCT
bjp-80949	34	14	suppressing	suppress	VERB
bjp-80949	34	15	activity	activity	NOUN
bjp-80949	34	16	.	.	PUNCT
bjp-80949	35	1	it	it	PRON
bjp-80949	35	2	can	can	AUX
bjp-80949	35	3	alleviate	alleviate	VERB
bjp-80949	35	4	oxidative	oxidative	ADJ
bjp-80949	35	5	stress	stress	NOUN
bjp-80949	35	6	by	by	ADP
bjp-80949	35	7	boosting	boost	VERB
bjp-80949	35	8	enzymatic	enzymatic	ADJ
bjp-80949	35	9	protection	protection	NOUN
bjp-80949	35	10	against	against	ADP
bjp-80949	35	11	oxidative	oxidative	ADJ
bjp-80949	35	12	stress	stress	NOUN
bjp-80949	35	13	like	like	ADP
bjp-80949	35	14	superoxide	superoxide	NOUN
bjp-80949	35	15	dismutase	dismutase	NOUN
bjp-80949	35	16	,	,	PUNCT
bjp-80949	35	17	catalase	catalase	NOUN
bjp-80949	35	18	,	,	PUNCT
bjp-80949	35	19	and	and	CCONJ
bjp-80949	35	20	glutathione	glutathione	NOUN
bjp-80949	35	21	,	,	PUNCT
bjp-80949	35	22	while	while	SCONJ
bjp-80949	35	23	also	also	ADV
bjp-80949	35	24	neutralizing	neutralize	VERB
bjp-80949	35	25	free	free	ADJ
bjp-80949	35	26	radicals	radical	NOUN
bjp-80949	35	27	such	such	ADJ
bjp-80949	35	28	as	as	ADP
bjp-80949	35	29	superoxide	superoxide	NOUN
bjp-80949	35	30	and	and	CCONJ
bjp-80949	35	31	hydrogen	hydrogen	NOUN
bjp-80949	35	32	peroxide	peroxide	NOUN
bjp-80949	35	33	(	(	PUNCT
bjp-80949	35	34	lee	lee	PROPN
bjp-80949	35	35	et	et	PROPN
bjp-80949	35	36	al	al	PROPN
bjp-80949	35	37	.	.	PROPN
bjp-80949	35	38	,	,	PUNCT
bjp-80949	35	39	2020	2020	NUM
bjp-80949	35	40	)	)	PUNCT
bjp-80949	35	41	.	.	PUNCT
bjp-80949	36	1	it	it	PRON
bjp-80949	36	2	was	be	AUX
bjp-80949	36	3	found	find	VERB
bjp-80949	36	4	that	that	SCONJ
bjp-80949	36	5	the	the	DET
bjp-80949	36	6	testicular	testicular	ADJ
bjp-80949	36	7	cells	cell	NOUN
bjp-80949	36	8	and	and	CCONJ
bjp-80949	36	9	liver	liver	NOUN
bjp-80949	36	10	dna	dna	NOUN
bjp-80949	36	11	of	of	ADP
bjp-80949	36	12	rats	rat	NOUN
bjp-80949	36	13	treated	treat	VERB
bjp-80949	36	14	with	with	ADP
bjp-80949	36	15	carvacrol	carvacrol	NOUN
bjp-80949	36	16	water	water	NOUN
bjp-80949	36	17	were	be	AUX
bjp-80949	36	18	more	more	ADV
bjp-80949	36	19	resistant	resistant	ADJ
bjp-80949	36	20	to	to	ADP
bjp-80949	36	21	hydrogen	hydrogen	NOUN
bjp-80949	36	22	peroxide	peroxide	NOUN
bjp-80949	36	23	oxidation	oxidation	NOUN
bjp-80949	36	24	compared	compare	VERB
bjp-80949	36	25	to	to	ADP
bjp-80949	36	26	the	the	DET
bjp-80949	36	27	control	control	NOUN
bjp-80949	36	28	group	group	NOUN
bjp-80949	36	29	(	(	PUNCT
bjp-80949	36	30	boduroglu	boduroglu	NOUN
bjp-80949	36	31	,	,	PUNCT
bjp-80949	36	32	2022	2022	NUM
bjp-80949	36	33	)	)	PUNCT
bjp-80949	36	34	.	.	PUNCT
bjp-80949	37	1	in	in	ADP
bjp-80949	37	2	a	a	DET
bjp-80949	37	3	trial	trial	NOUN
bjp-80949	37	4	using	use	VERB
bjp-80949	37	5	mda	mda	PROPN
bjp-80949	37	6	-	-	PUNCT
bjp-80949	37	7	mb	mb	PROPN
bjp-80949	37	8	231	231	NUM
bjp-80949	37	9	cell	cell	NOUN
bjp-80949	37	10	line	line	NOUN
bjp-80949	37	11	,	,	PUNCT
bjp-80949	37	12	obtained	obtain	VERB
bjp-80949	37	13	from	from	ADP
bjp-80949	37	14	breast	breast	NOUN
bjp-80949	37	15	carcinoma	carcinoma	NOUN
bjp-80949	37	16	,	,	PUNCT
bjp-80949	37	17	carvacrol	carvacrol	PROPN
bjp-80949	37	18	was	be	AUX
bjp-80949	37	19	found	find	VERB
bjp-80949	37	20	to	to	PART
bjp-80949	37	21	exhibit	exhibit	VERB
bjp-80949	37	22	anti	anti	ADJ
bjp-80949	37	23	-	-	ADJ
bjp-80949	37	24	carcinogenic	carcinogenic	ADJ
bjp-80949	37	25	effects	effect	NOUN
bjp-80949	37	26	(	(	PUNCT
bjp-80949	37	27	arunasree	arunasree	NOUN
bjp-80949	37	28	,	,	PUNCT
bjp-80949	37	29	2010	2010	NUM
bjp-80949	37	30	)	)	PUNCT
bjp-80949	37	31	.	.	PUNCT
bjp-80949	38	1	cetuximab	cetuximab	NOUN
bjp-80949	38	2	(	(	PUNCT
bjp-80949	38	3	imc	imc	PROPN
bjp-80949	38	4	-	-	PUNCT
bjp-80949	38	5	c225	c225	PROPN
bjp-80949	38	6	,	,	PUNCT
bjp-80949	38	7	erbitux	erbitux	PROPN
bjp-80949	38	8	;	;	PUNCT
bjp-80949	38	9	imclone	imclone	PROPN
bjp-80949	38	10	systems	systems	PROPN
bjp-80949	38	11	inc	inc	PROPN
bjp-80949	38	12	.	.	PROPN
bjp-80949	38	13	,	,	PUNCT
bjp-80949	38	14	new	new	PROPN
bjp-80949	38	15	york	york	PROPN
bjp-80949	38	16	)	)	PUNCT
bjp-80949	38	17	is	be	AUX
bjp-80949	38	18	a	a	DET
bjp-80949	38	19	chimeric	chimeric	ADJ
bjp-80949	38	20	human	human	ADJ
bjp-80949	38	21	-	-	PUNCT
bjp-80949	38	22	murine	murine	NOUN
bjp-80949	38	23	igg1	igg1	NOUN
bjp-80949	38	24	monoclonal	monoclonal	NOUN
bjp-80949	38	25	antibody	antibody	NOUN
bjp-80949	38	26	that	that	PRON
bjp-80949	38	27	targets	target	VERB
bjp-80949	38	28	outer	outer	ADJ
bjp-80949	38	29	domain	domain	NOUN
bjp-80949	38	30	of	of	ADP
bjp-80949	38	31	epidermal	epidermal	ADJ
bjp-80949	38	32	growth	growth	NOUN
bjp-80949	38	33	factor	factor	NOUN
bjp-80949	38	34	receptor	receptor	NOUN
bjp-80949	38	35	(	(	PUNCT
bjp-80949	38	36	egfr	egfr	X
bjp-80949	38	37	)	)	PUNCT
bjp-80949	38	38	(	(	PUNCT
bjp-80949	38	39	gill	gill	NOUN
bjp-80949	38	40	et	et	PROPN
bjp-80949	38	41	al	al	PROPN
bjp-80949	38	42	.	.	PROPN
bjp-80949	38	43	,	,	PUNCT
bjp-80949	38	44	1984	1984	NUM
bjp-80949	38	45	)	)	PUNCT
bjp-80949	38	46	.	.	PUNCT
bjp-80949	39	1	cetuximab	cetuximab	NOUN
bjp-80949	39	2	has	have	VERB
bjp-80949	39	3	a	a	DET
bjp-80949	39	4	binding	bind	VERB
bjp-80949	39	5	affinity	affinity	NOUN
bjp-80949	39	6	to	to	PART
bjp-80949	39	7	egfr	egfr	VERB
bjp-80949	39	8	that	that	PRON
bjp-80949	39	9	is	be	AUX
bjp-80949	39	10	ten	ten	NUM
bjp-80949	39	11	times	time	NOUN
bjp-80949	39	12	greater	great	ADJ
bjp-80949	39	13	than	than	ADP
bjp-80949	39	14	that	that	PRON
bjp-80949	39	15	of	of	ADP
bjp-80949	39	16	endogenous	endogenous	ADJ
bjp-80949	39	17	ligands	ligand	NOUN
bjp-80949	39	18	like	like	ADP
bjp-80949	39	19	egf	egf	PROPN
bjp-80949	39	20	and	and	CCONJ
bjp-80949	39	21	transforming	transform	VERB
bjp-80949	39	22	growth	growth	NOUN
bjp-80949	39	23	factor	factor	NOUN
bjp-80949	39	24	-	-	PUNCT
bjp-80949	39	25	α	α	X
bjp-80949	39	26	(	(	PUNCT
bjp-80949	39	27	tgf	tgf	PROPN
bjp-80949	39	28	-	-	PUNCT
bjp-80949	39	29	α	α	NOUN
bjp-80949	39	30	)	)	PUNCT
bjp-80949	39	31	.	.	PUNCT
bjp-80949	40	1	this	this	DET
bjp-80949	40	2	binding	bind	VERB
bjp-80949	40	3	inhibits	inhibit	VERB
bjp-80949	40	4	receptor	receptor	NOUN
bjp-80949	40	5	tyrosine	tyrosine	PROPN
bjp-80949	40	6	kinase	kinase	PROPN
bjp-80949	40	7	activity	activity	NOUN
bjp-80949	40	8	and	and	CCONJ
bjp-80949	40	9	the	the	DET
bjp-80949	40	10	associated	associated	ADJ
bjp-80949	40	11	mapk	mapk	NOUN
bjp-80949	40	12	,	,	PUNCT
bjp-80949	40	13	pi3k	pi3k	PROPN
bjp-80949	40	14	/	/	SYM
bjp-80949	40	15	akt	akt	PROPN
bjp-80949	40	16	,	,	PUNCT
bjp-80949	40	17	and	and	CCONJ
bjp-80949	40	18	jak	jak	PROPN
bjp-80949	40	19	/	/	SYM
bjp-80949	40	20	stat	stat	PROPN
bjp-80949	40	21	pathways	pathway	NOUN
bjp-80949	40	22	(	(	PUNCT
bjp-80949	40	23	herbst	herbst	PROPN
bjp-80949	40	24	and	and	CCONJ
bjp-80949	40	25	shin	shin	NOUN
bjp-80949	40	26	,	,	PUNCT
bjp-80949	40	27	2002	2002	NUM
bjp-80949	40	28	)	)	PUNCT
bjp-80949	40	29	.	.	PUNCT
bjp-80949	41	1	when	when	SCONJ
bjp-80949	41	2	it	it	PRON
bjp-80949	41	3	binds	bind	VERB
bjp-80949	41	4	to	to	PART
bjp-80949	41	5	egfr	egfr	VERB
bjp-80949	41	6	,	,	PUNCT
bjp-80949	41	7	various	various	ADJ
bjp-80949	41	8	pro	pro	ADJ
bjp-80949	41	9	-	-	ADJ
bjp-80949	41	10	apoptotic	apoptotic	ADJ
bjp-80949	41	11	pathways	pathway	NOUN
bjp-80949	41	12	are	be	AUX
bjp-80949	41	13	activated	activate	VERB
bjp-80949	41	14	within	within	ADP
bjp-80949	41	15	the	the	DET
bjp-80949	41	16	cell	cell	NOUN
bjp-80949	41	17	(	(	PUNCT
bjp-80949	41	18	cheng	cheng	PROPN
bjp-80949	41	19	et	et	PROPN
bjp-80949	41	20	al	al	PROPN
bjp-80949	41	21	.	.	PROPN
bjp-80949	41	22	,	,	PUNCT
bjp-80949	41	23	2013	2013	NUM
bjp-80949	41	24	)	)	PUNCT
bjp-80949	41	25	.	.	PUNCT
bjp-80949	42	1	laboratory	laboratory	NOUN
bjp-80949	42	2	studies	study	NOUN
bjp-80949	42	3	have	have	AUX
bjp-80949	42	4	illustrated	illustrate	VERB
bjp-80949	42	5	that	that	DET
bjp-80949	42	6	cetuximab	cetuximab	NOUN
bjp-80949	42	7	exhibits	exhibit	VERB
bjp-80949	42	8	cytotoxic	cytotoxic	ADJ
bjp-80949	42	9	and	and	CCONJ
bjp-80949	42	10	antiproliferative	antiproliferative	ADJ
bjp-80949	42	11	effects	effect	NOUN
bjp-80949	42	12	.	.	PUNCT
bjp-80949	43	1	moreover	moreover	ADV
bjp-80949	43	2	,	,	PUNCT
bjp-80949	43	3	cetuximab	cetuximab	NOUN
bjp-80949	43	4	has	have	AUX
bjp-80949	43	5	been	be	AUX
bjp-80949	43	6	evidenced	evidence	VERB
bjp-80949	43	7	to	to	PART
bjp-80949	43	8	suppress	suppress	VERB
bjp-80949	43	9	tumor	tumor	NOUN
bjp-80949	43	10	progression	progression	NOUN
bjp-80949	43	11	in	in	ADP
bjp-80949	43	12	engrafted	engraft	VERB
bjp-80949	43	13	tumor	tumor	NOUN
bjp-80949	43	14	models	model	NOUN
bjp-80949	43	15	(	(	PUNCT
bjp-80949	43	16	wu	wu	PROPN
bjp-80949	43	17	et	et	PROPN
bjp-80949	43	18	al	al	PROPN
bjp-80949	43	19	.	.	PROPN
bjp-80949	43	20	,	,	PUNCT
bjp-80949	43	21	1995	1995	NUM
bjp-80949	43	22	;	;	PUNCT
bjp-80949	43	23	baselga	baselga	NUM
bjp-80949	43	24	,	,	PUNCT
bjp-80949	43	25	2001	2001	NUM
bjp-80949	43	26	;	;	PUNCT
bjp-80949	43	27	overholser	overholser	NOUN
bjp-80949	43	28	et	et	PROPN
bjp-80949	43	29	al	al	PROPN
bjp-80949	43	30	.	.	PROPN
bjp-80949	43	31	,	,	PUNCT
bjp-80949	43	32	2000	2000	NUM
bjp-80949	43	33	)	)	PUNCT
bjp-80949	43	34	.	.	PUNCT
bjp-80949	44	1	furthermore	furthermore	ADV
bjp-80949	44	2	,	,	PUNCT
bjp-80949	44	3	studies	study	NOUN
bjp-80949	44	4	in	in	ADP
bjp-80949	44	5	mice	mouse	NOUN
bjp-80949	44	6	have	have	AUX
bjp-80949	44	7	indicated	indicate	VERB
bjp-80949	44	8	that	that	SCONJ
bjp-80949	44	9	cetuximab	cetuximab	NOUN
bjp-80949	44	10	can	can	AUX
bjp-80949	44	11	improve	improve	VERB
bjp-80949	44	12	the	the	DET
bjp-80949	44	13	tumorsuppressing	tumorsuppressing	NOUN
bjp-80949	44	14	effects	effect	NOUN
bjp-80949	44	15	of	of	ADP
bjp-80949	44	16	various	various	ADJ
bjp-80949	44	17	chemotherapeutic	chemotherapeutic	ADJ
bjp-80949	44	18	agents	agent	NOUN
bjp-80949	44	19	and	and	CCONJ
bjp-80949	44	20	radiotherapy	radiotherapy	NOUN
bjp-80949	44	21	(	(	PUNCT
bjp-80949	44	22	buchsbaum	buchsbaum	NOUN
bjp-80949	44	23	et	et	PROPN
bjp-80949	44	24	al	al	PROPN
bjp-80949	44	25	.	.	PROPN
bjp-80949	44	26	,	,	PUNCT
bjp-80949	44	27	2002	2002	NUM
bjp-80949	44	28	;	;	PUNCT
bjp-80949	44	29	bruns	brun	NOUN
bjp-80949	44	30	et	et	PROPN
bjp-80949	44	31	al	al	PROPN
bjp-80949	44	32	.	.	PROPN
bjp-80949	44	33	,	,	PUNCT
bjp-80949	44	34	2000	2000	NUM
bjp-80949	44	35	)	)	PUNCT
bjp-80949	44	36	.	.	PUNCT
bjp-80949	45	1	they	they	PRON
bjp-80949	45	2	reported	report	VERB
bjp-80949	45	3	that	that	SCONJ
bjp-80949	45	4	combination	combination	NOUN
bjp-80949	45	5	therapy	therapy	NOUN
bjp-80949	45	6	with	with	ADP
bjp-80949	45	7	5fluorouracil	5fluorouracil	NUM
bjp-80949	45	8	led	lead	VERB
bjp-80949	45	9	to	to	ADP
bjp-80949	45	10	greater	great	ADJ
bjp-80949	45	11	regression	regression	NOUN
bjp-80949	45	12	of	of	ADP
bjp-80949	45	13	tumor	tumor	NOUN
bjp-80949	45	14	growth	growth	NOUN
bjp-80949	45	15	in	in	ADP
bjp-80949	45	16	vivo	vivo	NOUN
bjp-80949	45	17	(	(	PUNCT
bjp-80949	45	18	overholser	overholser	NOUN
bjp-80949	45	19	et	et	PROPN
bjp-80949	45	20	al	al	PROPN
bjp-80949	45	21	.	.	PROPN
bjp-80949	45	22	,	,	PUNCT
bjp-80949	45	23	2000	2000	NUM
bjp-80949	45	24	)	)	PUNCT
bjp-80949	45	25	.	.	PUNCT
bjp-80949	46	1	following	follow	VERB
bjp-80949	46	2	the	the	DET
bjp-80949	46	3	completion	completion	NOUN
bjp-80949	46	4	of	of	ADP
bjp-80949	46	5	chemotherapy	chemotherapy	NOUN
bjp-80949	46	6	,	,	PUNCT
bjp-80949	46	7	cetuximab	cetuximab	PROPN
bjp-80949	46	8	administration	administration	NOUN
bjp-80949	46	9	is	be	AUX
bjp-80949	46	10	typically	typically	ADV
bjp-80949	46	11	continued	continue	VERB
bjp-80949	46	12	until	until	ADP
bjp-80949	46	13	disease	disease	NOUN
bjp-80949	46	14	progression	progression	NOUN
bjp-80949	46	15	or	or	CCONJ
bjp-80949	46	16	unacceptable	unacceptable	ADJ
bjp-80949	46	17	toxicity	toxicity	NOUN
bjp-80949	46	18	occurs	occur	VERB
bjp-80949	46	19	.	.	PUNCT
bjp-80949	47	1	as	as	ADP
bjp-80949	47	2	with	with	ADP
bjp-80949	47	3	other	other	ADJ
bjp-80949	47	4	egfrtargeted	egfrtargeted	ADJ
bjp-80949	47	5	therapies	therapy	NOUN
bjp-80949	47	6	,	,	PUNCT
bjp-80949	47	7	the	the	DET
bjp-80949	47	8	primary	primary	ADJ
bjp-80949	47	9	adverse	adverse	ADJ
bjp-80949	47	10	effects	effect	NOUN
bjp-80949	47	11	include	include	VERB
bjp-80949	47	12	acne	acne	NOUN
bjp-80949	47	13	-	-	PUNCT
bjp-80949	47	14	like	like	ADJ
bjp-80949	47	15	skin	skin	NOUN
bjp-80949	47	16	rash	rash	NOUN
bjp-80949	47	17	and	and	CCONJ
bjp-80949	47	18	diarrhea	diarrhea	NOUN
bjp-80949	47	19	.	.	PUNCT
bjp-80949	48	1	recently	recently	ADV
bjp-80949	48	2	,	,	PUNCT
bjp-80949	48	3	numerous	numerous	ADJ
bjp-80949	48	4	researchers	researcher	NOUN
bjp-80949	48	5	have	have	AUX
bjp-80949	48	6	revealed	reveal	VERB
bjp-80949	48	7	outcomes	outcome	NOUN
bjp-80949	48	8	in	in	ADP
bjp-80949	48	9	both	both	DET
bjp-80949	48	10	laboratory	laboratory	NOUN
bjp-80949	48	11	conditions	condition	NOUN
bjp-80949	48	12	and	and	CCONJ
bjp-80949	48	13	living	living	NOUN
bjp-80949	48	14	organisms	organism	NOUN
bjp-80949	48	15	cancer	cancer	NOUN
bjp-80949	48	16	scientific	scientific	ADJ
bjp-80949	48	17	inquiries	inquiry	NOUN
bjp-80949	48	18	that	that	SCONJ
bjp-80949	48	19	combining	combine	VERB
bjp-80949	48	20	chemotherapeutic	chemotherapeutic	ADJ
bjp-80949	48	21	agents	agent	NOUN
bjp-80949	48	22	with	with	ADP
bjp-80949	48	23	herbal	herbal	ADJ
bjp-80949	48	24	compounds	compound	NOUN
bjp-80949	48	25	can	can	AUX
bjp-80949	48	26	yield	yield	VERB
bjp-80949	48	27	additive	additive	ADJ
bjp-80949	48	28	or	or	CCONJ
bjp-80949	48	29	synergistic	synergistic	ADJ
bjp-80949	48	30	anti	anti	ADJ
bjp-80949	48	31	-cancer	-cancer	NOUN
bjp-80949	48	32	effects	effect	NOUN
bjp-80949	48	33	.	.	PUNCT
bjp-80949	49	1	given	give	VERB
bjp-80949	49	2	the	the	DET
bjp-80949	49	3	harmlessness	harmlessness	NOUN
bjp-80949	49	4	and	and	CCONJ
bjp-80949	49	5	tumorsuppressing	tumorsuppresse	VERB
bjp-80949	49	6	properties	property	NOUN
bjp-80949	49	7	of	of	ADP
bjp-80949	49	8	botanical	botanical	ADJ
bjp-80949	49	9	ingredients	ingredient	NOUN
bjp-80949	49	10	like	like	ADP
bjp-80949	49	11	carvacrol	carvacrol	NOUN
bjp-80949	49	12	,	,	PUNCT
bjp-80949	49	13	such	such	ADJ
bjp-80949	49	14	phenolic	phenolic	ADJ
bjp-80949	49	15	monoterpene	monoterpene	NOUN
bjp-80949	49	16	agent	agent	NOUN
bjp-80949	49	17	may	may	AUX
bjp-80949	49	18	offer	offer	VERB
bjp-80949	49	19	a	a	DET
bjp-80949	49	20	harmless	harmless	ADJ
bjp-80949	49	21	and	and	CCONJ
bjp-80949	49	22	low	low	ADJ
bjp-80949	49	23	-	-	PUNCT
bjp-80949	49	24	cost	cost	NOUN
bjp-80949	49	25	therapeutic	therapeutic	ADJ
bjp-80949	49	26	approach	approach	NOUN
bjp-80949	49	27	for	for	ADP
bjp-80949	49	28	lung	lung	NOUN
bjp-80949	49	29	cancer	cancer	NOUN
bjp-80949	49	30	patients	patient	NOUN
bjp-80949	49	31	by	by	ADP
bjp-80949	49	32	mitigating	mitigate	VERB
bjp-80949	49	33	the	the	DET
bjp-80949	49	34	adverse	adverse	ADJ
bjp-80949	49	35	effects	effect	NOUN
bjp-80949	49	36	of	of	ADP
bjp-80949	49	37	chemotherapeutics	chemotherapeutic	NOUN
bjp-80949	49	38	such	such	ADJ
bjp-80949	49	39	as	as	ADP
bjp-80949	49	40	cetuximab	cetuximab	NOUN
bjp-80949	49	41	.	.	PUNCT
bjp-80949	50	1	the	the	DET
bjp-80949	50	2	intention	intention	NOUN
bjp-80949	50	3	of	of	ADP
bjp-80949	50	4	this	this	DET
bjp-80949	50	5	study	study	NOUN
bjp-80949	50	6	was	be	AUX
bjp-80949	50	7	to	to	PART
bjp-80949	50	8	investigate	investigate	VERB
bjp-80949	50	9	the	the	DET
bjp-80949	50	10	celldestructive	celldestructive	NOUN
bjp-80949	50	11	,	,	PUNCT
bjp-80949	50	12	membrane	membrane	NOUN
bjp-80949	50	13	-	-	PUNCT
bjp-80949	50	14	impairing	impair	VERB
bjp-80949	50	15	,	,	PUNCT
bjp-80949	50	16	antioxidant	antioxidant	ADJ
bjp-80949	50	17	,	,	PUNCT
bjp-80949	50	18	apoptotic	apoptotic	ADJ
bjp-80949	50	19	repercussions	repercussion	NOUN
bjp-80949	50	20	and	and	CCONJ
bjp-80949	50	21	mechanisms	mechanism	NOUN
bjp-80949	50	22	of	of	ADP
bjp-80949	50	23	intervention	intervention	NOUN
bjp-80949	50	24	of	of	ADP
bjp-80949	50	25	cetuximab	cetuximab	NOUN
bjp-80949	50	26	and	and	CCONJ
bjp-80949	50	27	carvacrol	carvacrol	NOUN
bjp-80949	50	28	on	on	ADP
bjp-80949	50	29	lung	lung	NOUN
bjp-80949	50	30	transformed	transform	VERB
bjp-80949	50	31	cells	cell	NOUN
bjp-80949	50	32	(	(	PUNCT
bjp-80949	50	33	a-549	a-549	PROPN
bjp-80949	50	34	and	and	CCONJ
bjp-80949	50	35	h1299	h1299	NUM
bjp-80949	50	36	)	)	PUNCT
bjp-80949	50	37	in	in	ADP
bjp-80949	50	38	vitro	vitro	VERB
bjp-80949	50	39	.	.	PUNCT
bjp-80949	51	1	as	as	ADP
bjp-80949	51	2	a	a	DET
bjp-80949	51	3	result	result	NOUN
bjp-80949	51	4	of	of	ADP
bjp-80949	51	5	this	this	DET
bjp-80949	51	6	study	study	NOUN
bjp-80949	51	7	,	,	PUNCT
bjp-80949	51	8	the	the	DET
bjp-80949	51	9	aim	aim	NOUN
bjp-80949	51	10	was	be	AUX
bjp-80949	51	11	to	to	PART
bjp-80949	51	12	propose	propose	VERB
bjp-80949	51	13	a	a	DET
bjp-80949	51	14	new	new	ADJ
bjp-80949	51	15	alternative	alternative	ADJ
bjp-80949	51	16	treatment	treatment	NOUN
bjp-80949	51	17	strategy	strategy	NOUN
bjp-80949	51	18	for	for	ADP
bjp-80949	51	19	cancer	cancer	NOUN
bjp-80949	51	20	patients	patient	NOUN
bjp-80949	51	21	by	by	ADP
bjp-80949	51	22	suggesting	suggest	VERB
bjp-80949	51	23	that	that	SCONJ
bjp-80949	51	24	lower	low	ADJ
bjp-80949	51	25	doses	dose	NOUN
bjp-80949	51	26	of	of	ADP
bjp-80949	51	27	cetuximab	cetuximab	NOUN
bjp-80949	51	28	could	could	AUX
bjp-80949	51	29	be	be	AUX
bjp-80949	51	30	used	use	VERB
bjp-80949	51	31	for	for	ADP
bjp-80949	51	32	those	those	PRON
bjp-80949	51	33	experiencing	experience	VERB
bjp-80949	51	34	adverse	adverse	ADJ
bjp-80949	51	35	effects	effect	NOUN
bjp-80949	51	36	from	from	ADP
bjp-80949	51	37	the	the	DET
bjp-80949	51	38	drug	drug	NOUN
bjp-80949	51	39	.	.	PUNCT
bjp-80949	52	1	materials	material	NOUN
bjp-80949	52	2	and	and	CCONJ
bjp-80949	52	3	methods	method	NOUN
bjp-80949	52	4	chemical	chemical	NOUN
bjp-80949	52	5	agents	agent	NOUN
bjp-80949	52	6	and	and	CCONJ
bjp-80949	52	7	pharmaceutical	pharmaceutical	NOUN
bjp-80949	52	8	cetuximab	cetuximab	NOUN
bjp-80949	52	9	(	(	PUNCT
bjp-80949	52	10	referred	refer	VERB
bjp-80949	52	11	to	to	ADP
bjp-80949	52	12	by	by	ADP
bjp-80949	52	13	several	several	ADJ
bjp-80949	52	14	names	name	NOUN
bjp-80949	52	15	,	,	PUNCT
bjp-80949	52	16	including	include	VERB
bjp-80949	52	17	c225	c225	PROPN
bjp-80949	52	18	-	-	SYM
bjp-80949	52	19	03	03	NUM
bjp-80949	52	20	,	,	PUNCT
bjp-80949	52	21	imc	imc	PROPN
bjp-80949	52	22	-	-	PUNCT
bjp-80949	52	23	c225	c225	PROPN
bjp-80949	52	24	,	,	PUNCT
bjp-80949	52	25	c225	c225	PROPN
bjp-80949	52	26	,	,	PUNCT
bjp-80949	52	27	and	and	CCONJ
bjp-80949	52	28	ch225	ch225	PROPN
bjp-80949	52	29	)	)	PUNCT
bjp-80949	52	30	was	be	AUX
bjp-80949	52	31	supplied	supply	VERB
bjp-80949	52	32	by	by	ADP
bjp-80949	52	33	merck	merck	PROPN
bjp-80949	52	34	serono	serono	PROPN
bjp-80949	52	35	(	(	PUNCT
bjp-80949	52	36	usa	usa	PROPN
bjp-80949	52	37	)	)	PUNCT
bjp-80949	52	38	.	.	PUNCT
bjp-80949	53	1	drugs	drug	NOUN
bjp-80949	53	2	were	be	AUX
bjp-80949	53	3	immediately	immediately	ADV
bjp-80949	53	4	diluted	dilute	VERB
bjp-80949	53	5	before	before	ADP
bjp-80949	53	6	being	be	AUX
bjp-80949	53	7	added	add	VERB
bjp-80949	53	8	to	to	ADP
bjp-80949	53	9	the	the	DET
bjp-80949	53	10	growth	growth	NOUN
bjp-80949	53	11	substrate	substrate	NOUN
bjp-80949	53	12	.	.	PUNCT
bjp-80949	54	1	carvacrol	carvacrol	NOUN
bjp-80949	54	2	was	be	AUX
bjp-80949	54	3	supplied	supply	VERB
bjp-80949	54	4	by	by	ADP
bjp-80949	54	5	sigma	sigma	PROPN
bjp-80949	54	6	chemical	chemical	PROPN
bjp-80949	54	7	co.	co.	PROPN
bjp-80949	54	8	(	(	PUNCT
bjp-80949	54	9	282197	282197	NUM
bjp-80949	54	10	,	,	PUNCT
bjp-80949	54	11	spain	spain	PROPN
bjp-80949	54	12	)	)	PUNCT
bjp-80949	54	13	and	and	CCONJ
bjp-80949	54	14	had	have	VERB
bjp-80949	54	15	98	98	NUM
bjp-80949	54	16	%	%	NOUN
bjp-80949	54	17	purity	purity	NOUN
bjp-80949	54	18	.	.	PUNCT
bjp-80949	55	1	colorimetric	colorimetric	ADJ
bjp-80949	55	2	caspase-3	caspase-3	NUM
bjp-80949	55	3	activity	activity	NOUN
bjp-80949	55	4	assay	assay	NOUN
bjp-80949	55	5	kit	kit	NOUN
bjp-80949	55	6	was	be	AUX
bjp-80949	55	7	kindly	kindly	ADV
bjp-80949	55	8	provided	provide	VERB
bjp-80949	55	9	by	by	ADP
bjp-80949	55	10	elabscience	elabscience	NOUN
bjp-80949	55	11	biotechnology	biotechnology	PROPN
bjp-80949	55	12	co.	co.	PROPN
bjp-80949	55	13	,	,	PUNCT
bjp-80949	55	14	ltd	ltd	PROPN
bjp-80949	55	15	(	(	PUNCT
bjp-80949	55	16	usa	usa	PROPN
bjp-80949	55	17	)	)	PUNCT
bjp-80949	55	18	.	.	PUNCT
bjp-80949	56	1	activity	activity	NOUN
bjp-80949	56	2	of	of	ADP
bjp-80949	56	3	lactate	lactate	NOUN
bjp-80949	56	4	dehydrogenase	dehydrogenase	NOUN
bjp-80949	56	5	evaluation	evaluation	NOUN
bjp-80949	56	6	kit	kit	NOUN
bjp-80949	56	7	(	(	PUNCT
bjp-80949	56	8	mak066	mak066	PROPN
bjp-80949	56	9	)	)	PUNCT
bjp-80949	56	10	was	be	AUX
bjp-80949	56	11	supplied	supply	VERB
bjp-80949	56	12	by	by	ADP
bjp-80949	56	13	sigma	sigma	PROPN
bjp-80949	56	14	-	-	PUNCT
bjp-80949	56	15	aldrich	aldrich	PROPN
bjp-80949	56	16	(	(	PUNCT
bjp-80949	56	17	usa	usa	PROPN
bjp-80949	56	18	)	)	PUNCT
bjp-80949	56	19	.	.	PUNCT
bjp-80949	57	1	rneasy	rneasy	PROPN
bjp-80949	57	2	mini	mini	PROPN
bjp-80949	57	3	kit	kit	PROPN
bjp-80949	57	4	,	,	PUNCT
bjp-80949	57	5	utilized	utilize	VERB
bjp-80949	57	6	for	for	ADP
bjp-80949	57	7	rna	rna	NOUN
bjp-80949	57	8	isolation	isolation	NOUN
bjp-80949	57	9	with	with	ADP
bjp-80949	57	10	high	high	ADJ
bjp-80949	57	11	purity	purity	NOUN
bjp-80949	57	12	from	from	ADP
bjp-80949	57	13	cells	cell	NOUN
bjp-80949	57	14	,	,	PUNCT
bjp-80949	57	15	was	be	AUX
bjp-80949	57	16	provided	provide	VERB
bjp-80949	57	17	by	by	ADP
bjp-80949	57	18	qiagen	qiagen	PROPN
bjp-80949	57	19	(	(	PUNCT
bjp-80949	57	20	usa	usa	PROPN
bjp-80949	57	21	)	)	PUNCT
bjp-80949	57	22	.	.	PUNCT
bjp-80949	58	1	titan	titan	PROPN
bjp-80949	58	2	one	one	NUM
bjp-80949	58	3	tube	tube	NOUN
bjp-80949	58	4	rt	rt	ADJ
bjp-80949	58	5	-	-	PUNCT
bjp-80949	58	6	pcr	pcr	ADJ
bjp-80949	58	7	system	system	NOUN
bjp-80949	58	8	kit	kit	NOUN
bjp-80949	58	9	,	,	PUNCT
bjp-80949	58	10	used	use	VERB
bjp-80949	58	11	for	for	ADP
bjp-80949	58	12	rt	rt	NOUN
bjp-80949	58	13	-	-	PUNCT
bjp-80949	58	14	pcr	pcr	NOUN
bjp-80949	58	15	,	,	PUNCT
bjp-80949	58	16	was	be	AUX
bjp-80949	58	17	supplied	supply	VERB
bjp-80949	58	18	by	by	ADP
bjp-80949	58	19	roche	roche	PROPN
bjp-80949	58	20	applied	apply	VERB
bjp-80949	58	21	science	science	NOUN
bjp-80949	58	22	(	(	PUNCT
bjp-80949	58	23	germany	germany	PROPN
bjp-80949	58	24	)	)	PUNCT
bjp-80949	58	25	.	.	PUNCT
bjp-80949	59	1	3-(4,5	3-(4,5	NUM
bjp-80949	59	2	-	-	PUNCT
bjp-80949	59	3	dimethylthiazol-2yl)-2,5	dimethylthiazol-2yl)-2,5	NUM
bjp-80949	59	4	-	-	PUNCT
bjp-80949	59	5	diphenyltetrazolium	diphenyltetrazolium	NOUN
bjp-80949	59	6	bromide	bromide	NOUN
bjp-80949	59	7	(	(	PUNCT
bjp-80949	59	8	mtt	mtt	PROPN
bjp-80949	59	9	)	)	PUNCT
bjp-80949	59	10	was	be	AUX
bjp-80949	59	11	purchased	purchase	VERB
bjp-80949	59	12	from	from	ADP
bjp-80949	59	13	gibco	gibco	PROPN
bjp-80949	59	14	(	(	PUNCT
bjp-80949	59	15	usa	usa	NOUN
bjp-80949	59	16	)	)	PUNCT
bjp-80949	59	17	cells	cell	NOUN
bjp-80949	59	18	used	use	VERB
bjp-80949	59	19	in	in	ADP
bjp-80949	59	20	the	the	DET
bjp-80949	59	21	study	study	NOUN
bjp-80949	59	22	h1299	h1299	PROPN
bjp-80949	59	23	and	and	CCONJ
bjp-80949	59	24	a-549	a-549	PROPN
bjp-80949	59	25	used	use	VERB
bjp-80949	59	26	in	in	ADP
bjp-80949	59	27	the	the	DET
bjp-80949	59	28	study	study	NOUN
bjp-80949	59	29	were	be	AUX
bjp-80949	59	30	commercially	commercially	ADV
bjp-80949	59	31	obtained	obtain	VERB
bjp-80949	59	32	from	from	ADP
bjp-80949	59	33	the	the	DET
bjp-80949	59	34	american	american	ADJ
bjp-80949	59	35	type	type	NOUN
bjp-80949	59	36	culture	culture	NOUN
bjp-80949	59	37	collection	collection	NOUN
bjp-80949	59	38	.	.	PUNCT
bjp-80949	60	1	both	both	DET
bjp-80949	60	2	cells	cell	NOUN
bjp-80949	60	3	used	use	VERB
bjp-80949	60	4	in	in	ADP
bjp-80949	60	5	the	the	DET
bjp-80949	60	6	studies	study	NOUN
bjp-80949	60	7	are	be	AUX
bjp-80949	60	8	members	member	NOUN
bjp-80949	60	9	of	of	ADP
bjp-80949	60	10	the	the	DET
bjp-80949	60	11	cell	cell	NOUN
bjp-80949	60	12	lines	line	NOUN
bjp-80949	60	13	from	from	ADP
bjp-80949	60	14	human	human	ADJ
bjp-80949	60	15	non	non	ADJ
bjp-80949	60	16	-	-	ADJ
bjp-80949	60	17	small	small	ADJ
bjp-80949	60	18	-	-	PUNCT
bjp-80949	60	19	cell	cell	NOUN
bjp-80949	60	20	lung	lung	NOUN
bjp-80949	60	21	carcinoma	carcinoma	NOUN
bjp-80949	60	22	(	(	PUNCT
bjp-80949	60	23	nsclc	nsclc	NOUN
bjp-80949	60	24	)	)	PUNCT
bjp-80949	60	25	.	.	PUNCT
bjp-80949	61	1	all	all	DET
bjp-80949	61	2	tested	test	VERB
bjp-80949	61	3	cellular	cellular	ADJ
bjp-80949	61	4	models	model	NOUN
bjp-80949	61	5	reproduced	reproduce	VERB
bjp-80949	61	6	under	under	ADP
bjp-80949	61	7	suitable	suitable	ADJ
bjp-80949	61	8	conditions	condition	NOUN
bjp-80949	61	9	.	.	PUNCT
bjp-80949	62	1	cells	cell	NOUN
bjp-80949	62	2	were	be	AUX
bjp-80949	62	3	propagated	propagate	VERB
bjp-80949	62	4	in	in	ADP
bjp-80949	62	5	roswell	roswell	PROPN
bjp-80949	62	6	park	park	PROPN
bjp-80949	62	7	memorial	memorial	PROPN
bjp-80949	62	8	institute	institute	PROPN
bjp-80949	62	9	1640	1640	NUM
bjp-80949	62	10	(	(	PUNCT
bjp-80949	62	11	rpmi	rpmi	NOUN
bjp-80949	62	12	1640	1640	NUM
bjp-80949	62	13	)	)	PUNCT
bjp-80949	62	14	medium	medium	ADJ
bjp-80949	62	15	and	and	CCONJ
bjp-80949	62	16	other	other	ADJ
bjp-80949	62	17	medium	medium	ADJ
bjp-80949	62	18	components	component	NOUN
bjp-80949	62	19	in	in	ADP
bjp-80949	62	20	appropriate	appropriate	ADJ
bjp-80949	62	21	proportions	proportion	NOUN
bjp-80949	62	22	.	.	PUNCT
bjp-80949	63	1	after	after	SCONJ
bjp-80949	63	2	the	the	DET
bjp-80949	63	3	cells	cell	NOUN
bjp-80949	63	4	reach	reach	VERB
bjp-80949	63	5	sufficient	sufficient	ADJ
bjp-80949	63	6	density	density	NOUN
bjp-80949	63	7	(	(	PUNCT
bjp-80949	63	8	more	more	ADJ
bjp-80949	63	9	than	than	ADP
bjp-80949	63	10	75	75	NUM
bjp-80949	63	11	%	%	NOUN
bjp-80949	63	12	)	)	PUNCT
bjp-80949	63	13	bangladesh	bangladesh	PROPN
bjp-80949	63	14	j	j	PROPN
bjp-80949	63	15	pharmacol	pharmacol	PROPN
bjp-80949	63	16	2025	2025	NUM
bjp-80949	63	17	;	;	PUNCT
bjp-80949	63	18	20	20	NUM
bjp-80949	63	19	:	:	SYM
bjp-80949	63	20	22	22	NUM
bjp-80949	63	21	-	-	SYM
bjp-80949	63	22	34	34	NUM
bjp-80949	63	23	23	23	NUM
bjp-80949	63	24	in	in	ADP
bjp-80949	63	25	the	the	DET
bjp-80949	63	26	culture	culture	NOUN
bjp-80949	63	27	vessel	vessel	NOUN
bjp-80949	63	28	,	,	PUNCT
bjp-80949	63	29	experimental	experimental	ADJ
bjp-80949	63	30	groups	group	NOUN
bjp-80949	63	31	were	be	AUX
bjp-80949	63	32	created	create	VERB
bjp-80949	63	33	and	and	CCONJ
bjp-80949	63	34	then	then	ADV
bjp-80949	63	35	monoclonal	monoclonal	NOUN
bjp-80949	63	36	antibody	antibody	NOUN
bjp-80949	63	37	(	(	PUNCT
bjp-80949	63	38	cetuximab	cetuximab	NOUN
bjp-80949	63	39	)	)	PUNCT
bjp-80949	63	40	(	(	PUNCT
bjp-80949	63	41	<	<	X
bjp-80949	63	42	ic50	ic50	PROPN
bjp-80949	63	43	)	)	PUNCT
bjp-80949	63	44	,	,	PUNCT
bjp-80949	63	45	and	and	CCONJ
bjp-80949	63	46	natural	natural	ADJ
bjp-80949	63	47	monoterpenic	monoterpenic	ADJ
bjp-80949	63	48	phenol	phenol	NOUN
bjp-80949	63	49	(	(	PUNCT
bjp-80949	63	50	carvacrol	carvacrol	NOUN
bjp-80949	63	51	)	)	PUNCT
bjp-80949	63	52	(	(	PUNCT
bjp-80949	63	53	<	<	X
bjp-80949	63	54	ic50	ic50	PROPN
bjp-80949	63	55	)	)	PUNCT
bjp-80949	63	56	,	,	PUNCT
bjp-80949	63	57	were	be	AUX
bjp-80949	63	58	introduced	introduce	VERB
bjp-80949	63	59	to	to	ADP
bjp-80949	63	60	the	the	DET
bjp-80949	63	61	cell	cell	NOUN
bjp-80949	63	62	cultures	culture	NOUN
bjp-80949	63	63	for	for	ADP
bjp-80949	63	64	a	a	DET
bjp-80949	63	65	duration	duration	NOUN
bjp-80949	63	66	of	of	ADP
bjp-80949	63	67	48	48	NUM
bjp-80949	63	68	hour	hour	NOUN
bjp-80949	63	69	.	.	PUNCT
bjp-80949	64	1	when	when	SCONJ
bjp-80949	64	2	comparing	compare	VERB
bjp-80949	64	3	a-549	a-549	PROPN
bjp-80949	64	4	cells	cell	NOUN
bjp-80949	64	5	and	and	CCONJ
bjp-80949	64	6	h1299	h1299	CCONJ
bjp-80949	64	7	cells	cell	NOUN
bjp-80949	64	8	in	in	ADP
bjp-80949	64	9	terms	term	NOUN
bjp-80949	64	10	of	of	ADP
bjp-80949	64	11	p53	p53	NOUN
bjp-80949	64	12	gene	gene	NOUN
bjp-80949	64	13	,	,	PUNCT
bjp-80949	64	14	it	it	PRON
bjp-80949	64	15	is	be	AUX
bjp-80949	64	16	known	know	VERB
bjp-80949	64	17	that	that	SCONJ
bjp-80949	64	18	a-549	a-549	PROPN
bjp-80949	64	19	cells	cell	NOUN
bjp-80949	64	20	have	have	VERB
bjp-80949	64	21	an	an	DET
bjp-80949	64	22	intact	intact	ADJ
bjp-80949	64	23	p53	p53	NOUN
bjp-80949	64	24	gene	gene	NOUN
bjp-80949	64	25	,	,	PUNCT
bjp-80949	64	26	while	while	SCONJ
bjp-80949	64	27	this	this	DET
bjp-80949	64	28	situation	situation	NOUN
bjp-80949	64	29	is	be	AUX
bjp-80949	64	30	the	the	DET
bjp-80949	64	31	opposite	opposite	ADJ
bjp-80949	64	32	in	in	ADP
bjp-80949	65	1	h1299	h1299	NOUN
bjp-80949	65	2	cells	cell	NOUN
bjp-80949	66	1	.	.	PUNCT
bjp-80949	67	1	cytotoxicity	cytotoxicity	NOUN
bjp-80949	67	2	assay	assay	VERB
bjp-80949	67	3	h1299	h1299	PROPN
bjp-80949	67	4	and	and	CCONJ
bjp-80949	67	5	a-549	a-549	PROPN
bjp-80949	67	6	cells	cell	NOUN
bjp-80949	67	7	(	(	PUNCT
bjp-80949	67	8	1	1	NUM
bjp-80949	67	9	x	x	SYM
bjp-80949	67	10	104	104	NUM
bjp-80949	67	11	)	)	PUNCT
bjp-80949	67	12	were	be	AUX
bjp-80949	67	13	plated	plate	VERB
bjp-80949	67	14	per	per	ADP
bjp-80949	67	15	well	well	ADV
bjp-80949	67	16	(	(	PUNCT
bjp-80949	67	17	200	200	NUM
bjp-80949	67	18	μl	μl	CCONJ
bjp-80949	67	19	)	)	PUNCT
bjp-80949	67	20	in	in	ADP
bjp-80949	67	21	a	a	DET
bjp-80949	67	22	medium	medium	NOUN
bjp-80949	67	23	.	.	PUNCT
bjp-80949	68	1	cell	cell	NOUN
bjp-80949	68	2	viability	viability	NOUN
bjp-80949	68	3	was	be	AUX
bjp-80949	68	4	determined	determine	VERB
bjp-80949	68	5	after	after	SCONJ
bjp-80949	68	6	cetuximab	cetuximab	NOUN
bjp-80949	68	7	and	and	CCONJ
bjp-80949	68	8	carvacrol	carvacrol	NOUN
bjp-80949	68	9	were	be	AUX
bjp-80949	68	10	exposed	expose	VERB
bjp-80949	68	11	to	to	ADP
bjp-80949	68	12	the	the	DET
bjp-80949	68	13	cells	cell	NOUN
bjp-80949	68	14	over	over	ADP
bjp-80949	68	15	a	a	DET
bjp-80949	68	16	48	48	NUM
bjp-80949	68	17	-	-	PUNCT
bjp-80949	68	18	hour	hour	NOUN
bjp-80949	68	19	period	period	NOUN
bjp-80949	68	20	.	.	PUNCT
bjp-80949	69	1	the	the	DET
bjp-80949	69	2	metabolic	metabolic	NOUN
bjp-80949	69	3	activity	activity	NOUN
bjp-80949	69	4	of	of	ADP
bjp-80949	69	5	cells	cell	NOUN
bjp-80949	69	6	,	,	PUNCT
bjp-80949	69	7	indicative	indicative	ADJ
bjp-80949	69	8	of	of	ADP
bjp-80949	69	9	living	live	VERB
bjp-80949	69	10	cell	cell	NOUN
bjp-80949	69	11	count	count	NOUN
bjp-80949	69	12	,	,	PUNCT
bjp-80949	69	13	was	be	AUX
bjp-80949	69	14	established	establish	VERB
bjp-80949	69	15	at	at	ADP
bjp-80949	69	16	48	48	NUM
bjp-80949	69	17	hour	hour	NOUN
bjp-80949	69	18	using	use	VERB
bjp-80949	69	19	mtt	mtt	NOUN
bjp-80949	69	20	assay	assay	VERB
bjp-80949	69	21	.	.	PUNCT
bjp-80949	70	1	the	the	DET
bjp-80949	70	2	working	work	VERB
bjp-80949	70	3	principle	principle	NOUN
bjp-80949	70	4	of	of	ADP
bjp-80949	70	5	the	the	DET
bjp-80949	70	6	mtt	mtt	NOUN
bjp-80949	70	7	test	test	NOUN
bjp-80949	70	8	is	be	AUX
bjp-80949	70	9	dependent	dependent	ADJ
bjp-80949	70	10	on	on	ADP
bjp-80949	70	11	the	the	DET
bjp-80949	70	12	conversion	conversion	NOUN
bjp-80949	70	13	of	of	ADP
bjp-80949	70	14	mtt	mtt	NOUN
bjp-80949	70	15	into	into	ADP
bjp-80949	70	16	insoluble	insoluble	ADJ
bjp-80949	70	17	formazan	formazan	NOUN
bjp-80949	70	18	by	by	ADP
bjp-80949	70	19	viable	viable	ADJ
bjp-80949	70	20	cells	cell	NOUN
bjp-80949	70	21	.	.	PUNCT
bjp-80949	71	1	after	after	SCONJ
bjp-80949	71	2	the	the	DET
bjp-80949	71	3	test	test	NOUN
bjp-80949	71	4	reagents	reagent	NOUN
bjp-80949	71	5	were	be	AUX
bjp-80949	71	6	dispensed	dispense	VERB
bjp-80949	71	7	into	into	ADP
bjp-80949	71	8	the	the	DET
bjp-80949	71	9	medium	medium	NOUN
bjp-80949	71	10	and	and	CCONJ
bjp-80949	71	11	processed	process	VERB
bjp-80949	71	12	for	for	ADP
bjp-80949	71	13	an	an	DET
bjp-80949	71	14	incubation	incubation	NOUN
bjp-80949	71	15	period	period	NOUN
bjp-80949	71	16	of	of	ADP
bjp-80949	71	17	2	2	NUM
bjp-80949	71	18	hours	hour	NOUN
bjp-80949	71	19	at	at	ADP
bjp-80949	71	20	37	37	NUM
bjp-80949	71	21	°	°	NOUN
bjp-80949	71	22	c	c	NOUN
bjp-80949	71	23	degrees	degree	NOUN
bjp-80949	71	24	,	,	PUNCT
bjp-80949	71	25	the	the	DET
bjp-80949	71	26	reaction	reaction	NOUN
bjp-80949	71	27	was	be	AUX
bjp-80949	71	28	terminated	terminate	VERB
bjp-80949	71	29	through	through	ADP
bjp-80949	71	30	incorporating	incorporate	VERB
bjp-80949	71	31	dimethyl	dimethyl	NOUN
bjp-80949	71	32	sulfoxide	sulfoxide	NOUN
bjp-80949	71	33	(	(	PUNCT
bjp-80949	71	34	dmso	dmso	NOUN
bjp-80949	71	35	)	)	PUNCT
bjp-80949	71	36	and	and	CCONJ
bjp-80949	71	37	incubation	incubation	NOUN
bjp-80949	71	38	was	be	AUX
bjp-80949	71	39	carried	carry	VERB
bjp-80949	71	40	out	out	ADP
bjp-80949	71	41	for	for	ADP
bjp-80949	71	42	another	another	DET
bjp-80949	71	43	1	1	NUM
bjp-80949	71	44	hour	hour	NOUN
bjp-80949	71	45	.	.	PUNCT
bjp-80949	72	1	afterwards	afterwards	ADV
bjp-80949	72	2	,	,	PUNCT
bjp-80949	72	3	cytotoxicity	cytotoxicity	NOUN
bjp-80949	72	4	was	be	AUX
bjp-80949	72	5	determined	determine	VERB
bjp-80949	72	6	by	by	ADP
bjp-80949	72	7	taking	take	VERB
bjp-80949	72	8	measurements	measurement	NOUN
bjp-80949	72	9	at	at	ADP
bjp-80949	72	10	490	490	NUM
bjp-80949	72	11	nm	nm	NOUN
bjp-80949	72	12	(	(	PUNCT
bjp-80949	72	13	mosmann	mosmann	PROPN
bjp-80949	72	14	,	,	PUNCT
bjp-80949	72	15	1983	1983	NUM
bjp-80949	72	16	)	)	PUNCT
bjp-80949	72	17	.	.	PUNCT
bjp-80949	73	1	eight	eight	NUM
bjp-80949	73	2	wells	well	NOUN
bjp-80949	73	3	were	be	AUX
bjp-80949	73	4	replicated	replicate	VERB
bjp-80949	73	5	for	for	ADP
bjp-80949	73	6	each	each	DET
bjp-80949	73	7	concentration	concentration	NOUN
bjp-80949	73	8	.	.	PUNCT
bjp-80949	74	1	ic50	ic50	PROPN
bjp-80949	74	2	values	value	NOUN
bjp-80949	74	3	(	(	PUNCT
bjp-80949	74	4	the	the	DET
bjp-80949	74	5	concentrations	concentration	NOUN
bjp-80949	74	6	that	that	PRON
bjp-80949	74	7	lead	lead	VERB
bjp-80949	74	8	to	to	ADP
bjp-80949	74	9	50	50	NUM
bjp-80949	74	10	%	%	NOUN
bjp-80949	74	11	growth	growth	NOUN
bjp-80949	74	12	inhibition	inhibition	NOUN
bjp-80949	74	13	)	)	PUNCT
bjp-80949	74	14	and	and	CCONJ
bjp-80949	74	15	lower	low	ADJ
bjp-80949	74	16	ic50	ic50	PROPN
bjp-80949	74	17	concentrations	concentration	NOUN
bjp-80949	74	18	(	(	PUNCT
bjp-80949	74	19	<	<	X
bjp-80949	74	20	ic50	ic50	PROPN
bjp-80949	74	21	)	)	PUNCT
bjp-80949	74	22	were	be	AUX
bjp-80949	74	23	calculated	calculate	VERB
bjp-80949	74	24	separately	separately	ADV
bjp-80949	74	25	for	for	ADP
bjp-80949	74	26	cetuximab	cetuximab	NOUN
bjp-80949	74	27	and	and	CCONJ
bjp-80949	74	28	carvacrol	carvacrol	NOUN
bjp-80949	74	29	.	.	PUNCT
bjp-80949	75	1	the	the	DET
bjp-80949	75	2	combination	combination	NOUN
bjp-80949	75	3	treatments	treatment	NOUN
bjp-80949	75	4	were	be	AUX
bjp-80949	75	5	then	then	ADV
bjp-80949	75	6	carried	carry	VERB
bjp-80949	75	7	out	out	ADP
bjp-80949	75	8	using	use	VERB
bjp-80949	75	9	these	these	DET
bjp-80949	75	10	calculated	calculate	VERB
bjp-80949	75	11	lower	low	ADJ
bjp-80949	75	12	ic50	ic50	PROPN
bjp-80949	75	13	values	value	NOUN
bjp-80949	75	14	.	.	PUNCT
bjp-80949	76	1	ultimately	ultimately	ADV
bjp-80949	76	2	,	,	PUNCT
bjp-80949	76	3	the	the	DET
bjp-80949	76	4	most	most	ADV
bjp-80949	76	5	therapeutically	therapeutically	ADV
bjp-80949	76	6	effective	effective	ADJ
bjp-80949	76	7	concentration	concentration	NOUN
bjp-80949	76	8	pairs	pair	NOUN
bjp-80949	76	9	were	be	AUX
bjp-80949	76	10	identified	identify	VERB
bjp-80949	76	11	based	base	VERB
bjp-80949	76	12	on	on	ADP
bjp-80949	76	13	cell	cell	NOUN
bjp-80949	76	14	viability	viability	NOUN
bjp-80949	76	15	results	result	NOUN
bjp-80949	76	16	after	after	ADP
bjp-80949	76	17	administering	administer	VERB
bjp-80949	76	18	cetuximab	cetuximab	NOUN
bjp-80949	76	19	(	(	PUNCT
bjp-80949	76	20	<	<	X
bjp-80949	76	21	ic50	ic50	PROPN
bjp-80949	76	22	)	)	PUNCT
bjp-80949	76	23	and	and	CCONJ
bjp-80949	76	24	carvacrol	carvacrol	NOUN
bjp-80949	76	25	(	(	PUNCT
bjp-80949	76	26	<	<	X
bjp-80949	76	27	ic50	ic50	PROPN
bjp-80949	76	28	)	)	PUNCT
bjp-80949	76	29	collectively	collectively	ADV
bjp-80949	76	30	.	.	PUNCT
bjp-80949	77	1	the	the	DET
bjp-80949	77	2	combination	combination	NOUN
bjp-80949	77	3	index	index	NOUN
bjp-80949	77	4	(	(	PUNCT
bjp-80949	77	5	ci	ci	NOUN
bjp-80949	77	6	)	)	PUNCT
bjp-80949	77	7	values	value	NOUN
bjp-80949	77	8	were	be	AUX
bjp-80949	77	9	determined	determine	VERB
bjp-80949	77	10	to	to	PART
bjp-80949	77	11	investigate	investigate	VERB
bjp-80949	77	12	the	the	DET
bjp-80949	77	13	nature	nature	NOUN
bjp-80949	77	14	of	of	ADP
bjp-80949	77	15	the	the	DET
bjp-80949	77	16	interaction	interaction	NOUN
bjp-80949	77	17	—	—	PUNCT
bjp-80949	77	18	additive	additive	ADJ
bjp-80949	77	19	,	,	PUNCT
bjp-80949	77	20	synergistic	synergistic	ADJ
bjp-80949	77	21	,	,	PUNCT
bjp-80949	77	22	or	or	CCONJ
bjp-80949	77	23	antagonistic	antagonistic	ADJ
bjp-80949	77	24	—	—	PUNCT
bjp-80949	77	25	between	between	ADP
bjp-80949	77	26	cetuximab	cetuximab	NOUN
bjp-80949	77	27	and	and	CCONJ
bjp-80949	77	28	carvacrol	carvacrol	NOUN
bjp-80949	77	29	in	in	ADP
bjp-80949	77	30	cell	cell	NOUN
bjp-80949	77	31	-	-	PUNCT
bjp-80949	77	32	based	base	VERB
bjp-80949	77	33	assays	assay	NOUN
bjp-80949	77	34	.	.	PUNCT
bjp-80949	78	1	the	the	DET
bjp-80949	78	2	formula	formula	NOUN
bjp-80949	78	3	used	use	VERB
bjp-80949	78	4	to	to	PART
bjp-80949	78	5	calculate	calculate	VERB
bjp-80949	78	6	the	the	DET
bjp-80949	78	7	ci	ci	NOUN
bjp-80949	78	8	is	be	AUX
bjp-80949	78	9	given	give	VERB
bjp-80949	78	10	below	below	ADV
bjp-80949	78	11	:	:	PUNCT
bjp-80949	78	12	ci	ci	PROPN
bjp-80949	78	13	=(	=(	PROPN
bjp-80949	78	14	ea	ea	PROPN
bjp-80949	78	15	+	+	PUNCT
bjp-80949	78	16	b)/(ea	b)/(ea	X
bjp-80949	78	17	+	+	CCONJ
bjp-80949	78	18	eb	eb	PROPN
bjp-80949	78	19	ea	ea	PROPN
bjp-80949	78	20	×	×	PROPN
bjp-80949	78	21	eb	eb	PROPN
bjp-80949	78	22	)	)	PUNCT
bjp-80949	78	23	(	(	PUNCT
bjp-80949	78	24	huang	huang	PROPN
bjp-80949	78	25	et	et	PROPN
bjp-80949	78	26	al	al	PROPN
bjp-80949	78	27	.	.	PROPN
bjp-80949	78	28	,	,	PUNCT
bjp-80949	78	29	2014	2014	NUM
bjp-80949	78	30	)	)	PUNCT
bjp-80949	78	31	where	where	SCONJ
bjp-80949	78	32	,	,	PUNCT
bjp-80949	78	33	ea	ea	PROPN
bjp-80949	78	34	+	+	CCONJ
bjp-80949	78	35	b	b	NOUN
bjp-80949	78	36	indicates	indicate	VERB
bjp-80949	78	37	the	the	DET
bjp-80949	78	38	extent	extent	NOUN
bjp-80949	78	39	of	of	ADP
bjp-80949	78	40	suppression	suppression	NOUN
bjp-80949	78	41	observed	observe	VERB
bjp-80949	78	42	when	when	SCONJ
bjp-80949	78	43	both	both	PRON
bjp-80949	78	44	carvacrol	carvacrol	NOUN
bjp-80949	78	45	and	and	CCONJ
bjp-80949	78	46	cetuximab	cetuximab	NOUN
bjp-80949	78	47	are	be	AUX
bjp-80949	78	48	administered	administer	VERB
bjp-80949	78	49	together	together	ADV
bjp-80949	78	50	,	,	PUNCT
bjp-80949	78	51	ea	ea	NOUN
bjp-80949	78	52	refers	refer	VERB
bjp-80949	78	53	to	to	ADP
bjp-80949	78	54	the	the	DET
bjp-80949	78	55	inhibition	inhibition	NOUN
bjp-80949	78	56	rate	rate	NOUN
bjp-80949	78	57	by	by	ADP
bjp-80949	78	58	carvacrol	carvacrol	NOUN
bjp-80949	78	59	alone	alone	ADV
bjp-80949	78	60	,	,	PUNCT
bjp-80949	78	61	and	and	CCONJ
bjp-80949	78	62	eb	eb	PROPN
bjp-80949	78	63	represents	represent	VERB
bjp-80949	78	64	the	the	DET
bjp-80949	78	65	inhibition	inhibition	NOUN
bjp-80949	78	66	rate	rate	NOUN
bjp-80949	78	67	by	by	ADP
bjp-80949	78	68	cetuximab	cetuximab	NOUN
bjp-80949	78	69	alone	alone	ADV
bjp-80949	78	70	.	.	PUNCT
bjp-80949	79	1	the	the	DET
bjp-80949	79	2	effect	effect	NOUN
bjp-80949	79	3	of	of	ADP
bjp-80949	79	4	drug	drug	NOUN
bjp-80949	79	5	co	co	NOUN
bjp-80949	79	6	-	-	NOUN
bjp-80949	79	7	administration	administration	NOUN
bjp-80949	79	8	was	be	AUX
bjp-80949	79	9	classified	classify	VERB
bjp-80949	79	10	as	as	SCONJ
bjp-80949	79	11	follows	follow	VERB
bjp-80949	79	12	:	:	PUNCT
bjp-80949	79	13	a	a	X
bjp-80949	79	14	)	)	PUNCT
bjp-80949	79	15	additive	additive	NOUN
bjp-80949	79	16	(	(	PUNCT
bjp-80949	79	17	+	+	NOUN
bjp-80949	79	18	)	)	PUNCT
bjp-80949	79	19	for	for	ADP
bjp-80949	79	20	ci	ci	NOUN
bjp-80949	79	21	values	value	NOUN
bjp-80949	79	22	between	between	ADP
bjp-80949	79	23	0.85	0.85	NUM
bjp-80949	79	24	and	and	CCONJ
bjp-80949	79	25	1.15	1.15	NUM
bjp-80949	79	26	;	;	PUNCT
bjp-80949	79	27	b	b	X
bjp-80949	79	28	)	)	PUNCT
bjp-80949	79	29	synergistic	synergistic	ADJ
bjp-80949	79	30	(	(	PUNCT
bjp-80949	79	31	+	+	NOUN
bjp-80949	79	32	+	+	NOUN
bjp-80949	79	33	)	)	PUNCT
bjp-80949	79	34	for	for	ADP
bjp-80949	79	35	ci	ci	NOUN
bjp-80949	79	36	values	value	NOUN
bjp-80949	79	37	between	between	ADP
bjp-80949	79	38	1.15	1.15	NUM
bjp-80949	79	39	and	and	CCONJ
bjp-80949	79	40	2.0	2.0	NUM
bjp-80949	79	41	;	;	PUNCT
bjp-80949	79	42	c	c	X
bjp-80949	79	43	)	)	PUNCT
bjp-80949	79	44	subtractive	subtractive	NOUN
bjp-80949	79	45	(	(	PUNCT
bjp-80949	79	46	-	-	PUNCT
bjp-80949	79	47	)	)	PUNCT
bjp-80949	79	48	for	for	ADP
bjp-80949	79	49	ci	ci	NOUN
bjp-80949	79	50	values	value	NOUN
bjp-80949	79	51	between	between	ADP
bjp-80949	79	52	0.85	0.85	NUM
bjp-80949	79	53	and	and	CCONJ
bjp-80949	79	54	0.55	0.55	NUM
bjp-80949	79	55	;	;	PUNCT
bjp-80949	79	56	and	and	CCONJ
bjp-80949	79	57	d	d	X
bjp-80949	79	58	)	)	PUNCT
bjp-80949	79	59	antagonistic	antagonistic	ADJ
bjp-80949	79	60	(	(	PUNCT
bjp-80949	79	61	—	—	PUNCT
bjp-80949	79	62	)	)	PUNCT
bjp-80949	79	63	for	for	ADP
bjp-80949	79	64	ci	ci	NOUN
bjp-80949	79	65	values	value	NOUN
bjp-80949	79	66	under	under	ADP
bjp-80949	79	67	0.55	0.55	NUM
bjp-80949	79	68	.	.	PUNCT
bjp-80949	80	1	control	control	NOUN
bjp-80949	80	2	groups	group	NOUN
bjp-80949	80	3	consisted	consist	VERB
bjp-80949	80	4	of	of	ADP
bjp-80949	80	5	cells	cell	NOUN
bjp-80949	80	6	that	that	PRON
bjp-80949	80	7	were	be	AUX
bjp-80949	80	8	not	not	PART
bjp-80949	80	9	exposed	expose	VERB
bjp-80949	80	10	to	to	ADP
bjp-80949	80	11	any	any	DET
bjp-80949	80	12	treatment	treatment	NOUN
bjp-80949	80	13	and	and	CCONJ
bjp-80949	80	14	those	those	PRON
bjp-80949	80	15	treated	treat	VERB
bjp-80949	80	16	with	with	ADP
bjp-80949	80	17	0.1%dmso	0.1%dmso	NUM
bjp-80949	80	18	.	.	PUNCT
bjp-80949	81	1	data	datum	NOUN
bjp-80949	81	2	were	be	AUX
bjp-80949	81	3	collected	collect	VERB
bjp-80949	81	4	from	from	ADP
bjp-80949	81	5	eight	eight	NUM
bjp-80949	81	6	independent	independent	ADJ
bjp-80949	81	7	repetitions	repetition	NOUN
bjp-80949	81	8	.	.	PUNCT
bjp-80949	82	1	lactate	lactate	NOUN
bjp-80949	82	2	dehydrogenase	dehydrogenase	NOUN
bjp-80949	82	3	(	(	PUNCT
bjp-80949	82	4	ldh	ldh	NOUN
bjp-80949	82	5	)	)	PUNCT
bjp-80949	82	6	enzyme	enzyme	NOUN
bjp-80949	82	7	activity	activity	NOUN
bjp-80949	82	8	ldh	ldh	NOUN
bjp-80949	82	9	activity	activity	NOUN
bjp-80949	82	10	was	be	AUX
bjp-80949	82	11	measured	measure	VERB
bjp-80949	82	12	after	after	ADP
bjp-80949	82	13	treating	treat	VERB
bjp-80949	82	14	a-549	a-549	PRON
bjp-80949	82	15	and	and	CCONJ
bjp-80949	83	1	h1299	h1299	NOUN
bjp-80949	83	2	cells	cell	NOUN
bjp-80949	83	3	with	with	ADP
bjp-80949	83	4	cetuximab	cetuximab	NOUN
bjp-80949	83	5	alone	alone	ADV
bjp-80949	83	6	(	(	PUNCT
bjp-80949	83	7	<	<	X
bjp-80949	83	8	ic50	ic50	PROPN
bjp-80949	83	9	)	)	PUNCT
bjp-80949	83	10	and	and	CCONJ
bjp-80949	83	11	a	a	DET
bjp-80949	83	12	combination	combination	NOUN
bjp-80949	83	13	of	of	ADP
bjp-80949	83	14	carvacrol	carvacrol	NOUN
bjp-80949	83	15	(	(	PUNCT
bjp-80949	83	16	<	<	X
bjp-80949	83	17	ic50	ic50	PROPN
bjp-80949	83	18	)	)	PUNCT
bjp-80949	83	19	concentrations	concentration	NOUN
bjp-80949	83	20	,	,	PUNCT
bjp-80949	83	21	which	which	PRON
bjp-80949	83	22	exhibited	exhibit	VERB
bjp-80949	83	23	the	the	DET
bjp-80949	83	24	strongest	strong	ADJ
bjp-80949	83	25	cytotoxic	cytotoxic	ADJ
bjp-80949	83	26	effects	effect	NOUN
bjp-80949	83	27	,	,	PUNCT
bjp-80949	83	28	for	for	ADP
bjp-80949	83	29	48	48	NUM
bjp-80949	83	30	hours	hour	NOUN
bjp-80949	83	31	.	.	PUNCT
bjp-80949	84	1	thus	thus	ADV
bjp-80949	84	2	,	,	PUNCT
bjp-80949	84	3	an	an	DET
bjp-80949	84	4	attempt	attempt	NOUN
bjp-80949	84	5	was	be	AUX
bjp-80949	84	6	made	make	VERB
bjp-80949	84	7	to	to	PART
bjp-80949	84	8	reveal	reveal	VERB
bjp-80949	84	9	the	the	DET
bjp-80949	84	10	destructive	destructive	ADJ
bjp-80949	84	11	effect	effect	NOUN
bjp-80949	84	12	on	on	ADP
bjp-80949	84	13	the	the	DET
bjp-80949	84	14	membrane	membrane	NOUN
bjp-80949	84	15	by	by	ADP
bjp-80949	84	16	examining	examine	VERB
bjp-80949	84	17	the	the	DET
bjp-80949	84	18	fluctuations	fluctuation	NOUN
bjp-80949	84	19	in	in	ADP
bjp-80949	84	20	ldh	ldh	NOUN
bjp-80949	84	21	activity	activity	NOUN
bjp-80949	84	22	.	.	PUNCT
bjp-80949	85	1	ldh	ldh	NOUN
bjp-80949	85	2	activity	activity	NOUN
bjp-80949	85	3	was	be	AUX
bjp-80949	85	4	measured	measure	VERB
bjp-80949	85	5	using	use	VERB
bjp-80949	85	6	a	a	DET
bjp-80949	85	7	commercially	commercially	ADV
bjp-80949	85	8	available	available	ADJ
bjp-80949	85	9	kit	kit	NOUN
bjp-80949	85	10	as	as	SCONJ
bjp-80949	85	11	outlined	outline	VERB
bjp-80949	85	12	by	by	ADP
bjp-80949	85	13	the	the	DET
bjp-80949	85	14	application	application	NOUN
bjp-80949	85	15	operating	operating	NOUN
bjp-80949	85	16	procedures	procedure	NOUN
bjp-80949	85	17	.	.	PUNCT
bjp-80949	86	1	in	in	ADP
bjp-80949	86	2	this	this	DET
bjp-80949	86	3	test	test	NOUN
bjp-80949	86	4	,	,	PUNCT
bjp-80949	86	5	ldh	ldh	PROPN
bjp-80949	86	6	facilitates	facilitate	VERB
bjp-80949	86	7	the	the	DET
bjp-80949	86	8	conversion	conversion	NOUN
bjp-80949	86	9	of	of	ADP
bjp-80949	86	10	nad	nad	PROPN
bjp-80949	86	11	to	to	PART
bjp-80949	86	12	nadh	nadh	VERB
bjp-80949	86	13	,	,	PUNCT
bjp-80949	86	14	which	which	PRON
bjp-80949	86	15	is	be	AUX
bjp-80949	86	16	box	box	NOUN
bjp-80949	86	17	1	1	NUM
bjp-80949	86	18	:	:	PUNCT
bjp-80949	86	19	glutathione	glutathione	NOUN
bjp-80949	86	20	peroxidase	peroxidase	NOUN
bjp-80949	86	21	activity	activity	NOUN
bjp-80949	86	22	principle	principle	NOUN
bjp-80949	86	23	glutathione	glutathione	NOUN
bjp-80949	86	24	peroxidase	peroxidase	NOUN
bjp-80949	86	25	(	(	PUNCT
bjp-80949	86	26	gpx	gpx	NOUN
bjp-80949	86	27	)	)	PUNCT
bjp-80949	86	28	activity	activity	NOUN
bjp-80949	86	29	is	be	AUX
bjp-80949	86	30	measured	measure	VERB
bjp-80949	86	31	spectrophotometrically	spectrophotometrically	ADV
bjp-80949	86	32	by	by	ADP
bjp-80949	86	33	coupling	couple	VERB
bjp-80949	86	34	the	the	DET
bjp-80949	86	35	enzymatic	enzymatic	ADJ
bjp-80949	86	36	reduction	reduction	NOUN
bjp-80949	86	37	of	of	ADP
bjp-80949	86	38	tertbutyl	tertbutyl	NOUN
bjp-80949	86	39	hydroperoxide	hydroperoxide	ADV
bjp-80949	86	40	with	with	ADP
bjp-80949	86	41	the	the	DET
bjp-80949	86	42	oxidation	oxidation	NOUN
bjp-80949	86	43	of	of	ADP
bjp-80949	86	44	reduced	reduced	ADJ
bjp-80949	86	45	glutathione	glutathione	NOUN
bjp-80949	86	46	(	(	PUNCT
bjp-80949	86	47	gsh	gsh	PROPN
bjp-80949	86	48	)	)	PUNCT
bjp-80949	86	49	.	.	PUNCT
bjp-80949	87	1	the	the	DET
bjp-80949	87	2	oxidized	oxidize	VERB
bjp-80949	87	3	glutathione	glutathione	NOUN
bjp-80949	87	4	(	(	PUNCT
bjp-80949	87	5	gssg	gssg	VERB
bjp-80949	87	6	)	)	PUNCT
bjp-80949	87	7	is	be	AUX
bjp-80949	87	8	then	then	ADV
bjp-80949	87	9	regenerated	regenerate	VERB
bjp-80949	87	10	to	to	PART
bjp-80949	87	11	gsh	gsh	VERB
bjp-80949	87	12	by	by	ADP
bjp-80949	87	13	glutathione	glutathione	NOUN
bjp-80949	87	14	reductase	reductase	NOUN
bjp-80949	87	15	in	in	ADP
bjp-80949	87	16	the	the	DET
bjp-80949	87	17	presence	presence	NOUN
bjp-80949	87	18	of	of	ADP
bjp-80949	87	19	nadph	nadph	PROPN
bjp-80949	87	20	.	.	PUNCT
bjp-80949	88	1	the	the	DET
bjp-80949	88	2	rate	rate	NOUN
bjp-80949	88	3	of	of	ADP
bjp-80949	88	4	decrease	decrease	NOUN
bjp-80949	88	5	in	in	ADP
bjp-80949	88	6	absorbance	absorbance	NOUN
bjp-80949	88	7	at	at	ADP
bjp-80949	88	8	340	340	NUM
bjp-80949	88	9	nm	nm	NOUN
bjp-80949	88	10	,	,	PUNCT
bjp-80949	88	11	due	due	ADP
bjp-80949	88	12	to	to	ADP
bjp-80949	88	13	the	the	DET
bjp-80949	88	14	oxidation	oxidation	NOUN
bjp-80949	88	15	of	of	ADP
bjp-80949	88	16	nadph	nadph	ADJ
bjp-80949	88	17	to	to	ADP
bjp-80949	88	18	nadp+	nadp+	NOUN
bjp-80949	88	19	,	,	PUNCT
bjp-80949	88	20	is	be	AUX
bjp-80949	88	21	directly	directly	ADV
bjp-80949	88	22	proportional	proportional	ADJ
bjp-80949	88	23	to	to	ADP
bjp-80949	88	24	the	the	DET
bjp-80949	88	25	gpx	gpx	NOUN
bjp-80949	88	26	activity	activity	NOUN
bjp-80949	88	27	in	in	ADP
bjp-80949	88	28	the	the	DET
bjp-80949	88	29	sample	sample	NOUN
bjp-80949	88	30	.	.	PUNCT
bjp-80949	89	1	requirements	requirement	NOUN
bjp-80949	89	2	a-549	a-549	PROPN
bjp-80949	89	3	cell	cell	NOUN
bjp-80949	89	4	;	;	PUNCT
bjp-80949	89	5	bovine	bovine	NOUN
bjp-80949	89	6	serum	serum	NOUN
bjp-80949	89	7	albumin	albumin	PROPN
bjp-80949	89	8	(	(	PUNCT
bjp-80949	89	9	bsa	bsa	PROPN
bjp-80949	89	10	)	)	PUNCT
bjp-80949	89	11	;	;	PUNCT
bjp-80949	89	12	bradford	bradford	NOUN
bjp-80949	89	13	reagent	reagent	NOUN
bjp-80949	89	14	;	;	PUNCT
bjp-80949	89	15	carvacrol	carvacrol	NOUN
bjp-80949	89	16	;	;	PUNCT
bjp-80949	89	17	centrifuge	centrifuge	NOUN
bjp-80949	89	18	;	;	PUNCT
bjp-80949	89	19	cetuximab	cetuximab	NOUN
bjp-80949	89	20	;	;	PUNCT
bjp-80949	89	21	glutathione	glutathione	NOUN
bjp-80949	89	22	reductase	reductase	NOUN
bjp-80949	89	23	;	;	PUNCT
bjp-80949	89	24	h1299	h1299	CCONJ
bjp-80949	89	25	cell	cell	NOUN
bjp-80949	89	26	;	;	PUNCT
bjp-80949	89	27	nadph	nadph	ADJ
bjp-80949	89	28	;	;	PUNCT
bjp-80949	89	29	phosphate	phosphate	ADJ
bjp-80949	89	30	buffered	buffer	VERB
bjp-80949	89	31	saline	saline	NOUN
bjp-80949	89	32	(	(	PUNCT
bjp-80949	89	33	pbs	pbs	PROPN
bjp-80949	89	34	)	)	PUNCT
bjp-80949	89	35	;	;	PUNCT
bjp-80949	89	36	reduced	reduce	VERB
bjp-80949	89	37	glutathione	glutathione	NOUN
bjp-80949	89	38	;	;	PUNCT
bjp-80949	89	39	tert	tert	NOUN
bjp-80949	89	40	-	-	PUNCT
bjp-80949	89	41	butyl	butyl	NOUN
bjp-80949	89	42	hydroperoxide	hydroperoxide	NOUN
bjp-80949	89	43	;	;	PUNCT
bjp-80949	89	44	ultrasonicator	ultrasonicator	NOUN
bjp-80949	89	45	;	;	PUNCT
bjp-80949	89	46	uv	uv	NOUN
bjp-80949	89	47	-	-	PUNCT
bjp-80949	89	48	vis	vis	X
bjp-80949	89	49	spectrophotometer	spectrophotometer	NOUN
bjp-80949	89	50	procedure	procedure	NOUN
bjp-80949	89	51	step	step	NOUN
bjp-80949	89	52	1	1	NUM
bjp-80949	89	53	:	:	PUNCT
bjp-80949	89	54	a-549	a-549	X
bjp-80949	89	55	and	and	CCONJ
bjp-80949	89	56	h1299	h1299	CCONJ
bjp-80949	89	57	cells	cell	NOUN
bjp-80949	89	58	were	be	AUX
bjp-80949	89	59	cultured	cultured	ADJ
bjp-80949	89	60	and	and	CCONJ
bjp-80949	89	61	treated	treat	VERB
bjp-80949	89	62	for	for	ADP
bjp-80949	89	63	48	48	NUM
bjp-80949	89	64	hours	hour	NOUN
bjp-80949	89	65	with	with	ADP
bjp-80949	89	66	cetuximab	cetuximab	NOUN
bjp-80949	89	67	alone	alone	ADJ
bjp-80949	89	68	and	and	CCONJ
bjp-80949	89	69	also	also	ADV
bjp-80949	89	70	together	together	ADV
bjp-80949	89	71	with	with	ADP
bjp-80949	89	72	carvacrol	carvacrol	NOUN
bjp-80949	89	73	(	(	PUNCT
bjp-80949	89	74	using	use	VERB
bjp-80949	89	75	the	the	DET
bjp-80949	89	76	most	most	ADV
bjp-80949	89	77	effective	effective	ADJ
bjp-80949	89	78	combination	combination	NOUN
bjp-80949	89	79	concentration	concentration	NOUN
bjp-80949	89	80	based	base	VERB
bjp-80949	89	81	on	on	ADP
bjp-80949	89	82	prior	prior	ADJ
bjp-80949	89	83	cytotoxicity	cytotoxicity	NOUN
bjp-80949	89	84	assay	assay	NOUN
bjp-80949	89	85	)	)	PUNCT
bjp-80949	89	86	.	.	PUNCT
bjp-80949	90	1	step	step	NOUN
bjp-80949	90	2	2	2	NUM
bjp-80949	90	3	:	:	PUNCT
bjp-80949	90	4	following	follow	VERB
bjp-80949	90	5	treatment	treatment	NOUN
bjp-80949	90	6	,	,	PUNCT
bjp-80949	90	7	cells	cell	NOUN
bjp-80949	90	8	were	be	AUX
bjp-80949	90	9	harvested	harvest	VERB
bjp-80949	90	10	and	and	CCONJ
bjp-80949	90	11	centrifuged	centrifuge	VERB
bjp-80949	90	12	at	at	ADP
bjp-80949	90	13	1,500	1,500	NUM
bjp-80949	90	14	x	x	SYM
bjp-80949	90	15	g	g	NOUN
bjp-80949	90	16	for	for	ADP
bjp-80949	90	17	10	10	NUM
bjp-80949	90	18	min	min	NOUN
bjp-80949	90	19	at	at	ADP
bjp-80949	90	20	4	4	NUM
bjp-80949	90	21	°	°	NOUN
bjp-80949	90	22	c	c	NOUN
bjp-80949	90	23	.	.	PUNCT
bjp-80949	91	1	step	step	NOUN
bjp-80949	91	2	3	3	NUM
bjp-80949	91	3	:	:	PUNCT
bjp-80949	91	4	the	the	DET
bjp-80949	91	5	pellet	pellet	NOUN
bjp-80949	91	6	was	be	AUX
bjp-80949	91	7	resuspended	resuspend	VERB
bjp-80949	91	8	in	in	ADP
bjp-80949	91	9	ice	ice	NOUN
bjp-80949	91	10	-	-	PUNCT
bjp-80949	91	11	cold	cold	ADJ
bjp-80949	91	12	pbs	pbs	NOUN
bjp-80949	91	13	and	and	CCONJ
bjp-80949	91	14	lysed	lyse	VERB
bjp-80949	91	15	via	via	ADP
bjp-80949	91	16	ultrasonication	ultrasonication	NOUN
bjp-80949	91	17	on	on	ADP
bjp-80949	91	18	ice	ice	NOUN
bjp-80949	91	19	(	(	PUNCT
bjp-80949	91	20	3	3	NUM
bjp-80949	91	21	-	-	SYM
bjp-80949	91	22	4	4	NUM
bjp-80949	91	23	pulses	pulse	NOUN
bjp-80949	91	24	of	of	ADP
bjp-80949	91	25	10	10	NUM
bjp-80949	91	26	sec	sec	PROPN
bjp-80949	91	27	each	each	PRON
bjp-80949	91	28	,	,	PUNCT
bjp-80949	91	29	with	with	ADP
bjp-80949	91	30	30	30	NUM
bjp-80949	91	31	sec	sec	PROPN
bjp-80949	91	32	intervals	interval	NOUN
bjp-80949	91	33	)	)	PUNCT
bjp-80949	91	34	.	.	PUNCT
bjp-80949	92	1	step	step	NOUN
bjp-80949	92	2	4	4	NUM
bjp-80949	92	3	:	:	PUNCT
bjp-80949	92	4	the	the	DET
bjp-80949	92	5	lysate	lysate	NOUN
bjp-80949	92	6	was	be	AUX
bjp-80949	92	7	centrifuged	centrifuge	VERB
bjp-80949	92	8	at	at	ADP
bjp-80949	92	9	12,000	12,000	NUM
bjp-80949	92	10	x	x	SYM
bjp-80949	92	11	g	g	NOUN
bjp-80949	92	12	for	for	ADP
bjp-80949	92	13	15	15	NUM
bjp-80949	92	14	min	min	NOUN
bjp-80949	92	15	at	at	ADP
bjp-80949	92	16	4	4	NUM
bjp-80949	92	17	°	°	ADP
bjp-80949	92	18	c	c	NOUN
bjp-80949	92	19	to	to	PART
bjp-80949	92	20	remove	remove	VERB
bjp-80949	92	21	cell	cell	NOUN
bjp-80949	92	22	debris	debris	NOUN
bjp-80949	92	23	.	.	PUNCT
bjp-80949	93	1	step	step	NOUN
bjp-80949	93	2	5	5	NUM
bjp-80949	93	3	:	:	PUNCT
bjp-80949	93	4	the	the	DET
bjp-80949	93	5	clear	clear	ADJ
bjp-80949	93	6	supernatant	supernatant	NOUN
bjp-80949	93	7	was	be	AUX
bjp-80949	93	8	collected	collect	VERB
bjp-80949	93	9	and	and	CCONJ
bjp-80949	93	10	used	use	VERB
bjp-80949	93	11	for	for	ADP
bjp-80949	93	12	both	both	PRON
bjp-80949	93	13	gpx	gpx	NOUN
bjp-80949	93	14	activity	activity	NOUN
bjp-80949	93	15	assay	assay	NOUN
bjp-80949	93	16	and	and	CCONJ
bjp-80949	93	17	total	total	ADJ
bjp-80949	93	18	protein	protein	NOUN
bjp-80949	93	19	quantification	quantification	NOUN
bjp-80949	93	20	.	.	PUNCT
bjp-80949	94	1	calculation	calculation	NOUN
bjp-80949	94	2	the	the	DET
bjp-80949	94	3	decrease	decrease	NOUN
bjp-80949	94	4	in	in	ADP
bjp-80949	94	5	absorbance	absorbance	NOUN
bjp-80949	94	6	at	at	ADP
bjp-80949	94	7	340	340	NUM
bjp-80949	94	8	nm	nm	NOUN
bjp-80949	94	9	was	be	AUX
bjp-80949	94	10	monitored	monitor	VERB
bjp-80949	94	11	for	for	ADP
bjp-80949	94	12	5	5	NUM
bjp-80949	94	13	min	min	NOUN
bjp-80949	94	14	at	at	ADP
bjp-80949	94	15	25	25	NUM
bjp-80949	94	16	°	°	ADP
bjp-80949	94	17	c	c	NOUN
bjp-80949	94	18	using	use	VERB
bjp-80949	94	19	a	a	DET
bjp-80949	94	20	uv	uv	NOUN
bjp-80949	94	21	-	-	PUNCT
bjp-80949	94	22	vis	vis	X
bjp-80949	94	23	spectrophotometer	spectrophotometer	NOUN
bjp-80949	94	24	.	.	PUNCT
bjp-80949	95	1	gpx	gpx	NOUN
bjp-80949	95	2	activity	activity	NOUN
bjp-80949	95	3	was	be	AUX
bjp-80949	95	4	calculated	calculate	VERB
bjp-80949	95	5	based	base	VERB
bjp-80949	95	6	on	on	ADP
bjp-80949	95	7	the	the	DET
bjp-80949	95	8	rate	rate	NOUN
bjp-80949	95	9	of	of	ADP
bjp-80949	95	10	nadph	nadph	ADJ
bjp-80949	95	11	consumption	consumption	NOUN
bjp-80949	95	12	.	.	PUNCT
bjp-80949	96	1	total	total	ADJ
bjp-80949	96	2	protein	protein	NOUN
bjp-80949	96	3	concentration	concentration	NOUN
bjp-80949	96	4	of	of	ADP
bjp-80949	96	5	the	the	DET
bjp-80949	96	6	lysates	lysate	NOUN
bjp-80949	96	7	was	be	AUX
bjp-80949	96	8	determined	determine	VERB
bjp-80949	96	9	using	use	VERB
bjp-80949	96	10	the	the	DET
bjp-80949	96	11	bradford	bradford	NOUN
bjp-80949	96	12	method	method	NOUN
bjp-80949	96	13	,	,	PUNCT
bjp-80949	96	14	with	with	ADP
bjp-80949	96	15	bsa	bsa	PROPN
bjp-80949	96	16	as	as	ADP
bjp-80949	96	17	the	the	DET
bjp-80949	96	18	standard	standard	NOUN
bjp-80949	96	19	.	.	PUNCT
bjp-80949	97	1	all	all	DET
bjp-80949	97	2	samples	sample	NOUN
bjp-80949	97	3	were	be	AUX
bjp-80949	97	4	analyzed	analyze	VERB
bjp-80949	97	5	in	in	ADP
bjp-80949	97	6	triplicate	triplicate	NOUN
bjp-80949	97	7	.	.	PUNCT
bjp-80949	98	1	one	one	NUM
bjp-80949	98	2	unit	unit	NOUN
bjp-80949	98	3	of	of	ADP
bjp-80949	98	4	gpx	gpx	NOUN
bjp-80949	98	5	activity	activity	NOUN
bjp-80949	98	6	is	be	AUX
bjp-80949	98	7	defined	define	VERB
bjp-80949	98	8	as	as	ADP
bjp-80949	98	9	the	the	DET
bjp-80949	98	10	amount	amount	NOUN
bjp-80949	98	11	of	of	ADP
bjp-80949	98	12	enzyme	enzyme	NOUN
bjp-80949	98	13	that	that	PRON
bjp-80949	98	14	catalyzes	catalyze	VERB
bjp-80949	98	15	the	the	DET
bjp-80949	98	16	oxidation	oxidation	NOUN
bjp-80949	98	17	of	of	ADP
bjp-80949	98	18	1	1	NUM
bjp-80949	98	19	µmol	µmol	ADV
bjp-80949	98	20	of	of	ADP
bjp-80949	98	21	nadph	nadph	ADJ
bjp-80949	98	22	per	per	ADP
bjp-80949	98	23	min	min	NOUN
bjp-80949	98	24	under	under	ADP
bjp-80949	98	25	assay	assay	NOUN
bjp-80949	98	26	conditions	condition	NOUN
bjp-80949	98	27	.	.	PUNCT
bjp-80949	99	1	references	reference	NOUN
bjp-80949	99	2	bradford	bradford	NOUN
bjp-80949	99	3	,	,	PUNCT
bjp-80949	99	4	1976	1976	NUM
bjp-80949	99	5	;	;	PUNCT
bjp-80949	99	6	flohe	flohe	NOUN
bjp-80949	99	7	and	and	CCONJ
bjp-80949	99	8	gunzler	gunzler	NOUN
bjp-80949	99	9	,	,	PUNCT
bjp-80949	99	10	1984	1984	NUM
bjp-80949	99	11	24	24	NUM
bjp-80949	99	12	bangladesh	bangladesh	PROPN
bjp-80949	99	13	j	j	PROPN
bjp-80949	99	14	pharmacol	pharmacol	PROPN
bjp-80949	99	15	2025	2025	NUM
bjp-80949	99	16	;	;	PUNCT
bjp-80949	99	17	20	20	NUM
bjp-80949	99	18	:	:	SYM
bjp-80949	99	19	22	22	NUM
bjp-80949	99	20	-	-	SYM
bjp-80949	99	21	34	34	NUM
bjp-80949	99	22	then	then	ADV
bjp-80949	99	23	measured	measure	VERB
bjp-80949	99	24	colorimetrically	colorimetrically	ADV
bjp-80949	99	25	at	at	ADP
bjp-80949	99	26	450	450	NUM
bjp-80949	99	27	nm	nm	NOUN
bjp-80949	99	28	.	.	PUNCT
bjp-80949	100	1	the	the	DET
bjp-80949	100	2	formula	formula	NOUN
bjp-80949	100	3	used	use	VERB
bjp-80949	100	4	to	to	PART
bjp-80949	100	5	calculate	calculate	VERB
bjp-80949	100	6	ldh	ldh	NOUN
bjp-80949	100	7	activity	activity	NOUN
bjp-80949	100	8	is	be	AUX
bjp-80949	100	9	given	give	VERB
bjp-80949	100	10	below	below	ADV
bjp-80949	100	11	:	:	PUNCT
bjp-80949	100	12	ldh	ldh	NOUN
bjp-80949	100	13	activity	activity	NOUN
bjp-80949	100	14	=	=	PUNCT
bjp-80949	100	15	the	the	DET
bjp-80949	100	16	amount	amount	NOUN
bjp-80949	100	17	of	of	ADP
bjp-80949	100	18	nadh	nadh	NOUN
bjp-80949	100	19	that	that	PRON
bjp-80949	100	20	occurs	occur	VERB
bjp-80949	100	21	between	between	ADP
bjp-80949	100	22	the	the	DET
bjp-80949	100	23	first	first	ADJ
bjp-80949	100	24	and	and	CCONJ
bjp-80949	100	25	last	last	ADJ
bjp-80949	100	26	measurement	measurement	NOUN
bjp-80949	100	27	(	(	PUNCT
bjp-80949	100	28	nmol	nmol	NOUN
bjp-80949	100	29	)	)	PUNCT
bjp-80949	100	30	×	×	NOUN
bjp-80949	100	31	sample	sample	NOUN
bjp-80949	100	32	dilution	dilution	NOUN
bjp-80949	100	33	factor	factor	NOUN
bjp-80949	100	34	/	/	SYM
bjp-80949	100	35	reaction	reaction	NOUN
bjp-80949	100	36	time	time	NOUN
bjp-80949	100	37	×	×	PROPN
bjp-80949	100	38	sample	sample	NOUN
bjp-80949	100	39	volume	volume	NOUN
bjp-80949	100	40	(	(	PUNCT
bjp-80949	100	41	ml	ml	NOUN
bjp-80949	100	42	)	)	PUNCT
bjp-80949	100	43	caspase-3	caspase-3	NUM
bjp-80949	100	44	activity	activity	NOUN
bjp-80949	100	45	by	by	ADP
bjp-80949	100	46	examining	examine	VERB
bjp-80949	100	47	the	the	DET
bjp-80949	100	48	changes	change	NOUN
bjp-80949	100	49	in	in	ADP
bjp-80949	100	50	caspase-3	caspase-3	NUM
bjp-80949	100	51	activity	activity	NOUN
bjp-80949	100	52	,	,	PUNCT
bjp-80949	100	53	a	a	DET
bjp-80949	100	54	crucial	crucial	ADJ
bjp-80949	100	55	enzyme	enzyme	NOUN
bjp-80949	100	56	in	in	ADP
bjp-80949	100	57	the	the	DET
bjp-80949	100	58	apoptosis	apoptosis	NOUN
bjp-80949	100	59	process	process	NOUN
bjp-80949	100	60	,	,	PUNCT
bjp-80949	100	61	after	after	ADP
bjp-80949	100	62	48	48	NUM
bjp-80949	100	63	hours	hour	NOUN
bjp-80949	100	64	of	of	ADP
bjp-80949	100	65	application	application	NOUN
bjp-80949	100	66	of	of	ADP
bjp-80949	100	67	cetuximab	cetuximab	NOUN
bjp-80949	100	68	alone	alone	ADJ
bjp-80949	100	69	and	and	CCONJ
bjp-80949	100	70	also	also	ADV
bjp-80949	100	71	in	in	ADP
bjp-80949	100	72	combination	combination	NOUN
bjp-80949	100	73	with	with	ADP
bjp-80949	100	74	carvacrol	carvacrol	NOUN
bjp-80949	100	75	(	(	PUNCT
bjp-80949	100	76	at	at	ADP
bjp-80949	100	77	the	the	DET
bjp-80949	100	78	concentration	concentration	NOUN
bjp-80949	100	79	combination	combination	NOUN
bjp-80949	100	80	that	that	PRON
bjp-80949	100	81	showed	show	VERB
bjp-80949	100	82	the	the	DET
bjp-80949	100	83	highest	high	ADJ
bjp-80949	100	84	cytotoxic	cytotoxic	ADJ
bjp-80949	100	85	effect	effect	NOUN
bjp-80949	100	86	)	)	PUNCT
bjp-80949	100	87	,	,	PUNCT
bjp-80949	100	88	the	the	DET
bjp-80949	100	89	apoptotic	apoptotic	ADJ
bjp-80949	100	90	effects	effect	NOUN
bjp-80949	100	91	of	of	ADP
bjp-80949	100	92	both	both	CCONJ
bjp-80949	100	93	alone	alone	ADJ
bjp-80949	100	94	and	and	CCONJ
bjp-80949	100	95	combined	combined	ADJ
bjp-80949	100	96	application	application	NOUN
bjp-80949	100	97	on	on	ADP
bjp-80949	100	98	cells	cell	NOUN
bjp-80949	100	99	were	be	AUX
bjp-80949	100	100	tried	try	VERB
bjp-80949	100	101	to	to	PART
bjp-80949	100	102	be	be	AUX
bjp-80949	100	103	explained	explain	VERB
bjp-80949	100	104	.	.	PUNCT
bjp-80949	101	1	apoptotic	apoptotic	ADJ
bjp-80949	101	2	enzyme	enzyme	NOUN
bjp-80949	101	3	performance	performance	NOUN
bjp-80949	101	4	was	be	AUX
bjp-80949	101	5	measured	measure	VERB
bjp-80949	101	6	through	through	ADP
bjp-80949	101	7	a	a	DET
bjp-80949	101	8	commercially	commercially	ADV
bjp-80949	101	9	available	available	ADJ
bjp-80949	101	10	colorimetric	colorimetric	ADJ
bjp-80949	101	11	based	base	VERB
bjp-80949	101	12	caspase-3	caspase-3	NUM
bjp-80949	101	13	activity	activity	NOUN
bjp-80949	101	14	detection	detection	NOUN
bjp-80949	101	15	kit	kit	NOUN
bjp-80949	101	16	(	(	PUNCT
bjp-80949	101	17	elabscience	elabscience	NOUN
bjp-80949	101	18	)	)	PUNCT
bjp-80949	101	19	,	,	PUNCT
bjp-80949	101	20	following	follow	VERB
bjp-80949	101	21	the	the	DET
bjp-80949	101	22	provided	provide	VERB
bjp-80949	101	23	protocol	protocol	NOUN
bjp-80949	101	24	.	.	PUNCT
bjp-80949	102	1	the	the	DET
bjp-80949	102	2	specimens	specimen	NOUN
bjp-80949	102	3	were	be	AUX
bjp-80949	102	4	analyzed	analyze	VERB
bjp-80949	102	5	at	at	ADP
bjp-80949	102	6	405	405	NUM
bjp-80949	102	7	nm	nm	NOUN
bjp-80949	102	8	with	with	ADP
bjp-80949	102	9	the	the	DET
bjp-80949	102	10	aid	aid	NOUN
bjp-80949	102	11	of	of	ADP
bjp-80949	102	12	a	a	DET
bjp-80949	102	13	microplate	microplate	NOUN
bjp-80949	102	14	reader	reader	NOUN
bjp-80949	102	15	.	.	PUNCT
bjp-80949	103	1	the	the	DET
bjp-80949	103	2	tests	test	NOUN
bjp-80949	103	3	were	be	AUX
bjp-80949	103	4	conducted	conduct	VERB
bjp-80949	103	5	in	in	ADP
bjp-80949	103	6	three	three	NUM
bjp-80949	103	7	repetitions	repetition	NOUN
bjp-80949	103	8	.	.	PUNCT
bjp-80949	104	1	the	the	DET
bjp-80949	104	2	results	result	NOUN
bjp-80949	104	3	are	be	AUX
bjp-80949	104	4	expressed	express	VERB
bjp-80949	104	5	as	as	ADP
bjp-80949	104	6	units	unit	NOUN
bjp-80949	104	7	per	per	ADP
bjp-80949	104	8	milligram	milligram	NOUN
bjp-80949	104	9	of	of	ADP
bjp-80949	104	10	protein	protein	NOUN
bjp-80949	104	11	.	.	PUNCT
bjp-80949	105	1	rna	rna	NOUN
bjp-80949	105	2	isolation	isolation	NOUN
bjp-80949	105	3	and	and	CCONJ
bjp-80949	105	4	gene	gene	NOUN
bjp-80949	105	5	transcriptional	transcriptional	NOUN
bjp-80949	105	6	activity	activity	NOUN
bjp-80949	105	7	reverse	reverse	VERB
bjp-80949	105	8	transcription	transcription	NOUN
bjp-80949	105	9	-	-	PUNCT
bjp-80949	105	10	based	base	VERB
bjp-80949	105	11	polymerase	polymerase	NOUN
bjp-80949	105	12	chain	chain	NOUN
bjp-80949	105	13	reaction	reaction	NOUN
bjp-80949	105	14	(	(	PUNCT
bjp-80949	105	15	rt	rt	ADJ
bjp-80949	105	16	-	-	PUNCT
bjp-80949	105	17	pcr	pcr	NOUN
bjp-80949	105	18	)	)	PUNCT
bjp-80949	105	19	method	method	NOUN
bjp-80949	105	20	was	be	AUX
bjp-80949	105	21	implemented	implement	VERB
bjp-80949	105	22	to	to	PART
bjp-80949	105	23	reveal	reveal	VERB
bjp-80949	105	24	whether	whether	SCONJ
bjp-80949	105	25	there	there	PRON
bjp-80949	105	26	was	be	VERB
bjp-80949	105	27	a	a	DET
bjp-80949	105	28	change	change	NOUN
bjp-80949	105	29	in	in	ADP
bjp-80949	105	30	the	the	DET
bjp-80949	105	31	transcriptional	transcriptional	ADJ
bjp-80949	105	32	levels	level	NOUN
bjp-80949	105	33	of	of	ADP
bjp-80949	105	34	expression	expression	NOUN
bjp-80949	105	35	of	of	ADP
bjp-80949	105	36	many	many	ADJ
bjp-80949	105	37	genes	gene	NOUN
bjp-80949	105	38	–	–	PUNCT
bjp-80949	105	39	proliferating	proliferate	VERB
bjp-80949	105	40	cell	cell	NOUN
bjp-80949	105	41	nuclear	nuclear	ADJ
bjp-80949	105	42	antigen	antigen	NOUN
bjp-80949	105	43	(	(	PUNCT
bjp-80949	105	44	pcna	pcna	PROPN
bjp-80949	105	45	)	)	PUNCT
bjp-80949	105	46	and	and	CCONJ
bjp-80949	105	47	various	various	ADJ
bjp-80949	105	48	cyclins	cyclin	NOUN
bjp-80949	105	49	(	(	PUNCT
bjp-80949	105	50	d1	d1	NOUN
bjp-80949	105	51	,	,	PUNCT
bjp-80949	105	52	e	e	NOUN
bjp-80949	105	53	,	,	PUNCT
bjp-80949	105	54	a	a	DET
bjp-80949	105	55	,	,	PUNCT
bjp-80949	105	56	d2	d2	PROPN
bjp-80949	105	57	,	,	PUNCT
bjp-80949	105	58	b	b	NOUN
bjp-80949	105	59	)	)	PUNCT
bjp-80949	105	60	,	,	PUNCT
bjp-80949	105	61	topoisomerase	topoisomerase	PROPN
bjp-80949	105	62	ii	ii	PROPN
bjp-80949	105	63	-	-	PUNCT
bjp-80949	105	64	alpha	alpha	PROPN
bjp-80949	105	65	,	,	PUNCT
bjp-80949	105	66	bax	bax	PROPN
bjp-80949	105	67	,	,	PUNCT
bjp-80949	105	68	and	and	CCONJ
bjp-80949	105	69	bcl-2	bcl-2	NOUN
bjp-80949	105	70	)	)	PUNCT
bjp-80949	105	71	in	in	ADP
bjp-80949	105	72	h1299	h1299	NOUN
bjp-80949	105	73	and	and	CCONJ
bjp-80949	105	74	a549	a549	PROPN
bjp-80949	105	75	cells	cell	NOUN
bjp-80949	105	76	.	.	PUNCT
bjp-80949	106	1	rna	rna	NOUN
bjp-80949	106	2	expression	expression	NOUN
bjp-80949	106	3	was	be	AUX
bjp-80949	106	4	analyzed	analyze	VERB
bjp-80949	106	5	after	after	ADP
bjp-80949	106	6	alone	alone	ADV
bjp-80949	106	7	or	or	CCONJ
bjp-80949	106	8	in	in	ADP
bjp-80949	106	9	combination	combination	NOUN
bjp-80949	106	10	with	with	ADP
bjp-80949	106	11	carvacrol	carvacrol	NOUN
bjp-80949	106	12	(	(	PUNCT
bjp-80949	106	13	at	at	ADP
bjp-80949	106	14	the	the	DET
bjp-80949	106	15	most	most	ADV
bjp-80949	106	16	effective	effective	ADJ
bjp-80949	106	17	cytotoxic	cytotoxic	ADJ
bjp-80949	106	18	concentration	concentration	NOUN
bjp-80949	106	19	)	)	PUNCT
bjp-80949	106	20	in	in	ADP
bjp-80949	106	21	h1299	h1299	NOUN
bjp-80949	106	22	and	and	CCONJ
bjp-80949	106	23	a-549	a-549	PROPN
bjp-80949	106	24	cells	cell	NOUN
bjp-80949	106	25	.	.	PUNCT
bjp-80949	107	1	gene	gene	NOUN
bjp-80949	107	2	expression	expression	NOUN
bjp-80949	107	3	analysis	analysis	NOUN
bjp-80949	107	4	was	be	AUX
bjp-80949	107	5	carried	carry	VERB
bjp-80949	107	6	out	out	ADP
bjp-80949	107	7	in	in	ADP
bjp-80949	107	8	three	three	NUM
bjp-80949	107	9	separate	separate	ADJ
bjp-80949	107	10	repetitions	repetition	NOUN
bjp-80949	107	11	.	.	PUNCT
bjp-80949	108	1	total	total	ADJ
bjp-80949	108	2	rna	rna	PROPN
bjp-80949	108	3	was	be	AUX
bjp-80949	108	4	isolated	isolate	VERB
bjp-80949	108	5	after	after	ADP
bjp-80949	108	6	48	48	NUM
bjp-80949	108	7	hours	hour	NOUN
bjp-80949	108	8	of	of	ADP
bjp-80949	108	9	treatment	treatment	NOUN
bjp-80949	108	10	according	accord	VERB
bjp-80949	108	11	to	to	ADP
bjp-80949	108	12	the	the	DET
bjp-80949	108	13	recommendation	recommendation	NOUN
bjp-80949	108	14	of	of	ADP
bjp-80949	108	15	the	the	DET
bjp-80949	108	16	commercially	commercially	ADV
bjp-80949	108	17	available	available	ADJ
bjp-80949	108	18	rneasy	rneasy	PROPN
bjp-80949	108	19	mini	mini	NOUN
bjp-80949	108	20	kit	kit	NOUN
bjp-80949	108	21	supplied	supply	VERB
bjp-80949	108	22	by	by	ADP
bjp-80949	108	23	qiagen	qiagen	PROPN
bjp-80949	108	24	.	.	PUNCT
bjp-80949	109	1	after	after	ADP
bjp-80949	109	2	rna	rna	NOUN
bjp-80949	109	3	harvesting	harvesting	NOUN
bjp-80949	109	4	,	,	PUNCT
bjp-80949	109	5	cdna	cdna	PROPN
bjp-80949	109	6	synthesis	synthesis	NOUN
bjp-80949	109	7	was	be	AUX
bjp-80949	109	8	undertaken	undertake	VERB
bjp-80949	109	9	using	use	VERB
bjp-80949	109	10	the	the	DET
bjp-80949	109	11	specified	specify	VERB
bjp-80949	109	12	steps	step	NOUN
bjp-80949	109	13	in	in	ADP
bjp-80949	109	14	roche	roche	PROPN
bjp-80949	109	15	applied	apply	VERB
bjp-80949	109	16	science	science	NOUN
bjp-80949	109	17	's	's	PART
bjp-80949	109	18	titan	titan	NOUN
bjp-80949	109	19	one	one	NUM
bjp-80949	109	20	tube	tube	NOUN
bjp-80949	109	21	rt	rt	ADJ
bjp-80949	109	22	-	-	PUNCT
bjp-80949	109	23	pcr	pcr	ADJ
bjp-80949	109	24	system	system	NOUN
bjp-80949	109	25	.	.	PUNCT
bjp-80949	110	1	a	a	DET
bjp-80949	110	2	total	total	NOUN
bjp-80949	110	3	of	of	ADP
bjp-80949	110	4	30	30	NUM
bjp-80949	110	5	cycles	cycle	NOUN
bjp-80949	110	6	of	of	ADP
bjp-80949	110	7	rt	rt	NOUN
bjp-80949	110	8	-	-	PUNCT
bjp-80949	110	9	pcr	pcr	PROPN
bjp-80949	110	10	were	be	AUX
bjp-80949	110	11	completed	complete	VERB
bjp-80949	110	12	.	.	PUNCT
bjp-80949	111	1	in	in	ADP
bjp-80949	111	2	the	the	DET
bjp-80949	111	3	rt	rt	ADJ
bjp-80949	111	4	-	-	PUNCT
bjp-80949	111	5	pcr	pcr	NOUN
bjp-80949	111	6	protocol	protocol	NOUN
bjp-80949	111	7	,	,	PUNCT
bjp-80949	111	8	denaturation	denaturation	NOUN
bjp-80949	111	9	step	step	NOUN
bjp-80949	111	10	at	at	ADP
bjp-80949	111	11	94	94	NUM
bjp-80949	111	12	°	°	ADP
bjp-80949	111	13	c	c	NOUN
bjp-80949	111	14	for	for	ADP
bjp-80949	111	15	1	1	NUM
bjp-80949	111	16	min	min	NOUN
bjp-80949	111	17	;	;	PUNCT
bjp-80949	111	18	annealing	anneal	VERB
bjp-80949	111	19	conducted	conduct	VERB
bjp-80949	111	20	for	for	ADP
bjp-80949	111	21	1	1	NUM
bjp-80949	111	22	min	min	NOUN
bjp-80949	111	23	at	at	ADP
bjp-80949	111	24	temperatures	temperature	NOUN
bjp-80949	111	25	between	between	ADP
bjp-80949	111	26	52	52	NUM
bjp-80949	111	27	°	°	NOUN
bjp-80949	111	28	c	c	NOUN
bjp-80949	111	29	and	and	CCONJ
bjp-80949	111	30	60	60	NUM
bjp-80949	111	31	°	°	NOUN
bjp-80949	111	32	c	c	NOUN
bjp-80949	111	33	(	(	PUNCT
bjp-80949	111	34	these	these	DET
bjp-80949	111	35	temperature	temperature	NOUN
bjp-80949	111	36	ranges	range	NOUN
bjp-80949	111	37	were	be	AUX
bjp-80949	111	38	used	use	VERB
bjp-80949	111	39	according	accord	VERB
bjp-80949	111	40	to	to	ADP
bjp-80949	111	41	genes	gene	NOUN
bjp-80949	111	42	)	)	PUNCT
bjp-80949	111	43	were	be	AUX
bjp-80949	111	44	performed	perform	VERB
bjp-80949	111	45	for	for	ADP
bjp-80949	111	46	each	each	DET
bjp-80949	111	47	gene	gene	NOUN
bjp-80949	111	48	.	.	PUNCT
bjp-80949	112	1	2	2	NUM
bjp-80949	112	2	min	min	NOUN
bjp-80949	112	3	elongation	elongation	NOUN
bjp-80949	112	4	was	be	AUX
bjp-80949	112	5	performed	perform	VERB
bjp-80949	112	6	at	at	ADP
bjp-80949	112	7	72	72	NUM
bjp-80949	112	8	°	°	NOUN
bjp-80949	112	9	c	c	NOUN
bjp-80949	112	10	,	,	PUNCT
bjp-80949	112	11	followed	follow	VERB
bjp-80949	112	12	by	by	ADP
bjp-80949	112	13	a	a	DET
bjp-80949	112	14	final	final	ADJ
bjp-80949	112	15	90	90	NUM
bjp-80949	112	16	sec	sec	PROPN
bjp-80949	112	17	elongation	elongation	NOUN
bjp-80949	112	18	at	at	ADP
bjp-80949	112	19	the	the	DET
bjp-80949	112	20	same	same	ADJ
bjp-80949	112	21	temperature	temperature	NOUN
bjp-80949	112	22	.	.	PUNCT
bjp-80949	113	1	bcl-2	bcl-2	NOUN
bjp-80949	113	2	gene	gene	NOUN
bjp-80949	113	3	was	be	AUX
bjp-80949	113	4	amplified	amplify	VERB
bjp-80949	113	5	using	use	VERB
bjp-80949	113	6	touchdown	touchdown	ADJ
bjp-80949	113	7	pcr	pcr	NOUN
bjp-80949	113	8	,	,	PUNCT
bjp-80949	113	9	starting	start	VERB
bjp-80949	113	10	with	with	ADP
bjp-80949	113	11	an	an	DET
bjp-80949	113	12	annealing	anneal	VERB
bjp-80949	113	13	temperature	temperature	NOUN
bjp-80949	113	14	of	of	ADP
bjp-80949	113	15	73	73	NUM
bjp-80949	113	16	°	°	NOUN
bjp-80949	113	17	c	c	NOUN
bjp-80949	113	18	,	,	PUNCT
bjp-80949	113	19	which	which	PRON
bjp-80949	113	20	was	be	AUX
bjp-80949	113	21	gradually	gradually	ADV
bjp-80949	113	22	decreased	decrease	VERB
bjp-80949	113	23	by	by	ADP
bjp-80949	113	24	1	1	NUM
bjp-80949	113	25	°	°	ADP
bjp-80949	113	26	c	c	NOUN
bjp-80949	113	27	per	per	ADP
bjp-80949	113	28	cycle	cycle	NOUN
bjp-80949	113	29	for	for	ADP
bjp-80949	113	30	the	the	DET
bjp-80949	113	31	first	first	ADJ
bjp-80949	113	32	10	10	NUM
bjp-80949	113	33	cycles	cycle	NOUN
bjp-80949	113	34	,	,	PUNCT
bjp-80949	113	35	and	and	CCONJ
bjp-80949	113	36	then	then	ADV
bjp-80949	113	37	held	hold	VERB
bjp-80949	113	38	at	at	ADP
bjp-80949	113	39	63	63	NUM
bjp-80949	113	40	°	°	ADP
bjp-80949	113	41	c	c	NOUN
bjp-80949	113	42	for	for	ADP
bjp-80949	113	43	the	the	DET
bjp-80949	113	44	remaining	remain	VERB
bjp-80949	113	45	25	25	NUM
bjp-80949	113	46	repetitions	repetition	NOUN
bjp-80949	113	47	.	.	PUNCT
bjp-80949	114	1	water	water	NOUN
bjp-80949	114	2	was	be	AUX
bjp-80949	114	3	used	use	VERB
bjp-80949	114	4	as	as	ADP
bjp-80949	114	5	the	the	DET
bjp-80949	114	6	control	control	NOUN
bjp-80949	114	7	group	group	NOUN
bjp-80949	114	8	.	.	PUNCT
bjp-80949	115	1	all	all	DET
bjp-80949	115	2	rt	rt	ADJ
bjp-80949	115	3	-	-	PUNCT
bjp-80949	115	4	pcr	pcr	ADJ
bjp-80949	115	5	experiments	experiment	NOUN
bjp-80949	115	6	were	be	AUX
bjp-80949	115	7	conducted	conduct	VERB
bjp-80949	115	8	in	in	ADP
bjp-80949	115	9	three	three	NUM
bjp-80949	115	10	replicates	replicate	NOUN
bjp-80949	115	11	.	.	PUNCT
bjp-80949	116	1	glyceraldehyde-3	glyceraldehyde-3	NUM
bjp-80949	116	2	-	-	ADJ
bjp-80949	116	3	phosphate	phosphate	ADJ
bjp-80949	116	4	dehydrogenase	dehydrogenase	NOUN
bjp-80949	116	5	(	(	PUNCT
bjp-80949	116	6	gapdh	gapdh	NOUN
bjp-80949	116	7	)	)	PUNCT
bjp-80949	116	8	was	be	AUX
bjp-80949	116	9	applied	apply	VERB
bjp-80949	116	10	as	as	ADP
bjp-80949	116	11	the	the	DET
bjp-80949	116	12	stable	stable	ADJ
bjp-80949	116	13	reference	reference	NOUN
bjp-80949	116	14	gene	gene	NOUN
bjp-80949	116	15	for	for	ADP
bjp-80949	116	16	expression	expression	NOUN
bjp-80949	116	17	normalization	normalization	NOUN
bjp-80949	116	18	.	.	PUNCT
bjp-80949	117	1	a	a	DET
bjp-80949	117	2	precise	precise	ADJ
bjp-80949	117	3	explanation	explanation	NOUN
bjp-80949	117	4	of	of	ADP
bjp-80949	117	5	the	the	DET
bjp-80949	117	6	genes	gene	NOUN
bjp-80949	117	7	and	and	CCONJ
bjp-80949	117	8	primers	primer	NOUN
bjp-80949	117	9	utilized	utilize	VERB
bjp-80949	117	10	in	in	ADP
bjp-80949	117	11	the	the	DET
bjp-80949	117	12	current	current	ADJ
bjp-80949	117	13	investigation	investigation	NOUN
bjp-80949	117	14	can	can	AUX
bjp-80949	117	15	be	be	AUX
bjp-80949	117	16	established	establish	VERB
bjp-80949	117	17	in	in	ADP
bjp-80949	117	18	table	table	NOUN
bjp-80949	117	19	i.	i.	NOUN
bjp-80949	117	20	all	all	PRON
bjp-80949	117	21	amplified	amplify	VERB
bjp-80949	117	22	dna	dna	NOUN
bjp-80949	117	23	fragments	fragment	NOUN
bjp-80949	117	24	were	be	AUX
bjp-80949	117	25	interpreted	interpret	VERB
bjp-80949	117	26	using	use	VERB
bjp-80949	117	27	2.5	2.5	NUM
bjp-80949	117	28	%	%	NOUN
bjp-80949	117	29	agar	agar	NOUN
bjp-80949	117	30	gel	gel	NOUN
bjp-80949	117	31	electrophoresis	electrophoresis	NOUN
bjp-80949	117	32	prepared	prepare	VERB
bjp-80949	117	33	using	use	VERB
bjp-80949	117	34	tbe	tbe	NOUN
bjp-80949	117	35	buffer	buffer	NOUN
bjp-80949	117	36	(	(	PUNCT
bjp-80949	117	37	containing	contain	VERB
bjp-80949	117	38	ethidium	ethidium	ADJ
bjp-80949	117	39	bromide	bromide	NOUN
bjp-80949	117	40	)	)	PUNCT
bjp-80949	117	41	.	.	PUNCT
bjp-80949	118	1	the	the	DET
bjp-80949	118	2	gel	gel	NOUN
bjp-80949	118	3	underwent	underwent	NOUN
bjp-80949	118	4	electrophoresis	electrophoresis	NOUN
bjp-80949	118	5	for	for	ADP
bjp-80949	118	6	30	30	NUM
bjp-80949	118	7	min	min	NOUN
bjp-80949	118	8	under	under	ADP
bjp-80949	118	9	a	a	DET
bjp-80949	118	10	constant	constant	ADJ
bjp-80949	118	11	voltage	voltage	NOUN
bjp-80949	118	12	of	of	ADP
bjp-80949	118	13	120	120	NUM
bjp-80949	118	14	v	v	NOUN
bjp-80949	118	15	,	,	PUNCT
bjp-80949	118	16	utilizing	utilize	VERB
bjp-80949	118	17	a	a	DET
bjp-80949	118	18	100	100	NUM
bjp-80949	118	19	bp	bp	PROPN
bjp-80949	118	20	dna	dna	PROPN
bjp-80949	118	21	ladder	ladder	NOUN
bjp-80949	118	22	used	use	VERB
bjp-80949	118	23	as	as	ADP
bjp-80949	118	24	molecular	molecular	ADJ
bjp-80949	118	25	weight	weight	NOUN
bjp-80949	118	26	references	reference	NOUN
bjp-80949	118	27	.	.	PUNCT
bjp-80949	119	1	band	band	NOUN
bjp-80949	119	2	density	density	NOUN
bjp-80949	119	3	was	be	AUX
bjp-80949	119	4	analyzed	analyze	VERB
bjp-80949	119	5	using	use	VERB
bjp-80949	119	6	adobe	adobe	PROPN
bjp-80949	119	7	photoshop	photoshop	PROPN
bjp-80949	119	8	cs4	cs4	PROPN
bjp-80949	119	9	.	.	PUNCT
bjp-80949	120	1	the	the	DET
bjp-80949	120	2	intensity	intensity	NOUN
bjp-80949	120	3	of	of	ADP
bjp-80949	120	4	pcr	pcr	NOUN
bjp-80949	120	5	bands	band	NOUN
bjp-80949	120	6	was	be	AUX
bjp-80949	120	7	evaluated	evaluate	VERB
bjp-80949	120	8	by	by	ADP
bjp-80949	120	9	normalizing	normalize	VERB
bjp-80949	120	10	to	to	ADP
bjp-80949	120	11	the	the	DET
bjp-80949	120	12	intensity	intensity	NOUN
bjp-80949	120	13	of	of	ADP
bjp-80949	120	14	the	the	DET
bjp-80949	120	15	housekeeping	housekeeping	NOUN
bjp-80949	120	16	gene	gene	NOUN
bjp-80949	120	17	.	.	PUNCT
bjp-80949	121	1	all	all	DET
bjp-80949	121	2	pcr	pcr	NOUN
bjp-80949	121	3	samples	sample	NOUN
bjp-80949	121	4	were	be	AUX
bjp-80949	121	5	examined	examine	VERB
bjp-80949	121	6	in	in	ADP
bjp-80949	121	7	relation	relation	NOUN
bjp-80949	121	8	to	to	ADP
bjp-80949	121	9	the	the	DET
bjp-80949	121	10	control	control	NOUN
bjp-80949	121	11	band	band	NOUN
bjp-80949	121	12	intensities	intensity	NOUN
bjp-80949	121	13	and	and	CCONJ
bjp-80949	121	14	the	the	DET
bjp-80949	121	15	outcomes	outcome	NOUN
bjp-80949	121	16	were	be	AUX
bjp-80949	121	17	given	give	VERB
bjp-80949	121	18	as	as	ADP
bjp-80949	121	19	percentage	percentage	NOUN
bjp-80949	121	20	control	control	NOUN
bjp-80949	121	21	(	(	PUNCT
bjp-80949	121	22	bijwaard	bijwaard	PROPN
bjp-80949	121	23	et	et	PROPN
bjp-80949	121	24	al	al	PROPN
bjp-80949	121	25	.	.	PROPN
bjp-80949	121	26	,	,	PUNCT
bjp-80949	121	27	2001	2001	NUM
bjp-80949	121	28	;	;	PUNCT
bjp-80949	122	1	huang	huang	PROPN
bjp-80949	122	2	et	et	PROPN
bjp-80949	122	3	al	al	PROPN
bjp-80949	122	4	.	.	PROPN
bjp-80949	122	5	,	,	PUNCT
bjp-80949	122	6	2003	2003	NUM
bjp-80949	122	7	)	)	PUNCT
bjp-80949	122	8	.	.	PUNCT
bjp-80949	123	1	statistical	statistical	ADJ
bjp-80949	123	2	analysis	analysis	NOUN
bjp-80949	123	3	replicate	replicate	NOUN
bjp-80949	123	4	consequences	consequence	NOUN
bjp-80949	123	5	were	be	AUX
bjp-80949	123	6	aggregated	aggregate	VERB
bjp-80949	123	7	and	and	CCONJ
bjp-80949	123	8	displayed	display	VERB
bjp-80949	123	9	as	as	ADP
bjp-80949	123	10	mean	mean	PROPN
bjp-80949	123	11	±	±	NUM
bjp-80949	123	12	sem	sem	PROPN
bjp-80949	123	13	.	.	PUNCT
bjp-80949	124	1	variance	variance	NOUN
bjp-80949	124	2	analysis	analysis	NOUN
bjp-80949	124	3	(	(	PUNCT
bjp-80949	124	4	anova	anova	PROPN
bjp-80949	124	5	)	)	PUNCT
bjp-80949	124	6	was	be	AUX
bjp-80949	124	7	accomplished	accomplish	VERB
bjp-80949	124	8	for	for	ADP
bjp-80949	124	9	quantitative	quantitative	ADJ
bjp-80949	124	10	assessment	assessment	NOUN
bjp-80949	124	11	.	.	PUNCT
bjp-80949	125	1	one	one	NUM
bjp-80949	125	2	-	-	PUNCT
bjp-80949	125	3	way	way	NOUN
bjp-80949	125	4	anova	anova	PROPN
bjp-80949	125	5	was	be	AUX
bjp-80949	125	6	conducted	conduct	VERB
bjp-80949	125	7	to	to	PART
bjp-80949	125	8	assess	assess	VERB
bjp-80949	125	9	if	if	SCONJ
bjp-80949	125	10	marked	mark	VERB
bjp-80949	125	11	differences	difference	NOUN
bjp-80949	125	12	were	be	AUX
bjp-80949	125	13	identified	identify	VERB
bjp-80949	125	14	between	between	ADP
bjp-80949	125	15	the	the	DET
bjp-80949	125	16	central	central	ADJ
bjp-80949	125	17	tendencies	tendency	NOUN
bjp-80949	125	18	of	of	ADP
bjp-80949	125	19	three	three	NUM
bjp-80949	125	20	or	or	CCONJ
bjp-80949	125	21	more	more	ADV
bjp-80949	125	22	independent	independent	ADJ
bjp-80949	125	23	groups	group	NOUN
bjp-80949	125	24	with	with	ADP
bjp-80949	125	25	respect	respect	NOUN
bjp-80949	125	26	to	to	ADP
bjp-80949	125	27	a	a	DET
bjp-80949	125	28	certain	certain	ADJ
bjp-80949	125	29	variable	variable	NOUN
bjp-80949	125	30	.	.	PUNCT
bjp-80949	126	1	tukey	tukey	PROPN
bjp-80949	126	2	's	's	PART
bjp-80949	126	3	test	test	NOUN
bjp-80949	126	4	was	be	AUX
bjp-80949	126	5	employed	employ	VERB
bjp-80949	126	6	for	for	ADP
bjp-80949	126	7	pairwise	pairwise	NOUN
bjp-80949	126	8	comparisons	comparison	NOUN
bjp-80949	126	9	.	.	PUNCT
bjp-80949	127	1	significant	significant	ADJ
bjp-80949	127	2	quantitative	quantitative	ADJ
bjp-80949	127	3	differences	difference	NOUN
bjp-80949	127	4	was	be	AUX
bjp-80949	127	5	recorded	record	VERB
bjp-80949	127	6	at	at	ADP
bjp-80949	127	7	p<0.05	p<0.05	PROPN
bjp-80949	127	8	.	.	PUNCT
bjp-80949	128	1	data	datum	NOUN
bjp-80949	128	2	analysis	analysis	NOUN
bjp-80949	128	3	was	be	AUX
bjp-80949	128	4	performed	perform	VERB
bjp-80949	128	5	with	with	ADP
bjp-80949	128	6	table	table	NOUN
bjp-80949	128	7	i	i	PRON
bjp-80949	128	8	sequence	sequence	NOUN
bjp-80949	128	9	of	of	ADP
bjp-80949	128	10	utilized	utilize	VERB
bjp-80949	128	11	primers	primer	NOUN
bjp-80949	128	12	gene	gene	VERB
bjp-80949	128	13	f	f	ADJ
bjp-80949	128	14	-	-	PUNCT
bjp-80949	128	15	primer	primer	NOUN
bjp-80949	128	16	sequence	sequence	NOUN
bjp-80949	128	17	(	(	PUNCT
bjp-80949	128	18	5’-3	5’-3	NOUN
bjp-80949	128	19	’	'	PUNCT
bjp-80949	128	20	)	)	PUNCT
bjp-80949	128	21	r	r	NOUN
bjp-80949	128	22	-	-	PUNCT
bjp-80949	128	23	primer	primer	NOUN
bjp-80949	128	24	sequence	sequence	NOUN
bjp-80949	128	25	(	(	PUNCT
bjp-80949	128	26	5’-3	5’-3	PROPN
bjp-80949	128	27	’	'	PUNCT
bjp-80949	128	28	)	)	PUNCT
bjp-80949	128	29	pcna	pcna	PROPN
bjp-80949	128	30	cgcgcagagggttggtagtt	cgcgcagagggttggtagtt	VERB
bjp-80949	128	31	aagccttcggagcgcagagt	aagccttcggagcgcagagt	PROPN
bjp-80949	128	32	bcl-2	bcl-2	PUNCT
bjp-80949	128	33	tgcacctgacgccct	tgcacctgacgccct	NOUN
bjp-80949	128	34	tcac	tcac	PROPN
bjp-80949	128	35	agacagccaggagaaatcaaacag	agacagccaggagaaatcaaacag	PROPN
bjp-80949	128	36	bax	bax	PROPN
bjp-80949	128	37	accaagaagctgagcgagtgtc	accaagaagctgagcgagtgtc	PROPN
bjp-80949	128	38	acaaagatggtcacggtctgcc	acaaagatggtcacggtctgcc	PROPN
bjp-80949	128	39	gapdh	gapdh	NOUN
bjp-80949	128	40	ttcattgacctcaactacat	ttcattgacctcaactacat	NOUN
bjp-80949	129	1	gaggggccatccacagtctt	gaggggccatccacagtctt	PROPN
bjp-80949	129	2	cyclin	cyclin	PROPN
bjp-80949	129	3	d1	d1	PROPN
bjp-80949	129	4	ccg	ccg	PROPN
bjp-80949	129	5	tcc	tcc	PROPN
bjp-80949	129	6	atg	atg	PROPN
bjp-80949	129	7	cgg	cgg	PROPN
bjp-80949	129	8	aag	aag	PROPN
bjp-80949	129	9	atc	atc	PROPN
bjp-80949	129	10	atg	atg	PROPN
bjp-80949	129	11	gcc	gcc	NOUN
bjp-80949	129	12	agc	agc	PROPN
bjp-80949	129	13	ggg	ggg	PROPN
bjp-80949	129	14	aag	aag	PROPN
bjp-80949	129	15	ac	ac	PROPN
bjp-80949	129	16	cyclin	cyclin	PROPN
bjp-80949	129	17	d2	d2	PROPN
bjp-80949	129	18	tacttcaagtgcgtgcagaaggac	tacttcaagtgcgtgcagaaggac	PROPN
bjp-80949	129	19	tcccacacttccagttgcgatcat	tcccacacttccagttgcgatcat	PROPN
bjp-80949	129	20	topoisomerase	topoisomerase	PROPN
bjp-80949	129	21	ii	ii	PROPN
bjp-80949	129	22	-	-	NOUN
bjp-80949	129	23	alpha	alpha	NOUN
bjp-80949	129	24	cagatcatggaaaatgctga	cagatcatggaaaatgctga	PROPN
bjp-80949	129	25	gcagcatcatcttcaggacc	gcagcatcatcttcaggacc	PROPN
bjp-80949	129	26	cyclin	cyclin	PROPN
bjp-80949	129	27	a	a	DET
bjp-80949	129	28	tggagagtgtatgtttgttgtggtg	tggagagtgtatgtttgttgtggtg	NOUN
bjp-80949	129	29	aaacttaacaatacaactaaactac	aaacttaacaatacaactaaactac	PROPN
bjp-80949	129	30	cyclin	cyclin	PROPN
bjp-80949	129	31	b	b	PROPN
bjp-80949	129	32	gacatggaagatgaagatcctaa	gacatggaagatgaagatcctaa	PROPN
bjp-80949	129	33	tcagcagtcacctcaccaatct	tcagcagtcacctcaccaatct	NOUN
bjp-80949	129	34	cyclin	cyclin	PROPN
bjp-80949	129	35	e	e	PROPN
bjp-80949	129	36	cagccaaaaatgcgagcaattc	cagccaaaaatgcgagcaattc	PROPN
bjp-80949	129	37	ttcatctcctgaacaagctccatc	ttcatctcctgaacaagctccatc	PROPN
bjp-80949	129	38	bangladesh	bangladesh	PROPN
bjp-80949	129	39	j	j	PROPN
bjp-80949	129	40	pharmacol	pharmacol	PROPN
bjp-80949	129	41	2025	2025	NUM
bjp-80949	129	42	;	;	PUNCT
bjp-80949	129	43	20	20	NUM
bjp-80949	129	44	:	:	SYM
bjp-80949	129	45	22	22	NUM
bjp-80949	129	46	-	-	SYM
bjp-80949	129	47	34	34	NUM
bjp-80949	129	48	25	25	NUM
bjp-80949	129	49	https://www.google.com.tr/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&ved=0ahukewii0ords6nvahwmffakhy1yamaqfggmmaa&url=https%3a%2f%2fen.wikipedia.org%2fwiki%2fcyclin_d1&usg=afqjcnhwazjwzp0tk4wcd_mjsgbdemwu2q	https://www.google.com.tr/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&ved=0ahukewii0ords6nvahwmffakhy1yamaqfggmmaa&url=https%3a%2f%2fen.wikipedia.org%2fwiki%2fcyclin_d1&usg=afqjcnhwazjwzp0tk4wcd_mjsgbdemwu2q	PROPN
bjp-80949	129	50	https://www.google.com.tr/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&ved=0ahukewii0ords6nvahwmffakhy1yamaqfggmmaa&url=https%3a%2f%2fen.wikipedia.org%2fwiki%2fcyclin_d1&usg=afqjcnhwazjwzp0tk4wcd_mjsgbdemwu2q	https://www.google.com.tr/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&ved=0ahukewii0ords6nvahwmffakhy1yamaqfggmmaa&url=https%3a%2f%2fen.wikipedia.org%2fwiki%2fcyclin_d1&usg=afqjcnhwazjwzp0tk4wcd_mjsgbdemwu2q	PROPN
bjp-80949	129	51	https://www.google.com.tr/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&ved=0ahukewii0ords6nvahwmffakhy1yamaqfggmmaa&url=https%3a%2f%2fen.wikipedia.org%2fwiki%2fcyclin_d1&usg=afqjcnhwazjwzp0tk4wcd_mjsgbdemwu2q	https://www.google.com.tr/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&ved=0ahukewii0ords6nvahwmffakhy1yamaqfggmmaa&url=https%3a%2f%2fen.wikipedia.org%2fwiki%2fcyclin_d1&usg=afqjcnhwazjwzp0tk4wcd_mjsgbdemwu2q	PROPN
bjp-80949	129	52	https://www.google.com.tr/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&ved=0ahukewii0ords6nvahwmffakhy1yamaqfggmmaa&url=https%3a%2f%2fen.wikipedia.org%2fwiki%2fcyclin_d1&usg=afqjcnhwazjwzp0tk4wcd_mjsgbdemwu2q	https://www.google.com.tr/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&ved=0ahukewii0ords6nvahwmffakhy1yamaqfggmmaa&url=https%3a%2f%2fen.wikipedia.org%2fwiki%2fcyclin_d1&usg=afqjcnhwazjwzp0tk4wcd_mjsgbdemwu2q	PROPN
bjp-80949	129	53	https://www.google.com.tr/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&ved=0ahukewii0ords6nvahwmffakhy1yamaqfggmmaa&url=https%3a%2f%2fen.wikipedia.org%2fwiki%2fcyclin_d1&usg=afqjcnhwazjwzp0tk4wcd_mjsgbdemwu2q	https://www.google.com.tr/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&ved=0ahukewii0ords6nvahwmffakhy1yamaqfggmmaa&url=https%3a%2f%2fen.wikipedia.org%2fwiki%2fcyclin_d1&usg=afqjcnhwazjwzp0tk4wcd_mjsgbdemwu2q	PROPN
bjp-80949	129	54	the	the	DET
bjp-80949	129	55	aid	aid	NOUN
bjp-80949	129	56	of	of	ADP
bjp-80949	129	57	minitab	minitab	PROPN
bjp-80949	129	58	software	software	PROPN
bjp-80949	129	59	,	,	PUNCT
bjp-80949	129	60	version	version	NOUN
bjp-80949	129	61	13.0	13.0	NUM
bjp-80949	129	62	.	.	PUNCT
bjp-80949	130	1	results	result	VERB
bjp-80949	130	2	influence	influence	NOUN
bjp-80949	130	3	on	on	ADP
bjp-80949	130	4	cell	cell	NOUN
bjp-80949	130	5	proliferation	proliferation	NOUN
bjp-80949	130	6	both	both	CCONJ
bjp-80949	130	7	a-549	a-549	PROPN
bjp-80949	130	8	and	and	CCONJ
bjp-80949	131	1	h1299	h1299	NOUN
bjp-80949	131	2	cells	cell	NOUN
bjp-80949	131	3	exhibited	exhibit	VERB
bjp-80949	131	4	a	a	DET
bjp-80949	131	5	concentrationdependent	concentrationdependent	NOUN
bjp-80949	131	6	response	response	NOUN
bjp-80949	131	7	to	to	ADP
bjp-80949	131	8	treatment	treatment	NOUN
bjp-80949	131	9	with	with	ADP
bjp-80949	131	10	cetuximab	cetuximab	NOUN
bjp-80949	131	11	and	and	CCONJ
bjp-80949	131	12	carvacrol	carvacrol	NOUN
bjp-80949	131	13	,	,	PUNCT
bjp-80949	131	14	with	with	SCONJ
bjp-80949	131	15	changes	change	NOUN
bjp-80949	131	16	in	in	ADP
bjp-80949	131	17	cell	cell	NOUN
bjp-80949	131	18	viability	viability	NOUN
bjp-80949	131	19	observed	observe	VERB
bjp-80949	131	20	.	.	PUNCT
bjp-80949	132	1	after	after	ADP
bjp-80949	132	2	treating	treat	VERB
bjp-80949	132	3	a-549	a-549	PROPN
bjp-80949	132	4	cells	cell	NOUN
bjp-80949	132	5	with	with	ADP
bjp-80949	132	6	different	different	ADJ
bjp-80949	132	7	concentrations	concentration	NOUN
bjp-80949	132	8	of	of	ADP
bjp-80949	132	9	cetuximab	cetuximab	NOUN
bjp-80949	132	10	for	for	ADP
bjp-80949	132	11	48	48	NUM
bjp-80949	132	12	hours	hour	NOUN
bjp-80949	132	13	,	,	PUNCT
bjp-80949	132	14	ic10	ic10	PROPN
bjp-80949	132	15	,	,	PUNCT
bjp-80949	132	16	ic20	ic20	PROPN
bjp-80949	132	17	,	,	PUNCT
bjp-80949	132	18	ic30	ic30	PROPN
bjp-80949	132	19	,	,	PUNCT
bjp-80949	132	20	ic40	ic40	PROPN
bjp-80949	132	21	,	,	PUNCT
bjp-80949	132	22	and	and	CCONJ
bjp-80949	132	23	ic50	ic50	PROPN
bjp-80949	132	24	values	value	NOUN
bjp-80949	132	25	were	be	AUX
bjp-80949	132	26	determined	determine	VERB
bjp-80949	132	27	to	to	PART
bjp-80949	132	28	be	be	AUX
bjp-80949	132	29	174	174	NUM
bjp-80949	132	30	,	,	PUNCT
bjp-80949	132	31	472	472	NUM
bjp-80949	132	32	,	,	PUNCT
bjp-80949	132	33	770	770	NUM
bjp-80949	132	34	,	,	PUNCT
bjp-80949	132	35	1067	1067	NUM
bjp-80949	132	36	,	,	PUNCT
bjp-80949	132	37	and	and	CCONJ
bjp-80949	132	38	1365	1365	NUM
bjp-80949	132	39	µg	µg	NOUN
bjp-80949	132	40	/	/	SYM
bjp-80949	132	41	ml	ml	NOUN
bjp-80949	132	42	,	,	PUNCT
bjp-80949	132	43	respectively	respectively	ADV
bjp-80949	132	44	.	.	PUNCT
bjp-80949	133	1	similarly	similarly	ADV
bjp-80949	133	2	,	,	PUNCT
bjp-80949	133	3	for	for	ADP
bjp-80949	133	4	h1299	h1299	NOUN
bjp-80949	133	5	cells	cell	NOUN
bjp-80949	133	6	exposed	expose	VERB
bjp-80949	133	7	to	to	ADP
bjp-80949	133	8	varying	vary	VERB
bjp-80949	133	9	cetuximab	cetuximab	NOUN
bjp-80949	133	10	concentrations	concentration	NOUN
bjp-80949	133	11	for	for	ADP
bjp-80949	133	12	48	48	NUM
bjp-80949	133	13	hours	hour	NOUN
bjp-80949	133	14	,	,	PUNCT
bjp-80949	133	15	ic10	ic10	PROPN
bjp-80949	133	16	,	,	PUNCT
bjp-80949	133	17	ic20	ic20	PROPN
bjp-80949	133	18	,	,	PUNCT
bjp-80949	133	19	ic30	ic30	PROPN
bjp-80949	133	20	,	,	PUNCT
bjp-80949	133	21	ic40	ic40	PROPN
bjp-80949	133	22	,	,	PUNCT
bjp-80949	133	23	and	and	CCONJ
bjp-80949	133	24	ic50	ic50	PROPN
bjp-80949	133	25	values	value	NOUN
bjp-80949	133	26	were	be	AUX
bjp-80949	133	27	determined	determine	VERB
bjp-80949	133	28	to	to	PART
bjp-80949	133	29	be	be	AUX
bjp-80949	133	30	102	102	NUM
bjp-80949	133	31	,	,	PUNCT
bjp-80949	133	32	369	369	NUM
bjp-80949	133	33	,	,	PUNCT
bjp-80949	133	34	636	636	NUM
bjp-80949	133	35	,	,	PUNCT
bjp-80949	133	36	904	904	NUM
bjp-80949	133	37	,	,	PUNCT
bjp-80949	133	38	and	and	CCONJ
bjp-80949	133	39	1171	1171	NUM
bjp-80949	133	40	µg	µg	NOUN
bjp-80949	133	41	/	/	SYM
bjp-80949	133	42	ml	ml	NOUN
bjp-80949	133	43	,	,	PUNCT
bjp-80949	133	44	respectively	respectively	ADV
bjp-80949	133	45	(	(	PUNCT
bjp-80949	133	46	data	datum	NOUN
bjp-80949	133	47	not	not	PART
bjp-80949	133	48	shown	show	VERB
bjp-80949	133	49	)	)	PUNCT
bjp-80949	133	50	.	.	PUNCT
bjp-80949	134	1	upon	upon	SCONJ
bjp-80949	134	2	treatment	treatment	NOUN
bjp-80949	134	3	of	of	ADP
bjp-80949	134	4	a-549	a-549	PROPN
bjp-80949	134	5	cells	cell	NOUN
bjp-80949	134	6	with	with	ADP
bjp-80949	134	7	a	a	DET
bjp-80949	134	8	range	range	NOUN
bjp-80949	134	9	of	of	ADP
bjp-80949	134	10	concentrations	concentration	NOUN
bjp-80949	134	11	of	of	ADP
bjp-80949	134	12	carvacrol	carvacrol	NOUN
bjp-80949	134	13	across	across	ADP
bjp-80949	134	14	48	48	NUM
bjp-80949	134	15	hours	hour	NOUN
bjp-80949	134	16	timeframe	timeframe	NOUN
bjp-80949	134	17	,	,	PUNCT
bjp-80949	134	18	ic10	ic10	PROPN
bjp-80949	134	19	,	,	PUNCT
bjp-80949	134	20	ic20	ic20	PROPN
bjp-80949	134	21	,	,	PUNCT
bjp-80949	134	22	ic30	ic30	PROPN
bjp-80949	134	23	,	,	PUNCT
bjp-80949	134	24	ic40	ic40	PROPN
bjp-80949	134	25	,	,	PUNCT
bjp-80949	134	26	and	and	CCONJ
bjp-80949	134	27	ic50	ic50	PROPN
bjp-80949	134	28	values	value	NOUN
bjp-80949	134	29	were	be	AUX
bjp-80949	134	30	found	find	VERB
bjp-80949	134	31	to	to	PART
bjp-80949	134	32	be	be	AUX
bjp-80949	134	33	11	11	NUM
bjp-80949	134	34	,	,	PUNCT
bjp-80949	134	35	21	21	NUM
bjp-80949	134	36	,	,	PUNCT
bjp-80949	134	37	31	31	NUM
bjp-80949	134	38	,	,	PUNCT
bjp-80949	134	39	41	41	NUM
bjp-80949	134	40	,	,	PUNCT
bjp-80949	134	41	and	and	CCONJ
bjp-80949	134	42	51	51	NUM
bjp-80949	134	43	µg	µg	NOUN
bjp-80949	134	44	/	/	SYM
bjp-80949	134	45	ml	ml	NOUN
bjp-80949	134	46	,	,	PUNCT
bjp-80949	134	47	respectively	respectively	ADV
bjp-80949	134	48	.	.	PUNCT
bjp-80949	135	1	similarly	similarly	ADV
bjp-80949	135	2	,	,	PUNCT
bjp-80949	135	3	for	for	ADP
bjp-80949	135	4	h1299	h1299	NOUN
bjp-80949	135	5	cells	cell	NOUN
bjp-80949	135	6	treated	treat	VERB
bjp-80949	135	7	with	with	ADP
bjp-80949	135	8	varying	vary	VERB
bjp-80949	135	9	concentrations	concentration	NOUN
bjp-80949	135	10	of	of	ADP
bjp-80949	135	11	carvacrol	carvacrol	NOUN
bjp-80949	135	12	for	for	ADP
bjp-80949	135	13	48	48	NUM
bjp-80949	135	14	hour	hour	NOUN
bjp-80949	135	15	,	,	PUNCT
bjp-80949	135	16	ic10	ic10	PROPN
bjp-80949	135	17	,	,	PUNCT
bjp-80949	135	18	ic20	ic20	PROPN
bjp-80949	135	19	,	,	PUNCT
bjp-80949	135	20	ic30	ic30	PROPN
bjp-80949	135	21	,	,	PUNCT
bjp-80949	135	22	ic40	ic40	PROPN
bjp-80949	135	23	,	,	PUNCT
bjp-80949	135	24	and	and	CCONJ
bjp-80949	135	25	ic50	ic50	PROPN
bjp-80949	135	26	values	value	NOUN
bjp-80949	135	27	were	be	AUX
bjp-80949	135	28	determined	determine	VERB
bjp-80949	135	29	to	to	PART
bjp-80949	135	30	be	be	AUX
bjp-80949	135	31	8	8	NUM
bjp-80949	135	32	µg	µg	NOUN
bjp-80949	135	33	/	/	SYM
bjp-80949	135	34	ml	ml	NOUN
bjp-80949	135	35	,	,	PUNCT
bjp-80949	135	36	17	17	NUM
bjp-80949	135	37	µg	µg	NOUN
bjp-80949	135	38	/	/	SYM
bjp-80949	135	39	ml	ml	NOUN
bjp-80949	135	40	,	,	PUNCT
bjp-80949	135	41	26	26	NUM
bjp-80949	135	42	µg	µg	NOUN
bjp-80949	135	43	/	/	SYM
bjp-80949	135	44	ml	ml	NOUN
bjp-80949	135	45	,	,	PUNCT
bjp-80949	135	46	35	35	NUM
bjp-80949	135	47	µg	µg	NOUN
bjp-80949	135	48	/	/	SYM
bjp-80949	135	49	ml	ml	NOUN
bjp-80949	135	50	,	,	PUNCT
bjp-80949	135	51	and	and	CCONJ
bjp-80949	135	52	49	49	NUM
bjp-80949	135	53	µg	µg	NOUN
bjp-80949	135	54	/	/	SYM
bjp-80949	135	55	ml	ml	NOUN
bjp-80949	135	56	,	,	PUNCT
bjp-80949	135	57	respectively	respectively	ADV
bjp-80949	135	58	(	(	PUNCT
bjp-80949	135	59	data	datum	NOUN
bjp-80949	135	60	not	not	PART
bjp-80949	135	61	shown	show	VERB
bjp-80949	135	62	)	)	PUNCT
bjp-80949	135	63	.	.	PUNCT
bjp-80949	136	1	this	this	DET
bjp-80949	136	2	investigation	investigation	NOUN
bjp-80949	136	3	was	be	AUX
bjp-80949	136	4	designed	design	VERB
bjp-80949	136	5	to	to	PART
bjp-80949	136	6	determine	determine	VERB
bjp-80949	136	7	whether	whether	SCONJ
bjp-80949	136	8	lower	low	ADJ
bjp-80949	136	9	concentrations	concentration	NOUN
bjp-80949	136	10	of	of	ADP
bjp-80949	136	11	carvacrol	carvacrol	NOUN
bjp-80949	136	12	,	,	PUNCT
bjp-80949	136	13	below	below	ADP
bjp-80949	136	14	its	its	PRON
bjp-80949	136	15	ic50	ic50	PROPN
bjp-80949	136	16	value	value	NOUN
bjp-80949	136	17	,	,	PUNCT
bjp-80949	136	18	could	could	AUX
bjp-80949	136	19	enhance	enhance	VERB
bjp-80949	136	20	the	the	DET
bjp-80949	136	21	cytotoxic	cytotoxic	ADJ
bjp-80949	136	22	effects	effect	NOUN
bjp-80949	136	23	of	of	ADP
bjp-80949	136	24	cetuximab	cetuximab	NOUN
bjp-80949	136	25	(	(	PUNCT
bjp-80949	136	26	<	<	X
bjp-80949	136	27	ic50	ic50	PROPN
bjp-80949	136	28	)	)	PUNCT
bjp-80949	136	29	in	in	ADP
bjp-80949	136	30	a-549	a-549	PROPN
bjp-80949	136	31	and	and	CCONJ
bjp-80949	136	32	h1299	h1299	CCONJ
bjp-80949	136	33	cells	cell	NOUN
bjp-80949	136	34	.	.	PUNCT
bjp-80949	137	1	to	to	PART
bjp-80949	137	2	identify	identify	VERB
bjp-80949	137	3	the	the	DET
bjp-80949	137	4	most	most	ADV
bjp-80949	137	5	effective	effective	ADJ
bjp-80949	137	6	cytotoxic	cytotoxic	ADJ
bjp-80949	137	7	response	response	NOUN
bjp-80949	137	8	,	,	PUNCT
bjp-80949	137	9	combinations	combination	NOUN
bjp-80949	137	10	of	of	ADP
bjp-80949	137	11	cetuximab	cetuximab	NOUN
bjp-80949	137	12	and	and	CCONJ
bjp-80949	137	13	carvacrol	carvacrol	NOUN
bjp-80949	137	14	at	at	ADP
bjp-80949	137	15	concentrations	concentration	NOUN
bjp-80949	137	16	below	below	ADP
bjp-80949	137	17	their	their	PRON
bjp-80949	137	18	ic₅₀	ic₅₀	PROPN
bjp-80949	137	19	values	value	NOUN
bjp-80949	137	20	were	be	AUX
bjp-80949	137	21	administered	administer	VERB
bjp-80949	137	22	and	and	CCONJ
bjp-80949	137	23	evaluated	evaluate	VERB
bjp-80949	137	24	(	(	PUNCT
bjp-80949	137	25	figure	figure	VERB
bjp-80949	137	26	1a	1a	NOUN
bjp-80949	137	27	-	-	PUNCT
bjp-80949	137	28	b	b	NOUN
bjp-80949	137	29	)	)	PUNCT
bjp-80949	137	30	.	.	PUNCT
bjp-80949	138	1	for	for	ADP
bjp-80949	138	2	a-549	a-549	PROPN
bjp-80949	138	3	cells	cell	NOUN
bjp-80949	138	4	,	,	PUNCT
bjp-80949	138	5	the	the	DET
bjp-80949	138	6	most	most	ADV
bjp-80949	138	7	effective	effective	ADJ
bjp-80949	138	8	combination	combination	NOUN
bjp-80949	138	9	was	be	AUX
bjp-80949	138	10	found	find	VERB
bjp-80949	138	11	to	to	PART
bjp-80949	138	12	be	be	AUX
bjp-80949	138	13	ic10	ic10	PROPN
bjp-80949	138	14	cetuximab	cetuximab	NOUN
bjp-80949	138	15	with	with	ADP
bjp-80949	138	16	ic10	ic10	PROPN
bjp-80949	138	17	carvacrol	carvacrol	NOUN
bjp-80949	138	18	(	(	PUNCT
bjp-80949	138	19	figure	figure	NOUN
bjp-80949	138	20	1a	1a	NOUN
bjp-80949	138	21	)	)	PUNCT
bjp-80949	138	22	.	.	PUNCT
bjp-80949	139	1	to	to	PART
bjp-80949	139	2	evaluate	evaluate	VERB
bjp-80949	139	3	the	the	DET
bjp-80949	139	4	interaction	interaction	NOUN
bjp-80949	139	5	between	between	ADP
bjp-80949	139	6	cetuximab	cetuximab	NOUN
bjp-80949	139	7	and	and	CCONJ
bjp-80949	139	8	carvacrol	carvacrol	PROPN
bjp-80949	139	9	,	,	PUNCT
bjp-80949	139	10	ci	ci	PROPN
bjp-80949	139	11	was	be	AUX
bjp-80949	139	12	computed	compute	VERB
bjp-80949	139	13	,	,	PUNCT
bjp-80949	139	14	which	which	PRON
bjp-80949	139	15	indicated	indicate	VERB
bjp-80949	139	16	whether	whether	SCONJ
bjp-80949	139	17	the	the	DET
bjp-80949	139	18	dual	dual	ADJ
bjp-80949	139	19	treatment	treatment	NOUN
bjp-80949	139	20	had	have	AUX
bjp-80949	139	21	combined	combine	VERB
bjp-80949	139	22	,	,	PUNCT
bjp-80949	139	23	synergistic	synergistic	ADJ
bjp-80949	139	24	,	,	PUNCT
bjp-80949	139	25	or	or	CCONJ
bjp-80949	139	26	100	100	NUM
bjp-80949	139	27	80	80	NUM
bjp-80949	139	28	60	60	NUM
bjp-80949	139	29	40	40	NUM
bjp-80949	139	30	20	20	NUM
bjp-80949	139	31	0	0	NUM
bjp-80949	139	32	%	%	NOUN
bjp-80949	140	1	c	c	NOUN
bjp-80949	140	2	e	e	NOUN
bjp-80949	140	3	ll	ll	NOUN
bjp-80949	140	4	v	v	PROPN
bjp-80949	140	5	ia	ia	PROPN
bjp-80949	140	6	b	b	PROPN
bjp-80949	140	7	ili	ili	PROPN
bjp-80949	141	1	ty	ty	INTJ
bjp-80949	141	2	100	100	NUM
bjp-80949	141	3	80	80	NUM
bjp-80949	141	4	60	60	NUM
bjp-80949	141	5	40	40	NUM
bjp-80949	141	6	20	20	NUM
bjp-80949	141	7	0	0	NUM
bjp-80949	141	8	%	%	NOUN
bjp-80949	142	1	c	c	NOUN
bjp-80949	142	2	e	e	NOUN
bjp-80949	142	3	ll	ll	AUX
bjp-80949	142	4	v	v	PROPN
bjp-80949	142	5	ia	ia	PROPN
bjp-80949	142	6	b	b	PROPN
bjp-80949	142	7	ili	ili	PROPN
bjp-80949	142	8	ty	ty	PROPN
bjp-80949	142	9	cetuximab	cetuximab	NOUN
bjp-80949	142	10	(	(	PUNCT
bjp-80949	142	11	ic10	ic10	PROPN
bjp-80949	142	12	)	)	PUNCT
bjp-80949	142	13	cetuximab	cetuximab	NOUN
bjp-80949	142	14	(	(	PUNCT
bjp-80949	142	15	ic20	ic20	PROPN
bjp-80949	142	16	)	)	PUNCT
bjp-80949	142	17	cetuximab	cetuximab	NOUN
bjp-80949	142	18	(	(	PUNCT
bjp-80949	142	19	ic30	ic30	PROPN
bjp-80949	142	20	)	)	PUNCT
bjp-80949	142	21	cetuximab	cetuximab	NOUN
bjp-80949	142	22	(	(	PUNCT
bjp-80949	142	23	ic40	ic40	PROPN
bjp-80949	142	24	)	)	PUNCT
bjp-80949	142	25	carvacrol	carvacrol	NOUN
bjp-80949	142	26	(	(	PUNCT
bjp-80949	142	27	ic10	ic10	PROPN
bjp-80949	142	28	)	)	PUNCT
bjp-80949	142	29	carvacrol	carvacrol	NOUN
bjp-80949	142	30	(	(	PUNCT
bjp-80949	142	31	ic20	ic20	PROPN
bjp-80949	142	32	)	)	PUNCT
bjp-80949	142	33	carvacrol	carvacrol	NOUN
bjp-80949	142	34	(	(	PUNCT
bjp-80949	142	35	ic30	ic30	PROPN
bjp-80949	142	36	)	)	PUNCT
bjp-80949	142	37	carvacrol	carvacrol	NOUN
bjp-80949	142	38	(	(	PUNCT
bjp-80949	142	39	ic40	ic40	PROPN
bjp-80949	142	40	)	)	PUNCT
bjp-80949	142	41	control	control	VERB
bjp-80949	142	42	a	a	DET
bjp-80949	142	43	b	b	NOUN
bjp-80949	142	44	a-549	a-549	NOUN
bjp-80949	142	45	cell	cell	NOUN
bjp-80949	142	46	lines	line	NOUN
bjp-80949	142	47	h1299	h1299	CCONJ
bjp-80949	142	48	cell	cell	NOUN
bjp-80949	142	49	lines	line	NOUN
bjp-80949	142	50	figure	figure	VERB
bjp-80949	142	51	1	1	NUM
bjp-80949	142	52	:	:	PUNCT
bjp-80949	142	53	cytotoxic	cytotoxic	ADJ
bjp-80949	142	54	effects	effect	NOUN
bjp-80949	142	55	of	of	ADP
bjp-80949	142	56	cetuximab	cetuximab	NOUN
bjp-80949	142	57	(	(	PUNCT
bjp-80949	142	58	ic10	ic10	PROPN
bjp-80949	142	59	,	,	PUNCT
bjp-80949	142	60	ic20	ic20	PROPN
bjp-80949	142	61	,	,	PUNCT
bjp-80949	142	62	ic30	ic30	PROPN
bjp-80949	142	63	,	,	PUNCT
bjp-80949	142	64	and	and	CCONJ
bjp-80949	142	65	ic40	ic40	PROPN
bjp-80949	142	66	)	)	PUNCT
bjp-80949	142	67	combined	combine	VERB
bjp-80949	142	68	with	with	ADP
bjp-80949	142	69	carvacrol	carvacrol	NOUN
bjp-80949	142	70	at	at	ADP
bjp-80949	142	71	ic10	ic10	PROPN
bjp-80949	142	72	,	,	PUNCT
bjp-80949	142	73	ic20	ic20	PROPN
bjp-80949	142	74	,	,	PUNCT
bjp-80949	142	75	ic30	ic30	PROPN
bjp-80949	142	76	and	and	CCONJ
bjp-80949	142	77	ic40	ic40	PROPN
bjp-80949	142	78	were	be	AUX
bjp-80949	142	79	assessed	assess	VERB
bjp-80949	142	80	over	over	ADP
bjp-80949	142	81	48	48	NUM
bjp-80949	142	82	hours	hour	NOUN
bjp-80949	142	83	period	period	NOUN
bjp-80949	142	84	on	on	ADP
bjp-80949	142	85	a-549	a-549	PROPN
bjp-80949	142	86	(	(	PUNCT
bjp-80949	142	87	a	a	NOUN
bjp-80949	142	88	)	)	PUNCT
bjp-80949	143	1	and	and	CCONJ
bjp-80949	143	2	h1299	h1299	ADV
bjp-80949	143	3	(	(	PUNCT
bjp-80949	143	4	b	b	NOUN
bjp-80949	143	5	)	)	PUNCT
bjp-80949	143	6	cells	cell	NOUN
bjp-80949	143	7	.	.	PUNCT
bjp-80949	144	1	results	result	NOUN
bjp-80949	144	2	are	be	AUX
bjp-80949	144	3	expressed	express	VERB
bjp-80949	144	4	as	as	ADP
bjp-80949	144	5	a	a	DET
bjp-80949	144	6	viability	viability	NOUN
bjp-80949	144	7	ratio	ratio	NOUN
bjp-80949	144	8	relative	relative	ADJ
bjp-80949	144	9	to	to	ADP
bjp-80949	144	10	the	the	DET
bjp-80949	144	11	control	control	NOUN
bjp-80949	144	12	group	group	NOUN
bjp-80949	144	13	,	,	PUNCT
bjp-80949	144	14	which	which	PRON
bjp-80949	144	15	included	include	VERB
bjp-80949	144	16	untreated	untreated	ADJ
bjp-80949	144	17	cells	cell	NOUN
bjp-80949	144	18	receiving	receive	VERB
bjp-80949	144	19	only	only	ADV
bjp-80949	144	20	the	the	DET
bjp-80949	144	21	medium	medium	NOUN
bjp-80949	144	22	.	.	PUNCT
bjp-80949	145	1	values	value	NOUN
bjp-80949	145	2	represent	represent	VERB
bjp-80949	145	3	the	the	DET
bjp-80949	145	4	mean	mean	NOUN
bjp-80949	145	5	of	of	ADP
bjp-80949	145	6	three	three	NUM
bjp-80949	145	7	independent	independent	ADJ
bjp-80949	145	8	trials	trial	NOUN
bjp-80949	145	9	,	,	PUNCT
bjp-80949	145	10	each	each	PRON
bjp-80949	145	11	comprising	comprise	VERB
bjp-80949	145	12	three	three	NUM
bjp-80949	145	13	replicates	replicate	NOUN
bjp-80949	145	14	,	,	PUNCT
bjp-80949	145	15	±	±	NUM
bjp-80949	145	16	sem	sem	NOUN
bjp-80949	145	17	a	a	DET
bjp-80949	145	18	a	a	DET
bjp-80949	145	19	a	a	DET
bjp-80949	145	20	a	a	DET
bjp-80949	145	21	a	a	DET
bjp-80949	145	22	a	a	DET
bjp-80949	145	23	a	a	DET
bjp-80949	145	24	a	a	DET
bjp-80949	145	25	a	a	DET
bjp-80949	145	26	a	a	DET
bjp-80949	145	27	a	a	DET
bjp-80949	145	28	a	a	DET
bjp-80949	145	29	a	a	DET
bjp-80949	145	30	a	a	DET
bjp-80949	145	31	a	a	DET
bjp-80949	145	32	a	a	DET
bjp-80949	145	33	a	a	DET
bjp-80949	145	34	a	a	DET
bjp-80949	145	35	a	a	DET
bjp-80949	145	36	a	a	DET
bjp-80949	145	37	a	a	DET
bjp-80949	145	38	a	a	DET
bjp-80949	145	39	a	a	DET
bjp-80949	145	40	a	a	DET
bjp-80949	145	41	a	a	DET
bjp-80949	145	42	a	a	DET
bjp-80949	145	43	a	a	DET
bjp-80949	145	44	a	a	DET
bjp-80949	145	45	a	a	DET
bjp-80949	145	46	a	a	DET
bjp-80949	145	47	a	a	DET
bjp-80949	145	48	a	a	DET
bjp-80949	145	49	26	26	NUM
bjp-80949	145	50	bangladesh	bangladesh	NOUN
bjp-80949	145	51	j	j	PROPN
bjp-80949	145	52	pharmacol	pharmacol	PROPN
bjp-80949	145	53	2025	2025	NUM
bjp-80949	145	54	;	;	PUNCT
bjp-80949	145	55	20	20	NUM
bjp-80949	145	56	:	:	SYM
bjp-80949	145	57	22	22	NUM
bjp-80949	145	58	-	-	SYM
bjp-80949	145	59	34	34	NUM
bjp-80949	145	60	opposing	oppose	VERB
bjp-80949	145	61	outcomes	outcome	NOUN
bjp-80949	145	62	.	.	PUNCT
bjp-80949	146	1	ci	ci	NOUN
bjp-80949	146	2	value	value	NOUN
bjp-80949	146	3	of	of	ADP
bjp-80949	146	4	2	2	NUM
bjp-80949	146	5	confirmed	confirm	VERB
bjp-80949	146	6	the	the	DET
bjp-80949	146	7	synergistic	synergistic	ADJ
bjp-80949	146	8	effect	effect	NOUN
bjp-80949	146	9	of	of	ADP
bjp-80949	146	10	the	the	DET
bjp-80949	146	11	ic10	ic10	PROPN
bjp-80949	146	12	cetuximab	cetuximab	NOUN
bjp-80949	146	13	and	and	CCONJ
bjp-80949	146	14	ic10	ic10	PROPN
bjp-80949	146	15	carvacrol	carvacrol	NOUN
bjp-80949	146	16	combination	combination	NOUN
bjp-80949	146	17	in	in	ADP
bjp-80949	146	18	a-549	a-549	PROPN
bjp-80949	146	19	cells	cell	NOUN
bjp-80949	146	20	.	.	PUNCT
bjp-80949	147	1	in	in	ADP
bjp-80949	147	2	h1299	h1299	NUM
bjp-80949	147	3	cells	cell	NOUN
bjp-80949	147	4	,	,	PUNCT
bjp-80949	147	5	the	the	DET
bjp-80949	147	6	most	most	ADV
bjp-80949	147	7	effective	effective	ADJ
bjp-80949	147	8	combination	combination	NOUN
bjp-80949	147	9	was	be	AUX
bjp-80949	147	10	ic20	ic20	PROPN
bjp-80949	147	11	cetuximab	cetuximab	NOUN
bjp-80949	147	12	with	with	ADP
bjp-80949	147	13	ic10	ic10	PROPN
bjp-80949	147	14	carvacrol	carvacrol	NOUN
bjp-80949	147	15	(	(	PUNCT
bjp-80949	147	16	figure	figure	NOUN
bjp-80949	147	17	1b	1b	NUM
bjp-80949	147	18	)	)	PUNCT
bjp-80949	147	19	,	,	PUNCT
bjp-80949	147	20	and	and	CCONJ
bjp-80949	147	21	ci	ci	NOUN
bjp-80949	147	22	value	value	NOUN
bjp-80949	147	23	of	of	ADP
bjp-80949	147	24	2	2	NUM
bjp-80949	147	25	again	again	ADV
bjp-80949	147	26	confirmed	confirm	VERB
bjp-80949	147	27	the	the	DET
bjp-80949	147	28	synergistic	synergistic	ADJ
bjp-80949	147	29	effect	effect	NOUN
bjp-80949	147	30	of	of	ADP
bjp-80949	147	31	this	this	DET
bjp-80949	147	32	combination	combination	NOUN
bjp-80949	147	33	.	.	PUNCT
bjp-80949	148	1	statistical	statistical	ADJ
bjp-80949	148	2	analysis	analysis	NOUN
bjp-80949	148	3	showed	show	VERB
bjp-80949	148	4	that	that	SCONJ
bjp-80949	148	5	the	the	DET
bjp-80949	148	6	impact	impact	NOUN
bjp-80949	148	7	of	of	ADP
bjp-80949	148	8	different	different	ADJ
bjp-80949	148	9	cell	cell	NOUN
bjp-80949	148	10	line	line	NOUN
bjp-80949	148	11	types	type	NOUN
bjp-80949	148	12	and	and	CCONJ
bjp-80949	148	13	the	the	DET
bjp-80949	148	14	influence	influence	NOUN
bjp-80949	148	15	of	of	ADP
bjp-80949	148	16	combined	combined	ADJ
bjp-80949	148	17	concentrations	concentration	NOUN
bjp-80949	148	18	on	on	ADP
bjp-80949	148	19	cytotoxicity	cytotoxicity	NOUN
bjp-80949	148	20	was	be	AUX
bjp-80949	148	21	significant	significant	ADJ
bjp-80949	148	22	(	(	PUNCT
bjp-80949	148	23	p<0.05	p<0.05	NOUN
bjp-80949	148	24	)	)	PUNCT
bjp-80949	148	25	.	.	PUNCT
bjp-80949	149	1	the	the	DET
bjp-80949	149	2	cellular	cellular	ADJ
bjp-80949	149	3	toxicity	toxicity	NOUN
bjp-80949	149	4	varied	vary	VERB
bjp-80949	149	5	significantly	significantly	ADV
bjp-80949	149	6	between	between	ADP
bjp-80949	149	7	every	every	DET
bjp-80949	149	8	cell	cell	NOUN
bjp-80949	149	9	line	line	NOUN
bjp-80949	149	10	(	(	PUNCT
bjp-80949	149	11	p<0.05	p<0.05	NOUN
bjp-80949	149	12	)	)	PUNCT
bjp-80949	149	13	.	.	PUNCT
bjp-80949	150	1	overall	overall	ADV
bjp-80949	150	2	,	,	PUNCT
bjp-80949	150	3	the	the	DET
bjp-80949	150	4	pairing	pairing	NOUN
bjp-80949	150	5	of	of	ADP
bjp-80949	150	6	cetuximab	cetuximab	NOUN
bjp-80949	150	7	and	and	CCONJ
bjp-80949	150	8	carvacrol	carvacrol	NOUN
bjp-80949	150	9	enhanced	enhance	VERB
bjp-80949	150	10	the	the	DET
bjp-80949	150	11	cytotoxic	cytotoxic	ADJ
bjp-80949	150	12	effects	effect	NOUN
bjp-80949	150	13	in	in	ADP
bjp-80949	150	14	both	both	PRON
bjp-80949	150	15	h1299	h1299	PROPN
bjp-80949	150	16	and	and	CCONJ
bjp-80949	150	17	a-549	a-549	PROPN
bjp-80949	150	18	cells	cell	NOUN
bjp-80949	150	19	relative	relative	ADJ
bjp-80949	150	20	to	to	ADP
bjp-80949	150	21	cetuximab	cetuximab	NOUN
bjp-80949	150	22	intervention	intervention	NOUN
bjp-80949	150	23	in	in	ADP
bjp-80949	150	24	isolation	isolation	NOUN
bjp-80949	150	25	.	.	PUNCT
bjp-80949	151	1	cell	cell	NOUN
bjp-80949	151	2	-	-	PUNCT
bjp-80949	151	3	killing	kill	VERB
bjp-80949	151	4	effect	effect	NOUN
bjp-80949	151	5	after	after	ADP
bjp-80949	151	6	48	48	NUM
bjp-80949	151	7	hours	hour	NOUN
bjp-80949	151	8	of	of	ADP
bjp-80949	151	9	exposure	exposure	NOUN
bjp-80949	152	1	,	,	PUNCT
bjp-80949	152	2	changes	change	NOUN
bjp-80949	152	3	in	in	ADP
bjp-80949	152	4	ldh	ldh	ADJ
bjp-80949	152	5	activity	activity	NOUN
bjp-80949	152	6	were	be	AUX
bjp-80949	152	7	assessed	assess	VERB
bjp-80949	152	8	in	in	ADP
bjp-80949	152	9	h1299	h1299	NOUN
bjp-80949	152	10	cells	cell	NOUN
bjp-80949	152	11	treated	treat	VERB
bjp-80949	152	12	with	with	ADP
bjp-80949	152	13	cetuximab	cetuximab	NOUN
bjp-80949	152	14	at	at	ADP
bjp-80949	152	15	ic20	ic20	PROPN
bjp-80949	152	16	concentration	concentration	NOUN
bjp-80949	152	17	,	,	PUNCT
bjp-80949	152	18	both	both	CCONJ
bjp-80949	152	19	alone	alone	ADJ
bjp-80949	152	20	and	and	CCONJ
bjp-80949	152	21	in	in	ADP
bjp-80949	152	22	combination	combination	NOUN
bjp-80949	152	23	with	with	ADP
bjp-80949	152	24	ic10	ic10	PROPN
bjp-80949	152	25	carvacrol	carvacrol	NOUN
bjp-80949	152	26	,	,	PUNCT
bjp-80949	152	27	which	which	PRON
bjp-80949	152	28	produced	produce	VERB
bjp-80949	152	29	the	the	DET
bjp-80949	152	30	strongest	strong	ADJ
bjp-80949	152	31	cytotoxic	cytotoxic	ADJ
bjp-80949	152	32	response	response	NOUN
bjp-80949	152	33	.	.	PUNCT
bjp-80949	153	1	a	a	DET
bjp-80949	153	2	significant	significant	ADJ
bjp-80949	153	3	elevation	elevation	NOUN
bjp-80949	153	4	in	in	ADP
bjp-80949	153	5	ldh	ldh	NOUN
bjp-80949	153	6	activity	activity	NOUN
bjp-80949	153	7	was	be	AUX
bjp-80949	153	8	observed	observe	VERB
bjp-80949	153	9	in	in	ADP
bjp-80949	153	10	treated	treat	VERB
bjp-80949	153	11	cells	cell	NOUN
bjp-80949	153	12	relative	relative	ADJ
bjp-80949	153	13	to	to	ADP
bjp-80949	153	14	the	the	DET
bjp-80949	153	15	vehicle	vehicle	NOUN
bjp-80949	153	16	control	control	PROPN
bjp-80949	153	17	group	group	NOUN
bjp-80949	153	18	.	.	PUNCT
bjp-80949	154	1	specifically	specifically	ADV
bjp-80949	154	2	,	,	PUNCT
bjp-80949	154	3	combination	combination	NOUN
bjp-80949	154	4	of	of	ADP
bjp-80949	154	5	cetuximab	cetuximab	NOUN
bjp-80949	154	6	and	and	CCONJ
bjp-80949	154	7	carvacrol	carvacrol	NOUN
bjp-80949	154	8	led	lead	VERB
bjp-80949	154	9	to	to	ADP
bjp-80949	154	10	a	a	DET
bjp-80949	154	11	239	239	NUM
bjp-80949	154	12	%	%	NOUN
bjp-80949	154	13	elevated	elevate	VERB
bjp-80949	154	14	in	in	ADP
bjp-80949	154	15	ldh	ldh	NOUN
bjp-80949	154	16	activity	activity	NOUN
bjp-80949	154	17	in	in	ADP
bjp-80949	154	18	h1299	h1299	NOUN
bjp-80949	154	19	cells	cell	NOUN
bjp-80949	154	20	relative	relative	ADJ
bjp-80949	154	21	to	to	ADP
bjp-80949	154	22	the	the	DET
bjp-80949	154	23	unexposed	unexposed	ADJ
bjp-80949	154	24	group	group	NOUN
bjp-80949	154	25	,	,	PUNCT
bjp-80949	154	26	which	which	PRON
bjp-80949	154	27	consisted	consist	VERB
bjp-80949	154	28	solely	solely	ADV
bjp-80949	154	29	of	of	ADP
bjp-80949	154	30	growth	growth	NOUN
bjp-80949	154	31	medium	medium	NOUN
bjp-80949	154	32	excluding	exclude	VERB
bjp-80949	154	33	any	any	DET
bjp-80949	154	34	treatment	treatment	NOUN
bjp-80949	154	35	(	(	PUNCT
bjp-80949	154	36	table	table	NOUN
bjp-80949	154	37	ii	ii	PROPN
bjp-80949	154	38	)	)	PUNCT
bjp-80949	154	39	.	.	PUNCT
bjp-80949	155	1	ldh	ldh	ADJ
bjp-80949	155	2	enzyme	enzyme	NOUN
bjp-80949	155	3	activity	activity	NOUN
bjp-80949	155	4	was	be	AUX
bjp-80949	155	5	assessed	assess	VERB
bjp-80949	155	6	following	follow	VERB
bjp-80949	155	7	the	the	DET
bjp-80949	155	8	treatment	treatment	NOUN
bjp-80949	155	9	of	of	ADP
bjp-80949	155	10	a-549	a-549	PROPN
bjp-80949	155	11	cells	cell	NOUN
bjp-80949	155	12	with	with	ADP
bjp-80949	155	13	ic10	ic10	PROPN
bjp-80949	155	14	cetuximab	cetuximab	NOUN
bjp-80949	155	15	alone	alone	ADJ
bjp-80949	155	16	and	and	CCONJ
bjp-80949	155	17	in	in	ADP
bjp-80949	155	18	combination	combination	NOUN
bjp-80949	155	19	with	with	ADP
bjp-80949	155	20	ic10	ic10	PROPN
bjp-80949	155	21	carvacrol	carvacrol	NOUN
bjp-80949	155	22	,	,	PUNCT
bjp-80949	155	23	which	which	PRON
bjp-80949	155	24	were	be	AUX
bjp-80949	155	25	found	find	VERB
bjp-80949	155	26	to	to	PART
bjp-80949	155	27	induce	induce	VERB
bjp-80949	155	28	the	the	DET
bjp-80949	155	29	strongest	strong	ADJ
bjp-80949	155	30	cytotoxic	cytotoxic	ADJ
bjp-80949	155	31	effects	effect	NOUN
bjp-80949	155	32	,	,	PUNCT
bjp-80949	155	33	over	over	ADP
bjp-80949	155	34	a	a	DET
bjp-80949	155	35	48	48	NUM
bjp-80949	155	36	h	h	NOUN
bjp-80949	155	37	period	period	NOUN
bjp-80949	155	38	(	(	PUNCT
bjp-80949	155	39	table	table	NOUN
bjp-80949	155	40	ii	ii	PROPN
bjp-80949	155	41	)	)	PUNCT
bjp-80949	155	42	.	.	PUNCT
bjp-80949	156	1	following	follow	VERB
bjp-80949	156	2	this	this	DET
bjp-80949	156	3	incubation	incubation	NOUN
bjp-80949	156	4	,	,	PUNCT
bjp-80949	156	5	a	a	DET
bjp-80949	156	6	notable	notable	ADJ
bjp-80949	156	7	increase	increase	NOUN
bjp-80949	156	8	in	in	ADP
bjp-80949	156	9	ldh	ldh	PROPN
bjp-80949	156	10	release	release	NOUN
bjp-80949	156	11	was	be	AUX
bjp-80949	156	12	observed	observe	VERB
bjp-80949	156	13	,	,	PUNCT
bjp-80949	156	14	with	with	ADP
bjp-80949	156	15	levels	level	NOUN
bjp-80949	156	16	rising	rise	VERB
bjp-80949	156	17	by	by	ADP
bjp-80949	156	18	approximately	approximately	ADV
bjp-80949	156	19	25	25	NUM
bjp-80949	156	20	%	%	NOUN
bjp-80949	156	21	for	for	ADP
bjp-80949	156	22	cetuximab	cetuximab	NOUN
bjp-80949	156	23	alone	alone	ADJ
bjp-80949	156	24	and	and	CCONJ
bjp-80949	156	25	by	by	ADP
bjp-80949	156	26	101	101	NUM
bjp-80949	156	27	%	%	NOUN
bjp-80949	156	28	for	for	ADP
bjp-80949	156	29	the	the	DET
bjp-80949	156	30	combination	combination	NOUN
bjp-80949	156	31	treatment	treatment	NOUN
bjp-80949	156	32	,	,	PUNCT
bjp-80949	156	33	in	in	ADP
bjp-80949	156	34	relation	relation	NOUN
bjp-80949	156	35	to	to	ADP
bjp-80949	156	36	the	the	DET
bjp-80949	156	37	baseline	baseline	NOUN
bjp-80949	156	38	(	(	PUNCT
bjp-80949	156	39	p<0.05	p<0.05	NOUN
bjp-80949	156	40	)	)	PUNCT
bjp-80949	156	41	.	.	PUNCT
bjp-80949	157	1	when	when	SCONJ
bjp-80949	157	2	evaluating	evaluate	VERB
bjp-80949	157	3	the	the	DET
bjp-80949	157	4	results	result	NOUN
bjp-80949	157	5	in	in	ADP
bjp-80949	157	6	relation	relation	NOUN
bjp-80949	157	7	to	to	ADP
bjp-80949	157	8	the	the	DET
bjp-80949	157	9	control	control	NOUN
bjp-80949	157	10	groups	group	NOUN
bjp-80949	157	11	,	,	PUNCT
bjp-80949	157	12	both	both	CCONJ
bjp-80949	157	13	a-549	a-549	X
bjp-80949	157	14	and	and	CCONJ
bjp-80949	157	15	h1299	h1299	CCONJ
bjp-80949	157	16	cells	cell	NOUN
bjp-80949	157	17	showed	show	VERB
bjp-80949	157	18	substantial	substantial	ADJ
bjp-80949	157	19	discrepancy	discrepancy	NOUN
bjp-80949	157	20	(	(	PUNCT
bjp-80949	157	21	p<0.05	p<0.05	NOUN
bjp-80949	157	22	)	)	PUNCT
bjp-80949	157	23	in	in	ADP
bjp-80949	157	24	ldh	ldh	ADJ
bjp-80949	157	25	enzymatic	enzymatic	ADJ
bjp-80949	157	26	activity	activity	NOUN
bjp-80949	157	27	following	follow	VERB
bjp-80949	157	28	treatment	treatment	NOUN
bjp-80949	157	29	with	with	ADP
bjp-80949	157	30	cetuximab	cetuximab	NOUN
bjp-80949	157	31	alone	alone	ADJ
bjp-80949	157	32	or	or	CCONJ
bjp-80949	157	33	the	the	DET
bjp-80949	157	34	cetuximab	cetuximab	NOUN
bjp-80949	157	35	-	-	PUNCT
bjp-80949	157	36	carvacrol	carvacrol	NOUN
bjp-80949	157	37	combination	combination	NOUN
bjp-80949	157	38	.	.	PUNCT
bjp-80949	158	1	additionally	additionally	ADV
bjp-80949	158	2	,	,	PUNCT
bjp-80949	158	3	the	the	DET
bjp-80949	158	4	combination	combination	NOUN
bjp-80949	158	5	treatment	treatment	NOUN
bjp-80949	158	6	led	lead	VERB
bjp-80949	158	7	to	to	ADP
bjp-80949	158	8	a	a	DET
bjp-80949	158	9	greater	great	ADJ
bjp-80949	158	10	elevation	elevation	NOUN
bjp-80949	158	11	in	in	ADP
bjp-80949	158	12	ldh	ldh	PROPN
bjp-80949	158	13	levels	level	NOUN
bjp-80949	158	14	than	than	ADP
bjp-80949	158	15	cetuximab	cetuximab	NOUN
bjp-80949	158	16	alone	alone	ADV
bjp-80949	158	17	in	in	ADP
bjp-80949	158	18	both	both	DET
bjp-80949	158	19	cell	cell	NOUN
bjp-80949	158	20	lines	line	NOUN
bjp-80949	158	21	,	,	PUNCT
bjp-80949	158	22	relative	relative	ADJ
bjp-80949	158	23	to	to	ADP
bjp-80949	158	24	their	their	PRON
bjp-80949	158	25	respective	respective	ADJ
bjp-80949	158	26	control	control	NOUN
bjp-80949	158	27	groups	group	NOUN
bjp-80949	158	28	.	.	PUNCT
bjp-80949	159	1	effects	effect	NOUN
bjp-80949	159	2	of	of	ADP
bjp-80949	159	3	cetuximab	cetuximab	NOUN
bjp-80949	159	4	and	and	CCONJ
bjp-80949	159	5	carvacrol	carvacrol	NOUN
bjp-80949	159	6	on	on	ADP
bjp-80949	159	7	oxidative	oxidative	ADJ
bjp-80949	159	8	stress	stress	NOUN
bjp-80949	159	9	following	follow	VERB
bjp-80949	159	10	48	48	NUM
bjp-80949	159	11	hours	hour	NOUN
bjp-80949	159	12	of	of	ADP
bjp-80949	159	13	treatment	treatment	NOUN
bjp-80949	159	14	with	with	ADP
bjp-80949	159	15	cetuximab	cetuximab	NOUN
bjp-80949	159	16	alone	alone	ADJ
bjp-80949	159	17	or	or	CCONJ
bjp-80949	159	18	together	together	ADV
bjp-80949	159	19	with	with	ADP
bjp-80949	159	20	carvacrol	carvacrol	NOUN
bjp-80949	159	21	,	,	PUNCT
bjp-80949	159	22	there	there	PRON
bjp-80949	159	23	was	be	VERB
bjp-80949	159	24	a	a	DET
bjp-80949	159	25	significant	significant	ADJ
bjp-80949	159	26	increase	increase	NOUN
bjp-80949	159	27	in	in	ADP
bjp-80949	159	28	the	the	DET
bjp-80949	159	29	antioxidant	antioxidant	ADJ
bjp-80949	159	30	enzyme	enzyme	NOUN
bjp-80949	159	31	glutathione	glutathione	NOUN
bjp-80949	159	32	peroxidase	peroxidase	NOUN
bjp-80949	159	33	(	(	PUNCT
bjp-80949	159	34	gpx	gpx	NOUN
bjp-80949	159	35	)	)	PUNCT
bjp-80949	159	36	levels	level	NOUN
bjp-80949	159	37	in	in	ADP
bjp-80949	159	38	both	both	CCONJ
bjp-80949	159	39	a-549	a-549	PROPN
bjp-80949	159	40	and	and	CCONJ
bjp-80949	159	41	h1299	h1299	CCONJ
bjp-80949	159	42	cells	cell	NOUN
bjp-80949	159	43	(	(	PUNCT
bjp-80949	159	44	table	table	NOUN
bjp-80949	159	45	ii	ii	PROPN
bjp-80949	159	46	)	)	PUNCT
bjp-80949	159	47	.	.	PUNCT
bjp-80949	160	1	cells	cell	NOUN
bjp-80949	160	2	treated	treat	VERB
bjp-80949	160	3	with	with	ADP
bjp-80949	160	4	either	either	DET
bjp-80949	160	5	cetuximab	cetuximab	NOUN
bjp-80949	160	6	alone	alone	ADJ
bjp-80949	160	7	or	or	CCONJ
bjp-80949	160	8	the	the	DET
bjp-80949	160	9	cetuximab	cetuximab	NOUN
bjp-80949	160	10	-	-	PUNCT
bjp-80949	160	11	carvacrol	carvacrol	NOUN
bjp-80949	160	12	combination	combination	NOUN
bjp-80949	160	13	showed	show	VERB
bjp-80949	160	14	a	a	DET
bjp-80949	160	15	marked	mark	VERB
bjp-80949	160	16	elevation	elevation	NOUN
bjp-80949	160	17	in	in	ADP
bjp-80949	160	18	gpx	gpx	NOUN
bjp-80949	160	19	and	and	CCONJ
bjp-80949	160	20	catalase	catalase	NOUN
bjp-80949	160	21	activity	activity	NOUN
bjp-80949	160	22	(	(	PUNCT
bjp-80949	160	23	p<0.05	p<0.05	NOUN
bjp-80949	160	24	)	)	PUNCT
bjp-80949	160	25	.	.	PUNCT
bjp-80949	161	1	in	in	ADP
bjp-80949	161	2	particular	particular	ADJ
bjp-80949	161	3	,	,	PUNCT
bjp-80949	161	4	when	when	SCONJ
bjp-80949	161	5	h1299	h1299	CCONJ
bjp-80949	161	6	were	be	AUX
bjp-80949	161	7	subjected	subject	VERB
bjp-80949	161	8	to	to	ADP
bjp-80949	161	9	the	the	DET
bjp-80949	161	10	combination	combination	NOUN
bjp-80949	161	11	treatment	treatment	NOUN
bjp-80949	161	12	for	for	ADP
bjp-80949	161	13	48	48	NUM
bjp-80949	161	14	hours	hour	NOUN
bjp-80949	161	15	,	,	PUNCT
bjp-80949	161	16	gpx	gpx	NOUN
bjp-80949	161	17	activity	activity	NOUN
bjp-80949	161	18	increased	increase	VERB
bjp-80949	161	19	approximately	approximately	ADV
bjp-80949	161	20	multiplied	multiply	VERB
bjp-80949	161	21	by	by	ADP
bjp-80949	161	22	1.6	1.6	NUM
bjp-80949	161	23	in	in	ADP
bjp-80949	161	24	contrast	contrast	NOUN
bjp-80949	161	25	to	to	ADP
bjp-80949	161	26	the	the	DET
bjp-80949	161	27	baseline	baseline	NOUN
bjp-80949	161	28	,	,	PUNCT
bjp-80949	161	29	which	which	PRON
bjp-80949	161	30	consisted	consist	VERB
bjp-80949	161	31	solely	solely	ADV
bjp-80949	161	32	of	of	ADP
bjp-80949	161	33	the	the	DET
bjp-80949	161	34	cellular	cellular	ADJ
bjp-80949	161	35	growth	growth	NOUN
bjp-80949	161	36	medium	medium	NOUN
bjp-80949	161	37	lacking	lack	VERB
bjp-80949	161	38	the	the	DET
bjp-80949	161	39	evaluated	evaluate	VERB
bjp-80949	161	40	compounds	compound	NOUN
bjp-80949	161	41	.	.	PUNCT
bjp-80949	162	1	without	without	ADP
bjp-80949	162	2	the	the	DET
bjp-80949	162	3	test	test	NOUN
bjp-80949	162	4	compounds	compound	NOUN
bjp-80949	162	5	.	.	PUNCT
bjp-80949	163	1	this	this	DET
bjp-80949	163	2	rise	rise	NOUN
bjp-80949	163	3	was	be	AUX
bjp-80949	163	4	statistically	statistically	ADV
bjp-80949	163	5	significant	significant	ADJ
bjp-80949	163	6	(	(	PUNCT
bjp-80949	163	7	p<0.05	p<0.05	NOUN
bjp-80949	163	8	)	)	PUNCT
bjp-80949	163	9	.	.	PUNCT
bjp-80949	164	1	the	the	DET
bjp-80949	164	2	results	result	NOUN
bjp-80949	164	3	suggest	suggest	VERB
bjp-80949	164	4	that	that	SCONJ
bjp-80949	164	5	both	both	DET
bjp-80949	164	6	cetuximab	cetuximab	NOUN
bjp-80949	164	7	alone	alone	ADJ
bjp-80949	164	8	and	and	CCONJ
bjp-80949	164	9	in	in	ADP
bjp-80949	164	10	combination	combination	NOUN
bjp-80949	164	11	with	with	ADP
bjp-80949	164	12	carvacrol	carvacrol	NOUN
bjp-80949	164	13	induced	induce	VERB
bjp-80949	164	14	oxidative	oxidative	ADJ
bjp-80949	164	15	stress	stress	NOUN
bjp-80949	164	16	in	in	ADP
bjp-80949	164	17	a-549	a-549	PROPN
bjp-80949	164	18	and	and	CCONJ
bjp-80949	164	19	h1299	h1299	CCONJ
bjp-80949	164	20	cells	cell	NOUN
bjp-80949	164	21	,	,	PUNCT
bjp-80949	164	22	likely	likely	ADJ
bjp-80949	164	23	via	via	ADP
bjp-80949	164	24	the	the	DET
bjp-80949	164	25	induction	induction	NOUN
bjp-80949	164	26	of	of	ADP
bjp-80949	164	27	reactive	reactive	ADJ
bjp-80949	164	28	oxygen	oxygen	NOUN
bjp-80949	164	29	species	specie	NOUN
bjp-80949	164	30	.	.	PUNCT
bjp-80949	165	1	impact	impact	NOUN
bjp-80949	165	2	on	on	ADP
bjp-80949	165	3	caspase-3	caspase-3	NUM
bjp-80949	165	4	enzyme	enzyme	NOUN
bjp-80949	165	5	activity	activity	NOUN
bjp-80949	165	6	the	the	DET
bjp-80949	165	7	ability	ability	NOUN
bjp-80949	165	8	of	of	ADP
bjp-80949	165	9	cetuximab	cetuximab	NOUN
bjp-80949	165	10	,	,	PUNCT
bjp-80949	165	11	both	both	CCONJ
bjp-80949	165	12	alone	alone	ADJ
bjp-80949	165	13	and	and	CCONJ
bjp-80949	165	14	in	in	ADP
bjp-80949	165	15	combination	combination	NOUN
bjp-80949	165	16	with	with	ADP
bjp-80949	165	17	carvacrol	carvacrol	NOUN
bjp-80949	165	18	,	,	PUNCT
bjp-80949	165	19	to	to	PART
bjp-80949	165	20	trigger	trigger	NOUN
bjp-80949	165	21	apoptosis	apoptosis	NOUN
bjp-80949	165	22	was	be	AUX
bjp-80949	165	23	evaluated	evaluate	VERB
bjp-80949	165	24	in	in	ADP
bjp-80949	165	25	a549	a549	PROPN
bjp-80949	165	26	and	and	CCONJ
bjp-80949	166	1	h1299	h1299	NUM
bjp-80949	166	2	cells	cell	NOUN
bjp-80949	166	3	following	follow	VERB
bjp-80949	166	4	48	48	NUM
bjp-80949	166	5	hours	hour	NOUN
bjp-80949	166	6	of	of	ADP
bjp-80949	166	7	treatment	treatment	NOUN
bjp-80949	166	8	.	.	PUNCT
bjp-80949	167	1	in	in	ADP
bjp-80949	167	2	a-549	a-549	PROPN
bjp-80949	167	3	cells	cell	NOUN
bjp-80949	167	4	,	,	PUNCT
bjp-80949	167	5	caspase-3	caspase-3	NUM
bjp-80949	167	6	activity	activity	NOUN
bjp-80949	167	7	increased	increase	VERB
bjp-80949	167	8	by	by	ADP
bjp-80949	167	9	1.6	1.6	NUM
bjp-80949	167	10	-	-	ADJ
bjp-80949	167	11	fold	fold	ADJ
bjp-80949	167	12	following	follow	VERB
bjp-80949	167	13	treatment	treatment	NOUN
bjp-80949	167	14	with	with	ADP
bjp-80949	167	15	the	the	DET
bjp-80949	167	16	combination	combination	NOUN
bjp-80949	167	17	of	of	ADP
bjp-80949	167	18	ic10	ic10	PROPN
bjp-80949	167	19	cetuximab	cetuximab	NOUN
bjp-80949	167	20	and	and	CCONJ
bjp-80949	167	21	ic10	ic10	PROPN
bjp-80949	167	22	carvacrol	carvacrol	NOUN
bjp-80949	167	23	.	.	PUNCT
bjp-80949	168	1	in	in	ADP
bjp-80949	168	2	h1299	h1299	NOUN
bjp-80949	168	3	cells	cell	NOUN
bjp-80949	168	4	,	,	PUNCT
bjp-80949	168	5	caspase-3	caspase-3	NUM
bjp-80949	168	6	activity	activity	NOUN
bjp-80949	168	7	was	be	AUX
bjp-80949	168	8	elevated	elevate	VERB
bjp-80949	168	9	by	by	ADP
bjp-80949	168	10	approximately	approximately	ADV
bjp-80949	168	11	1.4	1.4	NUM
bjp-80949	168	12	-	-	NOUN
bjp-80949	168	13	fold	fold	ADJ
bjp-80949	168	14	after	after	ADP
bjp-80949	168	15	exposure	exposure	NOUN
bjp-80949	168	16	to	to	ADP
bjp-80949	168	17	the	the	DET
bjp-80949	168	18	combination	combination	NOUN
bjp-80949	168	19	of	of	ADP
bjp-80949	168	20	ic20	ic20	PROPN
bjp-80949	168	21	cetuximab	cetuximab	NOUN
bjp-80949	168	22	and	and	CCONJ
bjp-80949	168	23	ic10	ic10	PROPN
bjp-80949	168	24	carvacrol	carvacrol	NOUN
bjp-80949	168	25	,	,	PUNCT
bjp-80949	168	26	in	in	ADP
bjp-80949	168	27	relation	relation	NOUN
bjp-80949	168	28	to	to	ADP
bjp-80949	168	29	the	the	DET
bjp-80949	168	30	control	control	NOUN
bjp-80949	168	31	group	group	NOUN
bjp-80949	168	32	(	(	PUNCT
bjp-80949	168	33	table	table	NOUN
bjp-80949	168	34	ii	ii	PROPN
bjp-80949	168	35	)	)	PUNCT
bjp-80949	168	36	.	.	PUNCT
bjp-80949	169	1	apoptosis	apoptosis	NOUN
bjp-80949	169	2	-	-	PUNCT
bjp-80949	169	3	inducing	induce	VERB
bjp-80949	169	4	effect	effect	NOUN
bjp-80949	169	5	induced	induce	VERB
bjp-80949	169	6	by	by	ADP
bjp-80949	169	7	cetuximabcarvacrol	cetuximabcarvacrol	NOUN
bjp-80949	169	8	combination	combination	NOUN
bjp-80949	169	9	was	be	AUX
bjp-80949	169	10	found	find	VERB
bjp-80949	169	11	to	to	PART
bjp-80949	169	12	be	be	AUX
bjp-80949	169	13	1.2	1.2	NUM
bjp-80949	169	14	times	time	NOUN
bjp-80949	169	15	stronger	strong	ADJ
bjp-80949	169	16	in	in	ADP
bjp-80949	169	17	a-549	a-549	PROPN
bjp-80949	169	18	cells	cell	NOUN
bjp-80949	169	19	than	than	ADP
bjp-80949	169	20	in	in	ADP
bjp-80949	169	21	h1299	h1299	CCONJ
bjp-80949	169	22	cells	cell	NOUN
bjp-80949	169	23	,	,	PUNCT
bjp-80949	169	24	with	with	ADP
bjp-80949	169	25	a-549	a-549	PROPN
bjp-80949	169	26	cells	cell	NOUN
bjp-80949	169	27	showing	show	VERB
bjp-80949	169	28	the	the	DET
bjp-80949	169	29	most	most	ADV
bjp-80949	169	30	pronounced	pronounced	ADJ
bjp-80949	169	31	increase	increase	NOUN
bjp-80949	169	32	in	in	ADP
bjp-80949	169	33	caspase3	caspase3	NOUN
bjp-80949	169	34	activity	activity	NOUN
bjp-80949	169	35	following	follow	VERB
bjp-80949	169	36	treatment	treatment	NOUN
bjp-80949	169	37	.	.	PUNCT
bjp-80949	170	1	b	b	X
bjp-80949	170	2	table	table	NOUN
bjp-80949	170	3	ii	ii	NOUN
bjp-80949	170	4	effects	effect	NOUN
bjp-80949	170	5	of	of	ADP
bjp-80949	170	6	carvacrol	carvacrol	NOUN
bjp-80949	170	7	with	with	ADP
bjp-80949	170	8	cetuximab	cetuximab	NOUN
bjp-80949	170	9	on	on	ADP
bjp-80949	170	10	different	different	ADJ
bjp-80949	170	11	parameters	parameter	NOUN
bjp-80949	170	12	in	in	ADP
bjp-80949	170	13	two	two	NUM
bjp-80949	170	14	cell	cell	NOUN
bjp-80949	170	15	lines	line	NOUN
bjp-80949	170	16	concentrations	concentration	NOUN
bjp-80949	170	17	ldh	ldh	X
bjp-80949	170	18	activity	activity	NOUN
bjp-80949	170	19	(	(	PUNCT
bjp-80949	170	20	mu	mu	NOUN
bjp-80949	170	21	/	/	SYM
bjp-80949	170	22	ml	ml	NOUN
bjp-80949	170	23	)	)	PUNCT
bjp-80949	170	24	caspase-3	caspase-3	NUM
bjp-80949	170	25	activity	activity	NOUN
bjp-80949	170	26	(	(	PUNCT
bjp-80949	170	27	µmol	µmol	NOUN
bjp-80949	170	28	/	/	SYM
bjp-80949	170	29	mg	mg	PROPN
bjp-80949	170	30	protein	protein	NOUN
bjp-80949	170	31	)	)	PUNCT
bjp-80949	170	32	gpx	gpx	NOUN
bjp-80949	170	33	activity	activity	NOUN
bjp-80949	170	34	(	(	PUNCT
bjp-80949	170	35	u	u	NOUN
bjp-80949	170	36	/	/	SYM
bjp-80949	170	37	mg	mg	PROPN
bjp-80949	170	38	protein	protein	NOUN
bjp-80949	170	39	)	)	PUNCT
bjp-80949	170	40	a-549	a-549	PROPN
bjp-80949	170	41	cell	cell	NOUN
bjp-80949	170	42	lines	line	NOUN
bjp-80949	170	43	cetuximab	cetuximab	NOUN
bjp-80949	170	44	(	(	PUNCT
bjp-80949	170	45	ic10	ic10	PROPN
bjp-80949	170	46	)	)	PUNCT
bjp-80949	170	47	144.7	144.7	NUM
bjp-80949	170	48	±	±	NUM
bjp-80949	170	49	 	 	SPACE
bjp-80949	170	50	0.4a	0.4a	NUM
bjp-80949	170	51	17.5	17.5	NUM
bjp-80949	170	52	±	±	NUM
bjp-80949	170	53	 	 	SPACE
bjp-80949	170	54	0.3a	0.3a	NOUN
bjp-80949	170	55	2.2	2.2	NUM
bjp-80949	170	56	±	±	NUM
bjp-80949	170	57	 	 	SPACE
bjp-80949	170	58	0.3a	0.3a	NOUN
bjp-80949	170	59	cetuximab	cetuximab	NOUN
bjp-80949	170	60	(	(	PUNCT
bjp-80949	170	61	ic10	ic10	PROPN
bjp-80949	170	62	)	)	PUNCT
bjp-80949	170	63	+	+	NUM
bjp-80949	170	64	carvacrol	carvacrol	NOUN
bjp-80949	170	65	(	(	PUNCT
bjp-80949	170	66	ic10	ic10	PROPN
bjp-80949	170	67	)	)	PUNCT
bjp-80949	170	68	233.3	233.3	NUM
bjp-80949	170	69	±	±	NUM
bjp-80949	170	70	 	 	SPACE
bjp-80949	170	71	0.4a	0.4a	NUM
bjp-80949	170	72	24.9	24.9	NUM
bjp-80949	170	73	±	±	NOUN
bjp-80949	170	74	 	 	SPACE
bjp-80949	170	75	0.3a	0.3a	NOUN
bjp-80949	170	76	2.5	2.5	NUM
bjp-80949	170	77	±	±	NUM
bjp-80949	170	78	 	 	SPACE
bjp-80949	170	79	1.0a	1.0a	NUM
bjp-80949	170	80	control	control	NOUN
bjp-80949	170	81	116.0	116.0	NUM
bjp-80949	170	82	±	±	NUM
bjp-80949	170	83	 	 	SPACE
bjp-80949	170	84	0.1a	0.1a	NOUN
bjp-80949	171	1	15.2	15.2	NUM
bjp-80949	171	2	±	±	NUM
bjp-80949	171	3	 	 	SPACE
bjp-80949	171	4	0.4a	0.4a	NUM
bjp-80949	171	5	1.1	1.1	NUM
bjp-80949	171	6	±	±	NUM
bjp-80949	171	7	 	 	SPACE
bjp-80949	171	8	0.3a	0.3a	NOUN
bjp-80949	172	1	h1299	h1299	CCONJ
bjp-80949	172	2	cell	cell	NOUN
bjp-80949	172	3	lines	line	NOUN
bjp-80949	172	4	cetuximab	cetuximab	NOUN
bjp-80949	172	5	(	(	PUNCT
bjp-80949	172	6	ic20	ic20	PROPN
bjp-80949	172	7	)	)	PUNCT
bjp-80949	172	8	272.7	272.7	NUM
bjp-80949	172	9	±	±	NUM
bjp-80949	172	10	 	 	SPACE
bjp-80949	172	11	0.7a	0.7a	NOUN
bjp-80949	172	12	17.0	17.0	NUM
bjp-80949	172	13	±	±	NUM
bjp-80949	172	14	 	 	SPACE
bjp-80949	172	15	0.4a	0.4a	NUM
bjp-80949	172	16	2.4	2.4	NUM
bjp-80949	172	17	±	±	NUM
bjp-80949	172	18	 	 	SPACE
bjp-80949	172	19	0.5a	0.5a	PROPN
bjp-80949	172	20	cetuximab	cetuximab	NOUN
bjp-80949	172	21	(	(	PUNCT
bjp-80949	172	22	ic20	ic20	PROPN
bjp-80949	172	23	)	)	PUNCT
bjp-80949	172	24	+	+	NUM
bjp-80949	172	25	carvacrol	carvacrol	NOUN
bjp-80949	172	26	(	(	PUNCT
bjp-80949	172	27	ic10	ic10	PROPN
bjp-80949	172	28	)	)	PUNCT
bjp-80949	172	29	345.5	345.5	NUM
bjp-80949	172	30	±	±	NUM
bjp-80949	172	31	 	 	SPACE
bjp-80949	172	32	0.7a	0.7a	NOUN
bjp-80949	173	1	21.0	21.0	NUM
bjp-80949	173	2	±	±	NUM
bjp-80949	173	3	0.4a	0.4a	NUM
bjp-80949	173	4	2.9	2.9	NUM
bjp-80949	173	5	±	±	NUM
bjp-80949	173	6	 	 	SPACE
bjp-80949	173	7	0.2a	0.2a	PROPN
bjp-80949	173	8	control	control	VERB
bjp-80949	173	9	102.0	102.0	NUM
bjp-80949	173	10	±	±	NUM
bjp-80949	173	11	 	 	SPACE
bjp-80949	173	12	0.6a	0.6a	NOUN
bjp-80949	173	13	15.5	15.5	NUM
bjp-80949	173	14	±	±	NUM
bjp-80949	173	15	 	 	SPACE
bjp-80949	173	16	0.2a	0.2a	PROPN
bjp-80949	173	17	1.8	1.8	NUM
bjp-80949	173	18	±	±	NUM
bjp-80949	173	19	 	 	SPACE
bjp-80949	173	20	0.9a	0.9a	NOUN
bjp-80949	173	21	data	datum	NOUN
bjp-80949	173	22	are	be	AUX
bjp-80949	173	23	mean	mean	PROPN
bjp-80949	173	24	±	±	NUM
bjp-80949	173	25	sem	sem	NOUN
bjp-80949	173	26	;	;	PUNCT
bjp-80949	173	27	ap	ap	PROPN
bjp-80949	173	28	means	mean	VERB
bjp-80949	173	29	<	<	X
bjp-80949	173	30	0.05	0.05	NUM
bjp-80949	173	31	(	(	PUNCT
bjp-80949	173	32	statistically	statistically	ADV
bjp-80949	173	33	significant	significant	ADJ
bjp-80949	173	34	)	)	PUNCT
bjp-80949	173	35	of	of	ADP
bjp-80949	173	36	carvacrol	carvacrol	NOUN
bjp-80949	173	37	with	with	ADP
bjp-80949	173	38	/	/	SYM
bjp-80949	173	39	without	without	ADP
bjp-80949	173	40	cetuximab	cetuximab	NOUN
bjp-80949	173	41	in	in	ADP
bjp-80949	173	42	comparison	comparison	NOUN
bjp-80949	173	43	to	to	PART
bjp-80949	173	44	control	control	VERB
bjp-80949	173	45	as	as	SCONJ
bjp-80949	173	46	determined	determine	VERB
bjp-80949	173	47	by	by	ADP
bjp-80949	173	48	anova	anova	PROPN
bjp-80949	173	49	with	with	ADP
bjp-80949	173	50	tukey	tukey	PROPN
bjp-80949	173	51	’s	’s	PART
bjp-80949	173	52	test	test	NOUN
bjp-80949	173	53	.	.	PUNCT
bjp-80949	174	1	ldh	ldh	PROPN
bjp-80949	174	2	refers	refer	VERB
bjp-80949	174	3	to	to	ADP
bjp-80949	174	4	lactate	lactate	NOUN
bjp-80949	174	5	dehydrogenase	dehydrogenase	NOUN
bjp-80949	174	6	,	,	PUNCT
bjp-80949	174	7	and	and	CCONJ
bjp-80949	174	8	gpx	gpx	NOUN
bjp-80949	174	9	represents	represent	VERB
bjp-80949	174	10	glutathione	glutathione	NOUN
bjp-80949	174	11	peroxidase	peroxidase	NOUN
bjp-80949	174	12	.	.	PUNCT
bjp-80949	175	1	each	each	DET
bjp-80949	175	2	value	value	NOUN
bjp-80949	175	3	is	be	AUX
bjp-80949	175	4	the	the	DET
bjp-80949	175	5	mean	mean	NOUN
bjp-80949	175	6	of	of	ADP
bjp-80949	175	7	three	three	NUM
bjp-80949	175	8	repetitions	repetition	NOUN
bjp-80949	175	9	for	for	ADP
bjp-80949	175	10	the	the	DET
bjp-80949	175	11	activities	activity	NOUN
bjp-80949	175	12	of	of	ADP
bjp-80949	175	13	ldh	ldh	PROPN
bjp-80949	175	14	,	,	PUNCT
bjp-80949	175	15	caspase-3	caspase-3	NUM
bjp-80949	175	16	,	,	PUNCT
bjp-80949	175	17	and	and	CCONJ
bjp-80949	175	18	gpx	gpx	PROPN
bjp-80949	175	19	bangladesh	bangladesh	PROPN
bjp-80949	175	20	j	j	PROPN
bjp-80949	175	21	pharmacol	pharmacol	PROPN
bjp-80949	175	22	2025	2025	NUM
bjp-80949	175	23	;	;	PUNCT
bjp-80949	175	24	20	20	NUM
bjp-80949	175	25	:	:	SYM
bjp-80949	175	26	22	22	NUM
bjp-80949	175	27	-	-	SYM
bjp-80949	175	28	34	34	NUM
bjp-80949	175	29	27	27	NUM
bjp-80949	175	30	all	all	DET
bjp-80949	175	31	applications	application	NOUN
bjp-80949	175	32	,	,	PUNCT
bjp-80949	175	33	including	include	VERB
bjp-80949	175	34	single	single	ADJ
bjp-80949	175	35	and	and	CCONJ
bjp-80949	175	36	combined	combined	ADJ
bjp-80949	175	37	applications	application	NOUN
bjp-80949	175	38	,	,	PUNCT
bjp-80949	175	39	have	have	VERB
bjp-80949	175	40	membrane	membrane	NOUN
bjp-80949	175	41	damaging	damaging	ADJ
bjp-80949	175	42	,	,	PUNCT
bjp-80949	175	43	oxidative	oxidative	ADJ
bjp-80949	175	44	stress	stress	NOUN
bjp-80949	175	45	inducing	induce	VERB
bjp-80949	175	46	effects	effect	NOUN
bjp-80949	175	47	and	and	CCONJ
bjp-80949	175	48	apoptosis	apoptosis	NOUN
bjp-80949	175	49	inducing	induce	VERB
bjp-80949	175	50	potentials	potential	NOUN
bjp-80949	175	51	showed	show	VERB
bjp-80949	175	52	significant	significant	ADJ
bjp-80949	175	53	differences	difference	NOUN
bjp-80949	175	54	when	when	SCONJ
bjp-80949	175	55	compared	compare	VERB
bjp-80949	175	56	to	to	ADP
bjp-80949	175	57	the	the	DET
bjp-80949	175	58	baseline	baseline	ADJ
bjp-80949	175	59	groups	group	NOUN
bjp-80949	175	60	(	(	PUNCT
bjp-80949	175	61	which	which	PRON
bjp-80949	175	62	were	be	AUX
bjp-80949	175	63	administered	administer	VERB
bjp-80949	175	64	only	only	ADV
bjp-80949	175	65	using	use	VERB
bjp-80949	175	66	the	the	DET
bjp-80949	175	67	culturing	culture	VERB
bjp-80949	175	68	solution	solution	NOUN
bjp-80949	175	69	and	and	CCONJ
bjp-80949	175	70	not	not	PART
bjp-80949	175	71	exposed	expose	VERB
bjp-80949	175	72	to	to	ADP
bjp-80949	175	73	any	any	DET
bjp-80949	175	74	test	test	NOUN
bjp-80949	175	75	compounds	compound	NOUN
bjp-80949	175	76	)	)	PUNCT
bjp-80949	175	77	in	in	ADP
bjp-80949	175	78	all	all	DET
bjp-80949	175	79	cell	cell	NOUN
bjp-80949	175	80	lines	line	NOUN
bjp-80949	175	81	(	(	PUNCT
bjp-80949	175	82	p<0.05	p<0.05	NOUN
bjp-80949	175	83	)	)	PUNCT
bjp-80949	175	84	.	.	PUNCT
bjp-80949	176	1	effects	effect	NOUN
bjp-80949	176	2	of	of	ADP
bjp-80949	176	3	on	on	ADP
bjp-80949	176	4	cell	cell	NOUN
bjp-80949	176	5	cycle	cycle	NOUN
bjp-80949	176	6	and	and	CCONJ
bjp-80949	176	7	apoptotic	apoptotic	ADJ
bjp-80949	176	8	mechanism	mechanism	NOUN
bjp-80949	176	9	rt	rt	ADJ
bjp-80949	176	10	-	-	PUNCT
bjp-80949	176	11	pcr	pcr	NOUN
bjp-80949	176	12	analysis	analysis	NOUN
bjp-80949	176	13	was	be	AUX
bjp-80949	176	14	carried	carry	VERB
bjp-80949	176	15	out	out	ADP
bjp-80949	176	16	using	use	VERB
bjp-80949	176	17	designated	designate	VERB
bjp-80949	176	18	primers	primer	NOUN
bjp-80949	176	19	for	for	ADP
bjp-80949	176	20	every	every	DET
bjp-80949	176	21	target	target	NOUN
bjp-80949	176	22	gene	gene	NOUN
bjp-80949	176	23	,	,	PUNCT
bjp-80949	176	24	using	use	VERB
bjp-80949	176	25	glyceraldehyde	glyceraldehyde	NOUN
bjp-80949	176	26	3phosphate	3phosphate	NUM
bjp-80949	176	27	dehydrogenase	dehydrogenase	NOUN
bjp-80949	176	28	(	(	PUNCT
bjp-80949	176	29	gapdh	gapdh	NOUN
bjp-80949	176	30	)	)	PUNCT
bjp-80949	176	31	as	as	ADP
bjp-80949	176	32	an	an	DET
bjp-80949	176	33	internal	internal	ADJ
bjp-80949	176	34	normalization	normalization	NOUN
bjp-80949	176	35	control	control	NOUN
bjp-80949	176	36	.	.	PUNCT
bjp-80949	177	1	cellular	cellular	ADJ
bjp-80949	177	2	proliferation	proliferation	NOUN
bjp-80949	177	3	marker	marker	NOUN
bjp-80949	177	4	pcna	pcna	NOUN
bjp-80949	177	5	is	be	AUX
bjp-80949	177	6	an	an	DET
bjp-80949	177	7	essential	essential	ADJ
bjp-80949	177	8	protein	protein	NOUN
bjp-80949	177	9	that	that	PRON
bjp-80949	177	10	plays	play	VERB
bjp-80949	177	11	a	a	DET
bjp-80949	177	12	vital	vital	ADJ
bjp-80949	177	13	function	function	NOUN
bjp-80949	177	14	in	in	ADP
bjp-80949	177	15	dna	dna	NOUN
bjp-80949	177	16	replication	replication	NOUN
bjp-80949	177	17	and	and	CCONJ
bjp-80949	177	18	repair	repair	NOUN
bjp-80949	177	19	mechanisms	mechanism	NOUN
bjp-80949	177	20	,	,	PUNCT
bjp-80949	177	21	functioning	function	VERB
bjp-80949	177	22	as	as	ADP
bjp-80949	177	23	a	a	DET
bjp-80949	177	24	cofactor	cofactor	NOUN
bjp-80949	177	25	for	for	ADP
bjp-80949	177	26	dna	dna	PROPN
bjp-80949	177	27	polymerase	polymerase	NOUN
bjp-80949	177	28	.	.	PUNCT
bjp-80949	178	1	it	it	PRON
bjp-80949	178	2	is	be	AUX
bjp-80949	178	3	vital	vital	ADJ
bjp-80949	178	4	for	for	ADP
bjp-80949	178	5	regulating	regulate	VERB
bjp-80949	178	6	the	the	DET
bjp-80949	178	7	cell	cell	NOUN
bjp-80949	178	8	cycle	cycle	NOUN
bjp-80949	178	9	,	,	PUNCT
bjp-80949	178	10	especially	especially	ADV
bjp-80949	178	11	during	during	ADP
bjp-80949	178	12	the	the	DET
bjp-80949	178	13	shift	shift	NOUN
bjp-80949	178	14	in	in	ADP
bjp-80949	178	15	the	the	DET
bjp-80949	178	16	cell	cell	NOUN
bjp-80949	178	17	cycle	cycle	NOUN
bjp-80949	178	18	from	from	ADP
bjp-80949	178	19	the	the	DET
bjp-80949	178	20	g1	g1	PROPN
bjp-80949	178	21	phase	phase	NOUN
bjp-80949	178	22	to	to	ADP
bjp-80949	178	23	the	the	DET
bjp-80949	178	24	s	s	NOUN
bjp-80949	178	25	phase	phase	NOUN
bjp-80949	178	26	.	.	PUNCT
bjp-80949	179	1	due	due	ADP
bjp-80949	179	2	to	to	ADP
bjp-80949	179	3	its	its	PRON
bjp-80949	179	4	increased	increase	VERB
bjp-80949	179	5	expression	expression	NOUN
bjp-80949	179	6	in	in	ADP
bjp-80949	179	7	proliferating	proliferate	VERB
bjp-80949	179	8	cells	cell	NOUN
bjp-80949	179	9	,	,	PUNCT
bjp-80949	179	10	pcna	pcna	PROPN
bjp-80949	179	11	is	be	AUX
bjp-80949	179	12	commonly	commonly	ADV
bjp-80949	179	13	used	use	VERB
bjp-80949	179	14	as	as	ADP
bjp-80949	179	15	a	a	DET
bjp-80949	179	16	marker	marker	NOUN
bjp-80949	179	17	for	for	ADP
bjp-80949	179	18	cell	cell	NOUN
bjp-80949	179	19	division	division	NOUN
bjp-80949	179	20	.	.	PUNCT
bjp-80949	180	1	the	the	DET
bjp-80949	180	2	expression	expression	NOUN
bjp-80949	180	3	of	of	ADP
bjp-80949	180	4	pcna	pcna	PROPN
bjp-80949	180	5	mrna	mrna	PROPN
bjp-80949	180	6	was	be	AUX
bjp-80949	180	7	analyzed	analyze	VERB
bjp-80949	180	8	to	to	PART
bjp-80949	180	9	assess	assess	VERB
bjp-80949	180	10	the	the	DET
bjp-80949	180	11	antiproliferative	antiproliferative	ADJ
bjp-80949	180	12	influence	influence	NOUN
bjp-80949	180	13	of	of	ADP
bjp-80949	180	14	cetuximab	cetuximab	NOUN
bjp-80949	180	15	by	by	ADP
bjp-80949	180	16	itself	itself	PRON
bjp-80949	180	17	and	and	CCONJ
bjp-80949	180	18	in	in	ADP
bjp-80949	180	19	conjunction	conjunction	NOUN
bjp-80949	180	20	with	with	ADP
bjp-80949	180	21	carvacrol	carvacrol	NOUN
bjp-80949	180	22	in	in	ADP
bjp-80949	180	23	a-549	a-549	PROPN
bjp-80949	180	24	and	and	CCONJ
bjp-80949	181	1	h1299	h1299	CCONJ
bjp-80949	181	2	cells	cell	NOUN
bjp-80949	181	3	.	.	PUNCT
bjp-80949	182	1	the	the	DET
bjp-80949	182	2	dual	dual	ADJ
bjp-80949	182	3	intervention	intervention	NOUN
bjp-80949	182	4	was	be	AUX
bjp-80949	182	5	observed	observe	VERB
bjp-80949	182	6	to	to	PART
bjp-80949	182	7	be	be	AUX
bjp-80949	182	8	enhanced	enhance	VERB
bjp-80949	182	9	efficient	efficient	ADJ
bjp-80949	182	10	in	in	ADP
bjp-80949	182	11	lowering	lower	VERB
bjp-80949	182	12	levels	level	NOUN
bjp-80949	182	13	of	of	ADP
bjp-80949	182	14	pcna	pcna	NOUN
bjp-80949	182	15	compared	compare	VERB
bjp-80949	182	16	to	to	ADP
bjp-80949	182	17	cetuximab	cetuximab	NOUN
bjp-80949	182	18	by	by	ADP
bjp-80949	182	19	itself	itself	PRON
bjp-80949	182	20	in	in	ADP
bjp-80949	182	21	all	all	DET
bjp-80949	182	22	cell	cell	NOUN
bjp-80949	182	23	types	type	NOUN
bjp-80949	182	24	.	.	PUNCT
bjp-80949	183	1	the	the	DET
bjp-80949	183	2	most	most	ADV
bjp-80949	183	3	notable	notable	ADJ
bjp-80949	183	4	decrease	decrease	NOUN
bjp-80949	183	5	in	in	ADP
bjp-80949	183	6	pcna	pcna	NOUN
bjp-80949	183	7	expression	expression	NOUN
bjp-80949	183	8	levels	level	NOUN
bjp-80949	183	9	was	be	AUX
bjp-80949	183	10	observed	observe	VERB
bjp-80949	183	11	in	in	ADP
bjp-80949	183	12	h1299	h1299	CCONJ
bjp-80949	183	13	human	human	ADJ
bjp-80949	183	14	lung	lung	NOUN
bjp-80949	183	15	carcinoma	carcinoma	NOUN
bjp-80949	183	16	cells	cell	NOUN
bjp-80949	183	17	,	,	PUNCT
bjp-80949	183	18	where	where	SCONJ
bjp-80949	183	19	expression	expression	NOUN
bjp-80949	183	20	reduced	reduce	VERB
bjp-80949	183	21	by	by	ADP
bjp-80949	183	22	20	20	NUM
bjp-80949	183	23	%	%	NOUN
bjp-80949	183	24	with	with	ADP
bjp-80949	183	25	cetuximab	cetuximab	NOUN
bjp-80949	183	26	by	by	ADP
bjp-80949	183	27	itself	itself	PRON
bjp-80949	183	28	and	and	CCONJ
bjp-80949	183	29	44	44	NUM
bjp-80949	183	30	%	%	NOUN
bjp-80949	183	31	with	with	ADP
bjp-80949	183	32	the	the	DET
bjp-80949	183	33	dual	dual	ADJ
bjp-80949	183	34	therapy	therapy	NOUN
bjp-80949	183	35	,	,	PUNCT
bjp-80949	183	36	when	when	SCONJ
bjp-80949	183	37	contrasted	contrast	VERB
bjp-80949	183	38	with	with	ADP
bjp-80949	183	39	the	the	DET
bjp-80949	183	40	unexposed	unexposed	ADJ
bjp-80949	183	41	group	group	NOUN
bjp-80949	183	42	(	(	PUNCT
bjp-80949	183	43	figure	figure	NOUN
bjp-80949	183	44	2b	2b	NOUN
bjp-80949	183	45	)	)	PUNCT
bjp-80949	183	46	.	.	PUNCT
bjp-80949	184	1	topoisomerase	topoisomerase	PROPN
bjp-80949	184	2	ii	ii	PROPN
bjp-80949	184	3	-	-	NOUN
bjp-80949	184	4	alpha	alpha	NOUN
bjp-80949	184	5	is	be	AUX
bjp-80949	184	6	a	a	DET
bjp-80949	184	7	critical	critical	ADJ
bjp-80949	184	8	enzyme	enzyme	NOUN
bjp-80949	184	9	that	that	PRON
bjp-80949	184	10	serves	serve	VERB
bjp-80949	184	11	a	a	DET
bjp-80949	184	12	crucial	crucial	ADJ
bjp-80949	184	13	influence	influence	NOUN
bjp-80949	184	14	in	in	ADP
bjp-80949	184	15	dna	dna	PROPN
bjp-80949	184	16	replication	replication	NOUN
bjp-80949	184	17	,	,	PUNCT
bjp-80949	184	18	transcription	transcription	NOUN
bjp-80949	184	19	,	,	PUNCT
bjp-80949	184	20	and	and	CCONJ
bjp-80949	184	21	chromosome	chromosome	NOUN
bjp-80949	184	22	segregation	segregation	NOUN
bjp-80949	184	23	.	.	PUNCT
bjp-80949	185	1	it	it	PRON
bjp-80949	185	2	modulates	modulate	VERB
bjp-80949	185	3	dna	dna	NOUN
bjp-80949	185	4	topology	topology	NOUN
bjp-80949	185	5	by	by	ADP
bjp-80949	185	6	introducing	introduce	VERB
bjp-80949	185	7	or	or	CCONJ
bjp-80949	185	8	removing	remove	VERB
bjp-80949	185	9	supercoils	supercoil	NOUN
bjp-80949	185	10	in	in	ADP
bjp-80949	185	11	the	the	DET
bjp-80949	185	12	dna	dna	PROPN
bjp-80949	185	13	structure	structure	NOUN
bjp-80949	185	14	,	,	PUNCT
bjp-80949	185	15	which	which	PRON
bjp-80949	185	16	is	be	AUX
bjp-80949	185	17	essential	essential	ADJ
bjp-80949	185	18	for	for	ADP
bjp-80949	185	19	processes	process	NOUN
bjp-80949	185	20	such	such	ADJ
bjp-80949	185	21	as	as	ADP
bjp-80949	185	22	cell	cell	NOUN
bjp-80949	185	23	division	division	NOUN
bjp-80949	185	24	,	,	PUNCT
bjp-80949	185	25	where	where	SCONJ
bjp-80949	185	26	it	it	PRON
bjp-80949	185	27	helps	helps	AUX
bjp-80949	185	28	untangle	untangle	VERB
bjp-80949	185	29	dna	dna	NOUN
bjp-80949	185	30	strands	strand	NOUN
bjp-80949	185	31	.	.	PUNCT
bjp-80949	186	1	the	the	DET
bjp-80949	186	2	most	most	ADV
bjp-80949	186	3	significant	significant	ADJ
bjp-80949	186	4	decrease	decrease	NOUN
bjp-80949	186	5	in	in	ADP
bjp-80949	186	6	expression	expression	NOUN
bjp-80949	186	7	of	of	ADP
bjp-80949	186	8	topoisomerase	topoisomerase	PROPN
bjp-80949	186	9	ii	ii	ADJ
bjp-80949	186	10	-	-	ADJ
bjp-80949	186	11	alpha	alpha	NOUN
bjp-80949	186	12	transcript	transcript	NOUN
bjp-80949	186	13	was	be	AUX
bjp-80949	186	14	observed	observe	VERB
bjp-80949	186	15	in	in	ADP
bjp-80949	186	16	human	human	ADJ
bjp-80949	186	17	lung	lung	NOUN
bjp-80949	186	18	carcinoma	carcinoma	NOUN
bjp-80949	186	19	a-549	a-549	PROPN
bjp-80949	186	20	cells	cell	NOUN
bjp-80949	186	21	following	follow	VERB
bjp-80949	186	22	the	the	DET
bjp-80949	186	23	two	two	NUM
bjp-80949	186	24	a	a	DET
bjp-80949	186	25	b	b	NOUN
bjp-80949	186	26	200	200	NUM
bjp-80949	186	27	160	160	NUM
bjp-80949	186	28	120	120	NUM
bjp-80949	186	29	80	80	NUM
bjp-80949	186	30	40	40	NUM
bjp-80949	186	31	0	0	NUM
bjp-80949	186	32	m	m	VERB
bjp-80949	186	33	r	r	NOUN
bjp-80949	186	34	n	n	NOUN
bjp-80949	186	35	a	a	DET
bjp-80949	186	36	e	e	NOUN
bjp-80949	186	37	x	x	X
bjp-80949	186	38	p	p	X
bjp-80949	186	39	re	re	ADP
bjp-80949	186	40	s	s	PROPN
bjp-80949	186	41	s	s	X
bjp-80949	186	42	io	io	X
bjp-80949	186	43	n	n	ADV
bjp-80949	186	44	%	%	NOUN
bjp-80949	186	45	c	c	NOUN
bjp-80949	186	46	o	o	NOUN
bjp-80949	186	47	n	n	PRON
bjp-80949	186	48	tr	tr	NOUN
bjp-80949	186	49	o	o	PROPN
bjp-80949	186	50	l	l	NOUN
bjp-80949	186	51	160	160	NUM
bjp-80949	186	52	120	120	NUM
bjp-80949	186	53	80	80	NUM
bjp-80949	186	54	40	40	NUM
bjp-80949	186	55	0	0	NUM
bjp-80949	187	1	m	m	VERB
bjp-80949	187	2	r	r	NOUN
bjp-80949	187	3	n	n	NOUN
bjp-80949	187	4	a	a	DET
bjp-80949	187	5	e	e	NOUN
bjp-80949	187	6	x	x	X
bjp-80949	187	7	p	p	X
bjp-80949	187	8	re	re	ADP
bjp-80949	187	9	s	s	PROPN
bjp-80949	187	10	s	s	X
bjp-80949	187	11	io	io	X
bjp-80949	187	12	n	n	ADV
bjp-80949	187	13	%	%	NOUN
bjp-80949	188	1	c	c	NOUN
bjp-80949	188	2	o	o	NOUN
bjp-80949	188	3	n	n	PRON
bjp-80949	188	4	tr	tr	NOUN
bjp-80949	188	5	o	o	NOUN
bjp-80949	188	6	l	l	NOUN
bjp-80949	188	7	cetuximab	cetuximab	NOUN
bjp-80949	188	8	(	(	PUNCT
bjp-80949	188	9	ic10	ic10	PROPN
bjp-80949	188	10	)	)	PUNCT
bjp-80949	188	11	cetuximab	cetuximab	NOUN
bjp-80949	188	12	(	(	PUNCT
bjp-80949	188	13	ic10	ic10	PROPN
bjp-80949	188	14	)	)	PUNCT
bjp-80949	188	15	+	+	NUM
bjp-80949	188	16	carvacrol	carvacrol	NOUN
bjp-80949	188	17	(	(	PUNCT
bjp-80949	188	18	ic10	ic10	PROPN
bjp-80949	188	19	)	)	PUNCT
bjp-80949	188	20	control	control	NOUN
bjp-80949	188	21	cetuximab	cetuximab	NOUN
bjp-80949	188	22	(	(	PUNCT
bjp-80949	188	23	ic20	ic20	PROPN
bjp-80949	188	24	)	)	PUNCT
bjp-80949	188	25	cetuximab	cetuximab	NOUN
bjp-80949	188	26	(	(	PUNCT
bjp-80949	188	27	ic20	ic20	PROPN
bjp-80949	188	28	)	)	PUNCT
bjp-80949	188	29	+	+	NUM
bjp-80949	188	30	carvacrol	carvacrol	NOUN
bjp-80949	188	31	(	(	PUNCT
bjp-80949	188	32	ic10	ic10	PROPN
bjp-80949	188	33	)	)	PUNCT
bjp-80949	188	34	control	control	NOUN
bjp-80949	188	35	pcna	pcna	PROPN
bjp-80949	188	36	cyclin	cyclin	PROPN
bjp-80949	188	37	d1	d1	PROPN
bjp-80949	188	38	bax	bax	PROPN
bjp-80949	188	39	cyclin	cyclin	PROPN
bjp-80949	188	40	e	e	PROPN
bjp-80949	188	41	cyclin	cyclin	PROPN
bjp-80949	188	42	b	b	PROPN
bjp-80949	188	43	cyclin	cyclin	PROPN
bjp-80949	188	44	a	a	DET
bjp-80949	188	45	cyclin	cyclin	PROPN
bjp-80949	188	46	d2	d2	PROPN
bjp-80949	188	47	bcl-2	bcl-2	VERB
bjp-80949	188	48	topoisomerase	topoisomerase	PROPN
bjp-80949	188	49	ii	ii	NOUN
bjp-80949	188	50	-	-	NOUN
bjp-80949	188	51	alpha	alpha	NOUN
bjp-80949	188	52	a	a	DET
bjp-80949	188	53	a	a	DET
bjp-80949	188	54	a	a	DET
bjp-80949	188	55	a	a	DET
bjp-80949	188	56	a	a	DET
bjp-80949	188	57	a	a	DET
bjp-80949	188	58	a	a	DET
bjp-80949	188	59	a	a	DET
bjp-80949	188	60	a	a	DET
bjp-80949	188	61	a	a	DET
bjp-80949	188	62	a	a	DET
bjp-80949	188	63	a	a	DET
bjp-80949	188	64	a	a	DET
bjp-80949	188	65	a	a	DET
bjp-80949	188	66	a	a	DET
bjp-80949	188	67	a	a	DET
bjp-80949	188	68	a	a	DET
bjp-80949	188	69	figure	figure	NOUN
bjp-80949	188	70	2	2	NUM
bjp-80949	188	71	:	:	PUNCT
bjp-80949	188	72	effects	effect	NOUN
bjp-80949	188	73	of	of	ADP
bjp-80949	188	74	cetuximab	cetuximab	NOUN
bjp-80949	188	75	,	,	PUNCT
bjp-80949	188	76	both	both	CCONJ
bjp-80949	188	77	alone	alone	ADJ
bjp-80949	188	78	and	and	CCONJ
bjp-80949	188	79	in	in	ADP
bjp-80949	188	80	combination	combination	NOUN
bjp-80949	188	81	with	with	ADP
bjp-80949	188	82	carvacrol	carvacrol	NOUN
bjp-80949	188	83	,	,	PUNCT
bjp-80949	188	84	on	on	ADP
bjp-80949	188	85	mrna	mrna	PROPN
bjp-80949	188	86	expression	expression	NOUN
bjp-80949	188	87	of	of	ADP
bjp-80949	188	88	pcna	pcna	NOUN
bjp-80949	188	89	,	,	PUNCT
bjp-80949	188	90	topoisomerase	topoisomerase	NOUN
bjp-80949	188	91	iialpha	iialpha	NOUN
bjp-80949	188	92	,	,	PUNCT
bjp-80949	188	93	cyclin	cyclin	NOUN
bjp-80949	188	94	d1	d1	PROPN
bjp-80949	188	95	,	,	PUNCT
bjp-80949	188	96	cyclin	cyclin	NOUN
bjp-80949	188	97	d2	d2	PROPN
bjp-80949	188	98	,	,	PUNCT
bjp-80949	188	99	cyclin	cyclin	NOUN
bjp-80949	188	100	e	e	PROPN
bjp-80949	188	101	,	,	PUNCT
bjp-80949	188	102	cyclin	cyclin	PROPN
bjp-80949	188	103	a	a	X
bjp-80949	188	104	,	,	PUNCT
bjp-80949	188	105	cyclin	cyclin	PROPN
bjp-80949	188	106	b	b	PROPN
bjp-80949	188	107	,	,	PUNCT
bjp-80949	188	108	bax	bax	PROPN
bjp-80949	188	109	,	,	PUNCT
bjp-80949	188	110	and	and	CCONJ
bjp-80949	188	111	bcl-2	bcl-2	NOUN
bjp-80949	188	112	were	be	AUX
bjp-80949	188	113	assessed	assess	VERB
bjp-80949	188	114	in	in	ADP
bjp-80949	188	115	a-549	a-549	PROPN
bjp-80949	188	116	(	(	PUNCT
bjp-80949	188	117	a	a	NOUN
bjp-80949	188	118	)	)	PUNCT
bjp-80949	188	119	and	and	CCONJ
bjp-80949	188	120	h1299	h1299	ADV
bjp-80949	188	121	(	(	PUNCT
bjp-80949	188	122	b	b	NOUN
bjp-80949	188	123	)	)	PUNCT
bjp-80949	188	124	cells	cell	NOUN
bjp-80949	188	125	.	.	PUNCT
bjp-80949	189	1	data	datum	NOUN
bjp-80949	189	2	are	be	AUX
bjp-80949	189	3	mean	mean	VERB
bjp-80949	189	4	±	±	NUM
bjp-80949	189	5	sem	sem	NOUN
bjp-80949	189	6	a-549	a-549	PROPN
bjp-80949	189	7	cell	cell	NOUN
bjp-80949	189	8	lines	line	NOUN
bjp-80949	189	9	h1299	h1299	CCONJ
bjp-80949	189	10	cell	cell	NOUN
bjp-80949	189	11	lines	line	NOUN
bjp-80949	189	12	a	a	DET
bjp-80949	189	13	a	a	DET
bjp-80949	189	14	a	a	DET
bjp-80949	189	15	a	a	DET
bjp-80949	189	16	a	a	DET
bjp-80949	189	17	a	a	DET
bjp-80949	189	18	a	a	DET
bjp-80949	189	19	a	a	DET
bjp-80949	189	20	a	a	DET
bjp-80949	189	21	a	a	DET
bjp-80949	189	22	a	a	DET
bjp-80949	189	23	a	a	DET
bjp-80949	189	24	a	a	DET
bjp-80949	189	25	a	a	DET
bjp-80949	189	26	a	a	DET
bjp-80949	189	27	a	a	DET
bjp-80949	189	28	a	a	DET
bjp-80949	189	29	a	a	DET
bjp-80949	189	30	a	a	DET
bjp-80949	189	31	a	a	DET
bjp-80949	189	32	28	28	NUM
bjp-80949	189	33	bangladesh	bangladesh	NOUN
bjp-80949	189	34	j	j	PROPN
bjp-80949	189	35	pharmacol	pharmacol	PROPN
bjp-80949	189	36	2025	2025	NUM
bjp-80949	189	37	;	;	PUNCT
bjp-80949	189	38	20	20	NUM
bjp-80949	189	39	:	:	SYM
bjp-80949	189	40	22	22	NUM
bjp-80949	189	41	-	-	SYM
bjp-80949	189	42	34	34	NUM
bjp-80949	189	43	conditions	condition	NOUN
bjp-80949	189	44	cetuximab	cetuximab	NOUN
bjp-80949	189	45	by	by	ADP
bjp-80949	189	46	itself	itself	PRON
bjp-80949	189	47	and	and	CCONJ
bjp-80949	189	48	combination	combination	NOUN
bjp-80949	189	49	treatments	treatment	NOUN
bjp-80949	189	50	.	.	PUNCT
bjp-80949	190	1	cetuximab	cetuximab	NOUN
bjp-80949	190	2	alone	alone	ADJ
bjp-80949	190	3	intervention	intervention	NOUN
bjp-80949	190	4	led	lead	VERB
bjp-80949	190	5	to	to	ADP
bjp-80949	190	6	38	38	NUM
bjp-80949	190	7	%	%	NOUN
bjp-80949	190	8	decrease	decrease	NOUN
bjp-80949	190	9	in	in	ADP
bjp-80949	190	10	topoisomerase	topoisomerase	ADJ
bjp-80949	190	11	ii	ii	ADJ
bjp-80949	190	12	-	-	ADJ
bjp-80949	190	13	alpha	alpha	ADJ
bjp-80949	190	14	gene	gene	NOUN
bjp-80949	190	15	transcript	transcript	NOUN
bjp-80949	190	16	expression	expression	NOUN
bjp-80949	190	17	in	in	ADP
bjp-80949	190	18	a-549	a-549	PROPN
bjp-80949	190	19	cells	cell	NOUN
bjp-80949	190	20	compared	compare	VERB
bjp-80949	190	21	to	to	ADP
bjp-80949	190	22	control	control	NOUN
bjp-80949	190	23	,	,	PUNCT
bjp-80949	190	24	whereas	whereas	SCONJ
bjp-80949	190	25	the	the	DET
bjp-80949	190	26	combination	combination	NOUN
bjp-80949	190	27	intervention	intervention	NOUN
bjp-80949	190	28	led	lead	VERB
bjp-80949	190	29	to	to	ADP
bjp-80949	190	30	more	more	ADV
bjp-80949	190	31	substantial	substantial	ADJ
bjp-80949	190	32	75	75	NUM
bjp-80949	190	33	%	%	NOUN
bjp-80949	190	34	decrease	decrease	NOUN
bjp-80949	190	35	(	(	PUNCT
bjp-80949	190	36	figure	figure	NOUN
bjp-80949	190	37	2a	2a	NUM
bjp-80949	190	38	)	)	PUNCT
bjp-80949	190	39	.	.	PUNCT
bjp-80949	191	1	cyclins	cyclin	VERB
bjp-80949	191	2	d1	d1	PROPN
bjp-80949	191	3	and	and	CCONJ
bjp-80949	191	4	d2	d2	PROPN
bjp-80949	191	5	are	be	AUX
bjp-80949	191	6	key	key	ADJ
bjp-80949	191	7	regulators	regulator	NOUN
bjp-80949	191	8	of	of	ADP
bjp-80949	191	9	the	the	DET
bjp-80949	191	10	cellular	cellular	ADJ
bjp-80949	191	11	proliferation	proliferation	NOUN
bjp-80949	191	12	cycle	cycle	NOUN
bjp-80949	191	13	,	,	PUNCT
bjp-80949	191	14	especially	especially	ADV
bjp-80949	191	15	during	during	ADP
bjp-80949	191	16	first	first	ADJ
bjp-80949	191	17	growth	growth	NOUN
bjp-80949	191	18	phase	phase	NOUN
bjp-80949	191	19	.	.	PUNCT
bjp-80949	192	1	the	the	DET
bjp-80949	192	2	influence	influence	NOUN
bjp-80949	192	3	of	of	ADP
bjp-80949	192	4	cetuximab	cetuximab	NOUN
bjp-80949	192	5	,	,	PUNCT
bjp-80949	192	6	alone	alone	ADJ
bjp-80949	192	7	and	and	CCONJ
bjp-80949	192	8	in	in	ADP
bjp-80949	192	9	combination	combination	NOUN
bjp-80949	192	10	with	with	ADP
bjp-80949	192	11	carvacrol	carvacrol	NOUN
bjp-80949	192	12	,	,	PUNCT
bjp-80949	192	13	on	on	ADP
bjp-80949	192	14	the	the	DET
bjp-80949	192	15	g1	g1	PROPN
bjp-80949	192	16	phase	phase	NOUN
bjp-80949	192	17	transition	transition	NOUN
bjp-80949	192	18	of	of	ADP
bjp-80949	192	19	the	the	DET
bjp-80949	192	20	cell	cell	NOUN
bjp-80949	192	21	cycle	cycle	NOUN
bjp-80949	192	22	was	be	AUX
bjp-80949	192	23	evaluated	evaluate	VERB
bjp-80949	192	24	by	by	ADP
bjp-80949	192	25	quantifying	quantify	VERB
bjp-80949	192	26	changes	change	NOUN
bjp-80949	192	27	in	in	ADP
bjp-80949	192	28	cyclinrelated	cyclinrelated	ADJ
bjp-80949	192	29	rna	rna	NOUN
bjp-80949	192	30	transcript	transcript	NOUN
bjp-80949	192	31	levels	level	NOUN
bjp-80949	192	32	.	.	PUNCT
bjp-80949	193	1	in	in	ADP
bjp-80949	193	2	adenocarcinomic	adenocarcinomic	ADJ
bjp-80949	193	3	human	human	ADJ
bjp-80949	193	4	alveolar	alveolar	ADJ
bjp-80949	193	5	basal	basal	ADJ
bjp-80949	193	6	epithelial	epithelial	ADJ
bjp-80949	193	7	a-549	a-549	PROPN
bjp-80949	193	8	cells	cell	NOUN
bjp-80949	193	9	treated	treat	VERB
bjp-80949	193	10	with	with	ADP
bjp-80949	193	11	cetuximab	cetuximab	NOUN
bjp-80949	193	12	individually	individually	ADV
bjp-80949	193	13	,	,	PUNCT
bjp-80949	193	14	cyclin	cyclin	NOUN
bjp-80949	193	15	d1	d1	PROPN
bjp-80949	193	16	transcript	transcript	NOUN
bjp-80949	193	17	level	level	NOUN
bjp-80949	193	18	diminished	diminish	VERB
bjp-80949	193	19	by	by	ADP
bjp-80949	193	20	30	30	NUM
bjp-80949	193	21	%	%	NOUN
bjp-80949	193	22	as	as	SCONJ
bjp-80949	193	23	opposed	oppose	VERB
bjp-80949	193	24	to	to	ADP
bjp-80949	193	25	the	the	DET
bjp-80949	193	26	experimental	experimental	ADJ
bjp-80949	193	27	baseline	baseline	PROPN
bjp-80949	193	28	group	group	NOUN
bjp-80949	193	29	.	.	PUNCT
bjp-80949	194	1	on	on	ADP
bjp-80949	194	2	the	the	DET
bjp-80949	194	3	other	other	ADJ
bjp-80949	194	4	hand	hand	NOUN
bjp-80949	194	5	,	,	PUNCT
bjp-80949	194	6	at	at	ADP
bjp-80949	194	7	the	the	DET
bjp-80949	194	8	time	time	NOUN
bjp-80949	194	9	that	that	DET
bjp-80949	194	10	cetuximab	cetuximab	NOUN
bjp-80949	194	11	was	be	AUX
bjp-80949	194	12	combined	combine	VERB
bjp-80949	194	13	with	with	ADP
bjp-80949	194	14	carvacrol	carvacrol	NOUN
bjp-80949	194	15	,	,	PUNCT
bjp-80949	194	16	the	the	DET
bjp-80949	194	17	most	most	ADV
bjp-80949	194	18	significant	significant	ADJ
bjp-80949	194	19	decrease	decrease	NOUN
bjp-80949	194	20	in	in	ADP
bjp-80949	194	21	cyclin	cyclin	NOUN
bjp-80949	194	22	d1	d1	PROPN
bjp-80949	194	23	was	be	AUX
bjp-80949	194	24	observed	observe	VERB
bjp-80949	194	25	in	in	ADP
bjp-80949	194	26	h1299	h1299	NOUN
bjp-80949	194	27	cells	cell	NOUN
bjp-80949	194	28	,	,	PUNCT
bjp-80949	194	29	where	where	SCONJ
bjp-80949	194	30	expression	expression	NOUN
bjp-80949	194	31	dropped	drop	VERB
bjp-80949	194	32	by	by	ADP
bjp-80949	194	33	62	62	NUM
bjp-80949	194	34	%	%	NOUN
bjp-80949	194	35	.	.	PUNCT
bjp-80949	195	1	for	for	ADP
bjp-80949	195	2	cyclin	cyclin	PROPN
bjp-80949	195	3	d2	d2	PROPN
bjp-80949	195	4	,	,	PUNCT
bjp-80949	195	5	the	the	DET
bjp-80949	195	6	greatest	great	ADJ
bjp-80949	195	7	reduction	reduction	NOUN
bjp-80949	195	8	was	be	AUX
bjp-80949	195	9	seen	see	VERB
bjp-80949	195	10	in	in	ADP
bjp-80949	195	11	h1299	h1299	NOUN
bjp-80949	195	12	cells	cell	NOUN
bjp-80949	195	13	,	,	PUNCT
bjp-80949	195	14	with	with	ADP
bjp-80949	195	15	a	a	DET
bjp-80949	195	16	32	32	NUM
bjp-80949	195	17	%	%	NOUN
bjp-80949	195	18	decrease	decrease	NOUN
bjp-80949	195	19	following	follow	VERB
bjp-80949	195	20	cetuximab	cetuximab	NOUN
bjp-80949	195	21	alone	alone	ADV
bjp-80949	195	22	,	,	PUNCT
bjp-80949	195	23	and	and	CCONJ
bjp-80949	195	24	a	a	DET
bjp-80949	195	25	49	49	NUM
bjp-80949	195	26	%	%	NOUN
bjp-80949	195	27	reduction	reduction	NOUN
bjp-80949	195	28	in	in	ADP
bjp-80949	195	29	a-549	a-549	PROPN
bjp-80949	195	30	cells	cell	NOUN
bjp-80949	195	31	after	after	ADP
bjp-80949	195	32	the	the	DET
bjp-80949	195	33	combined	combined	ADJ
bjp-80949	195	34	treatment	treatment	NOUN
bjp-80949	195	35	.	.	PUNCT
bjp-80949	196	1	overall	overall	ADV
bjp-80949	196	2	,	,	PUNCT
bjp-80949	196	3	the	the	DET
bjp-80949	196	4	combination	combination	NOUN
bjp-80949	196	5	treatment	treatment	NOUN
bjp-80949	196	6	was	be	AUX
bjp-80949	196	7	more	more	ADV
bjp-80949	196	8	effective	effective	ADJ
bjp-80949	196	9	than	than	ADP
bjp-80949	196	10	cetuximab	cetuximab	NOUN
bjp-80949	196	11	alone	alone	ADV
bjp-80949	196	12	in	in	ADP
bjp-80949	196	13	lowering	lower	VERB
bjp-80949	196	14	the	the	DET
bjp-80949	196	15	levels	level	NOUN
bjp-80949	196	16	of	of	ADP
bjp-80949	196	17	both	both	DET
bjp-80949	196	18	cyclin	cyclin	NOUN
bjp-80949	196	19	d1	d1	PROPN
bjp-80949	196	20	and	and	CCONJ
bjp-80949	196	21	d2	d2	PROPN
bjp-80949	196	22	in	in	ADP
bjp-80949	196	23	both	both	DET
bjp-80949	196	24	cell	cell	NOUN
bjp-80949	196	25	lines	line	NOUN
bjp-80949	196	26	(	(	PUNCT
bjp-80949	196	27	figure	figure	NOUN
bjp-80949	196	28	2a	2a	NUM
bjp-80949	196	29	-	-	PUNCT
bjp-80949	196	30	b	b	NOUN
bjp-80949	196	31	)	)	PUNCT
bjp-80949	196	32	.	.	PUNCT
bjp-80949	197	1	cyclin	cyclin	PROPN
bjp-80949	197	2	e	e	PROPN
bjp-80949	197	3	is	be	AUX
bjp-80949	197	4	a	a	DET
bjp-80949	197	5	key	key	ADJ
bjp-80949	197	6	protein	protein	NOUN
bjp-80949	197	7	involved	involve	VERB
bjp-80949	197	8	in	in	ADP
bjp-80949	197	9	modulating	modulate	VERB
bjp-80949	197	10	the	the	DET
bjp-80949	197	11	cell	cell	NOUN
bjp-80949	197	12	proliferation	proliferation	NOUN
bjp-80949	197	13	cycle	cycle	NOUN
bjp-80949	197	14	,	,	PUNCT
bjp-80949	197	15	especially	especially	ADV
bjp-80949	197	16	throughout	throughout	ADP
bjp-80949	197	17	the	the	DET
bjp-80949	197	18	shift	shift	NOUN
bjp-80949	197	19	beginning	begin	VERB
bjp-80949	197	20	with	with	ADP
bjp-80949	197	21	g1	g1	PROPN
bjp-80949	197	22	step	step	NOUN
bjp-80949	197	23	to	to	ADP
bjp-80949	197	24	the	the	DET
bjp-80949	197	25	s	s	PART
bjp-80949	197	26	step	step	NOUN
bjp-80949	197	27	.	.	PUNCT
bjp-80949	198	1	in	in	ADP
bjp-80949	198	2	human	human	ADJ
bjp-80949	198	3	lung	lung	NOUN
bjp-80949	198	4	adenocarcinoma	adenocarcinoma	NOUN
bjp-80949	198	5	cells	cell	NOUN
bjp-80949	198	6	(	(	PUNCT
bjp-80949	198	7	a-549	a-549	PROPN
bjp-80949	198	8	)	)	PUNCT
bjp-80949	198	9	,	,	PUNCT
bjp-80949	198	10	cetuximab	cetuximab	NOUN
bjp-80949	198	11	administration	administration	NOUN
bjp-80949	198	12	in	in	ADP
bjp-80949	198	13	isolation	isolation	NOUN
bjp-80949	198	14	led	lead	VERB
bjp-80949	198	15	to	to	ADP
bjp-80949	198	16	a	a	DET
bjp-80949	198	17	35	35	NUM
bjp-80949	198	18	%	%	NOUN
bjp-80949	198	19	reduction	reduction	NOUN
bjp-80949	198	20	in	in	ADP
bjp-80949	198	21	cyclin	cyclin	NOUN
bjp-80949	198	22	e	e	NOUN
bjp-80949	198	23	transcription	transcription	NOUN
bjp-80949	198	24	level	level	NOUN
bjp-80949	198	25	in	in	ADP
bjp-80949	198	26	contrast	contrast	NOUN
bjp-80949	198	27	to	to	ADP
bjp-80949	198	28	the	the	DET
bjp-80949	198	29	experimental	experimental	ADJ
bjp-80949	198	30	baseline	baseline	NOUN
bjp-80949	198	31	,	,	PUNCT
bjp-80949	198	32	whereas	whereas	SCONJ
bjp-80949	198	33	the	the	DET
bjp-80949	198	34	combination	combination	NOUN
bjp-80949	198	35	treatment	treatment	NOUN
bjp-80949	198	36	contributed	contribute	VERB
bjp-80949	198	37	to	to	PART
bjp-80949	198	38	extended	extend	VERB
bjp-80949	198	39	substantial	substantial	ADJ
bjp-80949	198	40	64	64	NUM
bjp-80949	198	41	%	%	NOUN
bjp-80949	198	42	diminution	diminution	NOUN
bjp-80949	198	43	in	in	ADP
bjp-80949	198	44	cyclin	cyclin	NOUN
bjp-80949	198	45	e	e	NOUN
bjp-80949	198	46	transcription	transcription	NOUN
bjp-80949	198	47	level	level	NOUN
bjp-80949	198	48	.	.	PUNCT
bjp-80949	199	1	the	the	DET
bjp-80949	199	2	most	most	ADV
bjp-80949	199	3	significant	significant	ADJ
bjp-80949	199	4	decrease	decrease	NOUN
bjp-80949	199	5	in	in	ADP
bjp-80949	199	6	cyclin	cyclin	PROPN
bjp-80949	199	7	e	e	NOUN
bjp-80949	199	8	levels	level	NOUN
bjp-80949	199	9	was	be	AUX
bjp-80949	199	10	seen	see	VERB
bjp-80949	199	11	in	in	ADP
bjp-80949	199	12	a-549	a-549	PROPN
bjp-80949	199	13	cells	cell	NOUN
bjp-80949	199	14	for	for	ADP
bjp-80949	199	15	both	both	DET
bjp-80949	199	16	treatments	treatment	NOUN
bjp-80949	199	17	(	(	PUNCT
bjp-80949	199	18	figure	figure	NOUN
bjp-80949	199	19	2a	2a	NUM
bjp-80949	199	20	)	)	PUNCT
bjp-80949	199	21	.	.	PUNCT
bjp-80949	200	1	furthermore	furthermore	ADV
bjp-80949	200	2	,	,	PUNCT
bjp-80949	200	3	cetuximab	cetuximab	NOUN
bjp-80949	200	4	in	in	ADP
bjp-80949	200	5	conjunction	conjunction	NOUN
bjp-80949	200	6	with	with	ADP
bjp-80949	200	7	carvacrol	carvacrol	NOUN
bjp-80949	200	8	proved	prove	VERB
bjp-80949	200	9	to	to	PART
bjp-80949	200	10	be	be	AUX
bjp-80949	200	11	extended	extend	VERB
bjp-80949	200	12	impactful	impactful	ADJ
bjp-80949	200	13	as	as	SCONJ
bjp-80949	200	14	opposed	oppose	VERB
bjp-80949	200	15	to	to	ADP
bjp-80949	200	16	cetuximab	cetuximab	NOUN
bjp-80949	200	17	by	by	ADP
bjp-80949	200	18	itself	itself	PRON
bjp-80949	200	19	in	in	ADP
bjp-80949	200	20	lowering	lower	VERB
bjp-80949	200	21	the	the	DET
bjp-80949	200	22	transcription	transcription	NOUN
bjp-80949	200	23	levels	level	NOUN
bjp-80949	200	24	of	of	ADP
bjp-80949	200	25	cyclins	cyclin	NOUN
bjp-80949	200	26	d1	d1	PROPN
bjp-80949	200	27	,	,	PUNCT
bjp-80949	200	28	d2	d2	PROPN
bjp-80949	200	29	,	,	PUNCT
bjp-80949	200	30	and	and	CCONJ
bjp-80949	200	31	e	e	NOUN
bjp-80949	200	32	-	-	NOUN
bjp-80949	200	33	proteins	protein	NOUN
bjp-80949	200	34	that	that	PRON
bjp-80949	200	35	regulate	regulate	VERB
bjp-80949	200	36	different	different	ADJ
bjp-80949	200	37	stages	stage	NOUN
bjp-80949	200	38	of	of	ADP
bjp-80949	200	39	the	the	DET
bjp-80949	200	40	g1	g1	PROPN
bjp-80949	200	41	phase	phase	NOUN
bjp-80949	200	42	.	.	PUNCT
bjp-80949	201	1	these	these	DET
bjp-80949	201	2	findings	finding	NOUN
bjp-80949	201	3	suggest	suggest	VERB
bjp-80949	201	4	that	that	SCONJ
bjp-80949	201	5	the	the	DET
bjp-80949	201	6	combined	combined	ADJ
bjp-80949	201	7	treatment	treatment	NOUN
bjp-80949	201	8	has	have	VERB
bjp-80949	201	9	a	a	DET
bjp-80949	201	10	more	more	ADV
bjp-80949	201	11	potent	potent	ADJ
bjp-80949	201	12	effect	effect	NOUN
bjp-80949	201	13	on	on	ADP
bjp-80949	201	14	the	the	DET
bjp-80949	201	15	initial	initial	ADJ
bjp-80949	201	16	growth	growth	NOUN
bjp-80949	201	17	phase	phase	NOUN
bjp-80949	201	18	of	of	ADP
bjp-80949	201	19	the	the	DET
bjp-80949	201	20	cell	cell	NOUN
bjp-80949	201	21	proliferation	proliferation	NOUN
bjp-80949	201	22	cycle	cycle	NOUN
bjp-80949	201	23	than	than	ADP
bjp-80949	201	24	cetuximab	cetuximab	NOUN
bjp-80949	201	25	alone	alone	ADV
bjp-80949	201	26	.	.	PUNCT
bjp-80949	202	1	in	in	ADP
bjp-80949	202	2	h1299	h1299	NOUN
bjp-80949	202	3	cells	cell	NOUN
bjp-80949	202	4	treated	treat	VERB
bjp-80949	202	5	with	with	ADP
bjp-80949	202	6	cetuximab	cetuximab	NOUN
bjp-80949	202	7	alone	alone	ADV
bjp-80949	202	8	,	,	PUNCT
bjp-80949	202	9	cyclin	cyclin	NOUN
bjp-80949	202	10	a	a	DET
bjp-80949	202	11	transcription	transcription	NOUN
bjp-80949	202	12	level	level	NOUN
bjp-80949	202	13	diminished	diminish	VERB
bjp-80949	202	14	by	by	ADP
bjp-80949	202	15	13	13	NUM
bjp-80949	202	16	%	%	NOUN
bjp-80949	202	17	as	as	SCONJ
bjp-80949	202	18	opposed	oppose	VERB
bjp-80949	202	19	to	to	ADP
bjp-80949	202	20	the	the	DET
bjp-80949	202	21	baseline	baseline	NOUN
bjp-80949	202	22	.	.	PUNCT
bjp-80949	203	1	in	in	ADP
bjp-80949	203	2	a-549	a-549	PROPN
bjp-80949	203	3	,	,	PUNCT
bjp-80949	203	4	cetuximab	cetuximab	NOUN
bjp-80949	203	5	alone	alone	ADV
bjp-80949	203	6	resulted	result	VERB
bjp-80949	203	7	in	in	ADP
bjp-80949	203	8	20	20	NUM
bjp-80949	203	9	%	%	NOUN
bjp-80949	203	10	reduction	reduction	NOUN
bjp-80949	203	11	in	in	ADP
bjp-80949	203	12	cyclin	cyclin	PROPN
bjp-80949	203	13	a	a	DET
bjp-80949	203	14	expression	expression	NOUN
bjp-80949	203	15	relative	relative	ADJ
bjp-80949	203	16	to	to	ADP
bjp-80949	203	17	the	the	DET
bjp-80949	203	18	control	control	NOUN
bjp-80949	203	19	group	group	NOUN
bjp-80949	203	20	(	(	PUNCT
bjp-80949	203	21	figure	figure	NOUN
bjp-80949	203	22	2a	2a	NUM
bjp-80949	203	23	-	-	PUNCT
bjp-80949	203	24	b	b	NOUN
bjp-80949	203	25	)	)	PUNCT
bjp-80949	203	26	.	.	PUNCT
bjp-80949	204	1	the	the	DET
bjp-80949	204	2	most	most	ADV
bjp-80949	204	3	notable	notable	ADJ
bjp-80949	204	4	decrease	decrease	NOUN
bjp-80949	204	5	in	in	ADP
bjp-80949	204	6	cyclin	cyclin	PROPN
bjp-80949	204	7	a	a	DET
bjp-80949	204	8	levels	level	NOUN
bjp-80949	204	9	,	,	PUNCT
bjp-80949	204	10	however	however	ADV
bjp-80949	204	11	,	,	PUNCT
bjp-80949	204	12	was	be	AUX
bjp-80949	204	13	detected	detect	VERB
bjp-80949	204	14	in	in	ADP
bjp-80949	204	15	a-549	a-549	PROPN
bjp-80949	204	16	cells	cell	NOUN
bjp-80949	204	17	following	follow	VERB
bjp-80949	204	18	both	both	DET
bjp-80949	204	19	cetuximab	cetuximab	NOUN
bjp-80949	204	20	on	on	ADP
bjp-80949	204	21	its	its	PRON
bjp-80949	204	22	own	own	ADJ
bjp-80949	204	23	and	and	CCONJ
bjp-80949	204	24	combination	combination	NOUN
bjp-80949	204	25	treatments	treatment	NOUN
bjp-80949	204	26	.	.	PUNCT
bjp-80949	205	1	in	in	ADP
bjp-80949	205	2	a-549	a-549	PROPN
bjp-80949	205	3	cells	cell	NOUN
bjp-80949	205	4	,	,	PUNCT
bjp-80949	205	5	cetuximab	cetuximab	NOUN
bjp-80949	205	6	treatment	treatment	NOUN
bjp-80949	205	7	on	on	ADP
bjp-80949	205	8	its	its	PRON
bjp-80949	205	9	own	own	ADJ
bjp-80949	205	10	caused	cause	VERB
bjp-80949	205	11	to	to	ADP
bjp-80949	205	12	30	30	NUM
bjp-80949	205	13	%	%	NOUN
bjp-80949	205	14	decrease	decrease	NOUN
bjp-80949	205	15	in	in	ADP
bjp-80949	205	16	cyclin	cyclin	PROPN
bjp-80949	205	17	b	b	PROPN
bjp-80949	205	18	transcription	transcription	NOUN
bjp-80949	205	19	level	level	NOUN
bjp-80949	205	20	as	as	SCONJ
bjp-80949	205	21	opposed	oppose	VERB
bjp-80949	205	22	to	to	ADP
bjp-80949	205	23	the	the	DET
bjp-80949	205	24	baseline	baseline	NOUN
bjp-80949	205	25	.	.	PUNCT
bjp-80949	206	1	however	however	ADV
bjp-80949	206	2	,	,	PUNCT
bjp-80949	206	3	in	in	ADP
bjp-80949	206	4	the	the	DET
bjp-80949	206	5	event	event	NOUN
bjp-80949	206	6	that	that	SCONJ
bjp-80949	206	7	cetuximab	cetuximab	NOUN
bjp-80949	206	8	was	be	AUX
bjp-80949	206	9	combined	combine	VERB
bjp-80949	206	10	with	with	ADP
bjp-80949	206	11	carvacrol	carvacrol	NOUN
bjp-80949	206	12	,	,	PUNCT
bjp-80949	206	13	there	there	PRON
bjp-80949	206	14	was	be	VERB
bjp-80949	206	15	a	a	DET
bjp-80949	206	16	more	more	ADV
bjp-80949	206	17	pronounced	pronounced	ADJ
bjp-80949	206	18	60	60	NUM
bjp-80949	206	19	%	%	NOUN
bjp-80949	206	20	decline	decline	NOUN
bjp-80949	206	21	in	in	ADP
bjp-80949	206	22	cyclin	cyclin	PROPN
bjp-80949	206	23	b	b	PROPN
bjp-80949	206	24	transcription	transcription	NOUN
bjp-80949	206	25	level	level	NOUN
bjp-80949	206	26	in	in	ADP
bjp-80949	206	27	contrast	contrast	NOUN
bjp-80949	206	28	to	to	ADP
bjp-80949	206	29	the	the	DET
bjp-80949	206	30	control	control	NOUN
bjp-80949	206	31	group	group	NOUN
bjp-80949	206	32	(	(	PUNCT
bjp-80949	206	33	figure	figure	NOUN
bjp-80949	206	34	2a	2a	NUM
bjp-80949	206	35	)	)	PUNCT
bjp-80949	206	36	.	.	PUNCT
bjp-80949	207	1	it	it	PRON
bjp-80949	207	2	has	have	AUX
bjp-80949	207	3	been	be	AUX
bjp-80949	207	4	shown	show	VERB
bjp-80949	207	5	that	that	SCONJ
bjp-80949	207	6	the	the	DET
bjp-80949	207	7	combination	combination	NOUN
bjp-80949	207	8	application	application	NOUN
bjp-80949	207	9	is	be	AUX
bjp-80949	207	10	more	more	ADV
bjp-80949	207	11	effective	effective	ADJ
bjp-80949	207	12	in	in	ADP
bjp-80949	207	13	arresting	arrest	VERB
bjp-80949	207	14	second	second	ADJ
bjp-80949	207	15	growth	growth	NOUN
bjp-80949	207	16	phase	phase	NOUN
bjp-80949	207	17	(	(	PUNCT
bjp-80949	207	18	g2	g2	PROPN
bjp-80949	207	19	)	)	PUNCT
bjp-80949	207	20	and	and	CCONJ
bjp-80949	207	21	mitotic	mitotic	ADJ
bjp-80949	207	22	(	(	PUNCT
bjp-80949	207	23	m	m	NOUN
bjp-80949	207	24	)	)	PUNCT
bjp-80949	207	25	phases	phase	NOUN
bjp-80949	207	26	of	of	ADP
bjp-80949	207	27	the	the	DET
bjp-80949	207	28	cell	cell	NOUN
bjp-80949	207	29	proliferation	proliferation	NOUN
bjp-80949	207	30	cycle	cycle	NOUN
bjp-80949	207	31	in	in	ADP
bjp-80949	207	32	both	both	DET
bjp-80949	207	33	cells	cell	NOUN
bjp-80949	207	34	than	than	ADP
bjp-80949	207	35	the	the	DET
bjp-80949	207	36	application	application	NOUN
bjp-80949	207	37	alone	alone	ADV
bjp-80949	207	38	.	.	PUNCT
bjp-80949	208	1	in	in	ADP
bjp-80949	208	2	both	both	PRON
bjp-80949	208	3	h1299	h1299	PROPN
bjp-80949	208	4	and	and	CCONJ
bjp-80949	208	5	a-549	a-549	PROPN
bjp-80949	208	6	cells	cell	NOUN
bjp-80949	208	7	,	,	PUNCT
bjp-80949	208	8	treatment	treatment	NOUN
bjp-80949	208	9	with	with	ADP
bjp-80949	208	10	cetuximab	cetuximab	NOUN
bjp-80949	208	11	alone	alone	ADJ
bjp-80949	208	12	and	and	CCONJ
bjp-80949	208	13	in	in	ADP
bjp-80949	208	14	combination	combination	NOUN
bjp-80949	208	15	with	with	ADP
bjp-80949	208	16	carvacrol	carvacrol	NOUN
bjp-80949	208	17	resulted	result	VERB
bjp-80949	208	18	in	in	ADP
bjp-80949	208	19	a	a	DET
bjp-80949	208	20	rise	rise	NOUN
bjp-80949	208	21	in	in	ADP
bjp-80949	208	22	bax	bax	PROPN
bjp-80949	208	23	mrna	mrna	PROPN
bjp-80949	208	24	levels	level	NOUN
bjp-80949	208	25	compared	compare	VERB
bjp-80949	208	26	to	to	ADP
bjp-80949	208	27	control	control	NOUN
bjp-80949	208	28	(	(	PUNCT
bjp-80949	208	29	figure	figure	NOUN
bjp-80949	208	30	2a	2a	NUM
bjp-80949	208	31	-	-	PUNCT
bjp-80949	208	32	b	b	NOUN
bjp-80949	208	33	)	)	PUNCT
bjp-80949	208	34	.	.	PUNCT
bjp-80949	209	1	in	in	ADP
bjp-80949	209	2	h1299	h1299	NUM
bjp-80949	209	3	cells	cell	NOUN
bjp-80949	209	4	,	,	PUNCT
bjp-80949	209	5	cetuximab	cetuximab	NOUN
bjp-80949	209	6	alone	alone	ADV
bjp-80949	209	7	induced	induce	VERB
bjp-80949	209	8	64	64	NUM
bjp-80949	209	9	%	%	NOUN
bjp-80949	209	10	increase	increase	NOUN
bjp-80949	209	11	in	in	ADP
bjp-80949	209	12	bax	bax	PROPN
bjp-80949	209	13	mrna	mrna	PROPN
bjp-80949	209	14	expression	expression	NOUN
bjp-80949	209	15	,	,	PUNCT
bjp-80949	209	16	while	while	SCONJ
bjp-80949	209	17	the	the	DET
bjp-80949	209	18	combination	combination	NOUN
bjp-80949	209	19	treatment	treatment	NOUN
bjp-80949	209	20	with	with	ADP
bjp-80949	209	21	cetuximab	cetuximab	NOUN
bjp-80949	209	22	and	and	CCONJ
bjp-80949	209	23	carvacrol	carvacrol	NOUN
bjp-80949	209	24	caused	cause	VERB
bjp-80949	209	25	88	88	NUM
bjp-80949	209	26	%	%	NOUN
bjp-80949	209	27	increase	increase	NOUN
bjp-80949	209	28	(	(	PUNCT
bjp-80949	209	29	figure	figure	NOUN
bjp-80949	209	30	2b	2b	NOUN
bjp-80949	209	31	)	)	PUNCT
bjp-80949	209	32	.	.	PUNCT
bjp-80949	210	1	regarding	regard	VERB
bjp-80949	210	2	bcl-2	bcl-2	NOUN
bjp-80949	210	3	,	,	PUNCT
bjp-80949	210	4	cetuximab	cetuximab	NOUN
bjp-80949	210	5	alone	alone	ADV
bjp-80949	210	6	led	lead	VERB
bjp-80949	210	7	to	to	ADP
bjp-80949	210	8	20	20	NUM
bjp-80949	210	9	%	%	NOUN
bjp-80949	210	10	decrease	decrease	NOUN
bjp-80949	210	11	in	in	ADP
bjp-80949	210	12	its	its	PRON
bjp-80949	210	13	mrna	mrna	NOUN
bjp-80949	210	14	expression	expression	NOUN
bjp-80949	210	15	in	in	ADP
bjp-80949	210	16	h1299	h1299	NOUN
bjp-80949	210	17	cells	cell	NOUN
bjp-80949	210	18	,	,	PUNCT
bjp-80949	210	19	whereas	whereas	SCONJ
bjp-80949	210	20	the	the	DET
bjp-80949	210	21	combination	combination	NOUN
bjp-80949	210	22	treatment	treatment	NOUN
bjp-80949	210	23	resulted	result	VERB
bjp-80949	210	24	in	in	ADP
bjp-80949	210	25	34	34	NUM
bjp-80949	210	26	%	%	NOUN
bjp-80949	210	27	reduction	reduction	NOUN
bjp-80949	210	28	(	(	PUNCT
bjp-80949	210	29	figure	figure	NOUN
bjp-80949	210	30	2b	2b	NOUN
bjp-80949	210	31	)	)	PUNCT
bjp-80949	210	32	.	.	PUNCT
bjp-80949	211	1	the	the	DET
bjp-80949	211	2	combination	combination	NOUN
bjp-80949	211	3	therapy	therapy	NOUN
bjp-80949	211	4	proved	prove	VERB
bjp-80949	211	5	to	to	PART
bjp-80949	211	6	be	be	AUX
bjp-80949	211	7	more	more	ADV
bjp-80949	211	8	effective	effective	ADJ
bjp-80949	211	9	than	than	ADP
bjp-80949	211	10	cetuximab	cetuximab	NOUN
bjp-80949	211	11	on	on	ADP
bjp-80949	211	12	its	its	PRON
bjp-80949	211	13	own	own	ADJ
bjp-80949	211	14	in	in	ADP
bjp-80949	211	15	lowering	lower	VERB
bjp-80949	211	16	bcl-2	bcl-2	NOUN
bjp-80949	211	17	expression	expression	NOUN
bjp-80949	211	18	in	in	ADP
bjp-80949	211	19	both	both	DET
bjp-80949	211	20	cell	cell	NOUN
bjp-80949	211	21	lines	line	NOUN
bjp-80949	211	22	.	.	PUNCT
bjp-80949	212	1	consequently	consequently	ADV
bjp-80949	212	2	,	,	PUNCT
bjp-80949	212	3	both	both	DET
bjp-80949	212	4	treatments	treatment	NOUN
bjp-80949	212	5	boosted	boost	VERB
bjp-80949	212	6	correlation	correlation	NOUN
bjp-80949	212	7	between	between	ADP
bjp-80949	212	8	bax	bax	PROPN
bjp-80949	212	9	and	and	CCONJ
bjp-80949	212	10	bcl-2	bcl-2	PUNCT
bjp-80949	212	11	in	in	ADP
bjp-80949	212	12	h1299	h1299	CCONJ
bjp-80949	212	13	along	along	ADV
bjp-80949	212	14	with	with	ADP
bjp-80949	212	15	a-549	a-549	PROPN
bjp-80949	212	16	cells	cell	NOUN
bjp-80949	212	17	,	,	PUNCT
bjp-80949	212	18	with	with	ADP
bjp-80949	212	19	the	the	DET
bjp-80949	212	20	combined	combine	VERB
bjp-80949	212	21	treatment	treatment	NOUN
bjp-80949	212	22	showing	show	VERB
bjp-80949	212	23	a	a	DET
bjp-80949	212	24	stronger	strong	ADJ
bjp-80949	212	25	effect	effect	NOUN
bjp-80949	212	26	than	than	ADP
bjp-80949	212	27	cetuximab	cetuximab	NOUN
bjp-80949	212	28	alone	alone	ADJ
bjp-80949	212	29	in	in	ADP
bjp-80949	212	30	enhancing	enhance	VERB
bjp-80949	212	31	this	this	DET
bjp-80949	212	32	ratio	ratio	NOUN
bjp-80949	212	33	.	.	PUNCT
bjp-80949	213	1	discussion	discussion	NOUN
bjp-80949	213	2	the	the	DET
bjp-80949	213	3	findings	finding	NOUN
bjp-80949	213	4	of	of	ADP
bjp-80949	213	5	this	this	DET
bjp-80949	213	6	study	study	NOUN
bjp-80949	213	7	demonstrate	demonstrate	VERB
bjp-80949	213	8	that	that	SCONJ
bjp-80949	213	9	the	the	DET
bjp-80949	213	10	combination	combination	NOUN
bjp-80949	213	11	of	of	ADP
bjp-80949	213	12	cetuximab	cetuximab	NOUN
bjp-80949	213	13	and	and	CCONJ
bjp-80949	213	14	carvacrol	carvacrol	NOUN
bjp-80949	213	15	exerts	exert	VERB
bjp-80949	213	16	a	a	DET
bjp-80949	213	17	more	more	ADV
bjp-80949	213	18	pronounced	pronounced	ADJ
bjp-80949	213	19	anticancer	anticancer	NOUN
bjp-80949	213	20	effect	effect	NOUN
bjp-80949	213	21	than	than	ADP
bjp-80949	213	22	cetuximab	cetuximab	NOUN
bjp-80949	213	23	alone	alone	ADJ
bjp-80949	213	24	in	in	ADP
bjp-80949	213	25	lung	lung	NOUN
bjp-80949	213	26	cancer	cancer	NOUN
bjp-80949	213	27	cell	cell	NOUN
bjp-80949	213	28	lines	line	NOUN
bjp-80949	213	29	a-549	a-549	PROPN
bjp-80949	213	30	and	and	CCONJ
bjp-80949	213	31	h1299	h1299	NOUN
bjp-80949	213	32	.	.	NOUN
bjp-80949	213	33	mtt	mtt	NOUN
bjp-80949	213	34	assays	assay	NOUN
bjp-80949	213	35	confirmed	confirm	VERB
bjp-80949	213	36	a	a	DET
bjp-80949	213	37	concentration	concentration	NOUN
bjp-80949	213	38	-	-	PUNCT
bjp-80949	213	39	dependent	dependent	ADJ
bjp-80949	213	40	inhibition	inhibition	NOUN
bjp-80949	213	41	of	of	ADP
bjp-80949	213	42	cell	cell	NOUN
bjp-80949	213	43	proliferation	proliferation	NOUN
bjp-80949	213	44	,	,	PUNCT
bjp-80949	213	45	with	with	ADP
bjp-80949	213	46	the	the	DET
bjp-80949	213	47	most	most	ADV
bjp-80949	213	48	effective	effective	ADJ
bjp-80949	213	49	combinations	combination	NOUN
bjp-80949	213	50	being	be	AUX
bjp-80949	213	51	ic₁₀	ic₁₀	PROPN
bjp-80949	213	52	cetuximab	cetuximab	NOUN
bjp-80949	213	53	+	+	CCONJ
bjp-80949	213	54	ic₁₀	ic₁₀	PROPN
bjp-80949	213	55	carvacrol	carvacrol	NOUN
bjp-80949	213	56	for	for	ADP
bjp-80949	213	57	a-549	a-549	PROPN
bjp-80949	213	58	and	and	CCONJ
bjp-80949	213	59	ic₂₀	ic₂₀	PROPN
bjp-80949	213	60	cetuximab	cetuximab	NOUN
bjp-80949	213	61	+	+	CCONJ
bjp-80949	213	62	ic₁₀	ic₁₀	PROPN
bjp-80949	213	63	carvacrol	carvacrol	NOUN
bjp-80949	213	64	for	for	ADP
bjp-80949	213	65	h1299	h1299	PROPN
bjp-80949	213	66	(	(	PUNCT
bjp-80949	213	67	ci	ci	NOUN
bjp-80949	213	68	=	=	NOUN
bjp-80949	213	69	2.0	2.0	NUM
bjp-80949	213	70	)	)	PUNCT
bjp-80949	213	71	,	,	PUNCT
bjp-80949	213	72	indicating	indicate	VERB
bjp-80949	213	73	strong	strong	ADJ
bjp-80949	213	74	synergistic	synergistic	ADJ
bjp-80949	213	75	interactions	interaction	NOUN
bjp-80949	213	76	.	.	PUNCT
bjp-80949	214	1	ldh	ldh	ADJ
bjp-80949	214	2	assays	assay	NOUN
bjp-80949	214	3	showed	show	VERB
bjp-80949	214	4	significantly	significantly	ADV
bjp-80949	214	5	elevated	elevate	VERB
bjp-80949	214	6	enzyme	enzyme	NOUN
bjp-80949	214	7	release	release	NOUN
bjp-80949	214	8	,	,	PUNCT
bjp-80949	214	9	particularly	particularly	ADV
bjp-80949	214	10	101.0	101.0	NUM
bjp-80949	214	11	%	%	NOUN
bjp-80949	214	12	in	in	ADP
bjp-80949	214	13	a-549	a-549	PROPN
bjp-80949	214	14	and	and	CCONJ
bjp-80949	214	15	239.0	239.0	NUM
bjp-80949	214	16	%	%	NOUN
bjp-80949	214	17	in	in	ADP
bjp-80949	214	18	h1299	h1299	PROPN
bjp-80949	214	19	(	(	PUNCT
bjp-80949	214	20	p<0.05	p<0.05	PROPN
bjp-80949	214	21	)	)	PUNCT
bjp-80949	214	22	,	,	PUNCT
bjp-80949	214	23	suggesting	suggest	VERB
bjp-80949	214	24	increased	increase	VERB
bjp-80949	214	25	membrane	membrane	NOUN
bjp-80949	214	26	damage	damage	NOUN
bjp-80949	214	27	.	.	PUNCT
bjp-80949	215	1	the	the	DET
bjp-80949	215	2	combination	combination	NOUN
bjp-80949	215	3	therapy	therapy	NOUN
bjp-80949	215	4	also	also	ADV
bjp-80949	215	5	significantly	significantly	ADV
bjp-80949	215	6	increased	increase	VERB
bjp-80949	215	7	caspase-3	caspase-3	NUM
bjp-80949	215	8	activity	activity	NOUN
bjp-80949	215	9	by	by	ADP
bjp-80949	215	10	1.6	1.6	NUM
bjp-80949	215	11	-	-	NOUN
bjp-80949	215	12	fold	fold	VERB
bjp-80949	215	13	in	in	ADP
bjp-80949	215	14	a-549	a-549	PROPN
bjp-80949	215	15	and	and	CCONJ
bjp-80949	215	16	1.4	1.4	NUM
bjp-80949	215	17	-	-	NOUN
bjp-80949	215	18	fold	fold	VERB
bjp-80949	215	19	in	in	ADP
bjp-80949	215	20	h1299	h1299	NOUN
bjp-80949	215	21	(	(	PUNCT
bjp-80949	215	22	p<0.05	p<0.05	PROPN
bjp-80949	215	23	)	)	PUNCT
bjp-80949	215	24	,	,	PUNCT
bjp-80949	215	25	highlighting	highlight	VERB
bjp-80949	215	26	enhanced	enhance	VERB
bjp-80949	215	27	apoptosis	apoptosis	NOUN
bjp-80949	215	28	.	.	PUNCT
bjp-80949	216	1	rtpcr	rtpcr	ADJ
bjp-80949	216	2	analysis	analysis	NOUN
bjp-80949	216	3	revealed	reveal	VERB
bjp-80949	216	4	downregulation	downregulation	NOUN
bjp-80949	216	5	of	of	ADP
bjp-80949	216	6	cell	cell	NOUN
bjp-80949	216	7	cycle	cycle	NOUN
bjp-80949	216	8	regulatory	regulatory	ADJ
bjp-80949	216	9	genes	gene	NOUN
bjp-80949	216	10	including	include	VERB
bjp-80949	216	11	pcna	pcna	NOUN
bjp-80949	216	12	,	,	PUNCT
bjp-80949	216	13	topoisomerase	topoisomerase	PROPN
bjp-80949	216	14	ii	ii	PROPN
bjp-80949	216	15	-	-	PUNCT
bjp-80949	216	16	α	α	NOUN
bjp-80949	216	17	,	,	PUNCT
bjp-80949	216	18	and	and	CCONJ
bjp-80949	216	19	cyclins	cyclin	VERB
bjp-80949	216	20	d1	d1	PROPN
bjp-80949	216	21	,	,	PUNCT
bjp-80949	216	22	d2	d2	PROPN
bjp-80949	216	23	,	,	PUNCT
bjp-80949	216	24	e	e	NOUN
bjp-80949	216	25	,	,	PUNCT
bjp-80949	216	26	a	a	PRON
bjp-80949	216	27	,	,	PUNCT
bjp-80949	216	28	and	and	CCONJ
bjp-80949	216	29	b	b	NOUN
bjp-80949	216	30	,	,	PUNCT
bjp-80949	216	31	with	with	ADP
bjp-80949	216	32	the	the	DET
bjp-80949	216	33	combined	combine	VERB
bjp-80949	216	34	treatment	treatment	NOUN
bjp-80949	216	35	producing	produce	VERB
bjp-80949	216	36	stronger	strong	ADJ
bjp-80949	216	37	effects	effect	NOUN
bjp-80949	216	38	(	(	PUNCT
bjp-80949	216	39	p<0.05	p<0.05	NOUN
bjp-80949	216	40	)	)	PUNCT
bjp-80949	216	41	.	.	PUNCT
bjp-80949	217	1	additionally	additionally	ADV
bjp-80949	217	2	,	,	PUNCT
bjp-80949	217	3	the	the	DET
bjp-80949	217	4	bax	bax	PROPN
bjp-80949	217	5	/	/	SYM
bjp-80949	217	6	bcl-2	bcl-2	NOUN
bjp-80949	217	7	ratio	ratio	NOUN
bjp-80949	217	8	was	be	AUX
bjp-80949	217	9	markedly	markedly	ADV
bjp-80949	217	10	increased	increase	VERB
bjp-80949	217	11	,	,	PUNCT
bjp-80949	217	12	further	far	ADV
bjp-80949	217	13	supporting	support	VERB
bjp-80949	217	14	apoptosis	apoptosis	NOUN
bjp-80949	217	15	induction	induction	NOUN
bjp-80949	217	16	.	.	PUNCT
bjp-80949	218	1	these	these	DET
bjp-80949	218	2	results	result	NOUN
bjp-80949	218	3	suggest	suggest	VERB
bjp-80949	218	4	that	that	SCONJ
bjp-80949	218	5	carvacrol	carvacrol	NOUN
bjp-80949	218	6	significantly	significantly	ADV
bjp-80949	218	7	enhances	enhance	VERB
bjp-80949	218	8	the	the	DET
bjp-80949	218	9	cytotoxic	cytotoxic	ADJ
bjp-80949	218	10	,	,	PUNCT
bjp-80949	218	11	oxidative	oxidative	ADJ
bjp-80949	218	12	,	,	PUNCT
bjp-80949	218	13	and	and	CCONJ
bjp-80949	218	14	apoptotic	apoptotic	ADJ
bjp-80949	218	15	effects	effect	NOUN
bjp-80949	218	16	of	of	ADP
bjp-80949	218	17	cetuximab	cetuximab	NOUN
bjp-80949	218	18	.	.	PUNCT
bjp-80949	219	1	epidermal	epidermal	ADJ
bjp-80949	219	2	growth	growth	NOUN
bjp-80949	219	3	factor	factor	NOUN
bjp-80949	219	4	receptor	receptor	NOUN
bjp-80949	219	5	(	(	PUNCT
bjp-80949	219	6	egfr	egfr	X
bjp-80949	219	7	)	)	PUNCT
bjp-80949	219	8	is	be	AUX
bjp-80949	219	9	known	know	VERB
bjp-80949	219	10	to	to	PART
bjp-80949	219	11	be	be	AUX
bjp-80949	219	12	overexpressed	overexpresse	VERB
bjp-80949	219	13	across	across	ADP
bjp-80949	219	14	various	various	ADJ
bjp-80949	219	15	cancer	cancer	NOUN
bjp-80949	219	16	types	type	NOUN
bjp-80949	219	17	,	,	PUNCT
bjp-80949	219	18	such	such	ADJ
bjp-80949	219	19	as	as	ADP
bjp-80949	219	20	head	head	NOUN
bjp-80949	219	21	and	and	CCONJ
bjp-80949	219	22	neck	neck	VERB
bjp-80949	219	23	squamous	squamous	ADJ
bjp-80949	219	24	cell	cell	NOUN
bjp-80949	219	25	carcinoma	carcinoma	NOUN
bjp-80949	219	26	(	(	PUNCT
bjp-80949	219	27	weichselbaum	weichselbaum	NOUN
bjp-80949	219	28	et	et	PROPN
bjp-80949	219	29	al	al	PROPN
bjp-80949	219	30	.	.	PROPN
bjp-80949	219	31	,	,	PUNCT
bjp-80949	219	32	1989	1989	NUM
bjp-80949	219	33	)	)	PUNCT
bjp-80949	219	34	(	(	PUNCT
bjp-80949	219	35	hnscc	hnscc	NOUN
bjp-80949	219	36	)	)	PUNCT
bjp-80949	219	37	,	,	PUNCT
bjp-80949	219	38	non	non	ADJ
bjp-80949	219	39	-	-	ADJ
bjp-80949	219	40	small	small	ADJ
bjp-80949	219	41	cell	cell	NOUN
bjp-80949	219	42	lung	lung	NOUN
bjp-80949	219	43	cancer	cancer	NOUN
bjp-80949	219	44	(	(	PUNCT
bjp-80949	219	45	veale	veale	NOUN
bjp-80949	219	46	et	et	PROPN
bjp-80949	219	47	al	al	PROPN
bjp-80949	219	48	.	.	PROPN
bjp-80949	219	49	,	,	PUNCT
bjp-80949	219	50	1987	1987	NUM
bjp-80949	219	51	)	)	PUNCT
bjp-80949	219	52	(	(	PUNCT
bjp-80949	219	53	nsclc	nsclc	NOUN
bjp-80949	219	54	)	)	PUNCT
bjp-80949	219	55	,	,	PUNCT
bjp-80949	219	56	as	as	ADV
bjp-80949	219	57	well	well	ADV
bjp-80949	219	58	as	as	ADP
bjp-80949	219	59	cancers	cancer	NOUN
bjp-80949	219	60	of	of	ADP
bjp-80949	219	61	the	the	DET
bjp-80949	219	62	colon	colon	NOUN
bjp-80949	219	63	,	,	PUNCT
bjp-80949	219	64	breast	breast	NOUN
bjp-80949	219	65	(	(	PUNCT
bjp-80949	219	66	lo	lo	PROPN
bjp-80949	219	67	et	et	PROPN
bjp-80949	219	68	al	al	PROPN
bjp-80949	219	69	.	.	PROPN
bjp-80949	219	70	,	,	PUNCT
bjp-80949	219	71	2006	2006	NUM
bjp-80949	219	72	)	)	PUNCT
bjp-80949	219	73	,	,	PUNCT
bjp-80949	219	74	pancreas	pancreas	NOUN
bjp-80949	219	75	bangladesh	bangladesh	PROPN
bjp-80949	219	76	j	j	PROPN
bjp-80949	219	77	pharmacol	pharmacol	PROPN
bjp-80949	219	78	2025	2025	NUM
bjp-80949	219	79	;	;	PUNCT
bjp-80949	219	80	20	20	NUM
bjp-80949	219	81	:	:	SYM
bjp-80949	219	82	22	22	NUM
bjp-80949	219	83	-	-	SYM
bjp-80949	219	84	34	34	NUM
bjp-80949	219	85	29	29	NUM
bjp-80949	219	86	(	(	PUNCT
bjp-80949	219	87	yasui	yasui	NOUN
bjp-80949	219	88	et	et	PROPN
bjp-80949	219	89	al	al	PROPN
bjp-80949	219	90	.	.	PROPN
bjp-80949	219	91	,	,	PUNCT
bjp-80949	219	92	1988	1988	NUM
bjp-80949	219	93	)	)	PUNCT
bjp-80949	219	94	,	,	PUNCT
bjp-80949	219	95	and	and	CCONJ
bjp-80949	219	96	brain	brain	NOUN
bjp-80949	219	97	(	(	PUNCT
bjp-80949	219	98	libermann	libermann	INTJ
bjp-80949	219	99	et	et	PROPN
bjp-80949	219	100	al	al	PROPN
bjp-80949	219	101	.	.	PROPN
bjp-80949	219	102	,	,	PUNCT
bjp-80949	219	103	1984	1984	NUM
bjp-80949	219	104	)	)	PUNCT
bjp-80949	219	105	.	.	PUNCT
bjp-80949	220	1	dysregulated	dysregulate	VERB
bjp-80949	220	2	egfr	egfr	NOUN
bjp-80949	220	3	signaling	signal	VERB
bjp-80949	220	4	in	in	ADP
bjp-80949	220	5	these	these	DET
bjp-80949	220	6	malignancies	malignancy	NOUN
bjp-80949	220	7	is	be	AUX
bjp-80949	220	8	associated	associate	VERB
bjp-80949	220	9	with	with	ADP
bjp-80949	220	10	poor	poor	ADJ
bjp-80949	220	11	patient	patient	ADJ
bjp-80949	220	12	prognosis	prognosis	NOUN
bjp-80949	220	13	.	.	PUNCT
bjp-80949	221	1	due	due	ADP
bjp-80949	221	2	to	to	ADP
bjp-80949	221	3	the	the	DET
bjp-80949	221	4	close	close	ADJ
bjp-80949	221	5	relationship	relationship	NOUN
bjp-80949	221	6	between	between	ADP
bjp-80949	221	7	egfr	egfr	NOUN
bjp-80949	221	8	and	and	CCONJ
bjp-80949	221	9	cancer	cancer	NOUN
bjp-80949	221	10	,	,	PUNCT
bjp-80949	221	11	treatments	treatment	VERB
bjp-80949	221	12	that	that	PRON
bjp-80949	221	13	target	target	VERB
bjp-80949	221	14	this	this	DET
bjp-80949	221	15	structure	structure	NOUN
bjp-80949	221	16	are	be	AUX
bjp-80949	221	17	being	be	AUX
bjp-80949	221	18	developed	develop	VERB
bjp-80949	221	19	and	and	CCONJ
bjp-80949	221	20	used	use	VERB
bjp-80949	221	21	today	today	NOUN
bjp-80949	221	22	(	(	PUNCT
bjp-80949	221	23	pearson	pearson	PROPN
bjp-80949	221	24	et	et	PROPN
bjp-80949	221	25	al	al	PROPN
bjp-80949	221	26	.	.	PROPN
bjp-80949	221	27	,	,	PUNCT
bjp-80949	221	28	2018	2018	NUM
bjp-80949	221	29	)	)	PUNCT
bjp-80949	221	30	.	.	PUNCT
bjp-80949	222	1	cetuximab	cetuximab	NOUN
bjp-80949	222	2	is	be	AUX
bjp-80949	222	3	a	a	DET
bjp-80949	222	4	chimeric	chimeric	ADJ
bjp-80949	222	5	monoclonal	monoclonal	NOUN
bjp-80949	222	6	antibody	antibody	NOUN
bjp-80949	222	7	,	,	PUNCT
bjp-80949	222	8	combining	combine	VERB
bjp-80949	222	9	both	both	CCONJ
bjp-80949	222	10	human	human	ADJ
bjp-80949	222	11	and	and	CCONJ
bjp-80949	222	12	mouse	mouse	NOUN
bjp-80949	222	13	components	component	NOUN
bjp-80949	222	14	,	,	PUNCT
bjp-80949	222	15	designed	design	VERB
bjp-80949	222	16	to	to	PART
bjp-80949	222	17	target	target	VERB
bjp-80949	222	18	egfr	egfr	NOUN
bjp-80949	222	19	.	.	PUNCT
bjp-80949	223	1	it	it	PRON
bjp-80949	223	2	attaches	attach	VERB
bjp-80949	223	3	to	to	ADP
bjp-80949	223	4	the	the	DET
bjp-80949	223	5	extracellular	extracellular	ADJ
bjp-80949	223	6	region	region	NOUN
bjp-80949	223	7	of	of	ADP
bjp-80949	223	8	egfr	egfr	NOUN
bjp-80949	223	9	,	,	PUNCT
bjp-80949	223	10	facilitating	facilitate	VERB
bjp-80949	223	11	receptor	receptor	NOUN
bjp-80949	223	12	internalization	internalization	NOUN
bjp-80949	223	13	and	and	CCONJ
bjp-80949	223	14	thereby	thereby	ADV
bjp-80949	223	15	reducing	reduce	VERB
bjp-80949	223	16	egfr	egfr	ADJ
bjp-80949	223	17	expression	expression	NOUN
bjp-80949	223	18	(	(	PUNCT
bjp-80949	223	19	prewett	prewett	NOUN
bjp-80949	223	20	et	et	PROPN
bjp-80949	223	21	al	al	PROPN
bjp-80949	223	22	.	.	PROPN
bjp-80949	223	23	,	,	PUNCT
bjp-80949	223	24	1996	1996	NUM
bjp-80949	223	25	)	)	PUNCT
bjp-80949	223	26	.	.	PUNCT
bjp-80949	224	1	cetuximab	cetuximab	NOUN
bjp-80949	224	2	has	have	AUX
bjp-80949	224	3	been	be	AUX
bjp-80949	224	4	proven	prove	VERB
bjp-80949	224	5	to	to	PART
bjp-80949	224	6	constrain	constrain	VERB
bjp-80949	224	7	the	the	DET
bjp-80949	224	8	enlargement	enlargement	NOUN
bjp-80949	224	9	of	of	ADP
bjp-80949	224	10	multiple	multiple	ADJ
bjp-80949	224	11	cancerous	cancerous	ADJ
bjp-80949	224	12	human	human	ADJ
bjp-80949	224	13	cell	cell	NOUN
bjp-80949	224	14	lines	line	NOUN
bjp-80949	224	15	that	that	PRON
bjp-80949	224	16	exhibit	exhibit	VERB
bjp-80949	224	17	increased	increase	VERB
bjp-80949	224	18	egfr	egfr	ADJ
bjp-80949	224	19	expression	expression	NOUN
bjp-80949	224	20	(	(	PUNCT
bjp-80949	224	21	matar	matar	NOUN
bjp-80949	224	22	et	et	PROPN
bjp-80949	224	23	al	al	PROPN
bjp-80949	224	24	.	.	PROPN
bjp-80949	224	25	,	,	PUNCT
bjp-80949	224	26	2004	2004	NUM
bjp-80949	224	27	;	;	PUNCT
bjp-80949	224	28	huether	huether	PROPN
bjp-80949	224	29	et	et	PROPN
bjp-80949	224	30	al	al	PROPN
bjp-80949	224	31	.	.	PROPN
bjp-80949	224	32	,	,	PUNCT
bjp-80949	224	33	2005	2005	NUM
bjp-80949	224	34	)	)	PUNCT
bjp-80949	224	35	.	.	PUNCT
bjp-80949	225	1	received	receive	VERB
bjp-80949	225	2	fda	fda	PROPN
bjp-80949	225	3	approval	approval	NOUN
bjp-80949	225	4	in	in	ADP
bjp-80949	225	5	2004	2004	NUM
bjp-80949	225	6	for	for	ADP
bjp-80949	225	7	the	the	DET
bjp-80949	225	8	intervention	intervention	NOUN
bjp-80949	225	9	of	of	ADP
bjp-80949	225	10	head	head	NOUN
bjp-80949	225	11	and	and	CCONJ
bjp-80949	225	12	neck	neck	NOUN
bjp-80949	225	13	cancers	cancer	NOUN
bjp-80949	225	14	(	(	PUNCT
bjp-80949	225	15	galizia	galizia	NOUN
bjp-80949	225	16	et	et	NOUN
bjp-80949	225	17	al	al	PROPN
bjp-80949	225	18	.	.	PROPN
bjp-80949	225	19	,	,	PUNCT
bjp-80949	225	20	2007	2007	NUM
bjp-80949	225	21	)	)	PUNCT
bjp-80949	225	22	,	,	PUNCT
bjp-80949	225	23	cetuximab	cetuximab	NOUN
bjp-80949	225	24	has	have	AUX
bjp-80949	225	25	also	also	ADV
bjp-80949	225	26	shown	show	VERB
bjp-80949	225	27	promise	promise	NOUN
bjp-80949	225	28	in	in	ADP
bjp-80949	225	29	treating	treat	VERB
bjp-80949	225	30	non	non	ADJ
bjp-80949	225	31	-	-	ADJ
bjp-80949	225	32	small	small	ADJ
bjp-80949	225	33	cell	cell	NOUN
bjp-80949	225	34	lung	lung	NOUN
bjp-80949	225	35	cancer	cancer	NOUN
bjp-80949	225	36	(	(	PUNCT
bjp-80949	225	37	nsclc	nsclc	NOUN
bjp-80949	225	38	)	)	PUNCT
bjp-80949	225	39	(	(	PUNCT
bjp-80949	225	40	pirker	pirker	NOUN
bjp-80949	225	41	et	et	PROPN
bjp-80949	225	42	al	al	PROPN
bjp-80949	225	43	.	.	PROPN
bjp-80949	225	44	,	,	PUNCT
bjp-80949	225	45	2009	2009	NUM
bjp-80949	225	46	;	;	PUNCT
bjp-80949	225	47	douillard	douillard	PROPN
bjp-80949	225	48	et	et	PROPN
bjp-80949	225	49	al	al	PROPN
bjp-80949	225	50	.	.	PROPN
bjp-80949	225	51	,	,	PUNCT
bjp-80949	225	52	2014	2014	NUM
bjp-80949	225	53	)	)	PUNCT
bjp-80949	225	54	.	.	PUNCT
bjp-80949	226	1	however	however	ADV
bjp-80949	226	2	,	,	PUNCT
bjp-80949	226	3	its	its	PRON
bjp-80949	226	4	effectiveness	effectiveness	NOUN
bjp-80949	226	5	as	as	ADP
bjp-80949	226	6	a	a	DET
bjp-80949	226	7	monotherapy	monotherapy	NOUN
bjp-80949	226	8	is	be	AUX
bjp-80949	226	9	limited	limit	VERB
bjp-80949	226	10	,	,	PUNCT
bjp-80949	226	11	with	with	ADP
bjp-80949	226	12	response	response	NOUN
bjp-80949	226	13	rates	rate	NOUN
bjp-80949	226	14	falling	fall	VERB
bjp-80949	226	15	below	below	ADP
bjp-80949	226	16	15	15	NUM
bjp-80949	226	17	%	%	NOUN
bjp-80949	226	18	in	in	ADP
bjp-80949	226	19	hnscc	hnscc	NOUN
bjp-80949	226	20	patients	patient	NOUN
bjp-80949	226	21	(	(	PUNCT
bjp-80949	226	22	petrelli	petrelli	PROPN
bjp-80949	226	23	et	et	PROPN
bjp-80949	226	24	al	al	PROPN
bjp-80949	226	25	.	.	PROPN
bjp-80949	226	26	,	,	PUNCT
bjp-80949	226	27	2014	2014	NUM
bjp-80949	226	28	)	)	PUNCT
bjp-80949	226	29	.	.	PUNCT
bjp-80949	227	1	therefore	therefore	ADV
bjp-80949	227	2	,	,	PUNCT
bjp-80949	227	3	evaluating	evaluate	VERB
bjp-80949	227	4	the	the	DET
bjp-80949	227	5	antitumor	antitumor	PROPN
bjp-80949	227	6	impacts	impact	NOUN
bjp-80949	227	7	of	of	ADP
bjp-80949	227	8	cetuximab	cetuximab	NOUN
bjp-80949	227	9	in	in	ADP
bjp-80949	227	10	combination	combination	NOUN
bjp-80949	227	11	therapies	therapy	NOUN
bjp-80949	227	12	has	have	AUX
bjp-80949	227	13	become	become	VERB
bjp-80949	227	14	crucial	crucial	ADJ
bjp-80949	227	15	.	.	PUNCT
bjp-80949	228	1	enhancing	enhance	VERB
bjp-80949	228	2	its	its	PRON
bjp-80949	228	3	anticancer	anticancer	NOUN
bjp-80949	228	4	potential	potential	NOUN
bjp-80949	228	5	and	and	CCONJ
bjp-80949	228	6	expanding	expand	VERB
bjp-80949	228	7	its	its	PRON
bjp-80949	228	8	clinical	clinical	ADJ
bjp-80949	228	9	applications	application	NOUN
bjp-80949	228	10	remain	remain	VERB
bjp-80949	228	11	key	key	ADJ
bjp-80949	228	12	challenges	challenge	NOUN
bjp-80949	228	13	.	.	PUNCT
bjp-80949	229	1	consequently	consequently	ADV
bjp-80949	229	2	,	,	PUNCT
bjp-80949	229	3	combination	combination	NOUN
bjp-80949	229	4	therapies	therapy	NOUN
bjp-80949	229	5	are	be	AUX
bjp-80949	229	6	being	be	AUX
bjp-80949	229	7	explored	explore	VERB
bjp-80949	229	8	to	to	PART
bjp-80949	229	9	improve	improve	VERB
bjp-80949	229	10	efficacy	efficacy	NOUN
bjp-80949	229	11	,	,	PUNCT
bjp-80949	229	12	reduce	reduce	VERB
bjp-80949	229	13	side	side	NOUN
bjp-80949	229	14	effects	effect	NOUN
bjp-80949	229	15	,	,	PUNCT
bjp-80949	229	16	and	and	CCONJ
bjp-80949	229	17	overcome	overcome	VERB
bjp-80949	229	18	resistance	resistance	NOUN
bjp-80949	229	19	,	,	PUNCT
bjp-80949	229	20	with	with	ADP
bjp-80949	229	21	natural	natural	ADJ
bjp-80949	229	22	products	product	NOUN
bjp-80949	229	23	gaining	gain	VERB
bjp-80949	229	24	increasing	increase	VERB
bjp-80949	229	25	attention	attention	NOUN
bjp-80949	229	26	in	in	ADP
bjp-80949	229	27	these	these	DET
bjp-80949	229	28	strategies	strategy	NOUN
bjp-80949	229	29	.	.	PUNCT
bjp-80949	230	1	carvacrol	carvacrol	NOUN
bjp-80949	230	2	,	,	PUNCT
bjp-80949	230	3	a	a	DET
bjp-80949	230	4	potential	potential	ADJ
bjp-80949	230	5	anticancer	anticancer	NOUN
bjp-80949	230	6	agent	agent	NOUN
bjp-80949	230	7	,	,	PUNCT
bjp-80949	230	8	has	have	AUX
bjp-80949	230	9	shown	show	VERB
bjp-80949	230	10	effectiveness	effectiveness	NOUN
bjp-80949	230	11	in	in	ADP
bjp-80949	230	12	suppressing	suppress	VERB
bjp-80949	230	13	cell	cell	NOUN
bjp-80949	230	14	growth	growth	NOUN
bjp-80949	230	15	,	,	PUNCT
bjp-80949	230	16	causing	cause	VERB
bjp-80949	230	17	cell	cell	NOUN
bjp-80949	230	18	cycle	cycle	NOUN
bjp-80949	230	19	blockage	blockage	NOUN
bjp-80949	230	20	,	,	PUNCT
bjp-80949	230	21	and	and	CCONJ
bjp-80949	230	22	triggering	trigger	VERB
bjp-80949	230	23	programmed	program	VERB
bjp-80949	230	24	cell	cell	NOUN
bjp-80949	230	25	death	death	NOUN
bjp-80949	230	26	in	in	ADP
bjp-80949	230	27	several	several	ADJ
bjp-80949	230	28	cancerous	cancerous	ADJ
bjp-80949	230	29	human	human	ADJ
bjp-80949	230	30	cell	cell	NOUN
bjp-80949	230	31	lines	line	NOUN
bjp-80949	230	32	(	(	PUNCT
bjp-80949	230	33	fatima	fatima	PROPN
bjp-80949	230	34	et	et	PROPN
bjp-80949	230	35	al	al	PROPN
bjp-80949	230	36	.	.	PROPN
bjp-80949	230	37	,	,	PUNCT
bjp-80949	230	38	2022	2022	NUM
bjp-80949	230	39	;	;	PUNCT
bjp-80949	230	40	mari	mari	PROPN
bjp-80949	230	41	et	et	PROPN
bjp-80949	230	42	al	al	PROPN
bjp-80949	230	43	.	.	PROPN
bjp-80949	230	44	,	,	PUNCT
bjp-80949	230	45	2021	2021	NUM
bjp-80949	230	46	;	;	PUNCT
bjp-80949	230	47	chiu	chiu	PROPN
bjp-80949	230	48	et	et	PROPN
bjp-80949	230	49	al	al	PROPN
bjp-80949	230	50	.	.	PROPN
bjp-80949	230	51	,	,	PUNCT
bjp-80949	230	52	2023	2023	NUM
bjp-80949	230	53	)	)	PUNCT
bjp-80949	230	54	.	.	PUNCT
bjp-80949	231	1	these	these	DET
bjp-80949	231	2	actions	action	NOUN
bjp-80949	231	3	contribute	contribute	VERB
bjp-80949	231	4	to	to	ADP
bjp-80949	231	5	enhancing	enhance	VERB
bjp-80949	231	6	the	the	DET
bjp-80949	231	7	susceptibility	susceptibility	NOUN
bjp-80949	231	8	of	of	ADP
bjp-80949	231	9	transformed	transform	VERB
bjp-80949	231	10	cells	cell	NOUN
bjp-80949	231	11	to	to	PART
bjp-80949	231	12	chemotherapy	chemotherapy	NOUN
bjp-80949	231	13	along	along	ADP
bjp-80949	231	14	with	with	ADP
bjp-80949	231	15	targeted	target	VERB
bjp-80949	231	16	therapies	therapy	NOUN
bjp-80949	231	17	.	.	PUNCT
bjp-80949	232	1	additionally	additionally	ADV
bjp-80949	232	2	,	,	PUNCT
bjp-80949	232	3	combining	combine	VERB
bjp-80949	232	4	carvacrol	carvacrol	NOUN
bjp-80949	232	5	with	with	ADP
bjp-80949	232	6	other	other	ADJ
bjp-80949	232	7	treatments	treatment	NOUN
bjp-80949	232	8	may	may	AUX
bjp-80949	232	9	improve	improve	VERB
bjp-80949	232	10	the	the	DET
bjp-80949	232	11	therapeutic	therapeutic	ADJ
bjp-80949	232	12	outcomes	outcome	NOUN
bjp-80949	232	13	of	of	ADP
bjp-80949	232	14	both	both	CCONJ
bjp-80949	232	15	chemotherapeutic	chemotherapeutic	ADJ
bjp-80949	232	16	agents	agent	NOUN
bjp-80949	232	17	and	and	CCONJ
bjp-80949	232	18	targeted	target	VERB
bjp-80949	232	19	drugs	drug	NOUN
bjp-80949	232	20	.	.	PUNCT
bjp-80949	233	1	based	base	VERB
bjp-80949	233	2	on	on	ADP
bjp-80949	233	3	existing	exist	VERB
bjp-80949	233	4	studies	study	NOUN
bjp-80949	233	5	,	,	PUNCT
bjp-80949	233	6	this	this	DET
bjp-80949	233	7	investigation	investigation	NOUN
bjp-80949	233	8	aimed	aim	VERB
bjp-80949	233	9	to	to	PART
bjp-80949	233	10	determine	determine	VERB
bjp-80949	233	11	whether	whether	SCONJ
bjp-80949	233	12	carvacrol	carvacrol	NOUN
bjp-80949	233	13	could	could	AUX
bjp-80949	233	14	contribute	contribute	VERB
bjp-80949	233	15	to	to	ADP
bjp-80949	233	16	overcoming	overcome	VERB
bjp-80949	233	17	acquired	acquire	VERB
bjp-80949	233	18	resistance	resistance	NOUN
bjp-80949	233	19	to	to	ADP
bjp-80949	233	20	cetuximab	cetuximab	NOUN
bjp-80949	233	21	.	.	PUNCT
bjp-80949	234	1	however	however	ADV
bjp-80949	234	2	,	,	PUNCT
bjp-80949	234	3	the	the	DET
bjp-80949	234	4	impact	impact	NOUN
bjp-80949	234	5	of	of	ADP
bjp-80949	234	6	carvacrol	carvacrol	NOUN
bjp-80949	234	7	on	on	ADP
bjp-80949	234	8	the	the	DET
bjp-80949	234	9	reaction	reaction	NOUN
bjp-80949	234	10	of	of	ADP
bjp-80949	234	11	nsclc	nsclc	NOUN
bjp-80949	234	12	cells	cell	NOUN
bjp-80949	234	13	to	to	AUX
bjp-80949	234	14	cetuximab	cetuximab	VERB
bjp-80949	234	15	,	,	PUNCT
bjp-80949	234	16	as	as	ADV
bjp-80949	234	17	well	well	ADV
bjp-80949	234	18	as	as	ADP
bjp-80949	234	19	the	the	DET
bjp-80949	234	20	mechanisms	mechanism	NOUN
bjp-80949	234	21	involved	involve	VERB
bjp-80949	234	22	,	,	PUNCT
bjp-80949	234	23	remains	remains	AUX
bjp-80949	234	24	poorly	poorly	ADV
bjp-80949	234	25	understood	understand	VERB
bjp-80949	234	26	.	.	PUNCT
bjp-80949	235	1	this	this	DET
bjp-80949	235	2	investigation	investigation	NOUN
bjp-80949	235	3	examines	examine	VERB
bjp-80949	235	4	the	the	DET
bjp-80949	235	5	therapeutic	therapeutic	ADJ
bjp-80949	235	6	impacts	impact	NOUN
bjp-80949	235	7	and	and	CCONJ
bjp-80949	235	8	underlying	underlying	ADJ
bjp-80949	235	9	dynamics	dynamic	NOUN
bjp-80949	235	10	of	of	ADP
bjp-80949	235	11	combining	combine	VERB
bjp-80949	235	12	cetuximab	cetuximab	NOUN
bjp-80949	235	13	with	with	ADP
bjp-80949	235	14	carvacrol	carvacrol	NOUN
bjp-80949	235	15	in	in	ADP
bjp-80949	235	16	a-549	a-549	PROPN
bjp-80949	235	17	and	and	CCONJ
bjp-80949	235	18	h1299	h1299	NUM
bjp-80949	235	19	nsclc	nsclc	NOUN
bjp-80949	235	20	cell	cell	NOUN
bjp-80949	235	21	lines	line	NOUN
bjp-80949	235	22	.	.	PUNCT
bjp-80949	236	1	the	the	DET
bjp-80949	236	2	findings	finding	NOUN
bjp-80949	236	3	indicate	indicate	VERB
bjp-80949	236	4	that	that	SCONJ
bjp-80949	236	5	the	the	DET
bjp-80949	236	6	combination	combination	NOUN
bjp-80949	236	7	of	of	ADP
bjp-80949	236	8	carvacrol	carvacrol	NOUN
bjp-80949	236	9	and	and	CCONJ
bjp-80949	236	10	cetuximab	cetuximab	NOUN
bjp-80949	236	11	significantly	significantly	ADV
bjp-80949	236	12	reduced	reduce	VERB
bjp-80949	236	13	the	the	DET
bjp-80949	236	14	viability	viability	NOUN
bjp-80949	236	15	and	and	CCONJ
bjp-80949	236	16	proliferation	proliferation	NOUN
bjp-80949	236	17	of	of	ADP
bjp-80949	236	18	a-549	a-549	PROPN
bjp-80949	236	19	and	and	CCONJ
bjp-80949	236	20	h1299	h1299	CCONJ
bjp-80949	236	21	cells	cell	NOUN
bjp-80949	236	22	.	.	PUNCT
bjp-80949	237	1	this	this	DET
bjp-80949	237	2	study	study	NOUN
bjp-80949	237	3	demonstrates	demonstrate	VERB
bjp-80949	237	4	that	that	SCONJ
bjp-80949	237	5	using	use	VERB
bjp-80949	237	6	lower	low	ADJ
bjp-80949	237	7	doses	dose	NOUN
bjp-80949	237	8	of	of	ADP
bjp-80949	237	9	cetuximab	cetuximab	NOUN
bjp-80949	237	10	in	in	ADP
bjp-80949	237	11	combination	combination	NOUN
bjp-80949	237	12	with	with	ADP
bjp-80949	237	13	carvacrol	carvacrol	NOUN
bjp-80949	237	14	enhances	enhance	VERB
bjp-80949	237	15	the	the	DET
bjp-80949	237	16	antitumor	antitumor	PROPN
bjp-80949	237	17	effects	effect	NOUN
bjp-80949	237	18	in	in	ADP
bjp-80949	237	19	these	these	DET
bjp-80949	237	20	cell	cell	NOUN
bjp-80949	237	21	lines	line	NOUN
bjp-80949	237	22	,	,	PUNCT
bjp-80949	237	23	showing	show	VERB
bjp-80949	237	24	a	a	DET
bjp-80949	237	25	synergistic	synergistic	ADJ
bjp-80949	237	26	impact	impact	NOUN
bjp-80949	237	27	compared	compare	VERB
bjp-80949	237	28	to	to	ADP
bjp-80949	237	29	cetuximab	cetuximab	NOUN
bjp-80949	237	30	alone	alone	ADV
bjp-80949	237	31	.	.	PUNCT
bjp-80949	238	1	detailed	detailed	ADJ
bjp-80949	238	2	analysis	analysis	NOUN
bjp-80949	238	3	revealed	reveal	VERB
bjp-80949	238	4	that	that	SCONJ
bjp-80949	238	5	the	the	DET
bjp-80949	238	6	underlying	underlying	ADJ
bjp-80949	238	7	mechanism	mechanism	NOUN
bjp-80949	238	8	of	of	ADP
bjp-80949	238	9	this	this	DET
bjp-80949	238	10	effect	effect	NOUN
bjp-80949	238	11	involves	involve	VERB
bjp-80949	238	12	disruption	disruption	NOUN
bjp-80949	238	13	of	of	ADP
bjp-80949	238	14	the	the	DET
bjp-80949	238	15	cell	cell	NOUN
bjp-80949	238	16	membrane	membrane	NOUN
bjp-80949	238	17	,	,	PUNCT
bjp-80949	238	18	induction	induction	NOUN
bjp-80949	238	19	of	of	ADP
bjp-80949	238	20	programmed	program	VERB
bjp-80949	238	21	cell	cell	NOUN
bjp-80949	238	22	death	death	NOUN
bjp-80949	238	23	,	,	PUNCT
bjp-80949	238	24	and	and	CCONJ
bjp-80949	238	25	cell	cell	NOUN
bjp-80949	238	26	cycle	cycle	NOUN
bjp-80949	238	27	arrest	arrest	NOUN
bjp-80949	238	28	in	in	ADP
bjp-80949	238	29	both	both	PRON
bjp-80949	238	30	a549	a549	PROPN
bjp-80949	238	31	and	and	CCONJ
bjp-80949	239	1	h1299	h1299	NOUN
bjp-80949	239	2	cells	cell	NOUN
bjp-80949	239	3	.	.	PUNCT
bjp-80949	240	1	studies	study	NOUN
bjp-80949	240	2	have	have	AUX
bjp-80949	240	3	shown	show	VERB
bjp-80949	240	4	that	that	DET
bjp-80949	240	5	cetuximab	cetuximab	NOUN
bjp-80949	240	6	,	,	PUNCT
bjp-80949	240	7	when	when	SCONJ
bjp-80949	240	8	used	use	VERB
bjp-80949	240	9	in	in	ADP
bjp-80949	240	10	combination	combination	NOUN
bjp-80949	240	11	with	with	ADP
bjp-80949	240	12	various	various	ADJ
bjp-80949	240	13	natural	natural	ADJ
bjp-80949	240	14	anticancer	anticancer	NOUN
bjp-80949	240	15	agents	agent	NOUN
bjp-80949	240	16	,	,	PUNCT
bjp-80949	240	17	can	can	AUX
bjp-80949	240	18	enhance	enhance	VERB
bjp-80949	240	19	apoptosis	apoptosis	NOUN
bjp-80949	240	20	in	in	ADP
bjp-80949	240	21	human	human	ADJ
bjp-80949	240	22	tumor	tumor	NOUN
bjp-80949	240	23	cells	cell	NOUN
bjp-80949	240	24	.	.	PUNCT
bjp-80949	241	1	as	as	ADP
bjp-80949	241	2	an	an	DET
bjp-80949	241	3	illustration	illustration	NOUN
bjp-80949	241	4	,	,	PUNCT
bjp-80949	241	5	an	an	DET
bjp-80949	241	6	exploration	exploration	NOUN
bjp-80949	241	7	established	establish	VERB
bjp-80949	241	8	that	that	DET
bjp-80949	241	9	cetuximab	cetuximab	NOUN
bjp-80949	241	10	blended	blend	VERB
bjp-80949	241	11	with	with	ADP
bjp-80949	241	12	genistein	genistein	NOUN
bjp-80949	241	13	,	,	PUNCT
bjp-80949	241	14	a	a	DET
bjp-80949	241	15	soy	soy	NOUN
bjp-80949	241	16	-	-	PUNCT
bjp-80949	241	17	derived	derive	VERB
bjp-80949	241	18	isoflavonoid	isoflavonoid	NOUN
bjp-80949	241	19	,	,	PUNCT
bjp-80949	241	20	resulted	result	VERB
bjp-80949	241	21	in	in	ADP
bjp-80949	241	22	significant	significant	ADJ
bjp-80949	241	23	antitumor	antitumor	NOUN
bjp-80949	241	24	effects	effect	NOUN
bjp-80949	241	25	in	in	ADP
bjp-80949	241	26	mice	mouse	NOUN
bjp-80949	241	27	with	with	ADP
bjp-80949	241	28	oral	oral	ADJ
bjp-80949	241	29	squamous	squamous	ADJ
bjp-80949	241	30	cell	cell	NOUN
bjp-80949	241	31	carcinoma	carcinoma	NOUN
bjp-80949	241	32	(	(	PUNCT
bjp-80949	241	33	oscc	oscc	ADJ
bjp-80949	241	34	)	)	PUNCT
bjp-80949	241	35	xenografts	xenograft	NOUN
bjp-80949	241	36	(	(	PUNCT
bjp-80949	241	37	park	park	NOUN
bjp-80949	241	38	et	et	PROPN
bjp-80949	241	39	al	al	PROPN
bjp-80949	241	40	.	.	PROPN
bjp-80949	241	41	,	,	PUNCT
bjp-80949	241	42	2010	2010	NUM
bjp-80949	241	43	)	)	PUNCT
bjp-80949	241	44	.	.	PUNCT
bjp-80949	242	1	similarly	similarly	ADV
bjp-80949	242	2	,	,	PUNCT
bjp-80949	242	3	when	when	SCONJ
bjp-80949	242	4	cetuximab	cetuximab	NOUN
bjp-80949	242	5	was	be	AUX
bjp-80949	242	6	in	in	ADP
bjp-80949	242	7	combination	combination	NOUN
bjp-80949	242	8	with	with	ADP
bjp-80949	242	9	docetaxel	docetaxel	NOUN
bjp-80949	242	10	,	,	PUNCT
bjp-80949	242	11	a	a	DET
bjp-80949	242	12	taxane	taxane	NOUN
bjp-80949	242	13	-	-	PUNCT
bjp-80949	242	14	based	base	VERB
bjp-80949	242	15	drug	drug	NOUN
bjp-80949	242	16	gathered	gather	VERB
bjp-80949	242	17	from	from	ADP
bjp-80949	242	18	european	european	PROPN
bjp-80949	242	19	yellow	yellow	PROPN
bjp-80949	242	20	tree	tree	NOUN
bjp-80949	242	21	,	,	PUNCT
bjp-80949	242	22	it	it	PRON
bjp-80949	242	23	effectively	effectively	ADV
bjp-80949	242	24	suppressed	suppress	VERB
bjp-80949	242	25	the	the	DET
bjp-80949	242	26	growth	growth	NOUN
bjp-80949	242	27	of	of	ADP
bjp-80949	242	28	non	non	ADJ
bjp-80949	242	29	-	-	ADJ
bjp-80949	242	30	small	small	ADJ
bjp-80949	242	31	cell	cell	NOUN
bjp-80949	242	32	lung	lung	NOUN
bjp-80949	242	33	cancer	cancer	NOUN
bjp-80949	242	34	pc9	pc9	PROPN
bjp-80949	242	35	/	/	SYM
bjp-80949	242	36	g2	g2	PROPN
bjp-80949	242	37	cells	cell	NOUN
bjp-80949	242	38	in	in	ADP
bjp-80949	242	39	both	both	CCONJ
bjp-80949	242	40	laboratory	laboratory	NOUN
bjp-80949	242	41	and	and	CCONJ
bjp-80949	242	42	animal	animal	NOUN
bjp-80949	242	43	models	model	NOUN
bjp-80949	242	44	(	(	PUNCT
bjp-80949	242	45	zhang	zhang	X
bjp-80949	242	46	et	et	PROPN
bjp-80949	242	47	al	al	PROPN
bjp-80949	242	48	.	.	PROPN
bjp-80949	242	49	,	,	PUNCT
bjp-80949	242	50	2014	2014	NUM
bjp-80949	242	51	)	)	PUNCT
bjp-80949	242	52	.	.	PUNCT
bjp-80949	243	1	additionally	additionally	ADV
bjp-80949	243	2	,	,	PUNCT
bjp-80949	243	3	the	the	DET
bjp-80949	243	4	compound	compound	NOUN
bjp-80949	243	5	guggulsterone	guggulsterone	NOUN
bjp-80949	243	6	,	,	PUNCT
bjp-80949	243	7	in	in	ADP
bjp-80949	243	8	a	a	DET
bjp-80949	243	9	natural	natural	ADJ
bjp-80949	243	10	manner	manner	NOUN
bjp-80949	243	11	found	find	VERB
bjp-80949	243	12	substance	substance	NOUN
bjp-80949	243	13	implemented	implement	VERB
bjp-80949	243	14	in	in	ADP
bjp-80949	243	15	conventional	conventional	ADJ
bjp-80949	243	16	indian	indian	ADJ
bjp-80949	243	17	medicine	medicine	NOUN
bjp-80949	243	18	,	,	PUNCT
bjp-80949	243	19	was	be	AUX
bjp-80949	243	20	shown	show	VERB
bjp-80949	243	21	to	to	PART
bjp-80949	243	22	amplify	amplify	VERB
bjp-80949	243	23	the	the	DET
bjp-80949	243	24	cell	cell	NOUN
bjp-80949	243	25	growth	growth	NOUN
bjp-80949	243	26	-	-	PUNCT
bjp-80949	243	27	blocking	block	VERB
bjp-80949	243	28	effects	effect	NOUN
bjp-80949	243	29	of	of	ADP
bjp-80949	243	30	cetuximab	cetuximab	NOUN
bjp-80949	243	31	in	in	ADP
bjp-80949	243	32	squamous	squamous	ADJ
bjp-80949	243	33	cell	cell	NOUN
bjp-80949	243	34	carcinoma	carcinoma	NOUN
bjp-80949	243	35	of	of	ADP
bjp-80949	243	36	the	the	DET
bjp-80949	243	37	head	head	NOUN
bjp-80949	243	38	and	and	CCONJ
bjp-80949	243	39	neck	neck	NOUN
bjp-80949	243	40	(	(	PUNCT
bjp-80949	243	41	hnscc	hnscc	NOUN
bjp-80949	243	42	)	)	PUNCT
bjp-80949	243	43	(	(	PUNCT
bjp-80949	243	44	leeman	leeman	PROPN
bjp-80949	243	45	-	-	PUNCT
bjp-80949	243	46	neill	neill	PROPN
bjp-80949	243	47	et	et	PROPN
bjp-80949	243	48	al	al	PROPN
bjp-80949	243	49	.	.	PROPN
bjp-80949	243	50	,	,	PUNCT
bjp-80949	243	51	2009	2009	NUM
bjp-80949	243	52	)	)	PUNCT
bjp-80949	243	53	.	.	PUNCT
bjp-80949	244	1	the	the	DET
bjp-80949	244	2	pairing	pairing	NOUN
bjp-80949	244	3	of	of	ADP
bjp-80949	244	4	cetuximab	cetuximab	NOUN
bjp-80949	244	5	and	and	CCONJ
bjp-80949	244	6	oridonin	oridonin	NOUN
bjp-80949	244	7	,	,	PUNCT
bjp-80949	244	8	an	an	DET
bjp-80949	244	9	active	active	ADJ
bjp-80949	244	10	compound	compound	NOUN
bjp-80949	244	11	derived	derive	VERB
bjp-80949	244	12	from	from	ADP
bjp-80949	244	13	rabdosia	rabdosia	PROPN
bjp-80949	244	14	rubescens	rubescens	PROPN
bjp-80949	244	15	,	,	PUNCT
bjp-80949	244	16	has	have	AUX
bjp-80949	244	17	demonstrated	demonstrate	VERB
bjp-80949	244	18	combined	combined	ADJ
bjp-80949	244	19	antitumor	antitumor	PROPN
bjp-80949	244	20	effects	effect	NOUN
bjp-80949	244	21	against	against	ADP
bjp-80949	244	22	laryngeal	laryngeal	ADJ
bjp-80949	244	23	squamous	squamous	ADJ
bjp-80949	244	24	cell	cell	NOUN
bjp-80949	244	25	carcinoma	carcinoma	NOUN
bjp-80949	244	26	(	(	PUNCT
bjp-80949	244	27	lscc	lscc	ADJ
bjp-80949	244	28	)	)	PUNCT
bjp-80949	244	29	in	in	ADP
bjp-80949	244	30	both	both	CCONJ
bjp-80949	244	31	laboratory	laboratory	NOUN
bjp-80949	244	32	and	and	CCONJ
bjp-80949	244	33	animal	animal	NOUN
bjp-80949	244	34	models	model	NOUN
bjp-80949	244	35	.	.	PUNCT
bjp-80949	245	1	notably	notably	ADV
bjp-80949	245	2	,	,	PUNCT
bjp-80949	245	3	this	this	DET
bjp-80949	245	4	combination	combination	NOUN
bjp-80949	245	5	resulted	result	VERB
bjp-80949	245	6	in	in	ADP
bjp-80949	245	7	enhanced	enhanced	ADJ
bjp-80949	245	8	anti	anti	ADJ
bjp-80949	245	9	-	-	ADJ
bjp-80949	245	10	proliferative	proliferative	ADJ
bjp-80949	245	11	activity	activity	NOUN
bjp-80949	245	12	in	in	ADP
bjp-80949	245	13	vitro	vitro	X
bjp-80949	245	14	,	,	PUNCT
bjp-80949	245	15	significantly	significantly	ADV
bjp-80949	245	16	inhibiting	inhibit	VERB
bjp-80949	245	17	p	p	NOUN
bjp-80949	245	18	-	-	PUNCT
bjp-80949	245	19	egfr	egfr	NOUN
bjp-80949	245	20	expression	expression	NOUN
bjp-80949	245	21	.	.	PUNCT
bjp-80949	246	1	in	in	ADP
bjp-80949	246	2	vivo	vivo	NOUN
bjp-80949	246	3	,	,	PUNCT
bjp-80949	246	4	the	the	DET
bjp-80949	246	5	combination	combination	NOUN
bjp-80949	246	6	treatment	treatment	NOUN
bjp-80949	246	7	led	lead	VERB
bjp-80949	246	8	to	to	ADP
bjp-80949	246	9	a	a	DET
bjp-80949	246	10	marked	mark	VERB
bjp-80949	246	11	reduction	reduction	NOUN
bjp-80949	246	12	in	in	ADP
bjp-80949	246	13	p	p	NOUN
bjp-80949	246	14	-	-	PUNCT
bjp-80949	246	15	egfr	egfr	NOUN
bjp-80949	246	16	levels	level	NOUN
bjp-80949	246	17	within	within	ADP
bjp-80949	246	18	tumor	tumor	NOUN
bjp-80949	246	19	tissues	tissue	NOUN
bjp-80949	246	20	and	and	CCONJ
bjp-80949	246	21	promoted	promote	VERB
bjp-80949	246	22	tumor	tumor	NOUN
bjp-80949	246	23	regression	regression	NOUN
bjp-80949	246	24	in	in	ADP
bjp-80949	246	25	hep-2	hep-2	PUNCT
bjp-80949	246	26	xenografts	xenograft	NOUN
bjp-80949	246	27	,	,	PUNCT
bjp-80949	246	28	outperforming	outperform	VERB
bjp-80949	246	29	treatments	treatment	NOUN
bjp-80949	246	30	with	with	ADP
bjp-80949	246	31	either	either	CCONJ
bjp-80949	246	32	cetuximab	cetuximab	NOUN
bjp-80949	246	33	or	or	CCONJ
bjp-80949	246	34	oridonin	oridonin	NOUN
bjp-80949	246	35	alone	alone	ADV
bjp-80949	246	36	.	.	PUNCT
bjp-80949	247	1	throughout	throughout	ADP
bjp-80949	247	2	the	the	DET
bjp-80949	247	3	study	study	NOUN
bjp-80949	247	4	,	,	PUNCT
bjp-80949	247	5	no	no	DET
bjp-80949	247	6	notable	notable	ADJ
bjp-80949	247	7	side	side	NOUN
bjp-80949	247	8	effects	effect	NOUN
bjp-80949	247	9	were	be	AUX
bjp-80949	247	10	observed	observe	VERB
bjp-80949	247	11	in	in	ADP
bjp-80949	247	12	the	the	DET
bjp-80949	247	13	treatment	treatment	NOUN
bjp-80949	247	14	groups	group	NOUN
bjp-80949	247	15	.	.	PUNCT
bjp-80949	248	1	the	the	DET
bjp-80949	248	2	results	result	NOUN
bjp-80949	248	3	demonstrated	demonstrate	VERB
bjp-80949	248	4	that	that	SCONJ
bjp-80949	248	5	combining	combine	VERB
bjp-80949	248	6	oridonin	oridonin	NOUN
bjp-80949	248	7	with	with	ADP
bjp-80949	248	8	cetuximab	cetuximab	NOUN
bjp-80949	248	9	not	not	PART
bjp-80949	248	10	only	only	ADV
bjp-80949	248	11	inhibited	inhibited	ADJ
bjp-80949	248	12	egfr	egfr	ADJ
bjp-80949	248	13	phosphorylation	phosphorylation	NOUN
bjp-80949	248	14	but	but	CCONJ
bjp-80949	248	15	also	also	ADV
bjp-80949	248	16	triggered	trigger	VERB
bjp-80949	248	17	considerable	considerable	ADJ
bjp-80949	248	18	apoptosis	apoptosis	NOUN
bjp-80949	248	19	in	in	ADP
bjp-80949	248	20	both	both	DET
bjp-80949	248	21	laboratory	laboratory	NOUN
bjp-80949	248	22	and	and	CCONJ
bjp-80949	248	23	animal	animal	NOUN
bjp-80949	248	24	models	model	NOUN
bjp-80949	248	25	.	.	PUNCT
bjp-80949	249	1	lscc	lscc	ADJ
bjp-80949	249	2	cells	cell	NOUN
bjp-80949	249	3	treated	treat	VERB
bjp-80949	249	4	with	with	ADP
bjp-80949	249	5	both	both	CCONJ
bjp-80949	249	6	oridonin	oridonin	ADJ
bjp-80949	249	7	and	and	CCONJ
bjp-80949	249	8	cetuximab	cetuximab	NOUN
bjp-80949	249	9	treatment	treatment	NOUN
bjp-80949	249	10	resulted	result	VERB
bjp-80949	249	11	in	in	ADP
bjp-80949	249	12	higher	high	ADJ
bjp-80949	249	13	levels	level	NOUN
bjp-80949	249	14	of	of	ADP
bjp-80949	249	15	fas	fas	NOUN
bjp-80949	249	16	,	,	PUNCT
bjp-80949	249	17	fasl	fasl	PROPN
bjp-80949	249	18	,	,	PUNCT
bjp-80949	249	19	and	and	CCONJ
bjp-80949	249	20	activated	activate	VERB
bjp-80949	249	21	caspase-8	caspase-8	NOUN
bjp-80949	249	22	compared	compare	VERB
bjp-80949	249	23	to	to	ADP
bjp-80949	249	24	such	such	ADJ
bjp-80949	249	25	treated	treat	VERB
bjp-80949	249	26	with	with	ADP
bjp-80949	249	27	oridonin	oridonin	NOUN
bjp-80949	249	28	by	by	ADP
bjp-80949	249	29	itself	itself	PRON
bjp-80949	249	30	.	.	PUNCT
bjp-80949	250	1	in	in	ADP
bjp-80949	250	2	hep-2	hep-2	PUNCT
bjp-80949	250	3	tumor	tumor	NOUN
bjp-80949	250	4	-	-	PUNCT
bjp-80949	250	5	bearing	bear	VERB
bjp-80949	250	6	mice	mouse	NOUN
bjp-80949	250	7	,	,	PUNCT
bjp-80949	250	8	the	the	DET
bjp-80949	250	9	combination	combination	NOUN
bjp-80949	250	10	therapy	therapy	NOUN
bjp-80949	250	11	led	lead	VERB
bjp-80949	250	12	to	to	ADP
bjp-80949	250	13	substantial	substantial	ADJ
bjp-80949	250	14	apoptosis	apoptosis	NOUN
bjp-80949	250	15	and	and	CCONJ
bjp-80949	250	16	a	a	DET
bjp-80949	250	17	substantial	substantial	ADJ
bjp-80949	250	18	enhancement	enhancement	NOUN
bjp-80949	250	19	in	in	ADP
bjp-80949	250	20	stimulated	stimulate	VERB
bjp-80949	250	21	caspase-8	caspase-8	NOUN
bjp-80949	250	22	as	as	ADV
bjp-80949	250	23	well	well	ADV
bjp-80949	250	24	as	as	ADP
bjp-80949	250	25	caspase-3	caspase-3	NUM
bjp-80949	250	26	,	,	PUNCT
bjp-80949	250	27	indicating	indicate	VERB
bjp-80949	250	28	that	that	SCONJ
bjp-80949	250	29	fas	fas	ADJ
bjp-80949	250	30	-	-	PUNCT
bjp-80949	250	31	mediated	mediate	VERB
bjp-80949	250	32	extrinsic	extrinsic	ADJ
bjp-80949	250	33	apoptotic	apoptotic	ADJ
bjp-80949	250	34	pathway	pathway	NOUN
bjp-80949	250	35	is	be	AUX
bjp-80949	250	36	essential	essential	ADJ
bjp-80949	250	37	in	in	ADP
bjp-80949	250	38	the	the	DET
bjp-80949	250	39	tumor	tumor	NOUN
bjp-80949	250	40	cell	cell	NOUN
bjp-80949	250	41	death	death	NOUN
bjp-80949	250	42	triggered	trigger	VERB
bjp-80949	250	43	by	by	ADP
bjp-80949	250	44	oridonin	oridonin	NOUN
bjp-80949	250	45	and	and	CCONJ
bjp-80949	250	46	cetuximab	cetuximab	NOUN
bjp-80949	250	47	(	(	PUNCT
bjp-80949	250	48	cao	cao	PROPN
bjp-80949	250	49	et	et	PROPN
bjp-80949	250	50	al	al	PROPN
bjp-80949	250	51	.	.	PROPN
bjp-80949	250	52	,	,	PUNCT
bjp-80949	250	53	2016	2016	NUM
bjp-80949	250	54	)	)	PUNCT
bjp-80949	250	55	.	.	PUNCT
bjp-80949	251	1	in	in	ADP
bjp-80949	251	2	a	a	DET
bjp-80949	251	3	separate	separate	ADJ
bjp-80949	251	4	study	study	NOUN
bjp-80949	251	5	,	,	PUNCT
bjp-80949	251	6	the	the	DET
bjp-80949	251	7	combination	combination	NOUN
bjp-80949	251	8	of	of	ADP
bjp-80949	251	9	honokiol	honokiol	NOUN
bjp-80949	251	10	,	,	PUNCT
bjp-80949	251	11	a	a	DET
bjp-80949	251	12	natural	natural	ADJ
bjp-80949	251	13	substance	substance	NOUN
bjp-80949	251	14	extracted	extract	VERB
bjp-80949	251	15	from	from	ADP
bjp-80949	251	16	the	the	DET
bjp-80949	251	17	tree	tree	NOUN
bjp-80949	251	18	's	's	PART
bjp-80949	251	19	outer	outer	ADJ
bjp-80949	251	20	layer	layer	NOUN
bjp-80949	251	21	and	and	CCONJ
bjp-80949	251	22	foliage	foliage	NOUN
bjp-80949	251	23	of	of	ADP
bjp-80949	251	24	the	the	DET
bjp-80949	251	25	chinese	chinese	ADJ
bjp-80949	251	26	magnolia	magnolia	PROPN
bjp-80949	251	27	tree	tree	NOUN
bjp-80949	251	28	,	,	PUNCT
bjp-80949	251	29	combined	combine	VERB
bjp-80949	251	30	with	with	ADP
bjp-80949	251	31	cetuximab	cetuximab	NOUN
bjp-80949	251	32	,	,	PUNCT
bjp-80949	251	33	was	be	AUX
bjp-80949	251	34	established	establish	VERB
bjp-80949	251	35	to	to	PART
bjp-80949	251	36	improve	improve	VERB
bjp-80949	251	37	the	the	DET
bjp-80949	251	38	susceptibility	susceptibility	NOUN
bjp-80949	251	39	of	of	ADP
bjp-80949	251	40	krasg13d	krasg13d	NOUN
bjp-80949	251	41	mutant	mutant	VERB
bjp-80949	251	42	colorectal	colorectal	ADJ
bjp-80949	251	43	cancer	cancer	NOUN
bjp-80949	251	44	(	(	PUNCT
bjp-80949	251	45	crc	crc	NOUN
bjp-80949	251	46	)	)	PUNCT
bjp-80949	251	47	cells	cell	NOUN
bjp-80949	251	48	in	in	ADP
bjp-80949	251	49	laboratory	laboratory	NOUN
bjp-80949	251	50	as	as	ADV
bjp-80949	251	51	well	well	ADV
bjp-80949	251	52	as	as	ADP
bjp-80949	251	53	animal	animal	NOUN
bjp-80949	251	54	models	model	NOUN
bjp-80949	251	55	.	.	PUNCT
bjp-80949	252	1	honokiol	honokiol	PROPN
bjp-80949	252	2	was	be	AUX
bjp-80949	252	3	found	find	VERB
bjp-80949	252	4	to	to	PART
bjp-80949	252	5	interfere	interfere	VERB
bjp-80949	252	6	with	with	ADP
bjp-80949	252	7	snx3retromer	snx3retromer	NUM
bjp-80949	252	8	dependent	dependent	ADJ
bjp-80949	252	9	vesicular	vesicular	ADJ
bjp-80949	252	10	transport	transport	NOUN
bjp-80949	252	11	,	,	PUNCT
bjp-80949	252	12	resulting	result	VERB
bjp-80949	252	13	in	in	ADP
bjp-80949	252	14	disrupted	disrupt	VERB
bjp-80949	252	15	proteolytic	proteolytic	ADJ
bjp-80949	252	16	activity	activity	NOUN
bjp-80949	252	17	in	in	ADP
bjp-80949	252	18	lysosomes	lysosome	NOUN
bjp-80949	252	19	and	and	CCONJ
bjp-80949	252	20	suppression	suppression	NOUN
bjp-80949	252	21	of	of	ADP
bjp-80949	252	22	autophagy	autophagy	NOUN
bjp-80949	252	23	and	and	CCONJ
bjp-80949	252	24	macropinocytosis	macropinocytosis	NOUN
bjp-80949	252	25	.	.	PUNCT
bjp-80949	253	1	honokiol	honokiol	PROPN
bjp-80949	253	2	was	be	AUX
bjp-80949	253	3	shown	show	VERB
bjp-80949	253	4	to	to	PART
bjp-80949	253	5	disrupt	disrupt	VERB
bjp-80949	253	6	snx3	snx3	PROPN
bjp-80949	253	7	-	-	PUNCT
bjp-80949	253	8	retromer	retromer	NOUN
bjp-80949	253	9	-	-	PUNCT
bjp-80949	253	10	mediated	mediate	VERB
bjp-80949	253	11	trafficking	trafficking	NOUN
bjp-80949	253	12	,	,	PUNCT
bjp-80949	253	13	leading	lead	VERB
bjp-80949	253	14	30	30	NUM
bjp-80949	253	15	bangladesh	bangladesh	NOUN
bjp-80949	253	16	j	j	PROPN
bjp-80949	253	17	pharmacol	pharmacol	PROPN
bjp-80949	253	18	2025	2025	NUM
bjp-80949	253	19	;	;	PUNCT
bjp-80949	253	20	20	20	NUM
bjp-80949	253	21	:	:	SYM
bjp-80949	253	22	22	22	NUM
bjp-80949	253	23	-	-	SYM
bjp-80949	253	24	34	34	NUM
bjp-80949	253	25	to	to	ADP
bjp-80949	253	26	impaired	impaired	ADJ
bjp-80949	253	27	lysosomal	lysosomal	ADJ
bjp-80949	253	28	proteolytic	proteolytic	ADJ
bjp-80949	253	29	function	function	NOUN
bjp-80949	253	30	and	and	CCONJ
bjp-80949	253	31	inhibition	inhibition	NOUN
bjp-80949	253	32	of	of	ADP
bjp-80949	253	33	autophagy	autophagy	NOUN
bjp-80949	253	34	and	and	CCONJ
bjp-80949	253	35	macropinocytosis	macropinocytosis	NOUN
bjp-80949	253	36	.	.	PUNCT
bjp-80949	254	1	additionally	additionally	ADV
bjp-80949	254	2	,	,	PUNCT
bjp-80949	254	3	honokiol	honokiol	NOUN
bjp-80949	254	4	blocked	block	VERB
bjp-80949	254	5	the	the	DET
bjp-80949	254	6	activation	activation	NOUN
bjp-80949	254	7	of	of	ADP
bjp-80949	254	8	ras	ras	PROPN
bjp-80949	254	9	through	through	ADP
bjp-80949	254	10	gdp	gdp	NOUN
bjp-80949	254	11	to	to	ADP
bjp-80949	254	12	gtp	gtp	PROPN
bjp-80949	254	13	exchange	exchange	NOUN
bjp-80949	254	14	,	,	PUNCT
bjp-80949	254	15	which	which	PRON
bjp-80949	254	16	further	far	ADV
bjp-80949	254	17	enhanced	enhance	VERB
bjp-80949	254	18	responsiveness	responsiveness	NOUN
bjp-80949	254	19	of	of	ADP
bjp-80949	254	20	krasg13d	krasg13d	NOUN
bjp-80949	254	21	mutant	mutant	VERB
bjp-80949	254	22	crc	crc	NOUN
bjp-80949	254	23	cells	cell	NOUN
bjp-80949	254	24	response	response	NOUN
bjp-80949	254	25	to	to	ADP
bjp-80949	254	26	cetuximab	cetuximab	NOUN
bjp-80949	254	27	treatment	treatment	NOUN
bjp-80949	254	28	.	.	PUNCT
bjp-80949	255	1	this	this	DET
bjp-80949	255	2	combination	combination	NOUN
bjp-80949	255	3	therapy	therapy	NOUN
bjp-80949	255	4	improved	improve	VERB
bjp-80949	255	5	cetuximab	cetuximab	NOUN
bjp-80949	255	6	efficacy	efficacy	NOUN
bjp-80949	255	7	by	by	ADP
bjp-80949	255	8	targeting	target	VERB
bjp-80949	255	9	the	the	DET
bjp-80949	255	10	snx3	snx3	PROPN
bjp-80949	255	11	retromer	retromer	NOUN
bjp-80949	255	12	in	in	ADP
bjp-80949	255	13	a	a	DET
bjp-80949	255	14	preclinical	preclinical	ADJ
bjp-80949	255	15	model	model	NOUN
bjp-80949	255	16	of	of	ADP
bjp-80949	255	17	krasg13d	krasg13d	NOUN
bjp-80949	255	18	mutant	mutant	VERB
bjp-80949	255	19	colorectal	colorectal	ADJ
bjp-80949	255	20	cancer	cancer	NOUN
bjp-80949	255	21	.	.	PUNCT
bjp-80949	256	1	these	these	DET
bjp-80949	256	2	results	result	NOUN
bjp-80949	256	3	offer	offer	VERB
bjp-80949	256	4	a	a	DET
bjp-80949	256	5	promising	promising	ADJ
bjp-80949	256	6	approach	approach	NOUN
bjp-80949	256	7	for	for	ADP
bjp-80949	256	8	enhancing	enhance	VERB
bjp-80949	256	9	targeted	target	VERB
bjp-80949	256	10	therapy	therapy	NOUN
bjp-80949	256	11	in	in	ADP
bjp-80949	256	12	individuals	individual	NOUN
bjp-80949	256	13	with	with	ADP
bjp-80949	256	14	kras	kra	NOUN
bjp-80949	256	15	mutant	mutant	ADJ
bjp-80949	256	16	colorectal	colorectal	ADJ
bjp-80949	256	17	cancer	cancer	NOUN
bjp-80949	256	18	(	(	PUNCT
bjp-80949	256	19	zhu	zhu	X
bjp-80949	256	20	et	et	PROPN
bjp-80949	256	21	al	al	PROPN
bjp-80949	256	22	.	.	PROPN
bjp-80949	256	23	,	,	PUNCT
bjp-80949	256	24	2024	2024	NUM
bjp-80949	256	25	)	)	PUNCT
bjp-80949	256	26	.	.	PUNCT
bjp-80949	257	1	in	in	ADP
bjp-80949	257	2	another	another	DET
bjp-80949	257	3	study	study	NOUN
bjp-80949	257	4	,	,	PUNCT
bjp-80949	257	5	the	the	DET
bjp-80949	257	6	findings	finding	NOUN
bjp-80949	257	7	indicate	indicate	VERB
bjp-80949	257	8	that	that	SCONJ
bjp-80949	257	9	honokiol	honokiol	NOUN
bjp-80949	257	10	could	could	AUX
bjp-80949	257	11	be	be	AUX
bjp-80949	257	12	a	a	DET
bjp-80949	257	13	potent	potent	ADJ
bjp-80949	257	14	natural	natural	ADJ
bjp-80949	257	15	compound	compound	NOUN
bjp-80949	257	16	for	for	ADP
bjp-80949	257	17	defeating	defeat	VERB
bjp-80949	257	18	resistance	resistance	NOUN
bjp-80949	257	19	developed	develop	VERB
bjp-80949	257	20	to	to	ADP
bjp-80949	257	21	cetuximab	cetuximab	NOUN
bjp-80949	257	22	.	.	PUNCT
bjp-80949	258	1	when	when	SCONJ
bjp-80949	258	2	honokiol	honokiol	PROPN
bjp-80949	258	3	was	be	AUX
bjp-80949	258	4	combined	combine	VERB
bjp-80949	258	5	with	with	ADP
bjp-80949	258	6	cetuximab	cetuximab	NOUN
bjp-80949	258	7	,	,	PUNCT
bjp-80949	258	8	significant	significant	ADJ
bjp-80949	258	9	reductions	reduction	NOUN
bjp-80949	258	10	were	be	AUX
bjp-80949	258	11	observed	observe	VERB
bjp-80949	258	12	in	in	ADP
bjp-80949	258	13	the	the	DET
bjp-80949	258	14	quantities	quantity	NOUN
bjp-80949	258	15	of	of	ADP
bjp-80949	258	16	pher2	pher2	NOUN
bjp-80949	258	17	,	,	PUNCT
bjp-80949	258	18	pher3	pher3	PROPN
bjp-80949	258	19	,	,	PUNCT
bjp-80949	258	20	pmapk	pmapk	NOUN
bjp-80949	258	21	,	,	PUNCT
bjp-80949	258	22	pakt	pakt	NOUN
bjp-80949	258	23	,	,	PUNCT
bjp-80949	258	24	and	and	CCONJ
bjp-80949	258	25	pc	pc	NOUN
bjp-80949	258	26	-	-	PUNCT
bjp-80949	258	27	raf	raf	PROPN
bjp-80949	258	28	(	(	PUNCT
bjp-80949	258	29	pearson	pearson	PROPN
bjp-80949	258	30	et	et	PROPN
bjp-80949	258	31	al	al	PROPN
bjp-80949	258	32	.	.	PROPN
bjp-80949	258	33	,	,	PUNCT
bjp-80949	258	34	2018	2018	NUM
bjp-80949	258	35	)	)	PUNCT
bjp-80949	258	36	,	,	PUNCT
bjp-80949	258	37	suggesting	suggest	VERB
bjp-80949	258	38	a	a	DET
bjp-80949	258	39	potential	potential	ADJ
bjp-80949	258	40	mechanism	mechanism	NOUN
bjp-80949	258	41	for	for	ADP
bjp-80949	258	42	improving	improve	VERB
bjp-80949	258	43	treatment	treatment	NOUN
bjp-80949	258	44	outcomes	outcome	NOUN
bjp-80949	258	45	in	in	ADP
bjp-80949	258	46	resistant	resistant	ADJ
bjp-80949	258	47	cancer	cancer	NOUN
bjp-80949	258	48	cases	case	NOUN
bjp-80949	258	49	.	.	PUNCT
bjp-80949	259	1	it	it	PRON
bjp-80949	259	2	is	be	AUX
bjp-80949	259	3	believed	believe	VERB
bjp-80949	259	4	that	that	SCONJ
bjp-80949	259	5	an	an	DET
bjp-80949	259	6	increase	increase	NOUN
bjp-80949	259	7	in	in	ADP
bjp-80949	259	8	reactive	reactive	ADJ
bjp-80949	259	9	oxygen	oxygen	NOUN
bjp-80949	259	10	species	specie	NOUN
bjp-80949	259	11	(	(	PUNCT
bjp-80949	259	12	ros	ros	PROPN
bjp-80949	259	13	)	)	PUNCT
bjp-80949	259	14	within	within	ADP
bjp-80949	259	15	cells	cell	NOUN
bjp-80949	259	16	could	could	AUX
bjp-80949	259	17	trigger	trigger	VERB
bjp-80949	259	18	apoptosis	apoptosis	NOUN
bjp-80949	259	19	through	through	ADP
bjp-80949	259	20	elevated	elevated	ADJ
bjp-80949	259	21	oxidative	oxidative	ADJ
bjp-80949	259	22	stress	stress	NOUN
bjp-80949	259	23	(	(	PUNCT
bjp-80949	259	24	pan	pan	NOUN
bjp-80949	259	25	et	et	PROPN
bjp-80949	259	26	al	al	PROPN
bjp-80949	259	27	.	.	PROPN
bjp-80949	259	28	,	,	PUNCT
bjp-80949	259	29	2014	2014	NUM
bjp-80949	259	30	)	)	PUNCT
bjp-80949	259	31	.	.	PUNCT
bjp-80949	260	1	on	on	ADP
bjp-80949	260	2	the	the	DET
bjp-80949	260	3	other	other	ADJ
bjp-80949	260	4	hand	hand	NOUN
bjp-80949	260	5	,	,	PUNCT
bjp-80949	260	6	cancers	cancer	NOUN
bjp-80949	260	7	,	,	PUNCT
bjp-80949	260	8	such	such	ADJ
bjp-80949	260	9	as	as	ADP
bjp-80949	260	10	those	those	PRON
bjp-80949	260	11	associated	associate	VERB
bjp-80949	260	12	with	with	ADP
bjp-80949	260	13	tobacco	tobacco	NOUN
bjp-80949	260	14	use	use	NOUN
bjp-80949	260	15	and	and	CCONJ
bjp-80949	260	16	driven	drive	VERB
bjp-80949	260	17	by	by	ADP
bjp-80949	260	18	ros	ros	PROPN
bjp-80949	260	19	,	,	PUNCT
bjp-80949	260	20	often	often	ADV
bjp-80949	260	21	show	show	VERB
bjp-80949	260	22	heightened	heighten	VERB
bjp-80949	260	23	mapk	mapk	NOUN
bjp-80949	260	24	activation	activation	NOUN
bjp-80949	260	25	.	.	PUNCT
bjp-80949	261	1	this	this	PRON
bjp-80949	261	2	includes	include	VERB
bjp-80949	261	3	oral	oral	ADJ
bjp-80949	261	4	and	and	CCONJ
bjp-80949	261	5	lung	lung	NOUN
bjp-80949	261	6	cancers	cancer	NOUN
bjp-80949	261	7	,	,	PUNCT
bjp-80949	261	8	as	as	ADV
bjp-80949	261	9	well	well	ADV
bjp-80949	261	10	as	as	ADP
bjp-80949	261	11	cancers	cancer	NOUN
bjp-80949	261	12	linked	link	VERB
bjp-80949	261	13	to	to	ADP
bjp-80949	261	14	viruses	virus	NOUN
bjp-80949	261	15	like	like	ADP
bjp-80949	261	16	epstein	epstein	PROPN
bjp-80949	261	17	-	-	PUNCT
bjp-80949	261	18	barr	barr	PROPN
bjp-80949	261	19	virus	virus	PROPN
bjp-80949	261	20	and	and	CCONJ
bjp-80949	261	21	hepatitis	hepatitis	PROPN
bjp-80949	261	22	c.	c.	NOUN
bjp-80949	261	23	in	in	ADP
bjp-80949	261	24	these	these	DET
bjp-80949	261	25	cancers	cancer	NOUN
bjp-80949	261	26	,	,	PUNCT
bjp-80949	261	27	ros	ros	PROPN
bjp-80949	261	28	play	play	VERB
bjp-80949	261	29	a	a	DET
bjp-80949	261	30	key	key	ADJ
bjp-80949	261	31	role	role	NOUN
bjp-80949	261	32	in	in	ADP
bjp-80949	261	33	regulatory	regulatory	ADJ
bjp-80949	261	34	signaling	signal	VERB
bjp-80949	261	35	networks	network	NOUN
bjp-80949	261	36	that	that	PRON
bjp-80949	261	37	may	may	AUX
bjp-80949	261	38	play	play	VERB
bjp-80949	261	39	a	a	DET
bjp-80949	261	40	role	role	NOUN
bjp-80949	261	41	in	in	ADP
bjp-80949	261	42	tumor	tumor	NOUN
bjp-80949	261	43	persistence	persistence	NOUN
bjp-80949	261	44	and	and	CCONJ
bjp-80949	261	45	progression	progression	NOUN
bjp-80949	261	46	(	(	PUNCT
bjp-80949	261	47	bonner	bonner	NOUN
bjp-80949	261	48	and	and	CCONJ
bjp-80949	261	49	arbiser	arbiser	NOUN
bjp-80949	261	50	,	,	PUNCT
bjp-80949	261	51	2014	2014	NUM
bjp-80949	261	52	)	)	PUNCT
bjp-80949	261	53	.	.	PUNCT
bjp-80949	262	1	one	one	NUM
bjp-80949	262	2	of	of	ADP
bjp-80949	262	3	the	the	DET
bjp-80949	262	4	findings	finding	NOUN
bjp-80949	262	5	from	from	ADP
bjp-80949	262	6	the	the	DET
bjp-80949	262	7	study	study	NOUN
bjp-80949	262	8	showed	show	VERB
bjp-80949	262	9	that	that	SCONJ
bjp-80949	262	10	combining	combine	VERB
bjp-80949	262	11	honokiol	honokiol	NOUN
bjp-80949	262	12	with	with	ADP
bjp-80949	262	13	cetuximab	cetuximab	NOUN
bjp-80949	262	14	led	lead	VERB
bjp-80949	262	15	to	to	ADP
bjp-80949	262	16	a	a	DET
bjp-80949	262	17	reduction	reduction	NOUN
bjp-80949	262	18	in	in	ADP
bjp-80949	262	19	ros	ros	PROPN
bjp-80949	262	20	production	production	NOUN
bjp-80949	262	21	(	(	PUNCT
bjp-80949	262	22	pearson	pearson	PROPN
bjp-80949	262	23	et	et	PROPN
bjp-80949	262	24	al	al	PROPN
bjp-80949	262	25	.	.	PROPN
bjp-80949	262	26	,	,	PUNCT
bjp-80949	262	27	2018	2018	NUM
bjp-80949	262	28	)	)	PUNCT
bjp-80949	262	29	.	.	PUNCT
bjp-80949	263	1	this	this	DET
bjp-80949	263	2	decrease	decrease	NOUN
bjp-80949	263	3	in	in	ADP
bjp-80949	263	4	ros	ros	PROPN
bjp-80949	263	5	was	be	AUX
bjp-80949	263	6	associated	associate	VERB
bjp-80949	263	7	with	with	ADP
bjp-80949	263	8	lower	low	ADJ
bjp-80949	263	9	cell	cell	NOUN
bjp-80949	263	10	proliferation	proliferation	NOUN
bjp-80949	263	11	and	and	CCONJ
bjp-80949	263	12	survival	survival	NOUN
bjp-80949	263	13	,	,	PUNCT
bjp-80949	263	14	a	a	DET
bjp-80949	263	15	halt	halt	NOUN
bjp-80949	263	16	in	in	ADP
bjp-80949	263	17	the	the	DET
bjp-80949	263	18	initial	initial	ADJ
bjp-80949	263	19	growth	growth	NOUN
bjp-80949	263	20	phase	phase	NOUN
bjp-80949	263	21	(	(	PUNCT
bjp-80949	263	22	g1	g1	PROPN
bjp-80949	263	23	)	)	PUNCT
bjp-80949	263	24	of	of	ADP
bjp-80949	263	25	the	the	DET
bjp-80949	263	26	cell	cell	NOUN
bjp-80949	263	27	proliferation	proliferation	NOUN
bjp-80949	263	28	cycle	cycle	NOUN
bjp-80949	263	29	,	,	PUNCT
bjp-80949	263	30	and	and	CCONJ
bjp-80949	263	31	delayed	delay	VERB
bjp-80949	263	32	tumor	tumor	NOUN
bjp-80949	263	33	growth	growth	NOUN
bjp-80949	263	34	in	in	ADP
bjp-80949	263	35	patient	patient	NOUN
bjp-80949	263	36	-	-	PUNCT
bjp-80949	263	37	derived	derive	VERB
bjp-80949	263	38	xenograft	xenograft	NOUN
bjp-80949	263	39	models	model	NOUN
bjp-80949	263	40	from	from	ADP
bjp-80949	263	41	cetuximab	cetuximab	NOUN
bjp-80949	263	42	-	-	PUNCT
bjp-80949	263	43	refractory	refractory	NOUN
bjp-80949	263	44	hnscc	hnscc	NOUN
bjp-80949	263	45	(	(	PUNCT
bjp-80949	263	46	pearson	pearson	PROPN
bjp-80949	263	47	et	et	PROPN
bjp-80949	263	48	al	al	PROPN
bjp-80949	263	49	.	.	PROPN
bjp-80949	263	50	,	,	PUNCT
bjp-80949	263	51	2018	2018	NUM
bjp-80949	263	52	)	)	PUNCT
bjp-80949	263	53	.	.	PUNCT
bjp-80949	264	1	another	another	DET
bjp-80949	264	2	study	study	NOUN
bjp-80949	264	3	demonstrated	demonstrate	VERB
bjp-80949	264	4	a	a	DET
bjp-80949	264	5	synergistic	synergistic	ADJ
bjp-80949	264	6	impact	impact	NOUN
bjp-80949	264	7	when	when	SCONJ
bjp-80949	264	8	125	125	NUM
bjp-80949	264	9	μg	μg	NOUN
bjp-80949	264	10	/	/	SYM
bjp-80949	264	11	ml	ml	NOUN
bjp-80949	264	12	of	of	ADP
bjp-80949	264	13	β	β	X
bjp-80949	264	14	-	-	ADJ
bjp-80949	264	15	elemene	elemene	NOUN
bjp-80949	264	16	was	be	AUX
bjp-80949	264	17	used	use	VERB
bjp-80949	264	18	in	in	ADP
bjp-80949	264	19	conjuction	conjuction	NOUN
bjp-80949	264	20	with	with	ADP
bjp-80949	264	21	25	25	NUM
bjp-80949	264	22	μg	μg	NOUN
bjp-80949	264	23	/	/	SYM
bjp-80949	264	24	ml	ml	PROPN
bjp-80949	264	25	of	of	ADP
bjp-80949	264	26	cetuximab	cetuximab	NOUN
bjp-80949	264	27	in	in	ADP
bjp-80949	264	28	colorectal	colorectal	ADJ
bjp-80949	264	29	cancer	cancer	NOUN
bjp-80949	264	30	(	(	PUNCT
bjp-80949	264	31	crc	crc	NOUN
bjp-80949	264	32	)	)	PUNCT
bjp-80949	264	33	cells	cell	NOUN
bjp-80949	264	34	with	with	ADP
bjp-80949	264	35	kras	kra	NOUN
bjp-80949	264	36	mutations	mutation	NOUN
bjp-80949	264	37	.	.	PUNCT
bjp-80949	265	1	in	in	ADP
bjp-80949	265	2	vitro	vitro	X
bjp-80949	265	3	,	,	PUNCT
bjp-80949	265	4	this	this	DET
bjp-80949	265	5	combination	combination	NOUN
bjp-80949	265	6	induced	induce	VERB
bjp-80949	265	7	the	the	DET
bjp-80949	265	8	accumulation	accumulation	NOUN
bjp-80949	265	9	of	of	ADP
bjp-80949	265	10	iron	iron	NOUN
bjp-80949	265	11	-	-	PUNCT
bjp-80949	265	12	mediated	mediate	VERB
bjp-80949	265	13	reactive	reactive	ADJ
bjp-80949	265	14	oxygen	oxygen	NOUN
bjp-80949	265	15	species	specie	NOUN
bjp-80949	265	16	(	(	PUNCT
bjp-80949	265	17	ros	ros	PROPN
bjp-80949	265	18	)	)	PUNCT
bjp-80949	265	19	,	,	PUNCT
bjp-80949	265	20	depletion	depletion	NOUN
bjp-80949	265	21	of	of	ADP
bjp-80949	265	22	glutathione	glutathione	NOUN
bjp-80949	265	23	(	(	PUNCT
bjp-80949	265	24	gsh	gsh	PROPN
bjp-80949	265	25	)	)	PUNCT
bjp-80949	265	26	,	,	PUNCT
bjp-80949	265	27	increased	increase	VERB
bjp-80949	265	28	lipid	lipid	NOUN
bjp-80949	265	29	degradation	degradation	NOUN
bjp-80949	265	30	,	,	PUNCT
bjp-80949	265	31	and	and	CCONJ
bjp-80949	265	32	enhanced	enhance	VERB
bjp-80949	265	33	expression	expression	NOUN
bjp-80949	265	34	of	of	ADP
bjp-80949	265	35	ho-1	ho-1	NOUN
bjp-80949	265	36	and	and	CCONJ
bjp-80949	265	37	transferrin	transferrin	NOUN
bjp-80949	265	38	.	.	PUNCT
bjp-80949	266	1	the	the	DET
bjp-80949	266	2	combination	combination	NOUN
bjp-80949	266	3	of	of	ADP
bjp-80949	266	4	β	β	NOUN
bjp-80949	266	5	-	-	ADJ
bjp-80949	266	6	elemene	elemene	NOUN
bjp-80949	266	7	and	and	CCONJ
bjp-80949	266	8	cetuximab	cetuximab	NOUN
bjp-80949	266	9	also	also	ADV
bjp-80949	266	10	led	lead	VERB
bjp-80949	266	11	to	to	ADP
bjp-80949	266	12	the	the	DET
bjp-80949	266	13	downregulation	downregulation	NOUN
bjp-80949	266	14	of	of	ADP
bjp-80949	266	15	key	key	ADJ
bjp-80949	266	16	proteins	protein	NOUN
bjp-80949	266	17	associated	associate	VERB
bjp-80949	266	18	with	with	ADP
bjp-80949	266	19	ferroptosis	ferroptosis	NOUN
bjp-80949	266	20	,	,	PUNCT
bjp-80949	266	21	such	such	ADJ
bjp-80949	266	22	as	as	ADP
bjp-80949	266	23	gpx4	gpx4	PROPN
bjp-80949	266	24	,	,	PUNCT
bjp-80949	266	25	slc7a11	slc7a11	PROPN
bjp-80949	266	26	,	,	PUNCT
bjp-80949	266	27	fth1	fth1	PROPN
bjp-80949	266	28	,	,	PUNCT
bjp-80949	266	29	glutaminase	glutaminase	NOUN
bjp-80949	266	30	,	,	PUNCT
bjp-80949	266	31	and	and	CCONJ
bjp-80949	266	32	slc40a1	slc40a1	PROPN
bjp-80949	266	33	,	,	PUNCT
bjp-80949	266	34	in	in	ADP
bjp-80949	266	35	crc	crc	NOUN
bjp-80949	266	36	cells	cell	NOUN
bjp-80949	266	37	harboring	harbor	VERB
bjp-80949	266	38	kras	kra	NOUN
bjp-80949	266	39	mutations	mutation	NOUN
bjp-80949	266	40	.	.	PUNCT
bjp-80949	267	1	this	this	DET
bjp-80949	267	2	approach	approach	NOUN
bjp-80949	267	3	also	also	ADV
bjp-80949	267	4	suppressed	suppress	VERB
bjp-80949	267	5	cell	cell	NOUN
bjp-80949	267	6	displacement	displacement	NOUN
bjp-80949	267	7	and	and	CCONJ
bjp-80949	267	8	reduced	reduce	VERB
bjp-80949	267	9	the	the	DET
bjp-80949	267	10	manifestation	manifestation	NOUN
bjp-80949	267	11	of	of	ADP
bjp-80949	267	12	mesenchymal	mesenchymal	ADJ
bjp-80949	267	13	markers	marker	NOUN
bjp-80949	267	14	,	,	PUNCT
bjp-80949	267	15	including	include	VERB
bjp-80949	267	16	vimentin	vimentin	NOUN
bjp-80949	267	17	,	,	PUNCT
bjp-80949	267	18	n	n	CCONJ
bjp-80949	267	19	-	-	PUNCT
bjp-80949	267	20	cadherin	cadherin	NOUN
bjp-80949	267	21	,	,	PUNCT
bjp-80949	267	22	slug	slug	NOUN
bjp-80949	267	23	,	,	PUNCT
bjp-80949	267	24	snail	snail	NOUN
bjp-80949	267	25	,	,	PUNCT
bjp-80949	267	26	and	and	CCONJ
bjp-80949	267	27	mmp-9	mmp-9	NUM
bjp-80949	267	28	,	,	PUNCT
bjp-80949	267	29	while	while	SCONJ
bjp-80949	267	30	promoting	promote	VERB
bjp-80949	267	31	the	the	DET
bjp-80949	267	32	manifestation	manifestation	NOUN
bjp-80949	267	33	of	of	ADP
bjp-80949	267	34	epithelial	epithelial	ADJ
bjp-80949	267	35	marker	marker	NOUN
bjp-80949	267	36	ecadherin	ecadherin	NOUN
bjp-80949	267	37	.	.	PUNCT
bjp-80949	268	1	in	in	ADP
bjp-80949	268	2	animal	animal	NOUN
bjp-80949	268	3	models	model	NOUN
bjp-80949	268	4	,	,	PUNCT
bjp-80949	268	5	the	the	DET
bjp-80949	268	6	pairing	pairing	NOUN
bjp-80949	268	7	of	of	ADP
bjp-80949	268	8	β	β	NOUN
bjp-80949	268	9	-	-	ADJ
bjp-80949	268	10	elemene	elemene	NOUN
bjp-80949	268	11	and	and	CCONJ
bjp-80949	268	12	cetuximab	cetuximab	NOUN
bjp-80949	268	13	significantly	significantly	ADV
bjp-80949	268	14	suppressed	suppress	VERB
bjp-80949	268	15	tumor	tumor	NOUN
bjp-80949	268	16	progression	progression	NOUN
bjp-80949	268	17	and	and	CCONJ
bjp-80949	268	18	lymphatic	lymphatic	ADJ
bjp-80949	268	19	tissues	tissue	NOUN
bjp-80949	268	20	metastasis	metastasis	NOUN
bjp-80949	268	21	in	in	ADP
bjp-80949	268	22	kras	kras	PROPN
bjp-80949	268	23	mutant	mutant	NOUN
bjp-80949	268	24	models	model	NOUN
bjp-80949	268	25	(	(	PUNCT
bjp-80949	268	26	chen	chen	PROPN
bjp-80949	268	27	et	et	PROPN
bjp-80949	268	28	al	al	PROPN
bjp-80949	268	29	.	.	PROPN
bjp-80949	268	30	,	,	PUNCT
bjp-80949	268	31	2020	2020	NUM
bjp-80949	268	32	)	)	PUNCT
bjp-80949	268	33	.	.	PUNCT
bjp-80949	269	1	a	a	DET
bjp-80949	269	2	study	study	NOUN
bjp-80949	269	3	examined	examine	VERB
bjp-80949	269	4	the	the	DET
bjp-80949	269	5	impact	impact	NOUN
bjp-80949	269	6	of	of	ADP
bjp-80949	269	7	combining	combine	VERB
bjp-80949	269	8	withaferin	withaferin	NOUN
bjp-80949	269	9	-	-	PUNCT
bjp-80949	269	10	a	a	NOUN
bjp-80949	269	11	,	,	PUNCT
bjp-80949	269	12	a	a	DET
bjp-80949	269	13	steroidal	steroidal	NOUN
bjp-80949	269	14	lactone	lactone	NOUN
bjp-80949	269	15	originating	originating	NOUN
bjp-80949	269	16	from	from	ADP
bjp-80949	269	17	the	the	DET
bjp-80949	269	18	indian	indian	ADJ
bjp-80949	269	19	ayurvedic	ayurvedic	ADJ
bjp-80949	269	20	herb	herb	PROPN
bjp-80949	269	21	withania	withania	PROPN
bjp-80949	269	22	somnifera	somnifera	PROPN
bjp-80949	269	23	(	(	PUNCT
bjp-80949	269	24	widely	widely	ADV
bjp-80949	269	25	referred	refer	VERB
bjp-80949	269	26	to	to	ADP
bjp-80949	269	27	as	as	ADP
bjp-80949	269	28	ashwagandha	ashwagandha	NOUN
bjp-80949	269	29	)	)	PUNCT
bjp-80949	269	30	,	,	PUNCT
bjp-80949	269	31	with	with	ADP
bjp-80949	269	32	5	5	NUM
bjp-80949	269	33	-	-	PUNCT
bjp-80949	269	34	fluorouracil	fluorouracil	NOUN
bjp-80949	269	35	in	in	ADP
bjp-80949	269	36	colorectal	colorectal	ADJ
bjp-80949	269	37	cancer	cancer	NOUN
bjp-80949	269	38	(	(	PUNCT
bjp-80949	269	39	crc	crc	NOUN
bjp-80949	269	40	)	)	PUNCT
bjp-80949	269	41	cells	cell	NOUN
bjp-80949	269	42	.	.	PUNCT
bjp-80949	270	1	the	the	DET
bjp-80949	270	2	results	result	NOUN
bjp-80949	270	3	showed	show	VERB
bjp-80949	270	4	that	that	SCONJ
bjp-80949	270	5	this	this	DET
bjp-80949	270	6	combination	combination	NOUN
bjp-80949	270	7	induced	induce	VERB
bjp-80949	270	8	both	both	CCONJ
bjp-80949	270	9	autophagy	autophagy	ADJ
bjp-80949	270	10	and	and	CCONJ
bjp-80949	270	11	apoptosis	apoptosis	NOUN
bjp-80949	270	12	through	through	ADP
bjp-80949	270	13	the	the	DET
bjp-80949	270	14	activation	activation	NOUN
bjp-80949	270	15	of	of	ADP
bjp-80949	270	16	endoplasmic	endoplasmic	ADJ
bjp-80949	270	17	reticulum	reticulum	NOUN
bjp-80949	270	18	stress	stress	NOUN
bjp-80949	270	19	,	,	PUNCT
bjp-80949	270	20	leading	lead	VERB
bjp-80949	270	21	to	to	ADP
bjp-80949	270	22	a	a	DET
bjp-80949	270	23	reduction	reduction	NOUN
bjp-80949	270	24	in	in	ADP
bjp-80949	270	25	cell	cell	NOUN
bjp-80949	270	26	proliferation	proliferation	NOUN
bjp-80949	270	27	potential	potential	NOUN
bjp-80949	270	28	and	and	CCONJ
bjp-80949	270	29	enhancing	enhance	VERB
bjp-80949	270	30	the	the	DET
bjp-80949	270	31	pharmaceutical	pharmaceutical	NOUN
bjp-80949	270	32	's	's	PART
bjp-80949	270	33	effectiveness	effectiveness	NOUN
bjp-80949	270	34	opposed	oppose	VERB
bjp-80949	270	35	to	to	ADP
bjp-80949	270	36	crc	crc	NOUN
bjp-80949	270	37	.	.	PUNCT
bjp-80949	271	1	furthermore	furthermore	ADV
bjp-80949	271	2	,	,	PUNCT
bjp-80949	271	3	the	the	DET
bjp-80949	271	4	pairing	pairing	NOUN
bjp-80949	271	5	therapy	therapy	NOUN
bjp-80949	271	6	reduced	reduce	VERB
bjp-80949	271	7	overactivation	overactivation	NOUN
bjp-80949	271	8	of	of	ADP
bjp-80949	271	9	critical	critical	ADJ
bjp-80949	271	10	proteins	protein	NOUN
bjp-80949	271	11	in	in	ADP
bjp-80949	271	12	the	the	DET
bjp-80949	271	13	wnt	wnt	PROPN
bjp-80949	271	14	/	/	SYM
bjp-80949	271	15	β	β	NOUN
bjp-80949	271	16	-	-	ADJ
bjp-80949	271	17	catenin	catenin	ADJ
bjp-80949	271	18	signaling	signal	VERB
bjp-80949	271	19	pathway	pathway	NOUN
bjp-80949	271	20	by	by	ADP
bjp-80949	271	21	removing	remove	VERB
bjp-80949	271	22	phosphate	phosphate	ADJ
bjp-80949	271	23	groups	group	NOUN
bjp-80949	271	24	from	from	ADP
bjp-80949	271	25	β	β	NOUN
bjp-80949	271	26	-	-	NOUN
bjp-80949	271	27	catenin	catenin	NOUN
bjp-80949	271	28	and	and	CCONJ
bjp-80949	271	29	gsk3β	gsk3β	PROPN
bjp-80949	271	30	at	at	ADP
bjp-80949	271	31	ser675	ser675	PROPN
bjp-80949	271	32	and	and	CCONJ
bjp-80949	271	33	ser9	ser9	PROPN
bjp-80949	271	34	,	,	PUNCT
bjp-80949	271	35	respectively	respectively	ADV
bjp-80949	271	36	,	,	PUNCT
bjp-80949	271	37	ultimately	ultimately	ADV
bjp-80949	271	38	causing	cause	VERB
bjp-80949	271	39	cellular	cellular	ADJ
bjp-80949	271	40	division	division	NOUN
bjp-80949	271	41	process	process	NOUN
bjp-80949	271	42	arrest	arrest	NOUN
bjp-80949	271	43	during	during	ADP
bjp-80949	271	44	the	the	DET
bjp-80949	271	45	g2	g2	PROPN
bjp-80949	271	46	/	/	SYM
bjp-80949	271	47	m	m	PROPN
bjp-80949	271	48	phase	phase	NOUN
bjp-80949	271	49	(	(	PUNCT
bjp-80949	271	50	alnuqaydan	alnuqaydan	NOUN
bjp-80949	271	51	et	et	PROPN
bjp-80949	271	52	al	al	PROPN
bjp-80949	271	53	.	.	PROPN
bjp-80949	271	54	,	,	PUNCT
bjp-80949	271	55	2020	2020	NUM
bjp-80949	271	56	)	)	PUNCT
bjp-80949	271	57	.	.	PUNCT
bjp-80949	272	1	this	this	DET
bjp-80949	272	2	study	study	NOUN
bjp-80949	272	3	has	have	VERB
bjp-80949	272	4	several	several	ADJ
bjp-80949	272	5	limitations	limitation	NOUN
bjp-80949	272	6	.	.	PUNCT
bjp-80949	273	1	reliance	reliance	NOUN
bjp-80949	273	2	on	on	ADP
bjp-80949	273	3	a-549	a-549	PROPN
bjp-80949	273	4	and	and	CCONJ
bjp-80949	273	5	h1299	h1299	CCONJ
bjp-80949	273	6	cell	cell	NOUN
bjp-80949	273	7	lines	line	NOUN
bjp-80949	273	8	may	may	AUX
bjp-80949	273	9	not	not	PART
bjp-80949	273	10	capture	capture	VERB
bjp-80949	273	11	the	the	DET
bjp-80949	273	12	heterogeneity	heterogeneity	NOUN
bjp-80949	273	13	of	of	ADP
bjp-80949	273	14	human	human	ADJ
bjp-80949	273	15	lung	lung	NOUN
bjp-80949	273	16	tumors	tumor	NOUN
bjp-80949	273	17	,	,	PUNCT
bjp-80949	273	18	limiting	limit	VERB
bjp-80949	273	19	generalizability	generalizability	NOUN
bjp-80949	273	20	.	.	PUNCT
bjp-80949	274	1	the	the	DET
bjp-80949	274	2	lack	lack	NOUN
bjp-80949	274	3	of	of	ADP
bjp-80949	274	4	in	in	ADP
bjp-80949	274	5	vivo	vivo	ADJ
bjp-80949	274	6	validation	validation	NOUN
bjp-80949	274	7	leaves	leave	NOUN
bjp-80949	274	8	efficacy	efficacy	NOUN
bjp-80949	274	9	,	,	PUNCT
bjp-80949	274	10	safety	safety	NOUN
bjp-80949	274	11	,	,	PUNCT
bjp-80949	274	12	and	and	CCONJ
bjp-80949	274	13	pharmacokinetics	pharmacokinetic	NOUN
bjp-80949	274	14	unassessed	unassesse	VERB
bjp-80949	274	15	.	.	PUNCT
bjp-80949	275	1	mtt	mtt	PROPN
bjp-80949	275	2	and	and	CCONJ
bjp-80949	275	3	ldh	ldh	PROPN
bjp-80949	275	4	assays	assay	NOUN
bjp-80949	275	5	,	,	PUNCT
bjp-80949	275	6	used	use	VERB
bjp-80949	275	7	to	to	PART
bjp-80949	275	8	assess	assess	VERB
bjp-80949	275	9	viability	viability	NOUN
bjp-80949	275	10	and	and	CCONJ
bjp-80949	275	11	cytotoxicity	cytotoxicity	NOUN
bjp-80949	275	12	,	,	PUNCT
bjp-80949	275	13	are	be	AUX
bjp-80949	275	14	prone	prone	ADJ
bjp-80949	275	15	to	to	ADP
bjp-80949	275	16	inaccuracies	inaccuracy	NOUN
bjp-80949	275	17	due	due	ADJ
bjp-80949	275	18	to	to	ADP
bjp-80949	275	19	metabolic	metabolic	NOUN
bjp-80949	275	20	interference	interference	NOUN
bjp-80949	275	21	and	and	CCONJ
bjp-80949	275	22	serumderived	serumderive	VERB
bjp-80949	275	23	ldh	ldh	PROPN
bjp-80949	275	24	,	,	PUNCT
bjp-80949	275	25	respectively	respectively	ADV
bjp-80949	275	26	.	.	PUNCT
bjp-80949	276	1	moreover	moreover	ADV
bjp-80949	276	2	,	,	PUNCT
bjp-80949	276	3	the	the	DET
bjp-80949	276	4	molecular	molecular	ADJ
bjp-80949	276	5	mechanisms	mechanism	NOUN
bjp-80949	276	6	underlying	underlie	VERB
bjp-80949	276	7	observed	observe	VERB
bjp-80949	276	8	biomarker	biomarker	NOUN
bjp-80949	276	9	changes	change	NOUN
bjp-80949	276	10	remain	remain	VERB
bjp-80949	276	11	unexplored	unexplored	ADJ
bjp-80949	276	12	.	.	PUNCT
bjp-80949	277	1	finally	finally	ADV
bjp-80949	277	2	,	,	PUNCT
bjp-80949	277	3	the	the	DET
bjp-80949	277	4	48	48	NUM
bjp-80949	277	5	-	-	PUNCT
bjp-80949	277	6	hour	hour	NOUN
bjp-80949	277	7	treatment	treatment	NOUN
bjp-80949	277	8	period	period	NOUN
bjp-80949	277	9	may	may	AUX
bjp-80949	277	10	not	not	PART
bjp-80949	277	11	reflect	reflect	VERB
bjp-80949	277	12	long	long	ADJ
bjp-80949	277	13	-	-	PUNCT
bjp-80949	277	14	term	term	NOUN
bjp-80949	277	15	effects	effect	NOUN
bjp-80949	277	16	or	or	CCONJ
bjp-80949	277	17	resistance	resistance	NOUN
bjp-80949	277	18	mechanisms	mechanism	NOUN
bjp-80949	277	19	,	,	PUNCT
bjp-80949	277	20	which	which	PRON
bjp-80949	277	21	are	be	AUX
bjp-80949	277	22	critical	critical	ADJ
bjp-80949	277	23	for	for	ADP
bjp-80949	277	24	evaluating	evaluate	VERB
bjp-80949	277	25	therapeutic	therapeutic	ADJ
bjp-80949	277	26	sustainability	sustainability	NOUN
bjp-80949	277	27	and	and	CCONJ
bjp-80949	277	28	informing	inform	VERB
bjp-80949	277	29	future	future	ADJ
bjp-80949	277	30	treatment	treatment	NOUN
bjp-80949	277	31	strategies	strategy	NOUN
bjp-80949	277	32	.	.	PUNCT
bjp-80949	278	1	conclusion	conclusion	NOUN
bjp-80949	278	2	combining	combine	VERB
bjp-80949	278	3	cetuximab	cetuximab	NOUN
bjp-80949	278	4	with	with	ADP
bjp-80949	278	5	carvacrol	carvacrol	NOUN
bjp-80949	278	6	at	at	ADP
bjp-80949	278	7	low	low	ADJ
bjp-80949	278	8	concentrations	concentration	NOUN
bjp-80949	278	9	effectively	effectively	ADV
bjp-80949	278	10	inhibits	inhibit	VERB
bjp-80949	278	11	lung	lung	NOUN
bjp-80949	278	12	cancer	cancer	NOUN
bjp-80949	278	13	cell	cell	NOUN
bjp-80949	278	14	proliferation	proliferation	NOUN
bjp-80949	278	15	by	by	ADP
bjp-80949	278	16	inducing	induce	VERB
bjp-80949	278	17	apoptosis	apoptosis	NOUN
bjp-80949	278	18	,	,	PUNCT
bjp-80949	278	19	oxidative	oxidative	ADJ
bjp-80949	278	20	stress	stress	NOUN
bjp-80949	278	21	,	,	PUNCT
bjp-80949	278	22	and	and	CCONJ
bjp-80949	278	23	cell	cell	NOUN
bjp-80949	278	24	cycle	cycle	NOUN
bjp-80949	278	25	arrest	arrest	NOUN
bjp-80949	278	26	,	,	PUNCT
bjp-80949	278	27	highlighting	highlight	VERB
bjp-80949	278	28	its	its	PRON
bjp-80949	278	29	potential	potential	NOUN
bjp-80949	278	30	as	as	ADP
bjp-80949	278	31	a	a	DET
bjp-80949	278	32	synergistic	synergistic	ADJ
bjp-80949	278	33	and	and	CCONJ
bjp-80949	278	34	less	less	ADV
bjp-80949	278	35	toxic	toxic	ADJ
bjp-80949	278	36	therapeutic	therapeutic	ADJ
bjp-80949	278	37	strategy	strategy	NOUN
bjp-80949	278	38	.	.	PUNCT
bjp-80949	279	1	financial	financial	ADJ
bjp-80949	279	2	support	support	VERB
bjp-80949	279	3	the	the	DET
bjp-80949	279	4	author	author	NOUN
bjp-80949	279	5	would	would	AUX
bjp-80949	279	6	like	like	VERB
bjp-80949	279	7	to	to	PART
bjp-80949	279	8	thank	thank	VERB
bjp-80949	279	9	the	the	DET
bjp-80949	279	10	scientific	scientific	ADJ
bjp-80949	279	11	and	and	CCONJ
bjp-80949	279	12	technological	technological	ADJ
bjp-80949	279	13	research	research	NOUN
bjp-80949	279	14	council	council	NOUN
bjp-80949	279	15	of	of	ADP
bjp-80949	279	16	turkey	turkey	PROPN
bjp-80949	279	17	(	(	PUNCT
bjp-80949	279	18	tubitak	tubitak	NOUN
bjp-80949	279	19	)	)	PUNCT
bjp-80949	279	20	(	(	PUNCT
bjp-80949	279	21	1919b012201653	1919b012201653	NUM
bjp-80949	279	22	)	)	PUNCT
bjp-80949	279	23	for	for	ADP
bjp-80949	279	24	financial	financial	ADJ
bjp-80949	279	25	support	support	NOUN
bjp-80949	279	26	of	of	ADP
bjp-80949	279	27	this	this	DET
bjp-80949	279	28	work	work	NOUN
bjp-80949	279	29	.	.	PUNCT
bjp-80949	280	1	ethical	ethical	ADJ
bjp-80949	280	2	issue	issue	NOUN
bjp-80949	280	3	cell	cell	NOUN
bjp-80949	280	4	lines	line	NOUN
bjp-80949	280	5	derived	derive	VERB
bjp-80949	280	6	from	from	ADP
bjp-80949	280	7	the	the	DET
bjp-80949	280	8	expansion	expansion	NOUN
bjp-80949	280	9	of	of	ADP
bjp-80949	280	10	primary	primary	ADJ
bjp-80949	280	11	cell	cell	NOUN
bjp-80949	280	12	cultures	culture	NOUN
bjp-80949	280	13	in	in	ADP
bjp-80949	280	14	vitro	vitro	X
bjp-80949	280	15	were	be	AUX
bjp-80949	280	16	not	not	PART
bjp-80949	280	17	relevant	relevant	ADJ
bjp-80949	280	18	material	material	NOUN
bjp-80949	280	19	,	,	PUNCT
bjp-80949	280	20	as	as	SCONJ
bjp-80949	280	21	all	all	DET
bjp-80949	280	22	the	the	DET
bjp-80949	280	23	original	original	ADJ
bjp-80949	280	24	cells	cell	NOUN
bjp-80949	280	25	were	be	AUX
bjp-80949	280	26	divided	divide	VERB
bjp-80949	280	27	and	and	CCONJ
bjp-80949	280	28	so	so	ADV
bjp-80949	280	29	the	the	DET
bjp-80949	280	30	cell	cell	NOUN
bjp-80949	280	31	line	line	NOUN
bjp-80949	280	32	had	have	AUX
bjp-80949	280	33	been	be	AUX
bjp-80949	280	34	created	create	VERB
bjp-80949	280	35	outside	outside	ADP
bjp-80949	280	36	of	of	ADP
bjp-80949	280	37	the	the	DET
bjp-80949	280	38	human	human	ADJ
bjp-80949	280	39	body	body	NOUN
bjp-80949	280	40	.	.	PUNCT
bjp-80949	281	1	the	the	DET
bjp-80949	281	2	storage	storage	NOUN
bjp-80949	281	3	and	and	CCONJ
bjp-80949	281	4	use	use	NOUN
bjp-80949	281	5	of	of	ADP
bjp-80949	281	6	cell	cell	NOUN
bjp-80949	281	7	lines	line	NOUN
bjp-80949	281	8	created	create	VERB
bjp-80949	281	9	from	from	ADP
bjp-80949	281	10	primary	primary	ADJ
bjp-80949	281	11	human	human	ADJ
bjp-80949	281	12	tissue	tissue	NOUN
bjp-80949	281	13	,	,	PUNCT
bjp-80949	281	14	for	for	ADP
bjp-80949	281	15	research	research	NOUN
bjp-80949	281	16	purposes	purpose	NOUN
bjp-80949	281	17	,	,	PUNCT
bjp-80949	281	18	did	do	AUX
bjp-80949	281	19	not	not	PART
bjp-80949	281	20	require	require	VERB
bjp-80949	281	21	ethical	ethical	ADJ
bjp-80949	281	22	approval	approval	NOUN
bjp-80949	281	23	.	.	PUNCT
bjp-80949	282	1	bangladesh	bangladesh	PROPN
bjp-80949	282	2	j	j	PROPN
bjp-80949	282	3	pharmacol	pharmacol	PROPN
bjp-80949	282	4	2025	2025	NUM
bjp-80949	282	5	;	;	PUNCT
bjp-80949	282	6	20	20	NUM
bjp-80949	282	7	:	:	SYM
bjp-80949	282	8	22	22	NUM
bjp-80949	282	9	-	-	SYM
bjp-80949	282	10	34	34	NUM
bjp-80949	282	11	31	31	NUM
bjp-80949	282	12	conflict	conflict	NOUN
bjp-80949	282	13	of	of	ADP
bjp-80949	282	14	interest	interest	NOUN
bjp-80949	282	15	authors	author	NOUN
bjp-80949	282	16	declare	declare	VERB
bjp-80949	282	17	no	no	DET
bjp-80949	282	18	conflict	conflict	NOUN
bjp-80949	282	19	of	of	ADP
bjp-80949	282	20	interest	interest	NOUN
bjp-80949	282	21	.	.	PUNCT
bjp-80949	283	1	acknowledgement	acknowledgement	NOUN
bjp-80949	283	2	authors	author	NOUN
bjp-80949	283	3	wish	wish	VERB
bjp-80949	283	4	to	to	PART
bjp-80949	283	5	thank	thank	VERB
bjp-80949	283	6	alanya	alanya	PROPN
bjp-80949	283	7	alaaddin	alaaddin	PROPN
bjp-80949	283	8	keykubat	keykubat	PROPN
bjp-80949	283	9	university	university	NOUN
bjp-80949	283	10	for	for	ADP
bjp-80949	283	11	providing	provide	VERB
bjp-80949	283	12	the	the	DET
bjp-80949	283	13	necessary	necessary	ADJ
bjp-80949	283	14	facilities	facility	NOUN
bjp-80949	283	15	to	to	PART
bjp-80949	283	16	conduct	conduct	VERB
bjp-80949	283	17	this	this	DET
bjp-80949	283	18	study	study	NOUN
bjp-80949	283	19	.	.	PUNCT
bjp-80949	284	1	references	reference	NOUN
bjp-80949	284	2	alar	alar	PROPN
bjp-80949	284	3	t	t	PROPN
bjp-80949	284	4	,	,	PUNCT
bjp-80949	284	5	şahin	şahin	PROPN
bjp-80949	284	6	em	em	PRON
bjp-80949	284	7	.	.	PUNCT
bjp-80949	285	1	akciger	akciger	PROPN
bjp-80949	285	2	kanseri	kanseri	PROPN
bjp-80949	285	3	:	:	PUNCT
bjp-80949	285	4	birinci	birinci	PROPN
bjp-80949	285	5	basamakta	basamakta	PROPN
bjp-80949	285	6	tanı	tanı	PROPN
bjp-80949	285	7	,	,	PUNCT
bjp-80949	285	8	tedavi	tedavi	VERB
bjp-80949	285	9	ve	ve	PROPN
bjp-80949	285	10	korunma	korunma	PROPN
bjp-80949	285	11	.	.	PUNCT
bjp-80949	286	1	smyrna	smyrna	PROPN
bjp-80949	286	2	tıp	tıp	PROPN
bjp-80949	286	3	dergisi	dergisi	PROPN
bjp-80949	286	4	.	.	PROPN
bjp-80949	286	5	2012	2012	NUM
bjp-80949	286	6	;	;	PUNCT
bjp-80949	286	7	2	2	NUM
bjp-80949	286	8	:	:	SYM
bjp-80949	286	9	68	68	NUM
bjp-80949	286	10	-	-	SYM
bjp-80949	286	11	74	74	NUM
bjp-80949	286	12	.	.	PUNCT
bjp-80949	287	1	alma	alma	PROPN
bjp-80949	287	2	mh	mh	PROPN
bjp-80949	287	3	,	,	PUNCT
bjp-80949	287	4	mavi	mavi	VERB
bjp-80949	287	5	a	a	PRON
bjp-80949	287	6	,	,	PUNCT
bjp-80949	287	7	yildirim	yildirim	PROPN
bjp-80949	287	8	a	a	PROPN
bjp-80949	287	9	,	,	PUNCT
bjp-80949	287	10	digrak	digrak	PROPN
bjp-80949	287	11	m	m	PROPN
bjp-80949	287	12	,	,	PUNCT
bjp-80949	287	13	hirata	hirata	ADJ
bjp-80949	287	14	t.	t.	NOUN
bjp-80949	287	15	screening	screen	VERB
bjp-80949	287	16	chemical	chemical	NOUN
bjp-80949	287	17	composition	composition	NOUN
bjp-80949	287	18	and	and	CCONJ
bjp-80949	287	19	in	in	ADP
bjp-80949	287	20	vitro	vitro	X
bjp-80949	287	21	antioxidant	antioxidant	ADJ
bjp-80949	287	22	and	and	CCONJ
bjp-80949	287	23	antimicrobial	antimicrobial	ADJ
bjp-80949	287	24	activities	activity	NOUN
bjp-80949	287	25	of	of	ADP
bjp-80949	287	26	the	the	DET
bjp-80949	287	27	essential	essential	ADJ
bjp-80949	287	28	oils	oil	NOUN
bjp-80949	287	29	from	from	ADP
bjp-80949	287	30	origanum	origanum	ADJ
bjp-80949	287	31	syriacum	syriacum	PROPN
bjp-80949	287	32	l.	l.	PROPN
bjp-80949	287	33	growing	grow	VERB
bjp-80949	287	34	in	in	ADP
bjp-80949	287	35	turkey	turkey	NOUN
bjp-80949	287	36	.	.	PUNCT
bjp-80949	288	1	biol	biol	PROPN
bjp-80949	288	2	pharm	pharm	PROPN
bjp-80949	288	3	bull	bull	PROPN
bjp-80949	288	4	.	.	PUNCT
bjp-80949	289	1	2003	2003	NUM
bjp-80949	289	2	;	;	PUNCT
bjp-80949	289	3	26	26	NUM
bjp-80949	289	4	:	:	PUNCT
bjp-80949	289	5	1725	1725	NUM
bjp-80949	289	6	-	-	SYM
bjp-80949	289	7	29	29	NUM
bjp-80949	289	8	.	.	PUNCT
bjp-80949	290	1	alnuqaydan	alnuqaydan	PROPN
bjp-80949	290	2	am	am	PROPN
bjp-80949	290	3	,	,	PUNCT
bjp-80949	290	4	rah	rah	PROPN
bjp-80949	290	5	b	b	NUM
bjp-80949	290	6	,	,	PUNCT
bjp-80949	290	7	almutary	almutary	PROPN
bjp-80949	290	8	ag	ag	PROPN
bjp-80949	290	9	,	,	PUNCT
bjp-80949	290	10	chauhan	chauhan	PROPN
bjp-80949	290	11	ss	ss	PROPN
bjp-80949	290	12	.	.	PUNCT
bjp-80949	291	1	synergistic	synergistic	ADJ
bjp-80949	291	2	antitumor	antitumor	PROPN
bjp-80949	291	3	effect	effect	NOUN
bjp-80949	291	4	of	of	ADP
bjp-80949	291	5	5	5	NUM
bjp-80949	291	6	-	-	PUNCT
bjp-80949	291	7	fluorouracil	fluorouracil	NOUN
bjp-80949	291	8	and	and	CCONJ
bjp-80949	291	9	withaferin	withaferin	NOUN
bjp-80949	291	10	-	-	PUNCT
bjp-80949	291	11	a	a	DET
bjp-80949	291	12	induces	induce	NOUN
bjp-80949	291	13	endoplasmic	endoplasmic	ADJ
bjp-80949	291	14	reticulum	reticulum	NOUN
bjp-80949	291	15	stress	stress	NOUN
bjp-80949	291	16	-	-	PUNCT
bjp-80949	291	17	mediated	mediate	VERB
bjp-80949	291	18	autophagy	autophagy	NOUN
bjp-80949	291	19	and	and	CCONJ
bjp-80949	291	20	apoptosis	apoptosis	NOUN
bjp-80949	291	21	in	in	ADP
bjp-80949	291	22	colorectal	colorectal	ADJ
bjp-80949	291	23	cancer	cancer	NOUN
bjp-80949	291	24	cells	cell	NOUN
bjp-80949	291	25	.	.	PUNCT
bjp-80949	292	1	am	be	AUX
bjp-80949	292	2	j	j	PROPN
bjp-80949	292	3	cancer	cancer	NOUN
bjp-80949	292	4	res	re	NOUN
bjp-80949	292	5	.	.	PUNCT
bjp-80949	293	1	2020	2020	NUM
bjp-80949	293	2	;	;	PUNCT
bjp-80949	293	3	10	10	NUM
bjp-80949	293	4	:	:	PUNCT
bjp-80949	293	5	799	799	NUM
bjp-80949	293	6	-	-	SYM
bjp-80949	293	7	815	815	NUM
bjp-80949	293	8	.	.	PUNCT
bjp-80949	294	1	arkali	arkali	PROPN
bjp-80949	294	2	g	g	PROPN
bjp-80949	294	3	,	,	PUNCT
bjp-80949	294	4	aksakal	aksakal	PROPN
bjp-80949	294	5	m	m	PROPN
bjp-80949	294	6	,	,	PUNCT
bjp-80949	294	7	kaya	kaya	PROPN
bjp-80949	294	8	şo	şo	PROPN
bjp-80949	294	9	.	.	PUNCT
bjp-80949	295	1	protective	protective	ADJ
bjp-80949	295	2	effects	effect	NOUN
bjp-80949	295	3	of	of	ADP
bjp-80949	295	4	carvacrol	carvacrol	NOUN
bjp-80949	295	5	against	against	ADP
bjp-80949	295	6	diabetes‐induced	diabetes‐induce	VERB
bjp-80949	295	7	reproductive	reproductive	ADJ
bjp-80949	295	8	damage	damage	NOUN
bjp-80949	295	9	in	in	ADP
bjp-80949	295	10	male	male	ADJ
bjp-80949	295	11	rats	rat	NOUN
bjp-80949	295	12	:	:	PUNCT
bjp-80949	295	13	modulation	modulation	NOUN
bjp-80949	295	14	of	of	ADP
bjp-80949	295	15	nrf2	nrf2	PROPN
bjp-80949	295	16	/	/	SYM
bjp-80949	295	17	ho‐1	ho‐1	X
bjp-80949	295	18	signaling	signal	VERB
bjp-80949	295	19	pathway	pathway	NOUN
bjp-80949	295	20	and	and	CCONJ
bjp-80949	295	21	inhibition	inhibition	NOUN
bjp-80949	295	22	of	of	ADP
bjp-80949	295	23	nf‐kb‐mediated	nf‐kb‐mediate	VERB
bjp-80949	295	24	testicular	testicular	ADJ
bjp-80949	295	25	apoptosis	apoptosis	NOUN
bjp-80949	295	26	and	and	CCONJ
bjp-80949	295	27	inflammation	inflammation	NOUN
bjp-80949	295	28	.	.	PUNCT
bjp-80949	296	1	andrologia	andrologia	NOUN
bjp-80949	296	2	2021	2021	NUM
bjp-80949	296	3	;	;	PUNCT
bjp-80949	296	4	53	53	NUM
bjp-80949	296	5	:	:	PUNCT
bjp-80949	296	6	e13899	e13899	NOUN
bjp-80949	296	7	.	.	PROPN
bjp-80949	296	8	arunasree	arunasree	PROPN
bjp-80949	296	9	km	km	PROPN
bjp-80949	296	10	.	.	PUNCT
bjp-80949	297	1	antiproliferative	antiproliferative	ADJ
bjp-80949	297	2	effects	effect	NOUN
bjp-80949	297	3	of	of	ADP
bjp-80949	297	4	carvacrol	carvacrol	NOUN
bjp-80949	297	5	on	on	ADP
bjp-80949	297	6	a	a	DET
bjp-80949	297	7	human	human	ADJ
bjp-80949	297	8	metastatic	metastatic	ADJ
bjp-80949	297	9	breast	breast	NOUN
bjp-80949	297	10	cancer	cancer	NOUN
bjp-80949	297	11	cell	cell	NOUN
bjp-80949	297	12	line	line	NOUN
bjp-80949	297	13	,	,	PUNCT
bjp-80949	297	14	mda	mda	PROPN
bjp-80949	297	15	-	-	PUNCT
bjp-80949	297	16	mb	mb	NOUN
bjp-80949	297	17	231	231	NUM
bjp-80949	297	18	.	.	PUNCT
bjp-80949	298	1	phytomedicine	phytomedicine	PROPN
bjp-80949	298	2	2010	2010	NUM
bjp-80949	298	3	;	;	PUNCT
bjp-80949	298	4	17	17	NUM
bjp-80949	298	5	:	:	PUNCT
bjp-80949	298	6	581	581	NUM
bjp-80949	298	7	-	-	SYM
bjp-80949	298	8	88	88	NUM
bjp-80949	298	9	.	.	PUNCT
bjp-80949	299	1	baselga	baselga	ADJ
bjp-80949	299	2	j.	j.	PROPN
bjp-80949	299	3	the	the	DET
bjp-80949	299	4	egfr	egfr	NOUN
bjp-80949	299	5	as	as	ADP
bjp-80949	299	6	a	a	DET
bjp-80949	299	7	target	target	NOUN
bjp-80949	299	8	for	for	ADP
bjp-80949	299	9	anticancer	anticancer	NOUN
bjp-80949	299	10	therapy	therapy	NOUN
bjp-80949	299	11	-	-	PUNCT
bjp-80949	299	12	focus	focus	NOUN
bjp-80949	299	13	on	on	ADP
bjp-80949	299	14	cetuximab	cetuximab	NOUN
bjp-80949	299	15	.	.	PUNCT
bjp-80949	300	1	eur	eur	PROPN
bjp-80949	300	2	j	j	PROPN
bjp-80949	300	3	cancer	cancer	NOUN
bjp-80949	300	4	.	.	PUNCT
bjp-80949	301	1	2001	2001	NUM
bjp-80949	301	2	;	;	PUNCT
bjp-80949	302	1	37	37	NUM
bjp-80949	302	2	:	:	SYM
bjp-80949	302	3	16	16	NUM
bjp-80949	302	4	-	-	SYM
bjp-80949	302	5	22	22	NUM
bjp-80949	302	6	.	.	PUNCT
bjp-80949	303	1	baykara	baykara	PROPN
bjp-80949	303	2	o.	o.	PROPN
bjp-80949	303	3	kanser	kanser	PROPN
bjp-80949	303	4	tedavisinde	tedavisinde	PROPN
bjp-80949	303	5	güncel	güncel	VERB
bjp-80949	303	6	yaklaşımlar	yaklaşımlar	ADJ
bjp-80949	303	7	.	.	PUNCT
bjp-80949	304	1	balıkesir	balıkesir	NOUN
bjp-80949	304	2	sağlık	sağlık	VERB
bjp-80949	304	3	bilimleri	bilimleri	NOUN
bjp-80949	304	4	dergisi	dergisi	PROPN
bjp-80949	304	5	.	.	PROPN
bjp-80949	304	6	2016	2016	NUM
bjp-80949	304	7	;	;	PUNCT
bjp-80949	304	8	5	5	NUM
bjp-80949	304	9	:	:	SYM
bjp-80949	304	10	154	154	NUM
bjp-80949	304	11	-	-	SYM
bjp-80949	304	12	65	65	NUM
bjp-80949	304	13	bijwaard	bijwaard	PROPN
bjp-80949	304	14	ke	ke	PROPN
bjp-80949	304	15	,	,	PUNCT
bjp-80949	304	16	aguilera	aguilera	PROPN
bjp-80949	304	17	ns	ns	PROPN
bjp-80949	304	18	,	,	PUNCT
bjp-80949	304	19	monczak	monczak	NOUN
bjp-80949	304	20	y	y	PROPN
bjp-80949	304	21	,	,	PUNCT
bjp-80949	304	22	trudel	trudel	PROPN
bjp-80949	304	23	m	m	PROPN
bjp-80949	304	24	,	,	PUNCT
bjp-80949	304	25	taubenberger	taubenberger	NOUN
bjp-80949	304	26	jk	jk	PROPN
bjp-80949	304	27	,	,	PUNCT
bjp-80949	304	28	lichy	lichy	NOUN
bjp-80949	304	29	jh	jh	PROPN
bjp-80949	304	30	.	.	PUNCT
bjp-80949	305	1	quantitative	quantitative	ADJ
bjp-80949	305	2	real	real	ADJ
bjp-80949	305	3	-	-	PUNCT
bjp-80949	305	4	time	time	NOUN
bjp-80949	305	5	reverse	reverse	ADJ
bjp-80949	305	6	transcription	transcription	NOUN
bjp-80949	305	7	-	-	PUNCT
bjp-80949	305	8	pcr	pcr	NOUN
bjp-80949	305	9	assay	assay	NOUN
bjp-80949	305	10	for	for	ADP
bjp-80949	305	11	cyclin	cyclin	NOUN
bjp-80949	305	12	d1	d1	NOUN
bjp-80949	305	13	expression	expression	NOUN
bjp-80949	305	14	:	:	PUNCT
bjp-80949	305	15	utility	utility	NOUN
bjp-80949	305	16	in	in	ADP
bjp-80949	305	17	the	the	DET
bjp-80949	305	18	diagnosis	diagnosis	NOUN
bjp-80949	305	19	of	of	ADP
bjp-80949	305	20	mantle	mantle	ADJ
bjp-80949	305	21	cell	cell	NOUN
bjp-80949	305	22	lymphoma	lymphoma	NOUN
bjp-80949	305	23	.	.	PUNCT
bjp-80949	306	1	clin	clin	PROPN
bjp-80949	306	2	chem	chem	PROPN
bjp-80949	306	3	.	.	PUNCT
bjp-80949	307	1	2001	2001	NUM
bjp-80949	307	2	;	;	PUNCT
bjp-80949	307	3	47	47	NUM
bjp-80949	307	4	:	:	SYM
bjp-80949	307	5	195	195	NUM
bjp-80949	307	6	-201	-201	PROPN
bjp-80949	307	7	.	.	PUNCT
bjp-80949	307	8	boduroglu	boduroglu	PROPN
bjp-80949	307	9	b	b	PROPN
bjp-80949	307	10	,	,	PUNCT
bjp-80949	307	11	investigation	investigation	NOUN
bjp-80949	307	12	of	of	ADP
bjp-80949	307	13	the	the	DET
bjp-80949	307	14	effect	effect	NOUN
bjp-80949	307	15	of	of	ADP
bjp-80949	307	16	carvacrol	carvacrol	NOUN
bjp-80949	307	17	against	against	ADP
bjp-80949	307	18	arsenic	arsenic	NOUN
bjp-80949	307	19	induced	induce	VERB
bjp-80949	307	20	oxidatıve	oxidatıve	ADJ
bjp-80949	307	21	stress	stress	NOUN
bjp-80949	307	22	in	in	ADP
bjp-80949	307	23	rats	rat	NOUN
bjp-80949	307	24	.	.	PUNCT
bjp-80949	308	1	master	master	NOUN
bjp-80949	308	2	's	's	PART
bjp-80949	308	3	thesis	thesis	NOUN
bjp-80949	308	4	,	,	PUNCT
bjp-80949	308	5	afyon	afyon	NOUN
bjp-80949	308	6	kocatepe	kocatepe	PROPN
bjp-80949	308	7	university	university	PROPN
bjp-80949	308	8	.	.	PUNCT
bjp-80949	309	1	gazlıgol	gazlıgol	NOUN
bjp-80949	309	2	yolu	yolu	NOUN
bjp-80949	309	3	,	,	PUNCT
bjp-80949	309	4	2022	2022	NUM
bjp-80949	309	5	,	,	PUNCT
bjp-80949	309	6	pp	pp	ADP
bjp-80949	309	7	1	1	NUM
bjp-80949	309	8	-	-	SYM
bjp-80949	309	9	64	64	NUM
bjp-80949	309	10	.	.	PUNCT
bjp-80949	310	1	bonner	bonner	PROPN
bjp-80949	310	2	my	my	PRON
bjp-80949	310	3	,	,	PUNCT
bjp-80949	310	4	arbiser	arbiser	ADJ
bjp-80949	310	5	jl	jl	PROPN
bjp-80949	310	6	.	.	PUNCT
bjp-80949	311	1	the	the	DET
bjp-80949	311	2	antioxidant	antioxidant	ADJ
bjp-80949	311	3	paradox	paradox	NOUN
bjp-80949	311	4	:	:	PUNCT
bjp-80949	311	5	what	what	PRON
bjp-80949	311	6	are	be	AUX
bjp-80949	311	7	antioxidants	antioxidant	NOUN
bjp-80949	311	8	and	and	CCONJ
bjp-80949	311	9	how	how	SCONJ
bjp-80949	311	10	should	should	AUX
bjp-80949	311	11	they	they	PRON
bjp-80949	311	12	be	be	AUX
bjp-80949	311	13	used	use	VERB
bjp-80949	311	14	in	in	ADP
bjp-80949	311	15	a	a	DET
bjp-80949	311	16	therapeutic	therapeutic	ADJ
bjp-80949	311	17	context	context	NOUN
bjp-80949	311	18	for	for	ADP
bjp-80949	311	19	cancer	cancer	NOUN
bjp-80949	311	20	.	.	PUNCT
bjp-80949	312	1	future	future	ADJ
bjp-80949	312	2	med	med	ADJ
bjp-80949	312	3	chem	chem	NOUN
bjp-80949	312	4	.	.	PUNCT
bjp-80949	313	1	2014	2014	NUM
bjp-80949	313	2	;	;	PUNCT
bjp-80949	313	3	6	6	NUM
bjp-80949	313	4	:	:	SYM
bjp-80949	313	5	1413	1413	NUM
bjp-80949	313	6	-	-	SYM
bjp-80949	313	7	22	22	NUM
bjp-80949	313	8	.	.	PUNCT
bjp-80949	314	1	bradford	bradford	PROPN
bjp-80949	314	2	mm	mm	PROPN
bjp-80949	314	3	.	.	PUNCT
bjp-80949	315	1	a	a	DET
bjp-80949	315	2	rapid	rapid	ADJ
bjp-80949	315	3	and	and	CCONJ
bjp-80949	315	4	sensitive	sensitive	ADJ
bjp-80949	315	5	method	method	NOUN
bjp-80949	315	6	for	for	ADP
bjp-80949	315	7	the	the	DET
bjp-80949	315	8	quantitation	quantitation	NOUN
bjp-80949	315	9	of	of	ADP
bjp-80949	315	10	microgram	microgram	ADJ
bjp-80949	315	11	quantities	quantity	NOUN
bjp-80949	315	12	of	of	ADP
bjp-80949	315	13	protein	protein	NOUN
bjp-80949	315	14	utilizing	utilize	VERB
bjp-80949	315	15	the	the	DET
bjp-80949	315	16	principle	principle	NOUN
bjp-80949	315	17	of	of	ADP
bjp-80949	315	18	protein	protein	NOUN
bjp-80949	315	19	-	-	PUNCT
bjp-80949	315	20	dye	dye	NOUN
bjp-80949	315	21	binding	binding	NOUN
bjp-80949	315	22	.	.	PUNCT
bjp-80949	316	1	anal	anal	ADJ
bjp-80949	316	2	biochem	biochem	PROPN
bjp-80949	316	3	.	.	PUNCT
bjp-80949	317	1	1976	1976	NUM
bjp-80949	317	2	;	;	PUNCT
bjp-80949	317	3	72	72	NUM
bjp-80949	317	4	:	:	PUNCT
bjp-80949	317	5	248	248	NUM
bjp-80949	317	6	-	-	SYM
bjp-80949	317	7	54	54	NUM
bjp-80949	317	8	.	.	PUNCT
bjp-80949	318	1	bruns	brun	NOUN
bjp-80949	318	2	,	,	PUNCT
bjp-80949	318	3	c.j	c.j	PROPN
bjp-80949	318	4	,	,	PUNCT
bjp-80949	318	5	harbison	harbison	PROPN
bjp-80949	318	6	mt	mt	PROPN
bjp-80949	318	7	,	,	PUNCT
bjp-80949	318	8	davis	davis	PROPN
bjp-80949	318	9	dw	dw	PROPN
bjp-80949	318	10	,	,	PUNCT
bjp-80949	318	11	portera	portera	PROPN
bjp-80949	318	12	ca	can	AUX
bjp-80949	318	13	,	,	PUNCT
bjp-80949	318	14	tsan	tsan	ADJ
bjp-80949	318	15	r	r	NOUN
bjp-80949	318	16	,	,	PUNCT
bjp-80949	318	17	mcconkey	mcconkey	NOUN
bjp-80949	318	18	dj	dj	PROPN
bjp-80949	318	19	.	.	PROPN
bjp-80949	318	20	,	,	PUNCT
bjp-80949	318	21	evans	evans	PROPN
bjp-80949	318	22	db	db	PROPN
bjp-80949	318	23	,	,	PUNCT
bjp-80949	318	24	abbruzzese	abbruzzese	PROPN
bjp-80949	318	25	jl	jl	PROPN
bjp-80949	318	26	,	,	PUNCT
bjp-80949	318	27	hicklin	hicklin	NOUN
bjp-80949	318	28	dj	dj	PROPN
bjp-80949	318	29	,	,	PUNCT
bjp-80949	318	30	radinsky	radinsky	ADJ
bjp-80949	318	31	r.	r.	ADJ
bjp-80949	318	32	epidermal	epidermal	ADJ
bjp-80949	318	33	growth	growth	NOUN
bjp-80949	318	34	factor	factor	NOUN
bjp-80949	318	35	receptor	receptor	NOUN
bjp-80949	318	36	blockade	blockade	NOUN
bjp-80949	318	37	with	with	ADP
bjp-80949	318	38	c225	c225	PROPN
bjp-80949	318	39	plus	plus	CCONJ
bjp-80949	318	40	gemcitabine	gemcitabine	NOUN
bjp-80949	318	41	results	result	NOUN
bjp-80949	318	42	in	in	ADP
bjp-80949	318	43	regression	regression	NOUN
bjp-80949	318	44	of	of	ADP
bjp-80949	318	45	human	human	ADJ
bjp-80949	318	46	pancreatic	pancreatic	ADJ
bjp-80949	318	47	carcinoma	carcinoma	NOUN
bjp-80949	318	48	growing	grow	VERB
bjp-80949	318	49	orthotopically	orthotopically	ADV
bjp-80949	318	50	in	in	ADP
bjp-80949	318	51	nude	nude	ADJ
bjp-80949	318	52	mice	mouse	NOUN
bjp-80949	318	53	by	by	ADP
bjp-80949	318	54	antiangiogenic	antiangiogenic	ADJ
bjp-80949	318	55	mechanisms	mechanism	NOUN
bjp-80949	318	56	.	.	PUNCT
bjp-80949	319	1	clin	clin	PROPN
bjp-80949	319	2	cancer	cancer	NOUN
bjp-80949	319	3	res	re	NOUN
bjp-80949	319	4	.	.	PROPN
bjp-80949	319	5	2000	2000	NUM
bjp-80949	319	6	;	;	PUNCT
bjp-80949	319	7	6	6	NUM
bjp-80949	319	8	:	:	SYM
bjp-80949	319	9	1936	1936	NUM
bjp-80949	319	10	-	-	SYM
bjp-80949	319	11	48	48	NUM
bjp-80949	319	12	.	.	PUNCT
bjp-80949	320	1	buchsbaum	buchsbaum	NOUN
bjp-80949	320	2	dj	dj	PROPN
bjp-80949	320	3	,	,	PUNCT
bjp-80949	320	4	bonner	bonner	PROPN
bjp-80949	320	5	ja	ja	PROPN
bjp-80949	320	6	,	,	PUNCT
bjp-80949	320	7	grizzle	grizzle	NOUN
bjp-80949	320	8	we	we	PRON
bjp-80949	320	9	,	,	PUNCT
bjp-80949	320	10	stackhouse	stackhouse	PROPN
bjp-80949	320	11	ma	ma	PROPN
bjp-80949	320	12	,	,	PUNCT
bjp-80949	320	13	carpenter	carpenter	PROPN
bjp-80949	320	14	m	m	PROPN
bjp-80949	320	15	,	,	PUNCT
bjp-80949	320	16	hicklin	hicklin	PROPN
bjp-80949	320	17	dj	dj	PROPN
bjp-80949	320	18	,	,	PUNCT
bjp-80949	320	19	bohlen	bohlen	PROPN
bjp-80949	320	20	p	p	PROPN
bjp-80949	320	21	,	,	PUNCT
bjp-80949	320	22	raisch	raisch	VERB
bjp-80949	320	23	kp	kp	PROPN
bjp-80949	320	24	.	.	PROPN
bjp-80949	321	1	treatment	treatment	NOUN
bjp-80949	321	2	of	of	ADP
bjp-80949	321	3	pancreatic	pancreatic	ADJ
bjp-80949	321	4	cancer	cancer	NOUN
bjp-80949	321	5	xenografts	xenograft	NOUN
bjp-80949	321	6	with	with	ADP
bjp-80949	321	7	erbitux	erbitux	PROPN
bjp-80949	321	8	(	(	PUNCT
bjp-80949	321	9	imc	imc	PROPN
bjp-80949	321	10	-	-	PUNCT
bjp-80949	321	11	c225	c225	PROPN
bjp-80949	321	12	)	)	PUNCT
bjp-80949	321	13	antiegfr	antiegfr	VERB
bjp-80949	321	14	antibody	antibody	NOUN
bjp-80949	321	15	,	,	PUNCT
bjp-80949	321	16	gemcitabine	gemcitabine	NOUN
bjp-80949	321	17	,	,	PUNCT
bjp-80949	321	18	and	and	CCONJ
bjp-80949	321	19	radiation	radiation	NOUN
bjp-80949	321	20	.	.	PUNCT
bjp-80949	322	1	int	int	PROPN
bjp-80949	322	2	j	j	PROPN
bjp-80949	322	3	radiat	radiat	PROPN
bjp-80949	322	4	oncol	oncol	ADJ
bjp-80949	322	5	biol	biol	PROPN
bjp-80949	322	6	phys	phy	NOUN
bjp-80949	322	7	.	.	PUNCT
bjp-80949	323	1	2002	2002	NUM
bjp-80949	323	2	;	;	PUNCT
bjp-80949	323	3	54	54	NUM
bjp-80949	323	4	:	:	SYM
bjp-80949	323	5	1180	1180	NUM
bjp-80949	323	6	-	-	SYM
bjp-80949	323	7	93	93	NUM
bjp-80949	323	8	.	.	PUNCT
bjp-80949	324	1	cao	cao	PROPN
bjp-80949	324	2	s	s	PROPN
bjp-80949	324	3	,	,	PUNCT
bjp-80949	324	4	xia	xia	PROPN
bjp-80949	324	5	m	m	PROPN
bjp-80949	324	6	,	,	PUNCT
bjp-80949	324	7	mao	mao	PROPN
bjp-80949	324	8	y	y	PROPN
bjp-80949	324	9	,	,	PUNCT
bjp-80949	324	10	zhang	zhang	PROPN
bjp-80949	325	1	q	q	PROPN
bjp-80949	325	2	,	,	PUNCT
bjp-80949	325	3	donkor	donkor	PROPN
bjp-80949	325	4	po	po	PROPN
bjp-80949	325	5	,	,	PUNCT
bjp-80949	325	6	qiu	qiu	PROPN
bjp-80949	325	7	f	f	PROPN
bjp-80949	325	8	,	,	PUNCT
bjp-80949	325	9	kang	kang	PROPN
bjp-80949	325	10	n.	n.	PROPN
bjp-80949	325	11	combined	combine	VERB
bjp-80949	325	12	oridonin	oridonin	NOUN
bjp-80949	325	13	with	with	ADP
bjp-80949	325	14	cetuximab	cetuximab	NOUN
bjp-80949	325	15	treatment	treatment	NOUN
bjp-80949	325	16	shows	show	VERB
bjp-80949	325	17	synergistic	synergistic	ADJ
bjp-80949	325	18	anticancer	anticancer	NOUN
bjp-80949	325	19	effects	effect	NOUN
bjp-80949	325	20	on	on	ADP
bjp-80949	325	21	laryngeal	laryngeal	ADJ
bjp-80949	325	22	squamous	squamous	ADJ
bjp-80949	325	23	cell	cell	NOUN
bjp-80949	325	24	carcinoma	carcinoma	NOUN
bjp-80949	325	25	:	:	PUNCT
bjp-80949	325	26	involvement	involvement	NOUN
bjp-80949	325	27	of	of	ADP
bjp-80949	325	28	inhibition	inhibition	NOUN
bjp-80949	325	29	of	of	ADP
bjp-80949	325	30	egfr	egfr	NOUN
bjp-80949	325	31	and	and	CCONJ
bjp-80949	325	32	activation	activation	NOUN
bjp-80949	325	33	of	of	ADP
bjp-80949	325	34	reactive	reactive	ADJ
bjp-80949	325	35	oxygen	oxygen	NOUN
bjp-80949	325	36	species	specie	NOUN
bjp-80949	325	37	-	-	PUNCT
bjp-80949	325	38	mediated	mediate	VERB
bjp-80949	325	39	jnk	jnk	PROPN
bjp-80949	325	40	pathway	pathway	NOUN
bjp-80949	325	41	.	.	PUNCT
bjp-80949	326	1	int	int	NOUN
bjp-80949	326	2	j	j	PROPN
bjp-80949	326	3	oncol	oncol	ADJ
bjp-80949	326	4	.	.	PUNCT
bjp-80949	327	1	2016	2016	NUM
bjp-80949	327	2	;	;	PUNCT
bjp-80949	327	3	49	49	NUM
bjp-80949	327	4	:	:	PUNCT
bjp-80949	327	5	2075	2075	NUM
bjp-80949	327	6	-	-	SYM
bjp-80949	327	7	87	87	NUM
bjp-80949	327	8	.	.	PUNCT
bjp-80949	328	1	chami	chami	PROPN
bjp-80949	328	2	n	n	CCONJ
bjp-80949	328	3	,	,	PUNCT
bjp-80949	328	4	chami	chami	PROPN
bjp-80949	328	5	f	f	PROPN
bjp-80949	328	6	,	,	PUNCT
bjp-80949	328	7	bennis	bennis	PROPN
bjp-80949	328	8	s	s	PROPN
bjp-80949	328	9	,	,	PUNCT
bjp-80949	328	10	trouillas	trouillas	PROPN
bjp-80949	328	11	j	j	PROPN
bjp-80949	328	12	,	,	PUNCT
bjp-80949	328	13	remmal	remmal	ADJ
bjp-80949	328	14	a.	a.	NOUN
bjp-80949	328	15	antifungal	antifungal	ADJ
bjp-80949	328	16	treatment	treatment	NOUN
bjp-80949	328	17	with	with	ADP
bjp-80949	328	18	carvacrol	carvacrol	NOUN
bjp-80949	328	19	and	and	CCONJ
bjp-80949	328	20	eugenol	eugenol	NOUN
bjp-80949	328	21	of	of	ADP
bjp-80949	328	22	oral	oral	ADJ
bjp-80949	328	23	candidiasis	candidiasis	NOUN
bjp-80949	328	24	in	in	ADP
bjp-80949	328	25	immunosuppressed	immunosuppressed	ADJ
bjp-80949	328	26	rats	rat	NOUN
bjp-80949	328	27	.	.	PUNCT
bjp-80949	329	1	brazil	brazil	PROPN
bjp-80949	329	2	j	j	PROPN
bjp-80949	329	3	infect	infect	VERB
bjp-80949	329	4	dis	dis	PROPN
bjp-80949	329	5	.	.	PUNCT
bjp-80949	330	1	2004	2004	NUM
bjp-80949	330	2	;	;	PUNCT
bjp-80949	330	3	8	8	NUM
bjp-80949	330	4	:	:	SYM
bjp-80949	330	5	21726	21726	NUM
bjp-80949	330	6	.	.	PUNCT
bjp-80949	331	1	chen	chen	PROPN
bjp-80949	331	2	p	p	PROPN
bjp-80949	331	3	,	,	PUNCT
bjp-80949	331	4	li	li	PROPN
bjp-80949	331	5	x	x	PROPN
bjp-80949	331	6	,	,	PUNCT
bjp-80949	331	7	zhang	zhang	PROPN
bjp-80949	331	8	r	r	PROPN
bjp-80949	331	9	,	,	PUNCT
bjp-80949	331	10	liu	liu	PROPN
bjp-80949	331	11	s	s	PROPN
bjp-80949	331	12	,	,	PUNCT
bjp-80949	331	13	xiang	xiang	PROPN
bjp-80949	331	14	y	y	PROPN
bjp-80949	331	15	,	,	PUNCT
bjp-80949	331	16	zhang	zhang	PROPN
bjp-80949	331	17	m	m	PROPN
bjp-80949	331	18	,	,	PUNCT
bjp-80949	331	19	chen	chen	PROPN
bjp-80949	331	20	x	x	PROPN
bjp-80949	331	21	,	,	PUNCT
bjp-80949	331	22	pan	pan	PROPN
bjp-80949	331	23	t	t	PROPN
bjp-80949	331	24	,	,	PUNCT
bjp-80949	331	25	yan	yan	PROPN
bjp-80949	331	26	l	l	PROPN
bjp-80949	331	27	,	,	PUNCT
bjp-80949	331	28	feng	feng	PROPN
bjp-80949	331	29	j	j	PROPN
bjp-80949	331	30	,	,	PUNCT
bjp-80949	331	31	duan	duan	PROPN
bjp-80949	331	32	t	t	PROPN
bjp-80949	331	33	,	,	PUNCT
bjp-80949	331	34	wang	wang	PROPN
bjp-80949	331	35	d	d	PROPN
bjp-80949	331	36	,	,	PUNCT
bjp-80949	331	37	chen	chen	PROPN
bjp-80949	331	38	b	b	PROPN
bjp-80949	331	39	,	,	PUNCT
bjp-80949	331	40	jin	jin	PROPN
bjp-80949	331	41	t	t	PROPN
bjp-80949	331	42	,	,	PUNCT
bjp-80949	331	43	wang	wang	PROPN
bjp-80949	331	44	w	w	PROPN
bjp-80949	331	45	,	,	PUNCT
bjp-80949	331	46	chen	chen	PROPN
bjp-80949	331	47	l	l	PROPN
bjp-80949	331	48	,	,	PUNCT
bjp-80949	331	49	huang	huang	PROPN
bjp-80949	331	50	x	x	PROPN
bjp-80949	331	51	,	,	PUNCT
bjp-80949	331	52	zhang	zhang	PROPN
bjp-80949	331	53	w	w	PROPN
bjp-80949	331	54	,	,	PUNCT
bjp-80949	331	55	sun	sun	PROPN
bjp-80949	331	56	y	y	PROPN
bjp-80949	331	57	,	,	PUNCT
bjp-80949	331	58	li	li	PROPN
bjp-80949	331	59	g	g	PROPN
bjp-80949	331	60	,	,	PUNCT
bjp-80949	331	61	kong	kong	PROPN
bjp-80949	331	62	l	l	PROPN
bjp-80949	331	63	,	,	PUNCT
bjp-80949	331	64	chen	chen	PROPN
bjp-80949	331	65	x	x	PROPN
bjp-80949	331	66	,	,	PUNCT
bjp-80949	331	67	li	li	PROPN
bjp-80949	331	68	y	y	PROPN
bjp-80949	331	69	,	,	PUNCT
bjp-80949	331	70	yang	yang	PROPN
bjp-80949	331	71	z	z	PROPN
bjp-80949	331	72	,	,	PUNCT
bjp-80949	331	73	zhang	zhang	PROPN
bjp-80949	331	74	q	q	PROPN
bjp-80949	331	75	,	,	PUNCT
bjp-80949	331	76	zhuo	zhuo	PROPN
bjp-80949	331	77	l	l	PROPN
bjp-80949	331	78	,	,	PUNCT
bjp-80949	331	79	sui	sui	PROPN
bjp-80949	331	80	x	x	SYM
bjp-80949	331	81	,	,	PUNCT
bjp-80949	331	82	xie	xie	PROPN
bjp-80949	331	83	t.	t.	PROPN
bjp-80949	331	84	combinative	combinative	PROPN
bjp-80949	331	85	treatment	treatment	NOUN
bjp-80949	331	86	of	of	ADP
bjp-80949	331	87	β	β	NOUN
bjp-80949	331	88	-	-	ADJ
bjp-80949	331	89	elemene	elemene	NOUN
bjp-80949	331	90	and	and	CCONJ
bjp-80949	331	91	cetuximab	cetuximab	NOUN
bjp-80949	331	92	is	be	AUX
bjp-80949	331	93	sensitive	sensitive	ADJ
bjp-80949	331	94	to	to	ADP
bjp-80949	331	95	kras	kras	PROPN
bjp-80949	331	96	mutant	mutant	ADJ
bjp-80949	331	97	colorectal	colorectal	ADJ
bjp-80949	331	98	cancer	cancer	NOUN
bjp-80949	331	99	cells	cell	NOUN
bjp-80949	331	100	by	by	ADP
bjp-80949	331	101	inducing	induce	VERB
bjp-80949	331	102	ferroptosis	ferroptosis	NOUN
bjp-80949	331	103	and	and	CCONJ
bjp-80949	331	104	inhibiting	inhibit	VERB
bjp-80949	331	105	epithelial	epithelial	ADJ
bjp-80949	331	106	-	-	PUNCT
bjp-80949	331	107	mesenchymal	mesenchymal	NOUN
bjp-80949	331	108	transformation	transformation	NOUN
bjp-80949	331	109	.	.	PUNCT
bjp-80949	332	1	theranostics	theranostic	NOUN
bjp-80949	332	2	2020	2020	NUM
bjp-80949	332	3	;	;	PUNCT
bjp-80949	332	4	10	10	NUM
bjp-80949	332	5	:	:	SYM
bjp-80949	332	6	5107	5107	NUM
bjp-80949	332	7	-	-	SYM
bjp-80949	332	8	19	19	NUM
bjp-80949	332	9	.	.	PUNCT
bjp-80949	333	1	cheng	cheng	PROPN
bjp-80949	333	2	yd	yd	PROPN
bjp-80949	333	3	,	,	PUNCT
bjp-80949	333	4	yang	yang	PROPN
bjp-80949	333	5	h	h	PROPN
bjp-80949	333	6	,	,	PUNCT
bjp-80949	333	7	chen	chen	PROPN
bjp-80949	333	8	gq	gq	PROPN
bjp-80949	333	9	,	,	PUNCT
bjp-80949	333	10	zhang	zhang	PROPN
bjp-80949	333	11	zc	zc	PROPN
bjp-80949	333	12	.	.	PROPN
bjp-80949	333	13	molecularly	molecularly	ADV
bjp-80949	333	14	targeted	target	VERB
bjp-80949	333	15	drugs	drug	NOUN
bjp-80949	333	16	for	for	ADP
bjp-80949	333	17	metastatic	metastatic	ADJ
bjp-80949	333	18	colorectal	colorectal	ADJ
bjp-80949	333	19	cancer	cancer	NOUN
bjp-80949	333	20	.	.	PUNCT
bjp-80949	334	1	drug	drug	NOUN
bjp-80949	334	2	des	des	PROPN
bjp-80949	334	3	devel	devel	NOUN
bjp-80949	334	4	ther	ther	ADV
bjp-80949	334	5	.	.	PUNCT
bjp-80949	335	1	2013	2013	NUM
bjp-80949	335	2	;	;	PUNCT
bjp-80949	335	3	7	7	NUM
bjp-80949	335	4	:	:	SYM
bjp-80949	335	5	1315	1315	NUM
bjp-80949	335	6	-	-	SYM
bjp-80949	335	7	22	22	NUM
bjp-80949	335	8	.	.	PUNCT
bjp-80949	336	1	chiu	chiu	PROPN
bjp-80949	336	2	kw	kw	PROPN
bjp-80949	336	3	,	,	PUNCT
bjp-80949	336	4	chen	chen	PROPN
bjp-80949	336	5	hy	hy	PROPN
bjp-80949	336	6	,	,	PUNCT
bjp-80949	336	7	chen	chen	PROPN
bjp-80949	336	8	cl	cl	PROPN
bjp-80949	336	9	,	,	PUNCT
bjp-80949	336	10	hsieh	hsieh	PROPN
bjp-80949	336	11	cp	cp	PROPN
bjp-80949	336	12	,	,	PUNCT
bjp-80949	336	13	huang	huang	PROPN
bjp-80949	336	14	yf	yf	PROPN
bjp-80949	336	15	.	.	PROPN
bjp-80949	337	1	attenuation	attenuation	NOUN
bjp-80949	337	2	of	of	ADP
bjp-80949	337	3	endoplasmic	endoplasmic	ADJ
bjp-80949	337	4	reticulum	reticulum	NOUN
bjp-80949	337	5	stress	stress	NOUN
bjp-80949	337	6	enhances	enhance	VERB
bjp-80949	337	7	carvacrolinduced	carvacrolinduced	ADJ
bjp-80949	337	8	apoptosis	apoptosis	NOUN
bjp-80949	337	9	in	in	ADP
bjp-80949	337	10	osteosarcoma	osteosarcoma	ADJ
bjp-80949	337	11	cell	cell	NOUN
bjp-80949	337	12	lines	line	NOUN
bjp-80949	337	13	.	.	PUNCT
bjp-80949	338	1	life	life	NOUN
bjp-80949	338	2	2023	2023	NUM
bjp-80949	338	3	;	;	PUNCT
bjp-80949	338	4	13	13	NUM
bjp-80949	338	5	:	:	SYM
bjp-80949	338	6	744-	744-	NUM
bjp-80949	338	7	.	.	PUNCT
bjp-80949	339	1	douillard	douillard	PROPN
bjp-80949	339	2	jy	jy	PROPN
bjp-80949	339	3	,	,	PUNCT
bjp-80949	339	4	pirker	pirker	NOUN
bjp-80949	339	5	r	r	PROPN
bjp-80949	339	6	,	,	PUNCT
bjp-80949	339	7	o'byrne	o'byrne	PROPN
bjp-80949	339	8	kj	kj	PROPN
bjp-80949	339	9	,	,	PUNCT
bjp-80949	339	10	kerr	kerr	PROPN
bjp-80949	339	11	km	km	PROPN
bjp-80949	339	12	,	,	PUNCT
bjp-80949	339	13	störkel	störkel	PROPN
bjp-80949	339	14	s	s	PROPN
bjp-80949	339	15	,	,	PUNCT
bjp-80949	339	16	von	von	PROPN
bjp-80949	339	17	heydebreck	heydebreck	PROPN
bjp-80949	339	18	a	a	PROPN
bjp-80949	339	19	,	,	PUNCT
bjp-80949	339	20	grote	grote	PROPN
bjp-80949	339	21	hj	hj	PROPN
bjp-80949	339	22	,	,	PUNCT
bjp-80949	339	23	celik	celik	VERB
bjp-80949	339	24	i	i	PRON
bjp-80949	339	25	,	,	PUNCT
bjp-80949	339	26	shepherd	shepherd	PROPN
bjp-80949	339	27	fa	fa	PROPN
bjp-80949	339	28	.	.	PROPN
bjp-80949	339	29	relationship	relationship	NOUN
bjp-80949	339	30	between	between	ADP
bjp-80949	339	31	egfr	egfr	ADJ
bjp-80949	339	32	expression	expression	NOUN
bjp-80949	339	33	,	,	PUNCT
bjp-80949	339	34	egfr	egfr	ADJ
bjp-80949	339	35	mutation	mutation	NOUN
bjp-80949	339	36	status	status	NOUN
bjp-80949	339	37	,	,	PUNCT
bjp-80949	339	38	and	and	CCONJ
bjp-80949	339	39	the	the	DET
bjp-80949	339	40	efficacy	efficacy	NOUN
bjp-80949	339	41	of	of	ADP
bjp-80949	339	42	chemotherapy	chemotherapy	NOUN
bjp-80949	339	43	plus	plus	CCONJ
bjp-80949	339	44	cetuximab	cetuximab	NOUN
bjp-80949	339	45	in	in	ADP
bjp-80949	339	46	flex	flex	ADJ
bjp-80949	339	47	study	study	NOUN
bjp-80949	339	48	patients	patient	NOUN
bjp-80949	339	49	with	with	ADP
bjp-80949	339	50	advanced	advanced	ADJ
bjp-80949	339	51	non	non	ADJ
bjp-80949	339	52	-	-	ADJ
bjp-80949	339	53	small	small	ADJ
bjp-80949	339	54	-	-	PUNCT
bjp-80949	339	55	cell	cell	NOUN
bjp-80949	339	56	lung	lung	NOUN
bjp-80949	339	57	cancer	cancer	NOUN
bjp-80949	339	58	.	.	PUNCT
bjp-80949	340	1	j	j	PROPN
bjp-80949	340	2	thorac	thorac	PROPN
bjp-80949	340	3	oncol	oncol	ADJ
bjp-80949	340	4	.	.	PUNCT
bjp-80949	341	1	2014	2014	NUM
bjp-80949	341	2	;	;	PUNCT
bjp-80949	341	3	9	9	NUM
bjp-80949	341	4	:	:	SYM
bjp-80949	341	5	717	717	NUM
bjp-80949	341	6	-	-	SYM
bjp-80949	341	7	24	24	NUM
bjp-80949	341	8	.	.	PUNCT
bjp-80949	342	1	fatima	fatima	PROPN
bjp-80949	342	2	k	k	PROPN
bjp-80949	342	3	,	,	PUNCT
bjp-80949	342	4	luqman	luqman	PROPN
bjp-80949	342	5	s	s	PROPN
bjp-80949	342	6	,	,	PUNCT
bjp-80949	342	7	meena	meena	PROPN
bjp-80949	342	8	a	a	PRON
bjp-80949	342	9	,	,	PUNCT
bjp-80949	342	10	carvacrol	carvacrol	NOUN
bjp-80949	342	11	arrests	arrest	NOUN
bjp-80949	342	12	the	the	DET
bjp-80949	342	13	proliferation	proliferation	NOUN
bjp-80949	342	14	of	of	ADP
bjp-80949	342	15	hypopharyngeal	hypopharyngeal	NOUN
bjp-80949	342	16	carcinoma	carcinoma	NOUN
bjp-80949	342	17	cells	cell	NOUN
bjp-80949	342	18	by	by	ADP
bjp-80949	342	19	suppressing	suppress	VERB
bjp-80949	342	20	ornithine	ornithine	ADJ
bjp-80949	342	21	decarboxylase	decarboxylase	NOUN
bjp-80949	342	22	and	and	CCONJ
bjp-80949	342	23	hyaluronidase	hyaluronidase	ADJ
bjp-80949	342	24	activities	activity	NOUN
bjp-80949	342	25	.	.	PUNCT
bjp-80949	343	1	front	front	ADJ
bjp-80949	343	2	nutr	nutr	NOUN
bjp-80949	343	3	.	.	PROPN
bjp-80949	343	4	2022	2022	NUM
bjp-80949	343	5	;	;	PUNCT
bjp-80949	343	6	9	9	NUM
bjp-80949	343	7	:	:	SYM
bjp-80949	343	8	857256	857256	NUM
bjp-80949	343	9	.	.	PUNCT
bjp-80949	343	10	flohé	flohé	ADJ
bjp-80949	343	11	l	l	NOUN
bjp-80949	343	12	,	,	PUNCT
bjp-80949	343	13	günzler	günzler	NOUN
bjp-80949	343	14	wa	wa	NOUN
bjp-80949	343	15	.	.	PROPN
bjp-80949	344	1	assays	assay	NOUN
bjp-80949	344	2	of	of	ADP
bjp-80949	344	3	glutathione	glutathione	NOUN
bjp-80949	344	4	peroxidase	peroxidase	NOUN
bjp-80949	344	5	.	.	PUNCT
bjp-80949	345	1	methods	method	NOUN
bjp-80949	345	2	enzymol	enzymol	PROPN
bjp-80949	345	3	.	.	PUNCT
bjp-80949	345	4	1984	1984	NUM
bjp-80949	345	5	;	;	PUNCT
bjp-80949	345	6	105	105	NUM
bjp-80949	345	7	:	:	SYM
bjp-80949	345	8	114	114	NUM
bjp-80949	345	9	-	-	SYM
bjp-80949	345	10	20	20	NUM
bjp-80949	345	11	.	.	PUNCT
bjp-80949	346	1	galizia	galizia	PROPN
bjp-80949	346	2	g	g	PROPN
bjp-80949	346	3	,	,	PUNCT
bjp-80949	346	4	lieto	lieto	NOUN
bjp-80949	346	5	e	e	NOUN
bjp-80949	346	6	,	,	PUNCT
bjp-80949	346	7	de	de	X
bjp-80949	346	8	vita	vita	X
bjp-80949	346	9	f	f	PROPN
bjp-80949	346	10	,	,	PUNCT
bjp-80949	346	11	orditura	orditura	NOUN
bjp-80949	346	12	m	m	PROPN
bjp-80949	346	13	,	,	PUNCT
bjp-80949	346	14	castellano	castellano	PROPN
bjp-80949	346	15	p	p	NOUN
bjp-80949	346	16	,	,	PUNCT
bjp-80949	346	17	troiani	troiani	PROPN
bjp-80949	346	18	t	t	PROPN
bjp-80949	346	19	,	,	PUNCT
bjp-80949	346	20	imperatore	imperatore	PROPN
bjp-80949	346	21	v	v	NOUN
bjp-80949	346	22	,	,	PUNCT
bjp-80949	346	23	ciardiello	ciardiello	PROPN
bjp-80949	346	24	f.	f.	PROPN
bjp-80949	346	25	cetuximab	cetuximab	PROPN
bjp-80949	346	26	,	,	PUNCT
bjp-80949	346	27	a	a	DET
bjp-80949	346	28	chimeric	chimeric	ADJ
bjp-80949	346	29	human	human	PROPN
bjp-80949	346	30	mouse	mouse	NOUN
bjp-80949	346	31	anti	anti	ADJ
bjp-80949	346	32	-	-	ADJ
bjp-80949	346	33	epidermal	epidermal	ADJ
bjp-80949	346	34	growth	growth	NOUN
bjp-80949	346	35	factor	factor	NOUN
bjp-80949	346	36	receptor	receptor	NOUN
bjp-80949	346	37	monoclonal	monoclonal	NOUN
bjp-80949	346	38	antibody	antibody	NOUN
bjp-80949	346	39	,	,	PUNCT
bjp-80949	346	40	in	in	ADP
bjp-80949	346	41	the	the	DET
bjp-80949	346	42	treatment	treatment	NOUN
bjp-80949	346	43	of	of	ADP
bjp-80949	346	44	human	human	ADJ
bjp-80949	346	45	colorectal	colorectal	ADJ
bjp-80949	346	46	cancer	cancer	NOUN
bjp-80949	346	47	.	.	PUNCT
bjp-80949	347	1	oncogene	oncogene	NOUN
bjp-80949	347	2	.	.	PUNCT
bjp-80949	348	1	2007	2007	NUM
bjp-80949	348	2	;	;	PUNCT
bjp-80949	348	3	26	26	NUM
bjp-80949	348	4	:	:	SYM
bjp-80949	348	5	3654	3654	NUM
bjp-80949	348	6	-	-	SYM
bjp-80949	348	7	60	60	NUM
bjp-80949	348	8	.	.	PUNCT
bjp-80949	349	1	gill	gill	PROPN
bjp-80949	349	2	gn	gn	PROPN
bjp-80949	349	3	,	,	PUNCT
bjp-80949	349	4	kawamoto	kawamoto	PROPN
bjp-80949	349	5	t	t	PROPN
bjp-80949	349	6	,	,	PUNCT
bjp-80949	349	7	cochet	cochet	PROPN
bjp-80949	349	8	c	c	PROPN
bjp-80949	349	9	,	,	PUNCT
bjp-80949	349	10	le	le	X
bjp-80949	349	11	a	a	X
bjp-80949	349	12	,	,	PUNCT
bjp-80949	349	13	sato	sato	PROPN
bjp-80949	349	14	jd	jd	PROPN
bjp-80949	349	15	,	,	PUNCT
bjp-80949	349	16	masui	masui	PROPN
bjp-80949	349	17	h	h	NOUN
bjp-80949	349	18	,	,	PUNCT
bjp-80949	349	19	mcleod	mcleod	PROPN
bjp-80949	349	20	c	c	PROPN
bjp-80949	349	21	,	,	PUNCT
bjp-80949	349	22	mendelsohn	mendelsohn	PROPN
bjp-80949	349	23	j.	j.	PROPN
bjp-80949	349	24	monoclonal	monoclonal	PROPN
bjp-80949	349	25	anti	anti	ADJ
bjp-80949	349	26	-	-	ADJ
bjp-80949	349	27	epidermal	epidermal	ADJ
bjp-80949	349	28	growth	growth	NOUN
bjp-80949	349	29	factor	factor	NOUN
bjp-80949	349	30	receptor	receptor	NOUN
bjp-80949	349	31	antibodies	antibody	NOUN
bjp-80949	349	32	which	which	PRON
bjp-80949	349	33	are	be	AUX
bjp-80949	349	34	inhibitors	inhibitor	NOUN
bjp-80949	349	35	of	of	ADP
bjp-80949	349	36	epidermal	epidermal	ADJ
bjp-80949	349	37	growth	growth	NOUN
bjp-80949	349	38	factor	factor	NOUN
bjp-80949	349	39	binding	bind	VERB
bjp-80949	349	40	and	and	CCONJ
bjp-80949	349	41	antagonists	antagonist	NOUN
bjp-80949	349	42	of	of	ADP
bjp-80949	349	43	epidermal	epidermal	ADJ
bjp-80949	349	44	growth	growth	NOUN
bjp-80949	349	45	factor	factor	NOUN
bjp-80949	349	46	-	-	PUNCT
bjp-80949	349	47	stimulated	stimulate	VERB
bjp-80949	349	48	tyrosine	tyrosine	NOUN
bjp-80949	349	49	protein	protein	NOUN
bjp-80949	349	50	kinase	kinase	PROPN
bjp-80949	349	51	activity	activity	NOUN
bjp-80949	349	52	.	.	PUNCT
bjp-80949	350	1	j	j	PROPN
bjp-80949	350	2	biol	biol	PROPN
bjp-80949	350	3	chem	chem	NOUN
bjp-80949	350	4	.	.	PUNCT
bjp-80949	351	1	1984	1984	NUM
bjp-80949	351	2	;	;	PUNCT
bjp-80949	352	1	259	259	NUM
bjp-80949	352	2	:	:	PUNCT
bjp-80949	352	3	7755	7755	NUM
bjp-80949	352	4	-	-	SYM
bjp-80949	352	5	60	60	NUM
bjp-80949	352	6	.	.	PUNCT
bjp-80949	353	1	hashemipour	hashemipour	PROPN
bjp-80949	353	2	h	h	PROPN
bjp-80949	353	3	,	,	PUNCT
bjp-80949	353	4	kermanshahi	kermanshahi	PROPN
bjp-80949	353	5	h	h	PROPN
bjp-80949	353	6	,	,	PUNCT
bjp-80949	353	7	golian	golian	PROPN
bjp-80949	353	8	a	a	PRON
bjp-80949	353	9	,	,	PUNCT
bjp-80949	353	10	veldkamp	veldkamp	ADJ
bjp-80949	353	11	t.	t.	NOUN
bjp-80949	353	12	metabolism	metabolism	NOUN
bjp-80949	353	13	and	and	CCONJ
bjp-80949	353	14	nutrition	nutrition	NOUN
bjp-80949	353	15	:	:	PUNCT
bjp-80949	353	16	effect	effect	NOUN
bjp-80949	353	17	of	of	ADP
bjp-80949	353	18	thymol	thymol	NOUN
bjp-80949	353	19	and	and	CCONJ
bjp-80949	353	20	carvacrol	carvacrol	NOUN
bjp-80949	353	21	feed	feed	NOUN
bjp-80949	353	22	supplementation	supplementation	NOUN
bjp-80949	353	23	on	on	ADP
bjp-80949	353	24	performance	performance	NOUN
bjp-80949	353	25	,	,	PUNCT
bjp-80949	353	26	antioxidant	antioxidant	ADJ
bjp-80949	353	27	enzyme	enzyme	NOUN
bjp-80949	353	28	activities	activity	NOUN
bjp-80949	353	29	,	,	PUNCT
bjp-80949	353	30	fatty	fatty	NOUN
bjp-80949	353	31	acid	acid	NOUN
bjp-80949	353	32	composition	composition	NOUN
bjp-80949	353	33	,	,	PUNCT
bjp-80949	353	34	digestive	digestive	ADJ
bjp-80949	353	35	enzyme	enzyme	NOUN
bjp-80949	353	36	32	32	NUM
bjp-80949	353	37	bangladesh	bangladesh	NOUN
bjp-80949	353	38	j	j	PROPN
bjp-80949	353	39	pharmacol	pharmacol	PROPN
bjp-80949	353	40	2025	2025	NUM
bjp-80949	353	41	;	;	PUNCT
bjp-80949	353	42	20	20	NUM
bjp-80949	353	43	:	:	SYM
bjp-80949	353	44	22	22	NUM
bjp-80949	353	45	-	-	SYM
bjp-80949	353	46	34	34	NUM
bjp-80949	353	47	activities	activity	NOUN
bjp-80949	353	48	,	,	PUNCT
bjp-80949	353	49	and	and	CCONJ
bjp-80949	353	50	immune	immune	ADJ
bjp-80949	353	51	response	response	NOUN
bjp-80949	353	52	in	in	ADP
bjp-80949	353	53	broiler	broiler	NOUN
bjp-80949	353	54	chickens	chicken	NOUN
bjp-80949	353	55	.	.	PUNCT
bjp-80949	354	1	poult	poult	PROPN
bjp-80949	354	2	sci	sci	PROPN
bjp-80949	354	3	.	.	PROPN
bjp-80949	354	4	2013	2013	NUM
bjp-80949	354	5	;	;	PUNCT
bjp-80949	354	6	92	92	NUM
bjp-80949	354	7	:	:	SYM
bjp-80949	354	8	2059	2059	NUM
bjp-80949	354	9	-	-	SYM
bjp-80949	354	10	69	69	NUM
bjp-80949	354	11	.	.	PUNCT
bjp-80949	355	1	herbst	herbst	PROPN
bjp-80949	355	2	rs	rs	PROPN
bjp-80949	355	3	,	,	PUNCT
bjp-80949	355	4	shin	shin	PROPN
bjp-80949	355	5	dm	dm	PROPN
bjp-80949	355	6	.	.	PUNCT
bjp-80949	355	7	monoclonal	monoclonal	NOUN
bjp-80949	355	8	antibodies	antibody	NOUN
bjp-80949	355	9	to	to	PART
bjp-80949	355	10	target	target	VERB
bjp-80949	355	11	epidermal	epidermal	ADJ
bjp-80949	355	12	growth	growth	NOUN
bjp-80949	355	13	factor	factor	NOUN
bjp-80949	355	14	receptor	receptor	NOUN
bjp-80949	355	15	–	–	PUNCT
bjp-80949	355	16	positive	positive	ADJ
bjp-80949	355	17	tumors	tumor	NOUN
bjp-80949	355	18	.	.	PUNCT
bjp-80949	356	1	cancer	cancer	NOUN
bjp-80949	356	2	2002	2002	NUM
bjp-80949	356	3	;	;	PUNCT
bjp-80949	356	4	94	94	NUM
bjp-80949	356	5	:	:	SYM
bjp-80949	356	6	1593	1593	NUM
bjp-80949	356	7	-	-	SYM
bjp-80949	356	8	611	611	NUM
bjp-80949	356	9	.	.	PUNCT
bjp-80949	357	1	huang	huang	PROPN
bjp-80949	357	2	f	f	PROPN
bjp-80949	357	3	,	,	PUNCT
bjp-80949	357	4	wu	wu	PROPN
bjp-80949	357	5	xn	xn	PROPN
bjp-80949	357	6	,	,	PUNCT
bjp-80949	357	7	chen	chen	PROPN
bjp-80949	357	8	jie	jie	PROPN
bjp-80949	357	9	,	,	PUNCT
bjp-80949	357	10	wang	wang	PROPN
bjp-80949	357	11	wx	wx	PROPN
bjp-80949	357	12	,	,	PUNCT
bjp-80949	357	13	lu	lu	PROPN
bjp-80949	357	14	zf	zf	PROPN
bjp-80949	357	15	.	.	PUNCT
bjp-80949	358	1	resveratrol	resveratrol	NOUN
bjp-80949	358	2	reverses	reverse	VERB
bjp-80949	358	3	multidrug	multidrug	NOUN
bjp-80949	358	4	resistance	resistance	NOUN
bjp-80949	358	5	in	in	ADP
bjp-80949	358	6	human	human	ADJ
bjp-80949	358	7	breast	breast	NOUN
bjp-80949	358	8	cancer	cancer	NOUN
bjp-80949	358	9	doxorubicin	doxorubicin	NOUN
bjp-80949	358	10	-	-	PUNCT
bjp-80949	358	11	resistant	resistant	ADJ
bjp-80949	358	12	cells	cell	NOUN
bjp-80949	358	13	.	.	PUNCT
bjp-80949	359	1	exp	exp	NOUN
bjp-80949	359	2	ther	ther	PROPN
bjp-80949	359	3	med	med	PROPN
bjp-80949	359	4	.	.	PUNCT
bjp-80949	359	5	2014	2014	NUM
bjp-80949	359	6	;	;	PUNCT
bjp-80949	359	7	7	7	NUM
bjp-80949	359	8	:	:	SYM
bjp-80949	359	9	1611	1611	NUM
bjp-80949	359	10	-	-	SYM
bjp-80949	359	11	16	16	NUM
bjp-80949	359	12	.	.	PUNCT
bjp-80949	360	1	huang	huang	PROPN
bjp-80949	360	2	st	st	PROPN
bjp-80949	360	3	,	,	PUNCT
bjp-80949	360	4	yang	yang	PROPN
bjp-80949	360	5	rc	rc	PROPN
bjp-80949	360	6	,	,	PUNCT
bjp-80949	360	7	yang	yang	PROPN
bjp-80949	360	8	lj	lj	PROPN
bjp-80949	360	9	,	,	PUNCT
bjp-80949	360	10	lee	lee	PROPN
bjp-80949	360	11	pn	pn	PROPN
bjp-80949	360	12	,	,	PUNCT
bjp-80949	360	13	pang	pang	PROPN
bjp-80949	360	14	jhs	jhs	PROPN
bjp-80949	360	15	.	.	PUNCT
bjp-80949	361	1	phyllanthus	phyllanthus	PROPN
bjp-80949	361	2	urinaria	urinaria	PROPN
bjp-80949	361	3	triggers	trigger	VERB
bjp-80949	361	4	the	the	DET
bjp-80949	361	5	apoptosis	apoptosis	NOUN
bjp-80949	361	6	and	and	CCONJ
bjp-80949	361	7	bcl-2	bcl-2	ADJ
bjp-80949	361	8	down	down	ADP
bjp-80949	361	9	-	-	PUNCT
bjp-80949	361	10	regulation	regulation	NOUN
bjp-80949	361	11	in	in	ADP
bjp-80949	361	12	lewis	lewis	PROPN
bjp-80949	361	13	lung	lung	NOUN
bjp-80949	361	14	carcinoma	carcinoma	NOUN
bjp-80949	361	15	cells	cell	NOUN
bjp-80949	361	16	.	.	PUNCT
bjp-80949	362	1	life	life	PROPN
bjp-80949	362	2	sci	sci	PROPN
bjp-80949	362	3	.	.	PROPN
bjp-80949	362	4	2003	2003	NUM
bjp-80949	362	5	;	;	PUNCT
bjp-80949	362	6	72	72	NUM
bjp-80949	362	7	:	:	SYM
bjp-80949	362	8	1705	1705	NUM
bjp-80949	362	9	-	-	SYM
bjp-80949	362	10	16	16	NUM
bjp-80949	362	11	.	.	PUNCT
bjp-80949	363	1	huether	huether	PROPN
bjp-80949	363	2	a	a	DET
bjp-80949	363	3	,	,	PUNCT
bjp-80949	363	4	hopfner	hopfner	ADJ
bjp-80949	363	5	m	m	PROPN
bjp-80949	363	6	,	,	PUNCT
bjp-80949	363	7	baradari	baradari	ADJ
bjp-80949	363	8	v	v	NOUN
bjp-80949	363	9	,	,	PUNCT
bjp-80949	363	10	schuppan	schuppan	NOUN
bjp-80949	363	11	d	d	NOUN
bjp-80949	363	12	,	,	PUNCT
bjp-80949	363	13	scherübl	scherübl	PROPN
bjp-80949	363	14	h.	h.	PROPN
bjp-80949	363	15	egfr	egfr	PROPN
bjp-80949	363	16	blockade	blockade	NOUN
bjp-80949	363	17	by	by	ADP
bjp-80949	363	18	cetuximab	cetuximab	NOUN
bjp-80949	363	19	alone	alone	ADJ
bjp-80949	363	20	or	or	CCONJ
bjp-80949	363	21	as	as	ADP
bjp-80949	363	22	combination	combination	NOUN
bjp-80949	363	23	therapy	therapy	NOUN
bjp-80949	363	24	for	for	ADP
bjp-80949	363	25	growth	growth	NOUN
bjp-80949	363	26	control	control	NOUN
bjp-80949	363	27	of	of	ADP
bjp-80949	363	28	hepatocellular	hepatocellular	ADJ
bjp-80949	363	29	cancer	cancer	NOUN
bjp-80949	363	30	.	.	PUNCT
bjp-80949	364	1	biochem	biochem	PROPN
bjp-80949	364	2	pharmacol	pharmacol	PROPN
bjp-80949	364	3	.	.	PUNCT
bjp-80949	365	1	2005	2005	NUM
bjp-80949	365	2	;	;	PUNCT
bjp-80949	365	3	70	70	NUM
bjp-80949	365	4	:	:	SYM
bjp-80949	365	5	1568	1568	NUM
bjp-80949	365	6	-	-	SYM
bjp-80949	365	7	78	78	NUM
bjp-80949	365	8	.	.	PUNCT
bjp-80949	366	1	jayakumar	jayakumar	PROPN
bjp-80949	366	2	s	s	PROPN
bjp-80949	366	3	,	,	PUNCT
bjp-80949	366	4	madankumar	madankumar	PROPN
bjp-80949	366	5	a	a	X
bjp-80949	366	6	,	,	PUNCT
bjp-80949	366	7	asokkumar	asokkumar	PROPN
bjp-80949	366	8	s	s	PROPN
bjp-80949	366	9	,	,	PUNCT
bjp-80949	366	10	raghunandhakumar	raghunandhakumar	PROPN
bjp-80949	366	11	s	s	PROPN
bjp-80949	366	12	,	,	PUNCT
bjp-80949	366	13	gokula	gokula	PROPN
bjp-80949	366	14	dhas	dha	VERB
bjp-80949	366	15	k	k	PROPN
bjp-80949	366	16	,	,	PUNCT
bjp-80949	366	17	kamaraj	kamaraj	PROPN
bjp-80949	366	18	s	s	PROPN
bjp-80949	366	19	,	,	PUNCT
bjp-80949	366	20	divya	divya	PROPN
bjp-80949	366	21	mg	mg	PROPN
bjp-80949	366	22	,	,	PUNCT
bjp-80949	366	23	devaki	devaki	VERB
bjp-80949	366	24	t.	t.	NOUN
bjp-80949	366	25	potential	potential	ADJ
bjp-80949	366	26	preventive	preventive	ADJ
bjp-80949	366	27	effect	effect	NOUN
bjp-80949	366	28	of	of	ADP
bjp-80949	366	29	carvacrol	carvacrol	NOUN
bjp-80949	366	30	against	against	ADP
bjp-80949	366	31	diethylnitrosamine	diethylnitrosamine	NOUN
bjp-80949	366	32	-	-	PUNCT
bjp-80949	366	33	induced	induce	VERB
bjp-80949	366	34	hepatocellular	hepatocellular	ADJ
bjp-80949	366	35	carcinoma	carcinoma	NOUN
bjp-80949	366	36	in	in	ADP
bjp-80949	366	37	rats	rat	NOUN
bjp-80949	366	38	.	.	PUNCT
bjp-80949	367	1	mol	mol	ADP
bjp-80949	367	2	cell	cell	NOUN
bjp-80949	367	3	biochem	biochem	PROPN
bjp-80949	367	4	.	.	PUNCT
bjp-80949	368	1	2012	2012	NUM
bjp-80949	368	2	;	;	PUNCT
bjp-80949	368	3	360	360	NUM
bjp-80949	368	4	:	:	PUNCT
bjp-80949	368	5	51	51	NUM
bjp-80949	368	6	-	-	SYM
bjp-80949	368	7	60	60	NUM
bjp-80949	368	8	.	.	PUNCT
bjp-80949	369	1	lee	lee	PROPN
bjp-80949	369	2	b	b	PROPN
bjp-80949	369	3	,	,	PUNCT
bjp-80949	369	4	yeom	yeom	PROPN
bjp-80949	369	5	m	m	PROPN
bjp-80949	369	6	,	,	PUNCT
bjp-80949	369	7	shim	shim	NOUN
bjp-80949	369	8	i	i	PRON
bjp-80949	369	9	,	,	PUNCT
bjp-80949	369	10	lee	lee	PROPN
bjp-80949	369	11	h	h	PROPN
bjp-80949	369	12	,	,	PUNCT
bjp-80949	369	13	hahm	hahm	PROPN
bjp-80949	369	14	d.	d.	PROPN
bjp-80949	369	15	inhibitory	inhibitory	ADJ
bjp-80949	369	16	effect	effect	NOUN
bjp-80949	369	17	of	of	ADP
bjp-80949	369	18	carvacrol	carvacrol	NOUN
bjp-80949	369	19	on	on	ADP
bjp-80949	369	20	lipopolysaccharide	lipopolysaccharide	ADV
bjp-80949	369	21	-	-	PUNCT
bjp-80949	369	22	induced	induce	VERB
bjp-80949	369	23	memory	memory	NOUN
bjp-80949	369	24	impairment	impairment	NOUN
bjp-80949	369	25	in	in	ADP
bjp-80949	369	26	rats	rat	NOUN
bjp-80949	369	27	.	.	PUNCT
bjp-80949	370	1	korean	korean	PROPN
bjp-80949	370	2	j	j	PROPN
bjp-80949	370	3	physiol	physiol	PROPN
bjp-80949	370	4	pharmacol	pharmacol	PROPN
bjp-80949	370	5	.	.	PUNCT
bjp-80949	371	1	2020	2020	NUM
bjp-80949	371	2	;	;	PUNCT
bjp-80949	371	3	24	24	NUM
bjp-80949	371	4	:	:	SYM
bjp-80949	371	5	27	27	NUM
bjp-80949	371	6	-	-	SYM
bjp-80949	371	7	37	37	NUM
bjp-80949	371	8	.	.	PUNCT
bjp-80949	371	9	leeman	leeman	PROPN
bjp-80949	371	10	-	-	PUNCT
bjp-80949	371	11	neill	neill	PROPN
bjp-80949	371	12	rj	rj	PROPN
bjp-80949	371	13	,	,	PUNCT
bjp-80949	371	14	wheeler	wheeler	NOUN
bjp-80949	371	15	se	se	PROPN
bjp-80949	371	16	,	,	PUNCT
bjp-80949	371	17	singh	singh	PROPN
bjp-80949	371	18	sv	sv	PROPN
bjp-80949	371	19	,	,	PUNCT
bjp-80949	371	20	thomas	thomas	PROPN
bjp-80949	371	21	sm	sm	PROPN
bjp-80949	371	22	,	,	PUNCT
bjp-80949	371	23	seethala	seethala	PROPN
bjp-80949	371	24	rr	rr	PROPN
bjp-80949	371	25	,	,	PUNCT
bjp-80949	371	26	neill	neill	PROPN
bjp-80949	371	27	db	db	PROPN
bjp-80949	371	28	,	,	PUNCT
bjp-80949	371	29	panahandeh	panahandeh	PROPN
bjp-80949	371	30	mc	mc	PROPN
bjp-80949	371	31	,	,	PUNCT
bjp-80949	371	32	hahm	hahm	PROPN
bjp-80949	371	33	er	er	INTJ
bjp-80949	371	34	,	,	PUNCT
bjp-80949	371	35	joyce	joyce	PROPN
bjp-80949	371	36	sc	sc	PROPN
bjp-80949	371	37	,	,	PUNCT
bjp-80949	371	38	sen	sen	PROPN
bjp-80949	371	39	m	m	PROPN
bjp-80949	371	40	,	,	PUNCT
bjp-80949	371	41	cai	cai	X
bjp-80949	372	1	q	q	X
bjp-80949	372	2	,	,	PUNCT
bjp-80949	372	3	freilino	freilino	X
bjp-80949	372	4	ml	ml	NOUN
bjp-80949	372	5	,	,	PUNCT
bjp-80949	372	6	li	li	PROPN
bjp-80949	372	7	c	c	PROPN
bjp-80949	372	8	,	,	PUNCT
bjp-80949	372	9	johnson	johnson	PROPN
bjp-80949	372	10	de	de	PROPN
bjp-80949	372	11	,	,	PUNCT
bjp-80949	372	12	grandis	grandis	PROPN
bjp-80949	372	13	jr	jr	PROPN
bjp-80949	372	14	.	.	PROPN
bjp-80949	372	15	guggulsterone	guggulsterone	NOUN
bjp-80949	372	16	enhances	enhance	VERB
bjp-80949	372	17	head	head	NOUN
bjp-80949	372	18	and	and	CCONJ
bjp-80949	372	19	neck	neck	NOUN
bjp-80949	372	20	cancer	cancer	NOUN
bjp-80949	372	21	therapies	therapy	NOUN
bjp-80949	372	22	via	via	ADP
bjp-80949	372	23	inhibition	inhibition	NOUN
bjp-80949	372	24	of	of	ADP
bjp-80949	372	25	signal	signal	ADJ
bjp-80949	372	26	transducer	transducer	NOUN
bjp-80949	372	27	and	and	CCONJ
bjp-80949	372	28	activator	activator	NOUN
bjp-80949	372	29	of	of	ADP
bjp-80949	372	30	transcription-3	transcription-3	PROPN
bjp-80949	372	31	.	.	PUNCT
bjp-80949	372	32	carcinogenesis	carcinogenesis	NOUN
bjp-80949	372	33	2009	2009	NUM
bjp-80949	372	34	;	;	PUNCT
bjp-80949	372	35	30	30	NUM
bjp-80949	372	36	:	:	SYM
bjp-80949	372	37	1848	1848	NUM
bjp-80949	372	38	-	-	SYM
bjp-80949	372	39	56	56	NUM
bjp-80949	372	40	.	.	PUNCT
bjp-80949	373	1	libermann	libermann	PROPN
bjp-80949	373	2	ta	ta	PROPN
bjp-80949	373	3	,	,	PUNCT
bjp-80949	373	4	razon	razon	PROPN
bjp-80949	373	5	n	n	SYM
bjp-80949	373	6	,	,	PUNCT
bjp-80949	373	7	bartal	bartal	NOUN
bjp-80949	373	8	ad	ad	NOUN
bjp-80949	373	9	,	,	PUNCT
bjp-80949	373	10	yarden	yarden	PROPN
bjp-80949	373	11	y	y	PROPN
bjp-80949	373	12	,	,	PUNCT
bjp-80949	373	13	schlessinger	schlessinger	PROPN
bjp-80949	373	14	j	j	PROPN
bjp-80949	373	15	,	,	PUNCT
bjp-80949	373	16	soreq	soreq	VERB
bjp-80949	373	17	h.	h.	NOUN
bjp-80949	373	18	expression	expression	NOUN
bjp-80949	373	19	of	of	ADP
bjp-80949	373	20	epidermal	epidermal	ADJ
bjp-80949	373	21	growth	growth	NOUN
bjp-80949	373	22	factor	factor	NOUN
bjp-80949	373	23	receptors	receptor	NOUN
bjp-80949	373	24	in	in	ADP
bjp-80949	373	25	human	human	ADJ
bjp-80949	373	26	brain	brain	NOUN
bjp-80949	373	27	tumors	tumor	NOUN
bjp-80949	373	28	.	.	PUNCT
bjp-80949	374	1	cancer	cancer	NOUN
bjp-80949	374	2	res	re	NOUN
bjp-80949	374	3	.	.	PUNCT
bjp-80949	374	4	1984	1984	NUM
bjp-80949	374	5	;	;	PUNCT
bjp-80949	374	6	44	44	NUM
bjp-80949	374	7	:	:	PUNCT
bjp-80949	374	8	753	753	NUM
bjp-80949	374	9	-	-	SYM
bjp-80949	374	10	60	60	NUM
bjp-80949	374	11	.	.	PUNCT
bjp-80949	375	1	lo	lo	PROPN
bjp-80949	375	2	hw	hw	PROPN
bjp-80949	375	3	,	,	PUNCT
bjp-80949	375	4	hsu	hsu	PROPN
bjp-80949	375	5	sc	sc	PROPN
bjp-80949	375	6	,	,	PUNCT
bjp-80949	375	7	hung	hung	PROPN
bjp-80949	375	8	mc	mc	PROPN
bjp-80949	375	9	.	.	PROPN
bjp-80949	375	10	egfr	egfr	PROPN
bjp-80949	375	11	signaling	signal	VERB
bjp-80949	375	12	pathway	pathway	NOUN
bjp-80949	375	13	in	in	ADP
bjp-80949	375	14	breast	breast	NOUN
bjp-80949	375	15	cancers	cancer	NOUN
bjp-80949	375	16	:	:	PUNCT
bjp-80949	375	17	from	from	ADP
bjp-80949	375	18	traditional	traditional	ADJ
bjp-80949	375	19	signal	signal	ADJ
bjp-80949	375	20	transduction	transduction	NOUN
bjp-80949	375	21	to	to	PART
bjp-80949	375	22	direct	direct	VERB
bjp-80949	375	23	nuclear	nuclear	ADJ
bjp-80949	375	24	translocalization	translocalization	NOUN
bjp-80949	375	25	.	.	PUNCT
bjp-80949	376	1	breast	breast	NOUN
bjp-80949	376	2	cancer	cancer	NOUN
bjp-80949	376	3	res	re	NOUN
bjp-80949	376	4	treat	treat	NOUN
bjp-80949	376	5	.	.	PUNCT
bjp-80949	377	1	2006	2006	NUM
bjp-80949	377	2	;	;	PUNCT
bjp-80949	377	3	95	95	NUM
bjp-80949	377	4	:	:	PUNCT
bjp-80949	377	5	211	211	NUM
bjp-80949	377	6	-	-	SYM
bjp-80949	377	7	18	18	NUM
bjp-80949	377	8	.	.	PUNCT
bjp-80949	378	1	kohrt	kohrt	PROPN
bjp-80949	378	2	he	he	PRON
bjp-80949	378	3	,	,	PUNCT
bjp-80949	378	4	colevas	colevas	PROPN
bjp-80949	378	5	ad	ad	NOUN
bjp-80949	378	6	,	,	PUNCT
bjp-80949	378	7	houot	houot	ADJ
bjp-80949	378	8	r	r	NOUN
bjp-80949	378	9	,	,	PUNCT
bjp-80949	378	10	weiskopf	weiskopf	X
bjp-80949	379	1	k	k	X
bjp-80949	379	2	,	,	PUNCT
bjp-80949	379	3	goldstein	goldstein	PROPN
bjp-80949	379	4	mj	mj	PROPN
bjp-80949	379	5	,	,	PUNCT
bjp-80949	379	6	lund	lund	PROPN
bjp-80949	379	7	p	p	PROPN
bjp-80949	379	8	,	,	PUNCT
bjp-80949	379	9	mueller	mueller	PROPN
bjp-80949	379	10	a	a	PROPN
bjp-80949	379	11	,	,	PUNCT
bjp-80949	379	12	sagiv	sagiv	PROPN
bjp-80949	379	13	-	-	PUNCT
bjp-80949	379	14	barfi	barfi	PROPN
bjp-80949	379	15	i	i	PROPN
bjp-80949	379	16	,	,	PUNCT
bjp-80949	379	17	marabelle	marabelle	PROPN
bjp-80949	379	18	a	a	NOUN
bjp-80949	379	19	,	,	PUNCT
bjp-80949	379	20	lira	lira	NOUN
bjp-80949	379	21	r	r	NOUN
bjp-80949	379	22	,	,	PUNCT
bjp-80949	379	23	troutner	troutner	NOUN
bjp-80949	379	24	e	e	NOUN
bjp-80949	379	25	,	,	PUNCT
bjp-80949	379	26	richards	richards	PROPN
bjp-80949	379	27	l	l	NOUN
bjp-80949	379	28	,	,	PUNCT
bjp-80949	379	29	rajapaska	rajapaska	ADJ
bjp-80949	379	30	a	a	PRON
bjp-80949	379	31	,	,	PUNCT
bjp-80949	379	32	hebb	hebb	PROPN
bjp-80949	379	33	j	j	PROPN
bjp-80949	379	34	,	,	PUNCT
bjp-80949	379	35	chester	chester	PROPN
bjp-80949	379	36	c	c	PROPN
bjp-80949	379	37	,	,	PUNCT
bjp-80949	379	38	waller	waller	PROPN
bjp-80949	379	39	e	e	PROPN
bjp-80949	379	40	,	,	PUNCT
bjp-80949	379	41	ostashko	ostashko	VERB
bjp-80949	379	42	a	a	PRON
bjp-80949	379	43	,	,	PUNCT
bjp-80949	379	44	weng	weng	PROPN
bjp-80949	379	45	wk	wk	PROPN
bjp-80949	379	46	,	,	PUNCT
bjp-80949	379	47	chen	chen	PROPN
bjp-80949	379	48	l	l	PROPN
bjp-80949	379	49	,	,	PUNCT
bjp-80949	379	50	czerwinski	czerwinski	PROPN
bjp-80949	379	51	d	d	NOUN
bjp-80949	379	52	,	,	PUNCT
bjp-80949	379	53	fu	fu	PROPN
bjp-80949	379	54	yx	yx	NOUN
bjp-80949	379	55	,	,	PUNCT
bjp-80949	379	56	sunwoo	sunwoo	PROPN
bjp-80949	379	57	j	j	PROPN
bjp-80949	379	58	,	,	PUNCT
bjp-80949	379	59	levy	levy	VERB
bjp-80949	379	60	r.	r.	NOUN
bjp-80949	379	61	targeting	target	VERB
bjp-80949	379	62	cd137	cd137	PROPN
bjp-80949	379	63	enhances	enhance	VERB
bjp-80949	379	64	the	the	DET
bjp-80949	379	65	efficacy	efficacy	NOUN
bjp-80949	379	66	of	of	ADP
bjp-80949	379	67	cetuximab	cetuximab	NOUN
bjp-80949	379	68	.	.	PUNCT
bjp-80949	380	1	j	j	PROPN
bjp-80949	380	2	clin	clin	PROPN
bjp-80949	380	3	invest	invest	PROPN
bjp-80949	380	4	.	.	PUNCT
bjp-80949	381	1	2014	2014	NUM
bjp-80949	381	2	;	;	PUNCT
bjp-80949	381	3	124	124	NUM
bjp-80949	381	4	:	:	SYM
bjp-80949	381	5	2668	2668	NUM
bjp-80949	381	6	-	-	SYM
bjp-80949	381	7	82	82	NUM
bjp-80949	381	8	.	.	PUNCT
bjp-80949	382	1	mari	mari	PROPN
bjp-80949	382	2	a	a	PRON
bjp-80949	382	3	,	,	PUNCT
bjp-80949	382	4	mani	mani	PROPN
bjp-80949	382	5	g	g	PROPN
bjp-80949	382	6	,	,	PUNCT
bjp-80949	382	7	nagabhishek	nagabhishek	PROPN
bjp-80949	382	8	sn	sn	PROPN
bjp-80949	382	9	,	,	PUNCT
bjp-80949	382	10	balaraman	balaraman	NOUN
bjp-80949	382	11	g	g	PROPN
bjp-80949	382	12	,	,	PUNCT
bjp-80949	382	13	subramanian	subramanian	PROPN
bjp-80949	382	14	n	n	CCONJ
bjp-80949	382	15	,	,	PUNCT
bjp-80949	382	16	mirza	mirza	PROPN
bjp-80949	382	17	fb	fb	PROPN
bjp-80949	382	18	,	,	PUNCT
bjp-80949	382	19	sundaram	sundaram	PROPN
bjp-80949	382	20	j	j	PROPN
bjp-80949	382	21	,	,	PUNCT
bjp-80949	382	22	thiruvengadam	thiruvengadam	PROPN
bjp-80949	382	23	d.	d.	PROPN
bjp-80949	382	24	carvacrol	carvacrol	PROPN
bjp-80949	382	25	promotes	promote	VERB
bjp-80949	382	26	cell	cell	NOUN
bjp-80949	382	27	cycle	cycle	NOUN
bjp-80949	382	28	arrest	arrest	NOUN
bjp-80949	382	29	and	and	CCONJ
bjp-80949	382	30	apoptosis	apoptosis	NOUN
bjp-80949	382	31	through	through	ADP
bjp-80949	382	32	pi3k	pi3k	PROPN
bjp-80949	382	33	/	/	SYM
bjp-80949	382	34	akt	akt	PROPN
bjp-80949	382	35	signaling	signal	VERB
bjp-80949	382	36	pathway	pathway	NOUN
bjp-80949	382	37	in	in	ADP
bjp-80949	382	38	mcf-7	mcf-7	CCONJ
bjp-80949	382	39	breast	breast	NOUN
bjp-80949	382	40	cancer	cancer	NOUN
bjp-80949	382	41	cells	cell	NOUN
bjp-80949	382	42	.	.	PUNCT
bjp-80949	383	1	chin	chin	PROPN
bjp-80949	383	2	j	j	PROPN
bjp-80949	383	3	integr	integr	PROPN
bjp-80949	383	4	med	me	VERB
bjp-80949	383	5	.	.	PROPN
bjp-80949	383	6	2021	2021	NUM
bjp-80949	383	7	;	;	PUNCT
bjp-80949	383	8	27	27	NUM
bjp-80949	383	9	:	:	SYM
bjp-80949	383	10	680	680	NUM
bjp-80949	383	11	-	-	SYM
bjp-80949	383	12	87	87	NUM
bjp-80949	383	13	.	.	PUNCT
bjp-80949	384	1	matar	matar	PROPN
bjp-80949	384	2	p	p	NOUN
bjp-80949	384	3	,	,	PUNCT
bjp-80949	384	4	rojo	rojo	PROPN
bjp-80949	384	5	f	f	PROPN
bjp-80949	384	6	,	,	PUNCT
bjp-80949	384	7	cassia	cassia	NOUN
bjp-80949	384	8	r	r	NOUN
bjp-80949	384	9	,	,	PUNCT
bjp-80949	384	10	moreno	moreno	PROPN
bjp-80949	384	11	-	-	PUNCT
bjp-80949	384	12	bueno	bueno	PROPN
bjp-80949	384	13	g	g	PROPN
bjp-80949	384	14	,	,	PUNCT
bjp-80949	384	15	di	di	PROPN
bjp-80949	384	16	cosimo	cosimo	PROPN
bjp-80949	384	17	s	s	PROPN
bjp-80949	384	18	,	,	PUNCT
bjp-80949	384	19	tabernero	tabernero	PROPN
bjp-80949	384	20	j	j	PROPN
bjp-80949	384	21	,	,	PUNCT
bjp-80949	384	22	guzmán	guzmán	PROPN
bjp-80949	384	23	m	m	PROPN
bjp-80949	384	24	,	,	PUNCT
bjp-80949	384	25	rodriguez	rodriguez	PROPN
bjp-80949	384	26	s	s	PROPN
bjp-80949	384	27	,	,	PUNCT
bjp-80949	384	28	arribas	arribas	PROPN
bjp-80949	384	29	j	j	PROPN
bjp-80949	384	30	,	,	PUNCT
bjp-80949	384	31	palacios	palacios	PROPN
bjp-80949	384	32	j	j	PROPN
bjp-80949	384	33	,	,	PUNCT
bjp-80949	384	34	baselga	baselga	ADJ
bjp-80949	384	35	j.	j.	PROPN
bjp-80949	384	36	combined	combine	VERB
bjp-80949	384	37	epidermal	epidermal	ADJ
bjp-80949	384	38	growth	growth	NOUN
bjp-80949	384	39	factor	factor	NOUN
bjp-80949	384	40	receptor	receptor	NOUN
bjp-80949	384	41	targeting	target	VERB
bjp-80949	384	42	with	with	ADP
bjp-80949	384	43	the	the	DET
bjp-80949	384	44	tyrosine	tyrosine	NOUN
bjp-80949	384	45	kinase	kinase	PROPN
bjp-80949	384	46	inhibitor	inhibitor	NOUN
bjp-80949	384	47	gefitinib	gefitinib	NOUN
bjp-80949	384	48	(	(	PUNCT
bjp-80949	384	49	zd1839	zd1839	PROPN
bjp-80949	384	50	)	)	PUNCT
bjp-80949	384	51	and	and	CCONJ
bjp-80949	384	52	the	the	DET
bjp-80949	384	53	monoclonal	monoclonal	NOUN
bjp-80949	384	54	antibody	antibody	NOUN
bjp-80949	384	55	cetuximab	cetuximab	NOUN
bjp-80949	384	56	(	(	PUNCT
bjp-80949	384	57	imcc225	imcc225	PROPN
bjp-80949	384	58	):	):	PUNCT
bjp-80949	384	59	superiority	superiority	NOUN
bjp-80949	384	60	over	over	ADP
bjp-80949	384	61	single	single	ADJ
bjp-80949	384	62	-	-	PUNCT
bjp-80949	384	63	agent	agent	NOUN
bjp-80949	384	64	receptor	receptor	NOUN
bjp-80949	384	65	targeting	target	VERB
bjp-80949	384	66	.	.	PUNCT
bjp-80949	385	1	clin	clin	PROPN
bjp-80949	385	2	cancer	cancer	NOUN
bjp-80949	385	3	res	re	NOUN
bjp-80949	385	4	.	.	PUNCT
bjp-80949	385	5	2004	2004	NUM
bjp-80949	385	6	;	;	PUNCT
bjp-80949	385	7	10	10	NUM
bjp-80949	385	8	:	:	SYM
bjp-80949	385	9	6487	6487	NUM
bjp-80949	385	10	-	-	SYM
bjp-80949	385	11	501	501	NUM
bjp-80949	385	12	.	.	PUNCT
bjp-80949	386	1	melo	melo	PROPN
bjp-80949	386	2	jo	jo	PROPN
bjp-80949	386	3	,	,	PUNCT
bjp-80949	386	4	fachin	fachin	PROPN
bjp-80949	386	5	al	al	PROPN
bjp-80949	386	6	,	,	PUNCT
bjp-80949	386	7	rizo	rizo	PROPN
bjp-80949	386	8	wf	wf	PROPN
bjp-80949	386	9	,	,	PUNCT
bjp-80949	386	10	jesus	jesus	PROPN
bjp-80949	386	11	hc	hc	PROPN
bjp-80949	386	12	,	,	PUNCT
bjp-80949	386	13	arrigoni	arrigoni	NOUN
bjp-80949	386	14	-	-	PUNCT
bjp-80949	386	15	blank	blank	NOUN
bjp-80949	386	16	mf	mf	PROPN
bjp-80949	386	17	,	,	PUNCT
bjp-80949	386	18	alves	alves	PROPN
bjp-80949	386	19	pb	pb	ADP
bjp-80949	386	20	,	,	PUNCT
bjp-80949	386	21	marins	marin	NOUN
bjp-80949	386	22	ma	ma	PROPN
bjp-80949	386	23	,	,	PUNCT
bjp-80949	386	24	frança	frança	PROPN
bjp-80949	386	25	sc	sc	PROPN
bjp-80949	386	26	,	,	PUNCT
bjp-80949	386	27	blank	blank	ADP
bjp-80949	386	28	af	af	PROPN
bjp-80949	386	29	.	.	PUNCT
bjp-80949	387	1	cytotoxic	cytotoxic	ADJ
bjp-80949	387	2	effects	effect	NOUN
bjp-80949	387	3	of	of	ADP
bjp-80949	387	4	essential	essential	ADJ
bjp-80949	387	5	oils	oil	NOUN
bjp-80949	387	6	from	from	ADP
bjp-80949	387	7	three	three	NUM
bjp-80949	387	8	lippia	lippia	NOUN
bjp-80949	387	9	gracilis	gracilis	NOUN
bjp-80949	387	10	schauer	schauer	NOUN
bjp-80949	387	11	genotypes	genotype	NOUN
bjp-80949	387	12	on	on	ADP
bjp-80949	387	13	hela	hela	PROPN
bjp-80949	387	14	,	,	PUNCT
bjp-80949	387	15	b16	b16	NOUN
bjp-80949	387	16	,	,	PUNCT
bjp-80949	387	17	and	and	CCONJ
bjp-80949	387	18	mcf-7	mcf-7	NOUN
bjp-80949	387	19	cells	cell	NOUN
bjp-80949	387	20	and	and	CCONJ
bjp-80949	387	21	normal	normal	ADJ
bjp-80949	387	22	human	human	ADJ
bjp-80949	387	23	fibroblasts	fibroblast	NOUN
bjp-80949	387	24	.	.	PUNCT
bjp-80949	388	1	genet	genet	NOUN
bjp-80949	388	2	mol	mol	ADP
bjp-80949	388	3	res	re	NOUN
bjp-80949	388	4	.	.	PUNCT
bjp-80949	388	5	2014	2014	NUM
bjp-80949	388	6	;	;	PUNCT
bjp-80949	388	7	13	13	NUM
bjp-80949	388	8	:	:	SYM
bjp-80949	388	9	2691	2691	NUM
bjp-80949	388	10	-	-	SYM
bjp-80949	388	11	97	97	NUM
bjp-80949	388	12	.	.	PUNCT
bjp-80949	389	1	mosmann	mosmann	PROPN
bjp-80949	389	2	t.	t.	PROPN
bjp-80949	389	3	rapid	rapid	ADJ
bjp-80949	389	4	colorimetric	colorimetric	ADJ
bjp-80949	389	5	assay	assay	NOUN
bjp-80949	389	6	for	for	ADP
bjp-80949	389	7	cellular	cellular	ADJ
bjp-80949	389	8	growth	growth	NOUN
bjp-80949	389	9	and	and	CCONJ
bjp-80949	389	10	survival	survival	NOUN
bjp-80949	389	11	:	:	PUNCT
bjp-80949	389	12	application	application	NOUN
bjp-80949	389	13	to	to	ADP
bjp-80949	389	14	proliferation	proliferation	NOUN
bjp-80949	389	15	and	and	CCONJ
bjp-80949	389	16	cytotoxicity	cytotoxicity	NOUN
bjp-80949	389	17	assays	assay	NOUN
bjp-80949	389	18	.	.	PUNCT
bjp-80949	390	1	j	j	PROPN
bjp-80949	390	2	immunol	immunol	NOUN
bjp-80949	390	3	methods	method	NOUN
bjp-80949	390	4	.	.	PUNCT
bjp-80949	390	5	1983	1983	NUM
bjp-80949	390	6	;	;	PUNCT
bjp-80949	390	7	65	65	NUM
bjp-80949	390	8	:	:	PUNCT
bjp-80949	390	9	55	55	NUM
bjp-80949	390	10	-	-	SYM
bjp-80949	390	11	63	63	NUM
bjp-80949	390	12	.	.	PUNCT
bjp-80949	391	1	njume	njume	PROPN
bjp-80949	391	2	c	c	PROPN
bjp-80949	391	3	,	,	PUNCT
bjp-80949	391	4	afolayan	afolayan	PROPN
bjp-80949	391	5	aj	aj	PROPN
bjp-80949	391	6	,	,	PUNCT
bjp-80949	391	7	ndip	ndip	PROPN
bjp-80949	391	8	rn	rn	PROPN
bjp-80949	391	9	.	.	PUNCT
bjp-80949	392	1	an	an	DET
bjp-80949	392	2	overview	overview	NOUN
bjp-80949	392	3	of	of	ADP
bjp-80949	392	4	antimicrobial	antimicrobial	ADJ
bjp-80949	392	5	resistance	resistance	NOUN
bjp-80949	392	6	and	and	CCONJ
bjp-80949	392	7	the	the	DET
bjp-80949	392	8	future	future	NOUN
bjp-80949	392	9	of	of	ADP
bjp-80949	392	10	medicinal	medicinal	ADJ
bjp-80949	392	11	plants	plant	NOUN
bjp-80949	392	12	in	in	ADP
bjp-80949	392	13	the	the	DET
bjp-80949	392	14	treatment	treatment	NOUN
bjp-80949	392	15	of	of	ADP
bjp-80949	392	16	helicobacter	helicobacter	NOUN
bjp-80949	392	17	pylori	pylori	NOUN
bjp-80949	392	18	infections	infection	NOUN
bjp-80949	392	19	.	.	PUNCT
bjp-80949	393	1	afr	afr	PROPN
bjp-80949	393	2	j	j	PROPN
bjp-80949	393	3	pharm	pharm	PROPN
bjp-80949	393	4	pharmacol	pharmacol	PROPN
bjp-80949	393	5	.	.	PUNCT
bjp-80949	393	6	2009	2009	NUM
bjp-80949	393	7	;	;	PUNCT
bjp-80949	393	8	3	3	NUM
bjp-80949	393	9	:	:	SYM
bjp-80949	393	10	685	685	NUM
bjp-80949	393	11	-	-	SYM
bjp-80949	393	12	99	99	NUM
bjp-80949	393	13	.	.	PUNCT
bjp-80949	394	1	overholser	overholser	PROPN
bjp-80949	394	2	jp	jp	PROPN
bjp-80949	394	3	,	,	PUNCT
bjp-80949	394	4	prewett	prewett	PROPN
bjp-80949	394	5	mc	mc	PROPN
bjp-80949	394	6	,	,	PUNCT
bjp-80949	394	7	hooper	hooper	PROPN
bjp-80949	394	8	at	at	ADP
bjp-80949	394	9	,	,	PUNCT
bjp-80949	394	10	waksal	waksal	NOUN
bjp-80949	394	11	hw	hw	PROPN
bjp-80949	394	12	,	,	PUNCT
bjp-80949	394	13	hicklin	hicklin	PROPN
bjp-80949	394	14	dj	dj	NOUN
bjp-80949	394	15	.	.	PUNCT
bjp-80949	394	16	epidermal	epidermal	ADJ
bjp-80949	394	17	growth	growth	NOUN
bjp-80949	394	18	factor	factor	NOUN
bjp-80949	394	19	receptor	receptor	NOUN
bjp-80949	394	20	blockade	blockade	NOUN
bjp-80949	394	21	by	by	ADP
bjp-80949	394	22	antibody	antibody	NOUN
bjp-80949	394	23	imc	imc	PROPN
bjp-80949	394	24	-	-	PUNCT
bjp-80949	394	25	c225	c225	PROPN
bjp-80949	394	26	inhibits	inhibit	VERB
bjp-80949	394	27	growth	growth	NOUN
bjp-80949	394	28	of	of	ADP
bjp-80949	394	29	a	a	DET
bjp-80949	394	30	human	human	ADJ
bjp-80949	394	31	pancreatic	pancreatic	ADJ
bjp-80949	394	32	carcinoma	carcinoma	NOUN
bjp-80949	394	33	xenograft	xenograft	NOUN
bjp-80949	394	34	in	in	ADP
bjp-80949	394	35	nude	nude	ADJ
bjp-80949	394	36	mice	mouse	NOUN
bjp-80949	394	37	.	.	PUNCT
bjp-80949	395	1	cancer	cancer	NOUN
bjp-80949	395	2	2000	2000	NUM
bjp-80949	395	3	;	;	PUNCT
bjp-80949	395	4	89	89	NUM
bjp-80949	395	5	:	:	SYM
bjp-80949	395	6	74	74	NUM
bjp-80949	395	7	-	-	SYM
bjp-80949	395	8	82	82	NUM
bjp-80949	395	9	.	.	PUNCT
bjp-80949	396	1	pan	pan	PROPN
bjp-80949	396	2	j	j	PROPN
bjp-80949	396	3	,	,	PUNCT
bjp-80949	396	4	zhang	zhang	PROPN
bjp-80949	396	5	q	q	PROPN
bjp-80949	396	6	,	,	PUNCT
bjp-80949	396	7	liu	liu	PROPN
bjp-80949	396	8	q	q	PROPN
bjp-80949	396	9	,	,	PUNCT
bjp-80949	396	10	komas	komas	PROPN
bjp-80949	396	11	sm	sm	PROPN
bjp-80949	396	12	,	,	PUNCT
bjp-80949	396	13	kalyanaraman	kalyanaraman	PROPN
bjp-80949	396	14	b	b	PROPN
bjp-80949	396	15	,	,	PUNCT
bjp-80949	396	16	lubet	lubet	PROPN
bjp-80949	396	17	ra	ra	PROPN
bjp-80949	396	18	,	,	PUNCT
bjp-80949	396	19	wang	wang	PROPN
bjp-80949	396	20	y	y	PROPN
bjp-80949	396	21	,	,	PUNCT
bjp-80949	396	22	you	you	PRON
bjp-80949	396	23	m.	m.	NOUN
bjp-80949	396	24	honokiol	honokiol	PROPN
bjp-80949	396	25	inhibits	inhibit	VERB
bjp-80949	396	26	lung	lung	NOUN
bjp-80949	396	27	tumorigenesis	tumorigenesis	NOUN
bjp-80949	396	28	through	through	ADP
bjp-80949	396	29	inhibition	inhibition	NOUN
bjp-80949	396	30	of	of	ADP
bjp-80949	396	31	mitochondrial	mitochondrial	ADJ
bjp-80949	396	32	function	function	NOUN
bjp-80949	396	33	.	.	PUNCT
bjp-80949	397	1	cancer	cancer	NOUN
bjp-80949	397	2	prev	prev	PROPN
bjp-80949	397	3	res	res	PROPN
bjp-80949	397	4	(	(	PUNCT
bjp-80949	397	5	phila	phila	PROPN
bjp-80949	397	6	)	)	PUNCT
bjp-80949	397	7	.	.	PUNCT
bjp-80949	398	1	2014	2014	NUM
bjp-80949	398	2	;	;	PUNCT
bjp-80949	398	3	7	7	NUM
bjp-80949	398	4	:	:	SYM
bjp-80949	398	5	1149	1149	NUM
bjp-80949	398	6	-	-	SYM
bjp-80949	398	7	59	59	NUM
bjp-80949	398	8	.	.	PUNCT
bjp-80949	399	1	park	park	NOUN
bjp-80949	399	2	sj	sj	PROPN
bjp-80949	399	3	,	,	PUNCT
bjp-80949	399	4	kim	kim	PROPN
bjp-80949	399	5	mj	mj	PROPN
bjp-80949	399	6	,	,	PUNCT
bjp-80949	399	7	kim	kim	PROPN
bjp-80949	399	8	yk	yk	PROPN
bjp-80949	399	9	,	,	PUNCT
bjp-80949	399	10	kim	kim	PROPN
bjp-80949	399	11	sm	sm	PROPN
bjp-80949	399	12	,	,	PUNCT
bjp-80949	399	13	park	park	PROPN
bjp-80949	399	14	jy	jy	PROPN
bjp-80949	399	15	,	,	PUNCT
bjp-80949	399	16	myoung	myoung	VERB
bjp-80949	399	17	h.	h.	PROPN
bjp-80949	399	18	combined	combine	VERB
bjp-80949	399	19	cetuximab	cetuximab	NOUN
bjp-80949	399	20	and	and	CCONJ
bjp-80949	399	21	genistein	genistein	PROPN
bjp-80949	399	22	treatment	treatment	NOUN
bjp-80949	399	23	shows	show	VERB
bjp-80949	399	24	additive	additive	ADJ
bjp-80949	399	25	anti	anti	ADJ
bjp-80949	399	26	-	-	ADJ
bjp-80949	399	27	cancer	cancer	ADJ
bjp-80949	399	28	effect	effect	NOUN
bjp-80949	399	29	on	on	ADP
bjp-80949	399	30	oral	oral	ADJ
bjp-80949	399	31	squamous	squamous	ADJ
bjp-80949	399	32	cell	cell	NOUN
bjp-80949	399	33	carcinoma	carcinoma	NOUN
bjp-80949	399	34	.	.	PUNCT
bjp-80949	400	1	cancer	cancer	NOUN
bjp-80949	400	2	lett	lett	PROPN
bjp-80949	400	3	.	.	PUNCT
bjp-80949	401	1	2010	2010	NUM
bjp-80949	401	2	;	;	PUNCT
bjp-80949	401	3	292	292	NUM
bjp-80949	401	4	:	:	SYM
bjp-80949	401	5	54	54	NUM
bjp-80949	401	6	-	-	SYM
bjp-80949	401	7	63	63	NUM
bjp-80949	401	8	.	.	PUNCT
bjp-80949	402	1	pearson	pearson	PROPN
bjp-80949	402	2	he	he	PRON
bjp-80949	402	3	,	,	PUNCT
bjp-80949	402	4	iida	iida	PROPN
bjp-80949	402	5	m	m	PROPN
bjp-80949	402	6	,	,	PUNCT
bjp-80949	402	7	orbuch	orbuch	PROPN
bjp-80949	402	8	ra	ra	PROPN
bjp-80949	402	9	,	,	PUNCT
bjp-80949	402	10	mcdaniel	mcdaniel	PROPN
bjp-80949	402	11	nk	nk	PROPN
bjp-80949	402	12	,	,	PUNCT
bjp-80949	402	13	nickel	nickel	NOUN
bjp-80949	402	14	kp	kp	PROPN
bjp-80949	402	15	,	,	PUNCT
bjp-80949	402	16	kimple	kimple	PROPN
bjp-80949	402	17	rj	rj	PROPN
bjp-80949	402	18	,	,	PUNCT
bjp-80949	402	19	arbiser	arbiser	PROPN
bjp-80949	402	20	jl	jl	PROPN
bjp-80949	402	21	,	,	PUNCT
bjp-80949	402	22	wheeler	wheeler	NOUN
bjp-80949	402	23	dl	dl	AUX
bjp-80949	402	24	.	.	PUNCT
bjp-80949	402	25	overcoming	overcome	VERB
bjp-80949	402	26	resistance	resistance	NOUN
bjp-80949	402	27	to	to	ADP
bjp-80949	402	28	cetuximab	cetuximab	NOUN
bjp-80949	402	29	with	with	ADP
bjp-80949	402	30	honokiol	honokiol	NOUN
bjp-80949	402	31	,	,	PUNCT
bjp-80949	402	32	a	a	DET
bjp-80949	402	33	small	small	ADJ
bjp-80949	402	34	-	-	PUNCT
bjp-80949	402	35	molecule	molecule	NOUN
bjp-80949	402	36	polyphenol	polyphenol	NOUN
bjp-80949	402	37	.	.	PUNCT
bjp-80949	403	1	mol	mol	ADP
bjp-80949	403	2	cancer	cancer	NOUN
bjp-80949	403	3	ther	ther	ADV
bjp-80949	403	4	.	.	PUNCT
bjp-80949	404	1	2018	2018	NUM
bjp-80949	404	2	;	;	PUNCT
bjp-80949	404	3	17	17	NUM
bjp-80949	404	4	:	:	SYM
bjp-80949	404	5	204	204	NUM
bjp-80949	404	6	-	-	SYM
bjp-80949	404	7	14	14	NUM
bjp-80949	404	8	.	.	PUNCT
bjp-80949	405	1	petrelli	petrelli	PROPN
bjp-80949	405	2	f	f	PROPN
bjp-80949	405	3	,	,	PUNCT
bjp-80949	405	4	coinu	coinu	NOUN
bjp-80949	405	5	a	a	DET
bjp-80949	405	6	,	,	PUNCT
bjp-80949	405	7	riboldi	riboldi	PROPN
bjp-80949	405	8	v	v	PROPN
bjp-80949	405	9	,	,	PUNCT
bjp-80949	405	10	borgonovo	borgonovo	PROPN
bjp-80949	405	11	k	k	PROPN
bjp-80949	405	12	,	,	PUNCT
bjp-80949	405	13	ghilardi	ghilardi	NOUN
bjp-80949	405	14	m	m	PROPN
bjp-80949	405	15	,	,	PUNCT
bjp-80949	405	16	cabiddu	cabiddu	PROPN
bjp-80949	405	17	m	m	PROPN
bjp-80949	405	18	,	,	PUNCT
bjp-80949	405	19	lonati	lonati	PROPN
bjp-80949	405	20	v	v	NOUN
bjp-80949	405	21	,	,	PUNCT
bjp-80949	405	22	sarti	sarti	X
bjp-80949	405	23	e	e	NOUN
bjp-80949	405	24	,	,	PUNCT
bjp-80949	405	25	barni	barni	PROPN
bjp-80949	405	26	s.	s.	PROPN
bjp-80949	405	27	concomitant	concomitant	PROPN
bjp-80949	405	28	platinum	platinum	NOUN
bjp-80949	405	29	-	-	PUNCT
bjp-80949	405	30	based	base	VERB
bjp-80949	405	31	chemotherapy	chemotherapy	NOUN
bjp-80949	405	32	or	or	CCONJ
bjp-80949	405	33	cetuximab	cetuximab	NOUN
bjp-80949	405	34	with	with	ADP
bjp-80949	405	35	radiotherapy	radiotherapy	NOUN
bjp-80949	405	36	for	for	ADP
bjp-80949	405	37	locally	locally	ADV
bjp-80949	405	38	advanced	advanced	ADJ
bjp-80949	405	39	head	head	NOUN
bjp-80949	405	40	and	and	CCONJ
bjp-80949	405	41	neck	neck	NOUN
bjp-80949	405	42	cancer	cancer	NOUN
bjp-80949	405	43	:	:	PUNCT
bjp-80949	405	44	a	a	DET
bjp-80949	405	45	systematic	systematic	ADJ
bjp-80949	405	46	review	review	NOUN
bjp-80949	405	47	and	and	CCONJ
bjp-80949	405	48	meta	meta	NOUN
bjp-80949	405	49	-	-	PUNCT
bjp-80949	405	50	analysis	analysis	NOUN
bjp-80949	405	51	of	of	ADP
bjp-80949	405	52	published	publish	VERB
bjp-80949	405	53	studies	study	NOUN
bjp-80949	405	54	.	.	PUNCT
bjp-80949	406	1	oral	oral	ADJ
bjp-80949	406	2	oncol	oncol	ADJ
bjp-80949	406	3	.	.	PUNCT
bjp-80949	407	1	2014	2014	NUM
bjp-80949	407	2	;	;	PUNCT
bjp-80949	407	3	50	50	NUM
bjp-80949	407	4	:	:	SYM
bjp-80949	407	5	1041	1041	NUM
bjp-80949	407	6	-	-	SYM
bjp-80949	407	7	48	48	NUM
bjp-80949	407	8	.	.	PUNCT
bjp-80949	408	1	pilau	pilau	PROPN
bjp-80949	408	2	mr	mr	PROPN
bjp-80949	408	3	,	,	PUNCT
bjp-80949	408	4	alves	alves	PROPN
bjp-80949	408	5	sh	sh	PROPN
bjp-80949	408	6	,	,	PUNCT
bjp-80949	408	7	weiblen	weiblen	ADJ
bjp-80949	408	8	r	r	NOUN
bjp-80949	408	9	,	,	PUNCT
bjp-80949	408	10	arenhart	arenhart	NOUN
bjp-80949	408	11	s	s	PROPN
bjp-80949	408	12	,	,	PUNCT
bjp-80949	408	13	cueto	cueto	PROPN
bjp-80949	408	14	ap	ap	PROPN
bjp-80949	408	15	,	,	PUNCT
bjp-80949	408	16	lovato	lovato	PROPN
bjp-80949	408	17	lt	lt	PROPN
bjp-80949	408	18	.	.	PROPN
bjp-80949	408	19	antiviral	antiviral	ADJ
bjp-80949	408	20	activity	activity	NOUN
bjp-80949	408	21	of	of	ADP
bjp-80949	408	22	the	the	DET
bjp-80949	408	23	lippia	lippia	NOUN
bjp-80949	408	24	graveolens	graveolen	VERB
bjp-80949	408	25	(	(	PUNCT
bjp-80949	408	26	mexican	mexican	ADJ
bjp-80949	408	27	oregano	oregano	NOUN
bjp-80949	408	28	)	)	PUNCT
bjp-80949	408	29	essential	essential	ADJ
bjp-80949	408	30	oil	oil	NOUN
bjp-80949	408	31	and	and	CCONJ
bjp-80949	408	32	its	its	PRON
bjp-80949	408	33	main	main	ADJ
bjp-80949	408	34	compound	compound	NOUN
bjp-80949	408	35	carvacrol	carvacrol	NOUN
bjp-80949	408	36	against	against	ADP
bjp-80949	408	37	human	human	ADJ
bjp-80949	408	38	and	and	CCONJ
bjp-80949	408	39	animal	animal	NOUN
bjp-80949	408	40	viruses	virus	NOUN
bjp-80949	408	41	.	.	PUNCT
bjp-80949	409	1	braz	braz	PROPN
bjp-80949	409	2	j	j	PROPN
bjp-80949	409	3	microbiol	microbiol	PROPN
bjp-80949	409	4	.	.	PUNCT
bjp-80949	410	1	2011	2011	NUM
bjp-80949	410	2	;	;	PUNCT
bjp-80949	410	3	42	42	NUM
bjp-80949	410	4	:	:	SYM
bjp-80949	410	5	1616	1616	NUM
bjp-80949	410	6	-	-	SYM
bjp-80949	410	7	24	24	NUM
bjp-80949	410	8	.	.	PUNCT
bjp-80949	411	1	pirker	pirker	NOUN
bjp-80949	411	2	r	r	PROPN
bjp-80949	411	3	,	,	PUNCT
bjp-80949	411	4	pereira	pereira	PROPN
bjp-80949	411	5	jr	jr	PROPN
bjp-80949	411	6	,	,	PUNCT
bjp-80949	411	7	szczesna	szczesna	NOUN
bjp-80949	411	8	a	a	PRON
bjp-80949	411	9	,	,	PUNCT
bjp-80949	411	10	von	von	PROPN
bjp-80949	411	11	pawel	pawel	PROPN
bjp-80949	411	12	j	j	PROPN
bjp-80949	411	13	,	,	PUNCT
bjp-80949	411	14	krzakowski	krzakowski	PROPN
bjp-80949	411	15	m	m	PROPN
bjp-80949	411	16	,	,	PUNCT
bjp-80949	411	17	ramlau	ramlau	PROPN
bjp-80949	411	18	r	r	NOUN
bjp-80949	411	19	,	,	PUNCT
bjp-80949	411	20	vynnychenko	vynnychenko	PROPN
bjp-80949	411	21	i	i	PRON
bjp-80949	411	22	,	,	PUNCT
bjp-80949	411	23	park	park	PROPN
bjp-80949	411	24	k	k	PROPN
bjp-80949	411	25	,	,	PUNCT
bjp-80949	411	26	yu	yu	PROPN
bjp-80949	411	27	ct	ct	PROPN
bjp-80949	411	28	,	,	PUNCT
bjp-80949	411	29	ganul	ganul	ADJ
bjp-80949	411	30	v	v	ADP
bjp-80949	411	31	,	,	PUNCT
bjp-80949	411	32	roh	roh	PROPN
bjp-80949	411	33	jk	jk	PROPN
bjp-80949	411	34	,	,	PUNCT
bjp-80949	411	35	bajetta	bajetta	PROPN
bjp-80949	411	36	e	e	NOUN
bjp-80949	411	37	,	,	PUNCT
bjp-80949	411	38	o'byrne	o'byrne	PROPN
bjp-80949	411	39	k	k	X
bjp-80949	411	40	,	,	PUNCT
bjp-80949	411	41	de	de	X
bjp-80949	411	42	marinis	marinis	NOUN
bjp-80949	411	43	f	f	X
bjp-80949	411	44	,	,	PUNCT
bjp-80949	411	45	eberhardt	eberhardt	PROPN
bjp-80949	411	46	w	w	PROPN
bjp-80949	411	47	,	,	PUNCT
bjp-80949	411	48	goddemeier	goddemei	ADJ
bjp-80949	411	49	t	t	PROPN
bjp-80949	411	50	,	,	PUNCT
bjp-80949	411	51	emig	emig	PROPN
bjp-80949	411	52	m	m	PROPN
bjp-80949	411	53	,	,	PUNCT
bjp-80949	411	54	gatzemeier	gatzemei	ADJ
bjp-80949	411	55	u	u	NOUN
bjp-80949	411	56	;	;	PUNCT
bjp-80949	411	57	flex	flex	ADJ
bjp-80949	411	58	study	study	NOUN
bjp-80949	411	59	team	team	NOUN
bjp-80949	411	60	.	.	PUNCT
bjp-80949	412	1	cetuximab	cetuximab	NOUN
bjp-80949	412	2	plus	plus	CCONJ
bjp-80949	412	3	chemotherapy	chemotherapy	NOUN
bjp-80949	412	4	in	in	ADP
bjp-80949	412	5	patients	patient	NOUN
bjp-80949	412	6	with	with	ADP
bjp-80949	412	7	advanced	advanced	ADJ
bjp-80949	412	8	non	non	ADJ
bjp-80949	412	9	-	-	ADJ
bjp-80949	412	10	small	small	ADJ
bjp-80949	412	11	-	-	PUNCT
bjp-80949	412	12	cell	cell	NOUN
bjp-80949	412	13	lung	lung	NOUN
bjp-80949	412	14	cancer	cancer	NOUN
bjp-80949	412	15	(	(	PUNCT
bjp-80949	412	16	flex	flex	ADJ
bjp-80949	412	17	):	):	PUNCT
bjp-80949	412	18	an	an	DET
bjp-80949	412	19	open	open	ADJ
bjp-80949	412	20	-	-	PUNCT
bjp-80949	412	21	label	label	NOUN
bjp-80949	412	22	randomised	randomise	VERB
bjp-80949	412	23	phase	phase	NOUN
bjp-80949	412	24	iii	iii	NOUN
bjp-80949	412	25	trial	trial	NOUN
bjp-80949	412	26	.	.	PUNCT
bjp-80949	413	1	lancet	lancet	PROPN
bjp-80949	413	2	2009	2009	NUM
bjp-80949	413	3	;	;	PUNCT
bjp-80949	413	4	373	373	NUM
bjp-80949	413	5	:	:	SYM
bjp-80949	413	6	1525	1525	NUM
bjp-80949	413	7	-	-	SYM
bjp-80949	413	8	31	31	NUM
bjp-80949	413	9	.	.	PUNCT
bjp-80949	414	1	prewett	prewett	PROPN
bjp-80949	414	2	m	m	PROPN
bjp-80949	414	3	,	,	PUNCT
bjp-80949	414	4	rockwell	rockwell	VERB
bjp-80949	414	5	p	p	PRON
bjp-80949	414	6	,	,	PUNCT
bjp-80949	414	7	rockwell	rockwell	PROPN
bjp-80949	414	8	rf	rf	PROPN
bjp-80949	414	9	,	,	PUNCT
bjp-80949	414	10	giorgio	giorgio	PROPN
bjp-80949	414	11	na	na	PROPN
bjp-80949	414	12	,	,	PUNCT
bjp-80949	414	13	mendelsohn	mendelsohn	PROPN
bjp-80949	414	14	j	j	PROPN
bjp-80949	414	15	,	,	PUNCT
bjp-80949	414	16	scher	scher	PROPN
bjp-80949	414	17	hi	hi	PROPN
bjp-80949	414	18	,	,	PUNCT
bjp-80949	414	19	goldstein	goldstein	PROPN
bjp-80949	414	20	ni	ni	PROPN
bjp-80949	414	21	.	.	PUNCT
bjp-80949	415	1	the	the	DET
bjp-80949	415	2	biologic	biologic	NOUN
bjp-80949	415	3	effects	effect	NOUN
bjp-80949	415	4	of	of	ADP
bjp-80949	415	5	c225	c225	PROPN
bjp-80949	415	6	,	,	PUNCT
bjp-80949	415	7	a	a	DET
bjp-80949	415	8	chimeric	chimeric	ADJ
bjp-80949	415	9	monoclonal	monoclonal	NOUN
bjp-80949	415	10	antibody	antibody	NOUN
bjp-80949	415	11	to	to	ADP
bjp-80949	415	12	the	the	DET
bjp-80949	415	13	egfr	egfr	NOUN
bjp-80949	415	14	,	,	PUNCT
bjp-80949	415	15	on	on	ADP
bjp-80949	415	16	human	human	ADJ
bjp-80949	415	17	prostate	prostate	NOUN
bjp-80949	415	18	carcinoma	carcinoma	NOUN
bjp-80949	415	19	.	.	PUNCT
bjp-80949	416	1	j	j	PROPN
bjp-80949	416	2	immunother	immunother	ADJ
bjp-80949	416	3	emphasis	emphasis	NOUN
bjp-80949	416	4	tumor	tumor	NOUN
bjp-80949	416	5	immunol	immunol	NOUN
bjp-80949	416	6	.	.	PUNCT
bjp-80949	416	7	1996	1996	NUM
bjp-80949	416	8	;	;	PUNCT
bjp-80949	416	9	19	19	NUM
bjp-80949	416	10	:	:	SYM
bjp-80949	416	11	419	419	NUM
bjp-80949	416	12	-	-	SYM
bjp-80949	416	13	27	27	NUM
bjp-80949	416	14	.	.	PUNCT
bjp-80949	417	1	radonic	radonic	ADJ
bjp-80949	417	2	a	a	PRON
bjp-80949	417	3	,	,	PUNCT
bjp-80949	417	4	milos	milos	PROPN
bjp-80949	417	5	m	m	PROPN
bjp-80949	417	6	,	,	PUNCT
bjp-80949	417	7	chemical	chemical	NOUN
bjp-80949	417	8	composition	composition	NOUN
bjp-80949	417	9	and	and	CCONJ
bjp-80949	417	10	in	in	ADP
bjp-80949	417	11	vitro	vitro	X
bjp-80949	417	12	evaluation	evaluation	NOUN
bjp-80949	417	13	of	of	ADP
bjp-80949	417	14	antioxidant	antioxidant	ADJ
bjp-80949	417	15	effect	effect	NOUN
bjp-80949	417	16	of	of	ADP
bjp-80949	417	17	free	free	ADJ
bjp-80949	417	18	volatile	volatile	ADJ
bjp-80949	417	19	compounds	compound	NOUN
bjp-80949	417	20	from	from	ADP
bjp-80949	417	21	satureja	satureja	PROPN
bjp-80949	417	22	montana	montana	PROPN
bjp-80949	417	23	l.	l.	PROPN
bjp-80949	417	24	free	free	PROPN
bjp-80949	417	25	radic	radic	PROPN
bjp-80949	417	26	res	re	NOUN
bjp-80949	417	27	.	.	PROPN
bjp-80949	417	28	2003	2003	NUM
bjp-80949	417	29	;	;	PUNCT
bjp-80949	417	30	37	37	NUM
bjp-80949	417	31	:	:	PUNCT
bjp-80949	417	32	673	673	NUM
bjp-80949	417	33	-	-	SYM
bjp-80949	417	34	79	79	NUM
bjp-80949	417	35	.	.	PUNCT
bjp-80949	418	1	rattanachaikunsopon	rattanachaikunsopon	PROPN
bjp-80949	418	2	p	p	X
bjp-80949	418	3	,	,	PUNCT
bjp-80949	418	4	phumkhachorn	phumkhachorn	ADJ
bjp-80949	418	5	p.	p.	NOUN
bjp-80949	418	6	assessment	assessment	NOUN
bjp-80949	418	7	of	of	ADP
bjp-80949	418	8	factors	factor	NOUN
bjp-80949	418	9	influencing	influence	VERB
bjp-80949	418	10	antimicrobial	antimicrobial	ADJ
bjp-80949	418	11	activity	activity	NOUN
bjp-80949	418	12	of	of	ADP
bjp-80949	418	13	carvacrol	carvacrol	NOUN
bjp-80949	418	14	and	and	CCONJ
bjp-80949	418	15	cymene	cymene	NOUN
bjp-80949	418	16	against	against	ADP
bjp-80949	418	17	vibrio	vibrio	ADJ
bjp-80949	418	18	cholerae	cholerae	NOUN
bjp-80949	418	19	in	in	ADP
bjp-80949	418	20	food	food	NOUN
bjp-80949	418	21	.	.	PUNCT
bjp-80949	419	1	j	j	PROPN
bjp-80949	419	2	biosci	biosci	PROPN
bjp-80949	419	3	bioeng	bioeng	PROPN
bjp-80949	419	4	.	.	PROPN
bjp-80949	419	5	2010	2010	NUM
bjp-80949	419	6	;	;	PUNCT
bjp-80949	419	7	110	110	NUM
bjp-80949	419	8	:	:	PUNCT
bjp-80949	419	9	614	614	NUM
bjp-80949	419	10	-	-	SYM
bjp-80949	419	11	19	19	NUM
bjp-80949	419	12	.	.	PUNCT
bjp-80949	420	1	bangladesh	bangladesh	PROPN
bjp-80949	420	2	j	j	PROPN
bjp-80949	420	3	pharmacol	pharmacol	PROPN
bjp-80949	420	4	2025	2025	NUM
bjp-80949	420	5	;	;	PUNCT
bjp-80949	420	6	20	20	NUM
bjp-80949	420	7	:	:	SYM
bjp-80949	420	8	22	22	NUM
bjp-80949	420	9	-	-	SYM
bjp-80949	420	10	34	34	NUM
bjp-80949	420	11	33	33	NUM
bjp-80949	420	12	author	author	NOUN
bjp-80949	420	13	info	info	NOUN
bjp-80949	420	14	ayse	ayse	PROPN
bjp-80949	420	15	erdogan	erdogan	PROPN
bjp-80949	420	16	(	(	PUNCT
bjp-80949	420	17	principal	principal	ADJ
bjp-80949	420	18	contact	contact	NOUN
bjp-80949	420	19	)	)	PUNCT
bjp-80949	420	20	e	e	NOUN
bjp-80949	420	21	-	-	NOUN
bjp-80949	420	22	mail	mail	NOUN
bjp-80949	420	23	:	:	PUNCT
bjp-80949	420	24	ayse.erdogan@alanya.edu.tr	ayse.erdogan@alanya.edu.tr	PROPN
bjp-80949	420	25	ravishankar	ravishankar	PROPN
bjp-80949	420	26	s	s	PROPN
bjp-80949	420	27	,	,	PUNCT
bjp-80949	420	28	zhu	zhu	PROPN
bjp-80949	420	29	l	l	NOUN
bjp-80949	420	30	,	,	PUNCT
bjp-80949	420	31	reyna	reyna	NOUN
bjp-80949	420	32	-	-	NOUN
bjp-80949	420	33	granados	granados	PROPN
bjp-80949	420	34	j	j	PROPN
bjp-80949	420	35	,	,	PUNCT
bjp-80949	420	36	law	law	PROPN
bjp-80949	420	37	b	b	PROPN
bjp-80949	420	38	,	,	PUNCT
bjp-80949	420	39	joens	joens	PROPN
bjp-80949	420	40	l	l	PROPN
bjp-80949	420	41	,	,	PUNCT
bjp-80949	420	42	friedman	friedman	PROPN
bjp-80949	420	43	m.	m.	PROPN
bjp-80949	420	44	carvacrol	carvacrol	PROPN
bjp-80949	420	45	and	and	CCONJ
bjp-80949	420	46	cinnamaldehyde	cinnamaldehyde	NOUN
bjp-80949	420	47	inactivate	inactivate	VERB
bjp-80949	420	48	antibiotic	antibiotic	ADJ
bjp-80949	420	49	-	-	PUNCT
bjp-80949	420	50	resistant	resistant	ADJ
bjp-80949	420	51	salmonella	salmonella	NOUN
bjp-80949	420	52	enterica	enterica	ADV
bjp-80949	420	53	in	in	ADP
bjp-80949	420	54	buffer	buffer	NOUN
bjp-80949	420	55	and	and	CCONJ
bjp-80949	420	56	on	on	ADP
bjp-80949	420	57	celery	celery	NOUN
bjp-80949	420	58	and	and	CCONJ
bjp-80949	420	59	oysters	oyster	NOUN
bjp-80949	420	60	.	.	PUNCT
bjp-80949	421	1	j	j	PROPN
bjp-80949	421	2	food	food	PROPN
bjp-80949	421	3	prot	prot	NOUN
bjp-80949	421	4	.	.	PUNCT
bjp-80949	422	1	2010	2010	NUM
bjp-80949	422	2	;	;	PUNCT
bjp-80949	422	3	73	73	NUM
bjp-80949	422	4	:	:	SYM
bjp-80949	422	5	234	234	NUM
bjp-80949	422	6	-	-	SYM
bjp-80949	422	7	40	40	NUM
bjp-80949	422	8	.	.	PUNCT
bjp-80949	423	1	rivas	rivas	PROPN
bjp-80949	423	2	l	l	PROPN
bjp-80949	423	3	,	,	PUNCT
bjp-80949	423	4	mcdonnell	mcdonnell	PROPN
bjp-80949	423	5	mj	mj	PROPN
bjp-80949	423	6	,	,	PUNCT
bjp-80949	423	7	burgess	burgess	PROPN
bjp-80949	423	8	cm	cm	PROPN
bjp-80949	423	9	,	,	PUNCT
bjp-80949	423	10	o'brien	o'brien	PROPN
bjp-80949	423	11	m	m	PROPN
bjp-80949	423	12	,	,	PUNCT
bjp-80949	423	13	navarro	navarro	PROPN
bjp-80949	423	14	-	-	PUNCT
bjp-80949	423	15	villa	villa	PROPN
bjp-80949	423	16	a	a	NOUN
bjp-80949	423	17	,	,	PUNCT
bjp-80949	423	18	fanning	fan	VERB
bjp-80949	423	19	s	s	PROPN
bjp-80949	423	20	,	,	PUNCT
bjp-80949	423	21	duffy	duffy	PROPN
bjp-80949	423	22	g.	g.	PROPN
bjp-80949	423	23	inhibition	inhibition	NOUN
bjp-80949	423	24	of	of	ADP
bjp-80949	423	25	verocytotoxigenic	verocytotoxigenic	ADJ
bjp-80949	423	26	escherichia	escherichia	NOUN
bjp-80949	423	27	coli	coli	NOUN
bjp-80949	423	28	in	in	ADP
bjp-80949	423	29	model	model	NOUN
bjp-80949	423	30	broth	broth	NOUN
bjp-80949	423	31	and	and	CCONJ
bjp-80949	423	32	rumen	ruman	NOUN
bjp-80949	423	33	systems	system	NOUN
bjp-80949	423	34	by	by	ADP
bjp-80949	423	35	carvacrol	carvacrol	NOUN
bjp-80949	423	36	and	and	CCONJ
bjp-80949	423	37	thymol	thymol	PROPN
bjp-80949	423	38	.	.	PUNCT
bjp-80949	424	1	int	int	PROPN
bjp-80949	424	2	j	j	PROPN
bjp-80949	424	3	food	food	PROPN
bjp-80949	424	4	microbiol	microbiol	PROPN
bjp-80949	424	5	.	.	PUNCT
bjp-80949	425	1	2010	2010	NUM
bjp-80949	425	2	;	;	PUNCT
bjp-80949	425	3	139	139	NUM
bjp-80949	425	4	:	:	SYM
bjp-80949	425	5	70	70	NUM
bjp-80949	425	6	-	-	SYM
bjp-80949	425	7	78	78	NUM
bjp-80949	425	8	.	.	PUNCT
bjp-80949	426	1	subak	subak	PROPN
bjp-80949	426	2	m	m	PROPN
bjp-80949	426	3	,	,	PUNCT
bjp-80949	426	4	aksel	aksel	PROPN
bjp-80949	426	5	n	n	CCONJ
bjp-80949	426	6	,	,	PUNCT
bjp-80949	426	7	kılıç	kılıç	PROPN
bjp-80949	426	8	oztürk	oztürk	PROPN
bjp-80949	426	9	y.	y.	PROPN
bjp-80949	426	10	incidence	incidence	PROPN
bjp-80949	426	11	of	of	ADP
bjp-80949	426	12	anemia	anemia	NOUN
bjp-80949	426	13	in	in	ADP
bjp-80949	426	14	cases	case	NOUN
bjp-80949	426	15	with	with	ADP
bjp-80949	426	16	lung	lung	NOUN
bjp-80949	426	17	cancer	cancer	NOUN
bjp-80949	426	18	at	at	ADP
bjp-80949	426	19	the	the	DET
bjp-80949	426	20	time	time	NOUN
bjp-80949	426	21	of	of	ADP
bjp-80949	426	22	diagnosis	diagnosis	NOUN
bjp-80949	426	23	and	and	CCONJ
bjp-80949	426	24	relation	relation	NOUN
bjp-80949	426	25	between	between	ADP
bjp-80949	426	26	cancer	cancer	NOUN
bjp-80949	426	27	types	type	NOUN
bjp-80949	426	28	.	.	PUNCT
bjp-80949	427	1	forbes	forbes	PROPN
bjp-80949	427	2	j	j	PROPN
bjp-80949	427	3	med	med	PROPN
bjp-80949	427	4	.	.	PUNCT
bjp-80949	427	5	2020	2020	NUM
bjp-80949	427	6	;	;	PUNCT
bjp-80949	427	7	1	1	NUM
bjp-80949	427	8	:	:	SYM
bjp-80949	427	9	11	11	NUM
bjp-80949	427	10	-	-	SYM
bjp-80949	427	11	14	14	NUM
bjp-80949	427	12	.	.	PUNCT
bjp-80949	428	1	ultee	ultee	VERB
bjp-80949	428	2	a	a	PRON
bjp-80949	428	3	,	,	PUNCT
bjp-80949	428	4	kets	kets	PROPN
bjp-80949	428	5	epw	epw	PROPN
bjp-80949	428	6	,	,	PUNCT
bjp-80949	428	7	smid	smid	PROPN
bjp-80949	428	8	ej	ej	PROPN
bjp-80949	428	9	.	.	PROPN
bjp-80949	428	10	mechanisms	mechanism	NOUN
bjp-80949	428	11	of	of	ADP
bjp-80949	428	12	action	action	NOUN
bjp-80949	428	13	of	of	ADP
bjp-80949	428	14	carvacrol	carvacrol	NOUN
bjp-80949	428	15	on	on	ADP
bjp-80949	428	16	the	the	DET
bjp-80949	428	17	food	food	NOUN
bjp-80949	428	18	-	-	PUNCT
bjp-80949	428	19	borne	bear	VERB
bjp-80949	428	20	pathogen	pathogen	NOUN
bjp-80949	428	21	bacillus	bacillus	NOUN
bjp-80949	428	22	cereus	cereus	NOUN
bjp-80949	428	23	.	.	PUNCT
bjp-80949	429	1	appl	appl	PROPN
bjp-80949	429	2	environ	environ	PROPN
bjp-80949	429	3	microbiol	microbiol	PROPN
bjp-80949	429	4	.	.	PUNCT
bjp-80949	430	1	1999	1999	NUM
bjp-80949	430	2	;	;	PUNCT
bjp-80949	430	3	65	65	NUM
bjp-80949	430	4	:	:	SYM
bjp-80949	430	5	4606	4606	NUM
bjp-80949	430	6	-	-	SYM
bjp-80949	430	7	10	10	NUM
bjp-80949	430	8	.	.	PUNCT
bjp-80949	431	1	veale	veale	NOUN
bjp-80949	431	2	d	d	PROPN
bjp-80949	431	3	,	,	PUNCT
bjp-80949	431	4	ashcroft	ashcroft	PROPN
bjp-80949	431	5	t	t	PROPN
bjp-80949	431	6	,	,	PUNCT
bjp-80949	431	7	marsh	marsh	PROPN
bjp-80949	431	8	c	c	PROPN
bjp-80949	431	9	,	,	PUNCT
bjp-80949	431	10	gibson	gibson	PROPN
bjp-80949	431	11	gj	gj	PROPN
bjp-80949	431	12	,	,	PUNCT
bjp-80949	431	13	harris	harris	PROPN
bjp-80949	431	14	al	al	PROPN
bjp-80949	431	15	.	.	PROPN
bjp-80949	431	16	epidermal	epidermal	ADJ
bjp-80949	431	17	growth	growth	NOUN
bjp-80949	431	18	factor	factor	NOUN
bjp-80949	431	19	receptors	receptor	NOUN
bjp-80949	431	20	in	in	ADP
bjp-80949	431	21	non	non	ADJ
bjp-80949	431	22	-	-	ADJ
bjp-80949	431	23	small	small	ADJ
bjp-80949	431	24	cell	cell	NOUN
bjp-80949	431	25	lung	lung	NOUN
bjp-80949	431	26	cancer	cancer	NOUN
bjp-80949	431	27	.	.	PUNCT
bjp-80949	432	1	br	br	PROPN
bjp-80949	432	2	j	j	PROPN
bjp-80949	432	3	cancer	cancer	NOUN
bjp-80949	432	4	.	.	PUNCT
bjp-80949	433	1	1987	1987	NUM
bjp-80949	433	2	;	;	PUNCT
bjp-80949	434	1	55	55	NUM
bjp-80949	434	2	:	:	SYM
bjp-80949	434	3	513	513	NUM
bjp-80949	434	4	-	-	SYM
bjp-80949	434	5	16	16	NUM
bjp-80949	434	6	.	.	PUNCT
bjp-80949	434	7	weichselbaum	weichselbaum	PROPN
bjp-80949	434	8	rr	rr	PROPN
bjp-80949	434	9	,	,	PUNCT
bjp-80949	434	10	dunphy	dunphy	PROPN
bjp-80949	434	11	ej	ej	PROPN
bjp-80949	434	12	,	,	PUNCT
bjp-80949	434	13	beckett	beckett	PROPN
bjp-80949	434	14	ma	ma	PROPN
bjp-80949	434	15	,	,	PUNCT
bjp-80949	434	16	tybor	tybor	PROPN
bjp-80949	434	17	ag	ag	PROPN
bjp-80949	434	18	,	,	PUNCT
bjp-80949	434	19	moran	moran	PROPN
bjp-80949	434	20	wj	wj	PROPN
bjp-80949	434	21	,	,	PUNCT
bjp-80949	434	22	goldman	goldman	PROPN
bjp-80949	434	23	me	i	PRON
bjp-80949	434	24	,	,	PUNCT
bjp-80949	434	25	vokes	vokes	PROPN
bjp-80949	434	26	ee	ee	PROPN
bjp-80949	434	27	,	,	PUNCT
bjp-80949	434	28	panje	panje	PROPN
bjp-80949	434	29	wr	wr	PROPN
bjp-80949	434	30	.	.	PUNCT
bjp-80949	434	31	epidermal	epidermal	ADJ
bjp-80949	434	32	growth	growth	NOUN
bjp-80949	434	33	factor	factor	NOUN
bjp-80949	434	34	receptor	receptor	NOUN
bjp-80949	434	35	gene	gene	NOUN
bjp-80949	434	36	amplification	amplification	NOUN
bjp-80949	434	37	and	and	CCONJ
bjp-80949	434	38	expression	expression	NOUN
bjp-80949	434	39	in	in	ADP
bjp-80949	434	40	head	head	NOUN
bjp-80949	434	41	and	and	CCONJ
bjp-80949	434	42	neck	neck	NOUN
bjp-80949	434	43	cancer	cancer	NOUN
bjp-80949	434	44	cell	cell	NOUN
bjp-80949	434	45	lines	line	NOUN
bjp-80949	434	46	.	.	PUNCT
bjp-80949	435	1	head	head	NOUN
bjp-80949	435	2	neck	neck	NOUN
bjp-80949	435	3	.	.	PUNCT
bjp-80949	436	1	1989	1989	NUM
bjp-80949	436	2	;	;	PUNCT
bjp-80949	436	3	11	11	NUM
bjp-80949	436	4	:	:	SYM
bjp-80949	436	5	437	437	NUM
bjp-80949	436	6	-	-	SYM
bjp-80949	436	7	42	42	NUM
bjp-80949	436	8	.	.	PUNCT
bjp-80949	437	1	wu	wu	PROPN
bjp-80949	437	2	x	x	PROPN
bjp-80949	437	3	,	,	PUNCT
bjp-80949	437	4	fan	fan	PROPN
bjp-80949	437	5	z	z	PROPN
bjp-80949	437	6	,	,	PUNCT
bjp-80949	437	7	masui	masui	NOUN
bjp-80949	437	8	h	h	NOUN
bjp-80949	437	9	,	,	PUNCT
bjp-80949	437	10	rosen	rosen	PROPN
bjp-80949	437	11	n	n	AUX
bjp-80949	437	12	,	,	PUNCT
bjp-80949	437	13	mendelsohn	mendelsohn	PROPN
bjp-80949	437	14	j.	j.	PROPN
bjp-80949	437	15	apoptosis	apoptosis	PROPN
bjp-80949	437	16	induced	induce	VERB
bjp-80949	437	17	by	by	ADP
bjp-80949	437	18	an	an	DET
bjp-80949	437	19	antiepidermal	antiepidermal	ADJ
bjp-80949	437	20	growth	growth	NOUN
bjp-80949	437	21	factor	factor	NOUN
bjp-80949	437	22	receptor	receptor	NOUN
bjp-80949	437	23	monoclonal	monoclonal	NOUN
bjp-80949	437	24	antibody	antibody	NOUN
bjp-80949	437	25	in	in	ADP
bjp-80949	437	26	a	a	DET
bjp-80949	437	27	human	human	ADJ
bjp-80949	437	28	colorectal	colorectal	ADJ
bjp-80949	437	29	carcinoma	carcinoma	NOUN
bjp-80949	437	30	cell	cell	NOUN
bjp-80949	437	31	line	line	NOUN
bjp-80949	437	32	and	and	CCONJ
bjp-80949	437	33	its	its	PRON
bjp-80949	437	34	delay	delay	NOUN
bjp-80949	437	35	by	by	ADP
bjp-80949	437	36	insulin	insulin	NOUN
bjp-80949	437	37	.	.	PUNCT
bjp-80949	438	1	j	j	PROPN
bjp-80949	438	2	clin	clin	PROPN
bjp-80949	438	3	invest	invest	PROPN
bjp-80949	438	4	.	.	PUNCT
bjp-80949	439	1	1995	1995	NUM
bjp-80949	439	2	;	;	PUNCT
bjp-80949	439	3	95	95	NUM
bjp-80949	439	4	:	:	SYM
bjp-80949	439	5	1897	1897	NUM
bjp-80949	439	6	-	-	SYM
bjp-80949	439	7	905	905	NUM
bjp-80949	439	8	.	.	PUNCT
bjp-80949	440	1	yaman	yaman	PROPN
bjp-80949	440	2	s	s	PROPN
bjp-80949	440	3	,	,	PUNCT
bjp-80949	440	4	ozdemir	ozdemir	PROPN
bjp-80949	440	5	z	z	PROPN
bjp-80949	440	6	,	,	PUNCT
bjp-80949	440	7	sit	sit	VERB
bjp-80949	440	8	m	m	PRON
bjp-80949	440	9	,	,	PUNCT
bjp-80949	440	10	ozer	ozer	PROPN
bjp-80949	440	11	b	b	PROPN
bjp-80949	440	12	,	,	PUNCT
bjp-80949	440	13	catal	catal	ADJ
bjp-80949	440	14	o.	o.	PROPN
bjp-80949	440	15	kekik	kekik	PROPN
bjp-80949	440	16	yagı	yagı	PROPN
bjp-80949	440	17	karvakrolun	karvakrolun	PROPN
bjp-80949	441	1	insan	insan	PROPN
bjp-80949	441	2	saglıgına	saglıgına	PROPN
bjp-80949	441	3	etkileri	etkileri	PROPN
bjp-80949	441	4	.	.	PUNCT
bjp-80949	442	1	setsci	setsci	PROPN
bjp-80949	442	2	conference	conference	NOUN
bjp-80949	442	3	indexing	indexing	NOUN
bjp-80949	442	4	system	system	NOUN
bjp-80949	442	5	.	.	PUNCT
bjp-80949	443	1	2018	2018	NUM
bjp-80949	443	2	;	;	PUNCT
bjp-80949	443	3	2	2	NUM
bjp-80949	443	4	:	:	SYM
bjp-80949	443	5	391	391	NUM
bjp-80949	443	6	-	-	SYM
bjp-80949	443	7	92	92	NUM
bjp-80949	443	8	.	.	PUNCT
bjp-80949	444	1	yasui	yasui	PROPN
bjp-80949	444	2	w	w	PROPN
bjp-80949	444	3	,	,	PUNCT
bjp-80949	444	4	sumiyoshi	sumiyoshi	PROPN
bjp-80949	444	5	h	h	PROPN
bjp-80949	444	6	,	,	PUNCT
bjp-80949	444	7	hata	hata	PROPN
bjp-80949	444	8	j	j	PROPN
bjp-80949	444	9	,	,	PUNCT
bjp-80949	444	10	kameda	kameda	PROPN
bjp-80949	444	11	t	t	PROPN
bjp-80949	444	12	,	,	PUNCT
bjp-80949	444	13	ochiai	ochiai	PROPN
bjp-80949	444	14	a	a	X
bjp-80949	444	15	,	,	PUNCT
bjp-80949	444	16	ito	ito	PROPN
bjp-80949	444	17	h	h	PROPN
bjp-80949	444	18	,	,	PUNCT
bjp-80949	444	19	tahara	tahara	ADJ
bjp-80949	444	20	e.	e.	NOUN
bjp-80949	444	21	expression	expression	NOUN
bjp-80949	444	22	of	of	ADP
bjp-80949	444	23	epidermal	epidermal	ADJ
bjp-80949	444	24	growth	growth	NOUN
bjp-80949	444	25	factor	factor	NOUN
bjp-80949	444	26	receptor	receptor	NOUN
bjp-80949	444	27	in	in	ADP
bjp-80949	444	28	human	human	ADJ
bjp-80949	444	29	gastric	gastric	ADJ
bjp-80949	444	30	and	and	CCONJ
bjp-80949	444	31	colonic	colonic	ADJ
bjp-80949	444	32	carcinomas	carcinoma	NOUN
bjp-80949	444	33	.	.	PUNCT
bjp-80949	445	1	cancer	cancer	NOUN
bjp-80949	445	2	res	re	NOUN
bjp-80949	445	3	.	.	PUNCT
bjp-80949	445	4	1988	1988	NUM
bjp-80949	445	5	;	;	PUNCT
bjp-80949	445	6	48	48	NUM
bjp-80949	445	7	:	:	SYM
bjp-80949	445	8	137	137	NUM
bjp-80949	445	9	-	-	SYM
bjp-80949	445	10	41	41	NUM
bjp-80949	445	11	.	.	PUNCT
bjp-80949	446	1	zamani	zamani	PROPN
bjp-80949	446	2	ag	ag	PROPN
bjp-80949	446	3	,	,	PUNCT
bjp-80949	446	4	zamani	zamani	PROPN
bjp-80949	446	5	a.	a.	NOUN
bjp-80949	446	6	mikrorna’lar	mikrorna’lar	PROPN
bjp-80949	446	7	ve	ve	VERB
bjp-80949	446	8	akciger	akciger	ADJ
bjp-80949	446	9	kanseri	kanseri	PROPN
bjp-80949	446	10	.	.	PUNCT
bjp-80949	447	1	tuberk	tuberk	NOUN
bjp-80949	447	2	toraks	torak	NOUN
bjp-80949	447	3	.	.	PUNCT
bjp-80949	448	1	2013	2013	NUM
bjp-80949	448	2	;	;	PUNCT
bjp-80949	448	3	61	61	NUM
bjp-80949	448	4	:	:	SYM
bjp-80949	448	5	57	57	NUM
bjp-80949	448	6	-	-	SYM
bjp-80949	448	7	62	62	NUM
bjp-80949	448	8	.	.	PUNCT
bjp-80949	449	1	zhang	zhang	PROPN
bjp-80949	449	2	l	l	PROPN
bjp-80949	449	3	,	,	PUNCT
bjp-80949	449	4	li	li	PROPN
bjp-80949	449	5	xf	xf	PROPN
bjp-80949	449	6	,	,	PUNCT
bjp-80949	449	7	tand	tand	PROPN
bjp-80949	449	8	l	l	NOUN
bjp-80949	449	9	,	,	PUNCT
bjp-80949	449	10	zhao	zhao	PROPN
bjp-80949	449	11	ym	ym	PROPN
bjp-80949	449	12	,	,	PUNCT
bjp-80949	449	13	zhou	zhou	PROPN
bjp-80949	449	14	cc	cc	PROPN
bjp-80949	449	15	.	.	PUNCT
bjp-80949	450	1	the	the	DET
bjp-80949	450	2	effects	effect	NOUN
bjp-80949	450	3	of	of	ADP
bjp-80949	450	4	cetuximab	cetuximab	NOUN
bjp-80949	450	5	in	in	ADP
bjp-80949	450	6	combination	combination	NOUN
bjp-80949	450	7	with	with	ADP
bjp-80949	450	8	docetaxel	docetaxel	NOUN
bjp-80949	450	9	for	for	ADP
bjp-80949	450	10	the	the	DET
bjp-80949	450	11	acquired	acquire	VERB
bjp-80949	450	12	resistance	resistance	NOUN
bjp-80949	450	13	to	to	ADP
bjp-80949	450	14	egfr	egfr	NOUN
bjp-80949	450	15	-	-	PUNCT
bjp-80949	450	16	tki	tki	PROPN
bjp-80949	450	17	in	in	ADP
bjp-80949	450	18	non	non	ADJ
bjp-80949	450	19	-	-	ADJ
bjp-80949	450	20	small	small	ADJ
bjp-80949	450	21	cell	cell	NOUN
bjp-80949	450	22	lung	lung	NOUN
bjp-80949	450	23	cancer	cancer	NOUN
bjp-80949	450	24	cells	cell	NOUN
bjp-80949	450	25	.	.	PUNCT
bjp-80949	451	1	tumor	tumor	NOUN
bjp-80949	451	2	.	.	PUNCT
bjp-80949	452	1	2014	2014	NUM
bjp-80949	452	2	;	;	PUNCT
bjp-80949	452	3	34	34	NUM
bjp-80949	452	4	:	:	PUNCT
bjp-80949	452	5	584	584	NUM
bjp-80949	452	6	-	-	SYM
bjp-80949	452	7	90	90	NUM
bjp-80949	452	8	.	.	PUNCT
bjp-80949	453	1	zhu	zhu	PROPN
bjp-80949	454	1	q	q	X
bjp-80949	454	2	,	,	PUNCT
bjp-80949	454	3	zhang	zhang	PROPN
bjp-80949	454	4	r	r	PROPN
bjp-80949	454	5	,	,	PUNCT
bjp-80949	454	6	gu	gu	NOUN
bjp-80949	454	7	x	x	PROPN
bjp-80949	454	8	,	,	PUNCT
bjp-80949	454	9	zhao	zhao	PROPN
bjp-80949	454	10	z	z	PROPN
bjp-80949	454	11	,	,	PUNCT
bjp-80949	454	12	gao	gao	PROPN
bjp-80949	454	13	q	q	PROPN
bjp-80949	454	14	,	,	PUNCT
bjp-80949	454	15	chen	chen	PROPN
bjp-80949	454	16	m	m	PROPN
bjp-80949	454	17	,	,	PUNCT
bjp-80949	454	18	wu	wu	PROPN
bjp-80949	454	19	q	q	PROPN
bjp-80949	454	20	,	,	PUNCT
bjp-80949	454	21	xie	xie	PROPN
bjp-80949	454	22	t	t	PROPN
bjp-80949	454	23	,	,	PUNCT
bjp-80949	454	24	sui	sui	PROPN
bjp-80949	454	25	x.	x.	PROPN
bjp-80949	454	26	honokiol	honokiol	PROPN
bjp-80949	454	27	enhances	enhance	VERB
bjp-80949	454	28	the	the	DET
bjp-80949	454	29	sensitivity	sensitivity	NOUN
bjp-80949	454	30	of	of	ADP
bjp-80949	454	31	cetuximab	cetuximab	NOUN
bjp-80949	454	32	in	in	ADP
bjp-80949	454	33	krasg13d	krasg13d	NOUN
bjp-80949	454	34	mutant	mutant	VERB
bjp-80949	454	35	colorectal	colorectal	ADJ
bjp-80949	454	36	cancer	cancer	NOUN
bjp-80949	454	37	through	through	ADP
bjp-80949	454	38	destroying	destroy	VERB
bjp-80949	454	39	snx3	snx3	ADJ
bjp-80949	454	40	-	-	PUNCT
bjp-80949	454	41	retromer	retromer	NOUN
bjp-80949	454	42	complex	complex	NOUN
bjp-80949	454	43	.	.	PUNCT
bjp-80949	455	1	theranostics	theranostic	NOUN
bjp-80949	455	2	2024	2024	NUM
bjp-80949	455	3	;	;	PUNCT
bjp-80949	455	4	14	14	NUM
bjp-80949	455	5	:	:	SYM
bjp-80949	455	6	5443	5443	NUM
bjp-80949	455	7	-	-	SYM
bjp-80949	455	8	60	60	NUM
bjp-80949	455	9	.	.	PUNCT
bjp-80949	456	1	34	34	NUM
bjp-80949	456	2	bangladesh	bangladesh	PROPN
bjp-80949	456	3	j	j	PROPN
bjp-80949	456	4	pharmacol	pharmacol	PROPN
bjp-80949	456	5	2025	2025	NUM
bjp-80949	456	6	;	;	PUNCT
bjp-80949	456	7	20	20	NUM
bjp-80949	456	8	:	:	SYM
bjp-80949	456	9	22	22	NUM
bjp-80949	456	10	-	-	SYM
bjp-80949	456	11	34	34	NUM
bjp-80949	456	12	mailto:ayse.erdogan@alanya.edu.tr	mailto:ayse.erdogan@alanya.edu.tr	PROPN